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Abstract
The aim of the research is to examine socio-historically the medical scientific disputes
relating to the so-called prion disease including scrapie, bovine spongiform
encephalopathy (BSE), transmissible mink encephalopathy (TME), chronic wasting
disease, kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker
(GSS) and fatal familial insomnia. BSE and new variant CJD have become the subject
of increasing debate and controversy involving many different professional and non¬
professional groups. Some scientists have launched large projects to examine the
nature of the fatal disease since the 1960s by studying a prototype of mad cow
disease, scrapie in sheep. While there are many different hypotheses regarding the
cause of scrapie, BSE and new variant CJD, currently the majority of scientists accept
a hypothesis called "prion theory". Prion theorists claim that the disease is caused by
abnormal proteins that contain no DNA, which has long been regarded as the
blueprint of every single life form. This theory has held centre stage of the severe
controversy, but the scientific community has gradually come to accept the prion
hypothesis. However, some researchers still do not agree with this view. To
understand these contemporary circumstances necessitate an examination of the
history of scientific disputes relating scrapie, and this research will analyse how
competing hypotheses have achieved and lost credibility within the scientific
community and wider arenas.
This research has three major aims. Firstly, it shows the history of scrapie research in
the context of development of biomedicine in the twentieth century. The
development of scrapie research corresponded with on-going institutional changes
in British and later American biomedicine. Secondly, this research examines the
relations between scientific practice and wider social transformations which have
been closely associated with the development of scientific knowledge. In particular,
the development of molecular biology and biotechnological enterprise has played a
vital role in building consensus around so-called prion research. Thirdly, this work
builds on an appropriate methodological framework from within the sociologically
viii
informed history of medicine, which has shown that medical scientific knowledge
can be analysed in ways similar to the analysis of other social beliefs and knowledge
systems. This work aims to contribute to that well-established tradition of social




Chapter 1 - Introduction
On 6 October 1997, the Nobel Assembly at the Karolinska Institute announced
the award of the Nobel Prize in Physiology or Medicine for 1997 to Stanley Prusiner
for his discovery of "Prions - a new biological principle of infection".1 The Nobel
Committee explained that Prusiner had added prions to the list of well-known
infectious agents including bacteria, viruses, fungi and parasites. According to
Prusiner, a prion is not a virus or a bacterium, but a protein devoid of nucleic acids
and RNA. Prions were held to be responsible for a category of diseases that has
become known as transmissible spongiform encephalopathies (TSEs) or prion
diseases, including scrapie (sheep and goats), bovine spongiform encephalopathy
(known as BSE or mad cow disease of cattle), transmissible mink encephalopathy
(mink), chronic wasting disease (deer), kuru (humans), Creutzfeldt-Jakob Disease
(humans), Gerstmann-Straussler-Scheinker disease (humans) and fatal familial
insomnia (humans). After Prusiner suggested his novel theory of infection in Science
in 1982,2 the scientific community entered a long period of controversy. The prion
theory was denounced by many scientists as "heretical", because it suggested that
the agent was proteinaceous in nature; it was therefore seen as a direct challenge to
the conventional wisdom of molecular biology, according to which only nucleic acids
could embody and transfer information. Subsequently, influential sections of the
wider scientific community gradually accepted Prusiner's once heretical idea.
Nevertheless, throughout the 1980s and 1990s, the two opposite parties of scientists
failed to reach agreement on the meaning of their scientific results.
In this context, the Nobel committee's decision seemed to put an end to the
twenty-year controversy. Although the award of the Nobel Prize to Prusiner implied
that the scientific community had finally endorsed his idea of the prion, the
1 Karolinska Institute (1997) 'The Nobel Assembly at the Karolinska Institute has today
decided to award the Nobel Prize in Physiology or medicine for 1997 to Stanley B. Prusiner',
Press Release (6 October 1997)




endorsement was by no means universal. Prusiner's winning of the Nobel Prize was
not enough to change the prion sceptic's mind. The sceptics have claimed that the
infectious agent is not a totally new biological entity, and that there is strong
evidence that the agent contains conventional genetic information. For two decades,
the two opposing camps have launched countless complicated and sophisticated
experiments in order to prove their theoretical arguments. Despite impressive
experimental accomplishments on the part of each of the two camps, they failed to
reach agreement on the nature of the infectious agent. Much about this controversial
subject still remains a mystery. Many scientists still believe that fundamental
questions about the nature of the infectious agent remain to be answered
conclusively.
With the 1985 outbreak of BSE, commonly known as mad cow disease, in the UK,
this group of diseases has been in the spotlight of public attention. The BSE outbreak
resulted in the slaughter of about two million cattle, and so far 117 people have
succumbed to new variant CJD.3 This climate of urgency focused scientific and public
attention on Prusiner's controversial theory. All of sudden, a small and minor
scientific endeavour became a major issue in medical and health science. The
outbreak of BSE takes centre stage in various accounts of the history of prions and
prion diseases, including accounts sociologists and historians of medicine. This
should be notable that those sociological and historical approaches on the prion
disease had focused mostly on the prion controversy in the period of the post-BSE
crisis. In particular, many researchers have dealt either with the role of mass media
and government policy in the controversy4 or with broad overview on mad cow
3 Department of Health (2002) 'Monthly Creutzfeldt-Jakob disease statistics', Department of
Health (www.doh.gov.uk/cjd/stats/nov02.htm)
4 Ratzan, S. C., ed. (1998) The Mad Cow Crisis: Health and the Public Good (London, UCL Press);
Gregory, Jane and Steve Miller (1998) Science in Public: communication, culture and credibility
(Cambridge, Mass: Perseus Publishing); Adam, Barbara (2000) 'The media timescapes of BSE
news', Stuart Allen, Barbara Adam, and Cynthia Carter (eds) Environmental Risks and the
Media (London: Routledge): 117-129; Little, Gavin (2001) 'BSE and the regulation of risk' The
Modern Law Review 64: 730-756; Miller, David (1999) 'Risk, science, and policy: definitional
struggles, information management, media and BSE' Social Science and Medicine 49:1239-1255;
Brookes, Rod (1999) 'Newspapers and national identity: the BSE/CJD crisis and the British
Press' Media, Culture & Society 21: 247-263; Jasanoff, S. (1997) 'Civilization and madness: the
great BSE scare of 1996', Public Understanding ofScience 6: 221-232; Seguin, Eve (2000) 'The UK
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disease.5 By contrast, this research deals much more with matters internal to the
scientific research process and community. In other words, the main theme of this
research is to show how researcher in this field conducted their experimental projects
and struggled to construct hypotheses to order to explain experimental results.
Historically, there are records of what is now considered to be a prion disease in
sheep from as far back as 1752. Since the first report of this disease - scrapie - various
groups in Britain and on the Continent have tried to elucidate its cause and nature.
This thesis begins with the long, and relatively unknown history of research on this
mysterious disease. A few words must be said about why the case of scrapie research
has been chosen. Although TSE includes at least seven neurodegenerative diseases,
and each of them has its own history, there are several reasons why scrapie is
significant in this historical study. Firstly, many researchers have regarded the
disease in sheep and goats as the prototype of prion diseases in humans and animals.
Secondly, it has a long history of research, and from the studies, scientists could
make a research model for other diseases. Furthermore, scrapie research is at the
crossroads of several disciplines, including biomedicine, veterinary science, virology,
genetics, microbiology, biochemistry and molecular biology. For these reasons, it can
be said that scrapie research has also encompassed much of modern biology and
biomedicine. It provides good resources for understanding current developments in
biomedicine, including prion research.
Long before the outbreak of BSE in Britain, a handful of scientists were involved
in scrapie research, and had been since the beginning of the twentieth century.
However, the research project was quite basic and primitive until the infectious agent
was transmitted into laboratory animals in 1961. From that point on, two big research
BSE crisis: strengths and weaknesses of existing conceptual approaches', Science and Public
Policy 27 (4): 293-302; Reeves, Carol (2002) 'An orthodox heresy: scientific rhetoric and the
science of prions' Science Communication 24 (1): 98-122; Dressel, Kerstin (2002) BSE-The new
dimension of uncertainty (Berlin: Edition-Sigma)
5 Lacey, Richard (1994) Mad cow disease (Jersey: Cypsela); Fisher, John R. (1997) 'Of plagues
and veterinarians: BSE in historical perspective', Argos 16 (2): 225-233; Fisher, John R. (1998)
'Cattle plagues past and present: the mystery of mad cow disease', Journal of Contemporary
History 33 (2): 215-228; Rhodes, Richard (1997) Deadly Feast: Tracking the Secrets of a Terrifying
New Plague. (New York: Simon & Schuster); Cooke, J. (1998) Cannibals, Cows, and the CJD
Catastrophe (London: Minerva); Schwartz, Maxime (2003) How the cows turned mad (Berkeley
6 Los Angeles: University of California Press)
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institutes in Scotland and England launched large-scale experimental projects to
examine the nature of the disease. To understand the current controversy on mad
cow disease and the nature of prion, it is necessary to review how scientists have
built up the concept of the disease. The history of scrapie research provides an
archetype of current understandings of the nature of the infectious agent of those
diseases.
This thesis comprises two parts: the first part will deal with the early history of
scrapie research and especially its development in the 1960s and 1970s. During that
time, many British scientists constructed various possible models of the nature of the
infectious agent. In particular, a group of researchers in the Institute for Research on
Animal Diseases (IRAD) at Compton, Berkshire, produced a remarkable result, i.e.
that the scrapie agent resisted radiation treatments. From this experiment, the
researchers suggested that the agent did not contain nucleic acids, which have been
thought of as carrying the blue print of all life forms on earth. At the time, scientists
believed that every nucleic acid-containing organism should be inactivated by
radiation treatment. However, the scrapie agent was not inactivated by such
treatment. This could be read as evidence for the absence of nucleic acids. In contrast,
at the same time, a collaborative research team in the Moredun Research Institute
and Animal Breeding Research Organisation (ABRO) in Edinburgh claimed on the
basis of a series of genetic and pathogenetic experiments that although the infectious
agent was very small and had other anomalous properties, nevertheless there was
strong evidence to show that it did in fact have an informational molecule. This
opposing speculation caused a controversy between the two camps during the 1970s.
The two groups of scientists clashed at various conferences and official meetings. The
dispute was not resolved at the time. Instead, the scientific confrontation was
brought to an end not by decisive scientific evidence, but by the intervention of a
governing body, the Agricultural Research Council (ARC). Consequently, this
section of my study of scrapie research mainly endeavours to show how divergent
positions within the controversy were sustained by differences of institutional
traditions and their research cultures and to elucidate the political circumstances that
led to the closure of the dispute.
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The second part deals with scrapie research in the 1980s and 1990s. In particular,
the prion controversy will be the central issue in this part. In 1982, Prusiner's
suggestion of the proteinaceous nature of the agent (implying that the agent might
consist of nothing but protein) caused a long battle between the prion group and its
sceptics. The present study will describe how Prusiner, at that time an unknown
neurologist in San Francisco, formulated the novel idea, which caused such a
controversy in the scientific community, and that came to public prominence with
the outbreak of mad cow disease in Britain. This part of the thesis will also
endeavour to answer the question: how did the prion theory become the mainstream
idea in the field of scrapie research? When Prusiner first put forward his theory in
1982, most scrapie researchers dismissed it as heretical. However, within 20 years he
had gained considerable scientific credibility from fellow scientists and the general
public. Correspondingly, his opponents, the prion sceptics, who were once the
mainstream in this field, had been marginalised. Nevertheless, the two groups
continued to pursue their own research project. For the last twenty years, the
opposing stances have not come to any point of agreement. Although there is a
propensity from time to time for each side to claim to have arrived at so-called
crucial experimental results, the data invariably turn out to be flexible and open to
interpretation. To explain this controversy and its outcome, the present study
considers some situational elements which play a role both in sustaining local
disagreement and in catalysing the process of consensus-building amongst a wider
constituency of fellow scientists and the public. A wide array of factors is involved,
ranging from personal characteristics to structural changes in the social
circumstances surrounding scientific practice. In this study, particular emphasis will
be placed on some social elements which can be seen to be involved in explaining the
controversy.
Running through the two parts of the thesis will be three predominant themes.
The first examines the history of scrapie research in the context of development of
biomedicine in the twentieth century. As I will show, the development of scrapie
research corresponded with on-going institutional changes in British and later
American biomedicine. Scrapie research was initially established through the
5
Introduction
development of veterinary medicine in Britain. The subject went onto the main
research agenda with the establishment of the Agricultural Research Council (ARC).
The early scientific debates between British researchers were deeply implicated in the
institutional restructuring of the ARC in the 1970s. Similarly, from the 1970s, the
prion controversy was equally deeply implicated in the changing culture of
American biomedical research. It is notable that the scrapie research can be located in
the context of the development of biomedicine in the twentieth century.
Secondly, this study of the controversy will examine the relations between
scientific practice and wider social transformations which have been closely
associated with the development of scientific knowledge. In particular, the
development of molecular biology and biotechnological enterprise has played a vital
role in building consensus around so-called prion research. Other historians have
argued that the development of molecular biology and its related technologies is
closely associated with wider social transformations after World War II.6 This co-
development of scientific practice and wider social transformation is called
"molecularisation". The present study will show not only how the scientific practice
of prion research has been strongly influenced by this scientific and social
transformation, but also that the consensus-building process has been affected by the
same wider scientific-social transformation.
Thirdly, the present study aims to contribute to that well-established tradition of
social history of science which refers primarily to the theoretical works of the
6 Wright, Susan (1986a) 'Recombinant DNA technology and its social transformation, 1972-
1982', Osiris 2: 303-360; Wright, Susan (1993) 'The social wrap of science: writing the history
of genetic engineering policy', Science, Technology and Human Values 18: 79-101; Wright, Susan
(1994) Molecular Politics: developing American and British regulatory policy for genetic
engineering (Chicago: University of Chicago Press); Wright, Susan (1998) 'Molecular politics
in a global economy7, Arnold Thackray (ed.) Private Science: biotechnology and the rise of the
molecular sciences (Philadelphia: University of Pennsylvania Press): 80-104; Kay, Lily E. (1992)
The Molecular Vision of Life: Caltech, the Rockefeller Foundation and the Rise of the New Biology
(Oxford: Oxford University Press); Kay, Lily E. (1998) 'Problematizing basic research in
molecular biology7, Arnold Thackray (ed.) Private Science: biotechnology and the rise of the
molecular sciences (Philadelphia: University of Pennsylvania Press): 20-38; Kay, Lily E. (2000)
Who Wrote the Book of Life? A history of the genetic code (Stanford, California: Stanford
University Press); De Chadarevian, Soraya & Harmke Kamminga (eds) (1998) Molecularising
Biology and Medicine: new practice and alliances, 1910s-1970s (London: Harwood Academic
Publisher); De Chadarevian, Soraya (2002) Designs for life: molecular biology after World War II
(Cambridge: Cambridge University Press)
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sociology of scientific knowledge (SSK).7 This study is informed by current concerns
in SSK, and among its purposes is that of strengthening the historiographic value of
examining the causal connection between socio-cultural conditions and the
production of scientific knowledge. This study shows how the clash between
different institutional traditions and cultures in America and Britain has shaped the
production of knowledge on scrapie. In particular, it shows how views on the nature
of the infectious agent are based upon differently patterned laboratory cultures and
different styles of scientific practice. I will show that these different styles were
embodied in particular patterns of scientific practice, including the formulation of
hypotheses, and the conduct, interpretation, and presentation of experiments.
Furthermore, it is worth noting that the present study may provide a good
empirical example in support of history of science that draws on SSK, namely
sociologically informed history of science. This study is based upon sociological
methods that are informed by SSK. One of the tenets of SSK in particular -
symmetrical social analysis of all knowledge, irrespective of our current evaluations
of its truth or its adequacy - offers a sound methodological approach for explaining
scientific practice. According to David Bloor, the same types of cause would explain
true and false beliefs.8 In other words, we should apply the same general explanatory
framework to analyse the generation and reception of both "true" and "false"
knowledge. 9 This sociological analysis encompasses all scientific knowledge,
including "right" knowledge as well as scientific knowledge now regarded as
7 The sociology of scientific knowledge is a sociological, historical and philosophical
movement in science studies since the early 1970s. In their studies of the social construction of
scientific knowledge, the authors looked at the social and cultural contingencies under which
knowledge claims are produced. In particular, this relativist movement suggests that both
true and false beliefs should be treated and explained symmetrically. For details, see Bloor,
David (1991) Knowledge and Social Imagery (Chicago: University of Chicago Press), Bames,
Barry & Bloor, David (1982) 'Relativism, rationalism and the sociology of knowledge' Martin
Hollis & Steve Lukes (eds) Rationality and Relativism (Oxford: Blackwell): 21-47; Shapin,
Steven and Simon Schaffer (1985) Leviathan and the Air-pump: Hobbes, Boyle, and the
experimental life (Princeton, New Jersey: Princeton University Press); Bames, Barry, Bloor,
David & Henry, John (1996) Scientific Knowledge; a sociological analysis (London: Athlone);
Bloor, David (2001) 'What is a social construct?' Facta Philosophica 3:141-156
8 Bloor, David (1991) op. cit. note 7: 7




inadequate. It is a methodological tenet that has been applied to good effect in this
empirical case. From the 1970s on, there were two big disputes on the nature of the
infectious agent. At each stage of development, consensus has been built differently.
In other words, a theoretical argument regarded as "true" knowledge in the 1970s
was later found wanting and was discarded. Throughout the prion controversy,
previously dominant knowledge became marginalised and regarded as inadequate
knowledge.10 In the context of this study, symmetrical analysis can provide a vital
methodological principle for analysing the history of scrapie research.
Materials and methods
This thesis has employed a variety of research methods. It is part historical
reconstruction of events using documents and interviews, and part sociological
analysis of scientists' practice and controversy. I examined what scientists have
reported about their research activities in formal reports (articles, graphs, statements
made at conferences, textbooks, and so forth). The materials range from articles in the
Journal of Parliament in 1752 to the current issues of Nature and Science. I have read at
least 1,700 scientific journal articles, books, statements, personal communication
letters, conference proceedings, meeting notes, minutes of council meetings
(including the Agricultural Council and Medical Research Council) and witness
statements of the BSE Inquiry. I also read newspaper accounts of scrapie research to
assess the kinds of information reaching the general public. These have been the
basic materials formy reconstruction of scientists' work activities.
I interviewed twenty prominent scrapie researchers both in Britain and America
about their different experimental experiences and perspectives on the subject of
scrapie research. I did most interviews and much of the fieldwork for observation of
laboratories between 2000 and 2001.1 visited several main scrapie research centres in
Britain and America including the Neuropathogenesis Unit (Edinburgh), the Institute
10 For more detailed discuss on the issue of relativism and symmetry, see Bloor, David (1984)
'The strengths of the strong programme', James Robert Brown (ed.) Scientific Rationality: the
sociological turn (Dordrecht: D. Reidel Publishing): 75-94; Collins, H.M. (1996) 'In praise of
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for Research on Animal Diseases (Compton, England), the Institute for Basic
Research (New York), the Maclaughlin Institute (Great Falls, Montana), the Rocky
Mountain Laboratory of the National Institutes of Health (Hamilton, Montana), and
the Institute for Neurodegenerative Diseases (University of California, San Francisco).
In a series of interviews, I was able to talk to leading researchers, postdoctoral
researchers, technicians and administrators of scrapie research institutes.
futile gestures: how scientific is the sociology of scientific knowledge?' Social Studies ofScience
26: 229-244
9
Background history of scrapie research, 1750-1960
Chapter 2 - Background history of scrapie research in Britain,
1750-1960
1. Introduction
Scrapie has a long history in Britain. It has only been in the spotlight since the
1980s, when the mass media brought it to public attention in connection with the
concerns over mad cow disease, but, arguably, it actually dates back to the
eighteenth century. For two centuries, agricultural industry suffered serious
economic losses due to several large-scale outbreaks of what, with the benefit of
hindsight, we can identify as scrapie. Of course, considerable difficulties attend any
attempt retrospectively to diagnose historical occurrences of a disease using modern
categories. I shall not try to address the profound epistemological and
methodological issues generated by this problem because the focus of my concerns
lies elsewhere. Nevertheless some mention must be made of the principles that
underlie the use of the word "scrapie" in the brief historical survey that I want to
give. It seems plausible to suppose that the farmers and shepherds who dealt with
sheep on a day to day basis would have been keen and intelligent observers of then-
behaviour and would be well able to identify unusual patterns of behaviour and the
symptoms of a number of forms of pathology, especially if these symptoms were
dramatic and manifested themselves in grossly unusual forms of behaviour. It is also
reasonable to assume that these observable symptoms will often have fallen into
clusters, though these will have been rather variable and rough and ready. For
obvious reasons, the names given to these descriptions of the symptom clusters will
themselves have been very varied and localised, though the descriptions of the
clusters themselves (using common, everyday language) will show some
recognisable continuities. On this basis I will allow myself to speak retrospectively of
"scrapie-like" diseases that have plagued farmers for many years. Although we
should exercise great caution here, for the sake of brevity, we may allow ourselves to
think of scrapie "itself" (that is, as an underlying cause or nexus of causes) as having
10
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been present for at least two centuries. This seems a reasonable way of making sense
of the reports of the last two hundred years, at least as judged by the descriptions
given in those records. I shall now survey these records and treat them as prima facie
responses to the occurrence of a scrapie-like phenomenon, with all the above-
mentioned qualifications taken for granted.
In this chapter, I shall review the early history of scrapie epidemics and research
on scrapie by some pioneering veterinary scientists. I will then show that the growth
of scientific research on scrapie has been closely associated with the
institutionalisation of veterinary and agricultural science, particularly in Britain. In
particular, two historically important events were crucial for scrapie research: the
establishment of the Moredun Institute, and the creation of the Agricultural Research
Council (ARC). The former was the one of the first private-funded agricultural
research institutes in the 1920s, and the latter was established as the government
support organisation for agricultural research in the 1930s. Both institutions played
an important part in developing and institutionalising scrapie research, which had
been largely dependent on folk knowledge up until then. Scrapie research became an
important research subject within veterinary science, and during the 1930s and 1940s,
a variety of experimental projects brought about the basic understanding of scrapie.
Subsequently, with the international outbreaks of scrapie in the 1950s, the
Agricultural Research Council decided to set up large-scale scrapie research
programmes in Edinburgh and Compton. The Moredun Institute in collaboration
with the Animal Breeding Research Organisation built up a joint research unit to
conduct genetic research in Edinburgh. In addition, another biochemical research
project was launched at the Institute for Research on Animal Disease in Compton.
These programmes were the first intensive large-scale research on scrapie in Britain,
and this was to bear fruit in the 1960s.
2. The first prevalence of scrapie in Britain: 1730-1820
The earliest written record of scrapie in England dates from the 1750s. This
account of the disease was given in the Journal of the House of Commons. Farmers in
11
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Boston, Lincolnshire, sought to restrain "jobbers" from mixing healthy sheep with
distempered animals and reselling them. At the time, the "jobbers" had a monopoly
of the sheep trade in Britain. In the decade 1745-1755, the distemper ravaged many
farms in Lincolnshire, and farmers and sheep breeders began to recognise that
epidemics of the disease were causing huge financial losses. Hence, in 1754, the
farmers drafted a petition to the House of Commons, in which the distemper in
question was referred to as "rickets" or "shakings".1 The House of Commons
appointed a special committee to investigate this problem.2
Subsequent writers traced the origins of the disease somewhat earlier. According
to Thomas Comber in 1772, a distemper called "rickets" had been known for forty
years in Lincolnshire. He outlined the symptoms of the disease and its existence in
the 1730s:
The principal symptoms of the first stage of this distemper is a kind of high
headedness. The affected sheep appear much wilder than usual. He bounced up
suddenly from his laire and runs to a distance as though he were pursued by dogs. In
the second stage the principal symptom of the sheep is his rubbing himself against
trees, posts, & c., with such fury as to pull off his wool and tear away his flesh. The
distressed animal has now a violent itching of the skin...but it does not appear that
there is ever any cutaneous eruption or salutary critical discharge. The third and last
stage...the poor animal appears stupid, separates from the flock, walks irregularly
(whence rickets), generally lies, and eats little. These symptoms increase in degree till
death follows a general consumption, which appears upon dissection of the carcass, the
juices or even solids having suffered a general dissolution insomuch that the solids
have no longer any of the good properties of flesh, nor the blood of its usual
colour...not any precise time from first symptom to death,...I do not find that this
distemper is infectious, but hereditary equally from sire and dam; and may be latent
one generation and reappear. A sheep once attacked never recovers; escaping it in early
years, never takes it.. .The disease was about forty years standing in England; came
from Lincolnshire hither, and yet I have never heard of the distemper in our country
(Yorkshire).3
His description reveals that the disease was understood to have originated in
Lincolnshire in the 1730s, where it was known as rickets or shakings. The sheep
1 House of Commons (1755) Journal: 27, 87, & 164-183; Parry, Herbert B (1983) Scrapie Disease
in Sheep (London: Academic Press): 37
2 Select Committee (1755) 'Report from the Select Committee on the petition of several
breeders and feeders of sheep in the county of Lincoln', Report of the Select Committees, First
Series. XI: 379
3 Comber, Thomas (1772) Real Improvements in Agriculture: Letters to Reade Peacock, Esq. and to
Dr. Hunter, Physician in York, concerning the Rickets in Sheep (London: print for W. Nicoll): 8
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affected by this scrapie-like disease showed several symptoms: sensitive reactions,
dizziness, itchiness, and paralysis of the body. The author believed that it was a
hereditary disease, not an infectious one. A similar disease was noted in Wiltshire in
the 1750s, and was severe from 1770 to 1810.4 The disease inWiltshire went under the
name of goggles, and several authors identified the goggles with the rickets in
Lincolnshire. An anonymous writer, a Gentleman in Wiltshire, wrote a remarkably
clinical and pathological description of the goggles in his letter to the Bath and West
of England Society:
Gentlemen,
Within these few years, we have had a disease among the sheep, now generally known
by the name of the goggles; a disease which has destroyed some in every flock round
this county, and made great havock in many. [...] it is not infectious, but hereditary,
and undoubtedly runs in blood. It has no affinity with giddiness, for they do not run
around. It most resembles the staggers in lambs, with this difference that whereas
staggery lambs, show weakness before, and fall forward, goggle sheep show a
weakness behind, and fall backward, when forced to run. When first observed to be
diseased, their ears drop, and they rub their tails much more than other sheep; they
then discover the weakness above mentioned, and grow poorer and weaker till they
cannot drag their limbs behind them, and at length die. I have examined a few and
found the viscera all round. I have blooded one, and found no inflammatory crust. I
can neither myself imagine, nor find one who can venture even to conjecture, the cause.
As it is a matter of consequence, perhaps, were you to make it the subject of the two
following premiums, it might be a means of stopping its progress: the first, to the
surgeon who shall dissect the greatest number of goggly sheep, and give the most
accurate description, with the best observations on the disease; and the second, to the
person who shall discover an effectual cure.
I am, Gentlemen, & c.5
The symptoms of goggles in Wiltshire, as described in this letter, were similar to
rickets in Lincolnshire. An epidemic of scrapie-like disease also occurred in the
Dorset area by the 1780s. According to John Claridge of Craig's Court:
4 Davis, Thomas of Longleat (1795) 'Extracts from a General View of the Agriculture of the
County of Wiltshire: with observations on the means of its improvement: drawn up for the
consideration of the Board of Agriculture and internal improvement', Letters and Papers on
Agriculture: Bath and West of England Society 7: 113-221; Collins, J. (1799) 'Some further
practical remarks on the nature of sheep and wool and the disorders of sheep', Letters and
Papers on Agriculture: Bath and West ofEngland Society 9:113-128
5 Gentleman of Wiltshire (1777) 'On the disease called the Goggles in sheep', Letters and
Papers on Agriculture: Bath and West ofEngland Society 1:42-44
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It is incumbent on me to take notice of a disorder peculiar to sheep, which is sometimes
fatally experienced in this county, called the Goggles; it attacks them at all ages, and no
remedy is at present known for it. [...] And this disorder has been known to be fatal to
the greatest part of flock.6
By the early nineteenth century, many documents testify to the fact that between
the 1770s and 1810s there was a severe epidemic of the disease. From these records,
the disease was prevalent in much of southern England (Dorset, East Anglia,
Lincolnshire, Devonshire, Oxfordshire, Cambridgeshire and so forth) under the
names of rickets, goggles and rubbers. Many farmers and landowners lost their
flocks within a few years, and it resulted in serious economic losses in these regions.
However, by the 1810s, this epidemic was gradually abating. Many authors in a
series surveying agriculture in the various English counties referred to its decline
between 1795 and 1813, when the disease gave less cause for concern in Dorset,
Hampshire, Oxfordshire, Berkshire, Bedfordshire and Wiltshire.7 Although the
severity of the epidemic in England declined from the 1830s, it continued to spread;
the disease reached as far as the Border area of Scotland in the mid-1800s. Records of
the Borders and Southern Scotland revealed that around 1853 some farmers reported
its existence under the name, "scrapie".8 The outbreak of the disease in the Borders
area appears to be the first to be given that name. John Cameron in Northumberland
gave another account of the outbreak in the Borders area:
The disease was well known on certain farms in Northumberland and Roxburghshire
sixty years ago [1850s], it may be noted in passing that at the present day [1910s] in
6 Claridge, John, of Craig's Court (1795) 'Extracts from a General View of the Agriculture of
the County of Dorset: with Observations on the means of its improvement', Letters and Papers
on Agriculture: Bath and West England Society 7: 72-73
7 Stevenson, W. (1812) General View of the Agriculture of the County of Dorset (London);
Vancouver, Charles (1813) General View of the Agriculture of the County of Hampshire including
the Isle of Wright (London); Vancouver, Charles (1808) General View of the Agriculture of the
County ofDevon; with Observations on the means of its improvement (London: printed for Richard
Phillips); Young, Arthur (1813) General View of the Agriculture of Oxfordshire (London); Cleeve,
Henry (1840) 'Practical essay on disease of sheep', journal of the Royal Agricultural Society of
England 1:295-345
8 Stockman, Stewart (1913) 'Scrapie: an obscure disease of sheep', journal of Comparative
Pathology and Therapeutics 26: 317-327
14
Background history of scrapie research, 1750-1960
Roxburghshire the disease is known by such further names as "scratchie" and "Cuddie
Trot."9
To sum up, since the 1750s a severe epidemic of a scrapie-like disease had spread
from southern England and reached right into Scotland by the 1850s. It became less
prevalent from the 1830s and in England the disease disappeared. The virulence or at
least the economic significance of the disease appeared by that time to have been on
the decline. With its decline, the disease generally received no more than passing
mention, alongside other diseases of sheep.
Author/Year Causes of Scrapie Reference |
T. Comber
(1772)
Hereditary "I do not find that this distemper is




Hereditary "it is not infectious, but hereditary, and
undoubtedly runs in blood."
J. Claridge
(1795)
Hereditary "some of the old-fashioned farmers think
that, as no such disease existed prior to the
introduction of the breed from other
countries, consequently its origin may be
imputed to this cause"
A. Young
(1800)
Hereditary (?) "The Spaniards did worst, next the new








Infectious "moreover, as this disorder is considered to
be infectious, the sheep are usually killed on





"The disorder is believed to be infectious or
hereditary, and a medical gentleman
attempted in vain to discover the cause"
W. Humfrey13
(1840)
Infectious "I am of opinion that this disease is
infectious"
Table 1: Concepts of scrapie aetiology (1750-1850)
9 Cameron, John (1913) 'Vide lecture to Northumberland Shepherds', Society at Ancroft,
Northumberland' Berwick News (13 February, 1913): 6
10 Willich, A. F. M. (1802) Domestic Encyclopaedia (London: printed for Murray and Highley)
Vol. Ill: 495
11 Vancouver, Charles (1811) General View of the Agriculture of the County of Cambridge
(London): 276
12 Stevenson, W. (1815) General View of the Agriculture of the County of Dorsetshire (London):
416-417
13 Humfrey, W., of Boxford (1840) 'Footnote to Cleeve's practical essay in disease of sheep',
Journal of the Royal Agricultural Society ofEngland 1: 297
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As seen in the writings mentioned above, the disease was called by different
names, but they all encompassed much the same symptoms: dizziness, nervousness,
rubbing, losing wool, paralysis, and so forth. Some writers also conducted relatively
simple pathological examinations, but they could find no specific features of the
disease.14 Opinion as to the cause of the disease also varied. Initially, many assumed
that it might be hereditary. The belief that "scrapie" was hereditary in character was
dominant in the earlier writings in the mid-eighteenth century. In the early
nineteenth century, opinion gradually changed, and it was thought that "scrapie"
might be an infectious disease.
As seen in the table, it is notable that aetiological accounts of the disease now
identified as scrapie, i.e., rickets, goggles, varied from one author to another,
although we can discern something of a shift in attribution over time. Initially,
opinion on the cause of the disease was assumed to be hereditary, introduced in the
bloodlines of imported sheep from the Continent. As a Gentleman of Wiltshire
argued in 1788, it was widely held that the disease had been found in imported
sheep. It was imported sheep from Spain and Saxony (mostly the Merino sheep) that
were blamed for causing the disease. In this period, many thought that scrapie might
be a hereditary disease rather than an infection. John Claridge of Craig's Court says,
"it is very difficult to assign the cause of the disorder [goggles]; but some of the old-
fashioned farmers think that, as no such disease existed prior to the introduction of
the breed from other countries, consequently its origin may be imputed to this cause;
but this is an argument perhaps of prejudice, grounded merely on conjecture, tho' I
own I am inclined to give it some credit".15 A plausible explanation for this change
was that when new fine-wooled sheep were introduced in England, and
coincidentally the disease spread through the same region, farmers and shepherds
might naturally assume that the disease was linked to the newly introduced sheep.16
14 A Gentleman of Wiltshire (1777) op. cit. note 5; Cleeve, Henry (1840) op. cit. note 7
15 Claridge, John, of Craig's Court (1795) op. cit. note 6: 73
16 Many early writings speculated that the origin of the disease was attributed to the
importation of Merino sheep from the Continent. Though the first large scale importation of
Merino sheep was recorded around 1788 [Carter, H.B. (1964) His Majesty's Spanish Flock: Sir
Joseph Banks and the Merinos of George III of England (London: Angus and Robertson)], there
were earlier cases of importation of Merino sheep from the Continent to England
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Still, some experts believed that the first prevalence of scrapie in Britain was more
than likely due to the introduction of the Merino sheep from the Continent.17 It later
became more common to suppose that the disease was infectious.
It is also important to note that the knowledge of the disease was based on the
local wisdom of farmers and shepherds. Prior to the eighteenth century, knowledge
of diseases of farm animals was largely local in character, embodied in the craft
knowledge and practices of local shepherds and stockmen. The records in which we
can identify scrapie were no exception. In this period in Britain, the so-called
enlightened gentry wrote most reports on scrapie, but the main source of the records
was the local farmers and shepherds. This is apparent in local variations both in how
the disease was described and in the names it was given. In the early nineteenth
century, there were some agricultural surveys to identify a wide range of different
and often locally-defined diseases of sheep.18 The agricultural surveys did not use the
concept of scrapie. Instead, authors focused on what we can see as scrapie-like
diseases, such as scab, turnsick, and sturdy. Many of these diseases, as well as rickets
and goggles as already mentioned, included some or all of the symptoms that are
now taken as diagnostic of scrapie. In the local context, people observed and named
the disease in terms of specific manifested symptoms, for instance paralysis of the
hind quarters (rickets, or turnsick), dizziness and blindness (goggles or sturdy), and
violent itching (rubbers, scratching, or scab).
It is also important to note that diversity of disease taxonomy and of aetiological
explanation persisted throughout the nineteenth century, despite efforts to survey
and standardise agricultural knowledge. For instance, in the work of John H. Steel,
[Walsingham, Thomas (1937) St. Albans Chronicle 1406-1420 (Oxford: Clarendon); Trow-
Smith, Robert (1957) A History of British Livestock Husbandry to 1700 (London: RKP): 112-113],
From those records of early importation, the correlation between the Merino sheep and
scrapie seems to be unlikely. However, the suspicions of farmers and shepherds that the
Merino sheep was the culprit were plausible, because in the early 1840s, there was an
outbreak of sheep-pox in Britain. Veterinary scientists discovered that the outbreak of the
sheep-pox was linked to the Merino sheep, which were imported from Saxony. The Merino
sheep was a likely object of suspicion as the cause of a new disease at the time [Pattison, Iain
(1984) The British Veterinary Profession 1791-1948 (London: J.A. Allen): 36]
17 Parry, Herbert B. (1983) op. cit. note 1
18 Youatt, William (1837) Sheep: Their Breeds, Management and Diseases (London: Robert
Baldwin); Spooner, W. C. (1844) History, Structure, Economy and Disease of Sheep (London)
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the goggles was categorised as one of the symptoms of turnsick, and rickets was
included as a symptom of louping-ill.19
3. The first veterinarian research on scrapie
At the turn of the twentieth century, with establishment of the veterinarian
profession in Britain, veterinarians began to recognise "scrapie" as a quite distinctive
disease entity. Since the year 1853, there had been another big epidemic of scrapie-
like disease in the Scottish Borders. Farmers in this area suffered huge economic
losses, thanks to new outbreaks. As the epidemic grew worse, farmers began to talk
about the disease openly, stimulating an initiative for scientists to continue their
investigation. In 1913, Stewart Stockman, the Chief Veterinary Officer (CVO) of the
Board of Agriculture, noted the increase in the disease, which he said "probably
explains the partial abandonment of secrecy."20 Thus, scrapie became an important
issue amongst veterinarians and farmers.
Research undertaken at the time would largely define the disease, as we now
know it, at least in terms of its detailed symptomatic and pathological presentation.
The term "scrape" or "scrapie" was a popular name used by farmers when referring
to the distemper in southern Scotland. In 1913, Stewart Stockman gave a lecture on
scrapie and published it in the Journal of Comparative Pathology and Therapeutics.21
Stockman had studied and taught veterinary pathology and bacteriology in
Edinburgh, hence his knowledge of the disease locally called scrapie, which has been
recognised as a serious problem in the Borders area since the 1850s.22 With John
McFadyean,23 who was regarded as a founding father of modern British veterinary
19 Steel, John Henry (18901A Treatise on the Disease of the Sheep (London: Longman)
20 Stockman, Stewart (1913) op. cit. note 8: 317
21 Stockman, Stewart (1913) op. cit. note 8
22 Pattison, Iain (1984) The British Veterinary Professon 1791-1948 (London: J.A. Allen): 110-111
23 John McFadyean played a significant role in establishing the veterinary profession in
Britain. He taught first at the Veterinary College in Edinburgh, then moved to the London
Veterinary School. He was a dean and professor of pathology and bacteriology at the London
School, and set up one of the first veterinary laboratories for veterinary diagnosis and
research in 1892. In 1894, he became principal of the oldest and largest British veterinary
school. According to Iain Pattison, "he was the most experienced veterinary pathologist in the
country, personally directing a unique laboratory. He owned and edited one of the world's
outstanding veterinary research journals, Journal of Comparative Pathology and Therapeutics, and
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science, Stockman was an advocate of the professionalisation of veterinary medicine,
and particularly of the development of a scientific model of professional knowledge
and practice. His review on scrapie identified the disease as an appropriate site to
develop this model through research, specifically he suggests that the disease is an
obscure disease of sheep, and could well be infectious.
Stockman's review raised the profile of scrapie as a serious threat for the
agricultural industry at the time. For this reason, scrapie was one of the urgent
subjects of investigation on the list of the first government-funded research into
animal diseases. When the Development Commission was established under the
Development and Road Improvement Funds Act in 1909,24 John McFadyean, who
was the Principal of London Veterinary College, tapped this source for the benefit of
the London veterinary school; the stun involved was £1,300, for studies on bovine
tuberculosis (£650), scrapie disease of sheep (£230), Johne's disease of cattle (£210),
and toxicity of the salts of zinc (£100).25 From the record of the allocation of research
funds, we can see that scrapie was regarded as one of the research priorities.
Presumably, it was due to Stockman's influence as a CVO to the Board of Agriculture
that funds were earmarked for scrapie. Thanks to the funds, Stockman could launch
a series of scientific researches on transmission, starting from the supposition that
scrapie was an infectious disease.
Around the same time, a veterinary researcher from the Royal College of
Physicians' Laboratory at Edinburgh, John Pool McGowan, published a book,
Investigation into the Disease of Sheep called "Scrapie".26 In his book McGowan claimed
that scrapie was caused by heavy infection with Sarcosporidia parasites which encyst
he was privy to the deliberations of the ruling council of the profession." [Pattison, Iain
(1984) op. cit. note 22:128]
24 Henderson, William (1981) 'British agricultural research and the Agricultural Research
Council: a personal historical account7, G.W. Cooke (ed.) Agricultural Research 1931-1981: A
History of the Agricultural Research Council (London: Agricultural Research Council): 8. The
Commission's function was to advise the Treasury on making grants or loans for the
development of rural and coastal areas, including grants for agricultural research. The Act
had significant implications for the establishment of veterinary science and agricultural
research. This was the first ever Government grant for veterinary research.
25 Ibid., 150
26 McGowan, J.P. (1914) Investigate into the Disease of Sheep called "Scrapie" (Edinburgh:
William Blackwood and Sons)
19
Background history of scrapie research, 1750-1960
in the muscle tissues of mammals. When McGowan conducted pathological
examinations and inoculation experiments with sheep suffering from scrapie, he
observed an interesting feature: the sarcocyst were always presents in large numbers
in the skeletal muscles of scrapie sheep. The sarcocyst parasite usually causes severe
itchiness in the host. With respect to this symptom, McGowan inoculated
sarcosporidial emulsions into rabbits, and reported that this induced the chief
symptom of scrapie, pruritus (or itching).27 From his investigation, he concluded that
scrapie was caused by sarcocyst parasite infection. Moreover, he speculated that this
parasite infection was not transmitted by physical contacts between sheep; rather, the
infection was transmitted from mother to the lamb through the uterine wall. In
addition, it could also be transmitted through the milk of diseased animals.28 This
maternal transmission implied that the disease was non-contagious, hereditary, and
congenital.
The idea of parasite infection met with strong criticism; one of the leading
veterinary scientists at the time, John McFadyean, published his objection to the
parasite theory of McGowan in 1918.29 McFadyean criticised McGowan on the
grounds that the latter's argument was based on assumptions which were improved
and improbable. McFadyean's criticims were three-fold: first, scrapie was, to his
mind, a contagious disease. According to the description of Stewart Stockman in
1913, there were several cases of contagious infection when sheep shared the same
pasture.30 Second, whereas McGowan claimed that scrapie arose de novo, and was not
the consequence of infection from a previous case of the disease (i.e., scrapie was
caused by spontaneous generation)/"McFadyean pointed out that the speculation of
spontaneous generation was based on a misunderstanding. This mistake came about
as a result of the fact that the incubation period of scrapie was remarkably long.
McFadyean conducted experiments on transmission for seven years, and concluded
27 Ibid., 110
28 Ibid., 101-109
29 McFadyean, John (1918) 'Scrapie', Journal of Comparative Pathology and Therapeutics 31: 102-
131
30 Stockman, Stewart (1913) op. cit. note 8
31 McGowan, J.P. (1918) 'Scrapie', Journal ofComparative Pathology and Therapeutics 31: 278-290
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that scrapie had a very long incubation period.32 Third, if the disease was caused by
parasite infection, then scrapie should occur anywhere the parasites were
distributed. McFadyean asserted that "in explanation of the fact that scrapie has
disappeared throughout nearly the whole of England, although sarcosporidia remain
in every flock and are present in the majority of individual sheep, he [McGowan] has
nothing serious to offer."33
The debate between McGowan and McFadyean was intensified in the Journal of
Comparative Pathology and Therapeutics in 1918. This controversy was all about the
issue of how to understand the unprecedented disease in terms of the germ theory,
which had become the newly established framework of biomedicine since the late
nineteenth century. On the one hand, McGowan believed that the main candidate for
the cause of the scrapie infection was congenital and hereditary infection with the
Sarcocystis parasite. On the other hand, McFadyean, who was a frontrunner of
bacteriology, believed that the disease could be attributed to contagious agent. The
debate came to an end with McGowan's parasite theory being abandoned, because
scrapie was observed to occur in animals where there was no sarcocystis. To
investigate the validity of McGowan's theory, Stockman launched a large-scale
programme of pathological and transmission experiments between 1921 and 1926.
From this series of experiments, Stockman had observed that when scrapie-affected
muscle extracts supposed to contain sarcocystis parasites were injected into normal
sheep, no apparent symptoms of scrapie were produced. This experimental result
underpinned McFadyean's speculations.34 Thus, the newly emerging bacteriological
explanation was confirmed by the work of McFadyean and Stockman, and played a
part in the abandoning of McGowan's parasitological approach.
Arising from the dispute between McGowan and McFadyean in 1918, one
significant fact was observed: namely, the incubation period of scrapie seemed to be
32 His experimental work was conducted between 1911 and 1918 at the London Veterinary
College. See McFadyean, John (1918) op. cit. note 29:121-131.
33 McFadyean, John (1918) 'Sarcosporidia as the cause of scrapie', Journal of Comparative
Pathology and Therapeutics 31: 293
34 Stockman, Stewart (1926) 'Contribution to the study of the disease known as scrapie',
Journal of Comparative Pathology arid Scrapie 39: 42-71
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very long.35 During the 1910s and 1920s, scientists in both Britain and the Continent
attempted to uncover the mysterious characteristics of scrapie. Stockman also
conducted anatomical investigations, and observed another important feature of
scrapie, its neurodegenerative character, which had already been reported by two
French researchers, Besnoit and Morel in 1898; their work showed that scrapie-
affected brain was characterised by vacuoles, and certain histopathological changes
in the medulla, spinal cord and peripheral nerves.36 Stockman's observation was the
first clinical examination of the neuropathological features of scrapie in Britain.
To sum up: the first scientific investigations on scrapie were closely associated
with professionalisation of veterinary medicine in the late nineteenth and early
twentieth century. The professionalisation of veterinary science played a role in
consolidating scrapie research as a veterinary subject.37 Scrapie was an important site
for consolidating the identity of veterinary medicine as a research-based scientific
enterprise, and for establishing what kinds of theories of disease causation (most
notably the bacterial theory of infection) would command credibility among the
scientific elite of the veterinary community. In short, research on scrapie played an
important role in the process of veterinary institutionalisation.
35 Ford, Brian (1996) BSE: the facts (London: Corgi Books): 37; McFadyean, John (1918) op. cit.
note 33
36 Besnoit, C. & Morel, C. (1898) 'Notes sur les lesions nerveuses de la tremblante du
mouton', C.R. Soc. Biol. 5: 536. Continental scientists tended to focus on the neurological
features of scrapie rather than cutaneous features. Moreover, when naming the disease, more
neurological features were articulated, for instance, die Traberkrankheit (the trotting disease),
das Drehen oder Traben (Turning or trotting), die Zitterkrankheit (trembling disease) in Germany
and la maladie convulsive (the convulsive disease), la maladie folle (the mad disease), la
tremblante (trembling disease) in French. On the other hand, British scientists had a tendency
to investigate the cutaneous features, which was why the name of disease also reflected this
tendency; for instance, rubbers, rickets, scratchie and scrapie.
37 For more on the issue of professionalisation of veterinary science, see Pattison, Iain (1984)
op. cit. note 22; Swade, Joanna (1999) Animals, Disease, and Human Society (London:
Routledge); Fisher, John R. (1993) 'Not quite a profession: the aspirations of veterinary
surgeons in England in the mid nineteenth Century7, Historical Research 66: 284-304; Fisher,
John R. (1993) 'British physicians, medical science, and the cattle plague, 1865-66', Bulletin of
the history ofmedicine 67: 615-669
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4. Institutionalisation of scrapie research
Mention has been made of the national movement to professionalise veterinary
medicine, but local demand to set up studies into the causes and nature of
agricultural diseases was also a significant factor in the history of agricultural
research. The participation of farmers and growers played an important role in
establishing research institutes. For instance, one of the earliest agricultural research
institutes was the National Fruit and Cider Institute at Long Ashton, founded by
Robert Neville Granville under the sponsorship of the Bath and West and Southern
Counties Society in 1903. The institute became the department of agriculture and
horticulture at the University of Bristol.38 Since that time, many other locally
supported research institutes had also been established, and the Animal Diseases
Research Association (ADRA) was one of them. The ADRA was established in 1920;
it was set up by landowners and farmers, particularly sheep breeders in Scotland, to
promote investigation into the diseases of livestock.39 This initiative attracted support
from the private sector and from the Development Fund through the Department of
Agriculture for Scotland. This enabled the Association to establish permanently its
Moredun Institute at Gilmerton, Edinburgh, in 1926.40
Another big step in the history of agricultural research was the establishment of
the Agricultural Research Council (ARC) in 1931. The ARC was designed to complete
the scientific organisation for the supervision of civil research.41 The establishment of
research institutes helped to promote the subject of scrapie research in Britain. In this
context, scrapie became one of the primary research issues for veterinary scientists.
One of the researchers in the Moredun Institute, S. H. Gaiger, published a detailed
report of the clinical symptoms and epidemiological patterns of the disease in 1924.42
38 Henderson,William (1981) op. cit. note 24: 9
39 Dickinson, Alan G. (1998) 'Transcription of oral hearings: day 31', The BSE Inquiry (11th
June 1998, London: the BSE Inquiry): 12; Angus, Kenneth (1990) A History of Animal Diseases
Research Association (Edinburgh: ADRA)
40 Henderson, William (1981) op. cit. note 24:12
41 Ibid., 21. For more detailed studies on the history of ARC, see Dejager, Timothy (1993)
'Pure science and practical interests: the origins of the Agricultural Research Council, 1930-
1937', Minerva 31:129-150
42 Gaiger, S.H. (1924) 'Scrapie', Journal ofComparative Pathology and Therapeutics 37: 259-277
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During the 1930s, scrapie was the main focus of the investigations at the Moredun
Institute, following the demonstration of the presence of an inoculable factor in
scrapie by two French scientists, Jean Cuille and Paul-Louis Chelle of Toulouse.43
This was the first successful transmission experiment, and generally established the
view that the disease was transmissible. This French success stimulated the British
researchers to launch a variety of investigations into scrapie. By 1934, intensive
microscopic studies of the disease had been carried out,44 and by 1937, the disease
was known to be caused by an infectious agent. There was convincing evidence of
spread by contamination of the pasture.45
However, of greater significance, and with more explosive implications, was the
accidental outcome of an experiment with louping-ill vaccine in 1935. A veterinarian,
William Gordon, was working with other researchers on the development of a
vaccine against louping-ill, which is another ovine disease that causes brain
inflammation, lethargy, poor co-ordination and death within days. The vaccine
Gordon's team developed consisted of homogenised brain, spinal cord and spleen
tissue taken from sheep infected with louping-ill, diluted in saline solution and
inactivated by adding a small amount of formaldehyde.46 As William Gordon wrote,
"this investigation had a more romantic turn and less fortunately a final dramatic
twist which led almost to catastrophe."47 In 1935, the vaccines were injected into
sheep with the expectation that the inoculated animals would become immune to the
louping-ill virus. It was successful. Within three years, however, the vaccinated
flocks began to develop scrapie. According to Hugh Fraser, who was a researcher in
43 Cuille, J. & Chelle, P.L. (1936) 'La maladie dite tremblante du mouton est-elle inoculable?',
Comptes Rettdus de Academie des Sciences (Paris) 203:1552-1554
44 ADRA (1935) Animal Diseases Research Association: Report 1934-1935 (Edinburgh: Moredun
Institute): 17; ADRA (1936) Animal Diseases Research Association: Report 1935-1936 (Edinburgh:
Moredun Institute): 18; Brownlee, A. (1940) 'Histo-pathological studies of scrapie, an obscure
disease of sheep', The Veterinary Journal 96: 254-264.
45 Angus, Kenneth (1990) op. cit. note 39: 35-36; ADRA (1938) Animal Diseases Research
Association: Report 1937-1938 (Edinburgh: Moredun Institute): 14; Greig, J. Russell (1940)
'Observations on the transmission of the disease by mediate contacf The Veterinary Journal 96:
203-206
46 Rhodes, Richard (1998) Deadly Feasts: tracking the secrets of a terrifying new plague (New York:
Simon & Schuster): 59
47 Gordon, W. S. (1946) 'Advances in veterinary research: louping-ill, tick-bome fever, and
scrapie.' The Veterinary Record 58 (47): 517
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the Moredun Institute, the eventual toll was high - about seven per cent of the 18,000
immunised sheep.48 Gordon immediately begun to suspect that the vaccine might be
to blame. He later recollected:
I visited most of the farms on which sheep had been vaccinated in 1935. It was at this
point that the investigation reached its dramatic phase; I shall not forget the profound
effect on my emotions when I visited these farms and was warmly welcomed because
of the great benefits resulting from the application of louping-ill vaccine, whereas the
chief purpose of my visit was to determine if scrapie was appearing in the inoculated
sheep. The enquiry made the position clear. Scrapie was developing in the sheep
vaccinated in 1935.49
As Gordon became concerned that scrapie had been transmitted with his vaccine,
he set up an extensive experiment to confirm how this might have occurred. With
funding from the ARC, he injected 788 sheep with scrapie-affected tissues in 1938.
This experiment confirmed that the louping-ill vaccine incident was caused by the
fact that the scrapie agent has a remarkable resistance to formalin. Gordon also
recorded various incubation periods from about 9 months to 3 years, and observed
the different susceptibility of different breeds of sheep to the disease.50
This accidental result of the experiment with louping-ill vaccine provided
valuable field data to help researchers understand the mysterious disease of scrapie.
It also allowed the characteristics of "experimental" scrapie to be studied in detail
and to be compared to those of naturally occurring cases. What Gordon and his
colleagues found was that the scrapie agent was too tough to be destroyed by
conventional methods of inactivation such as formaldehyde. Iain Pattison, who was
involved with this experiment as a pathologist, calls the experiment "the earliest
flush of scrapie cases."51 Following this accidental experiment, the Moredun Institute
launched biochemical research on the disease.52
48 Fraser, Hugh (1996) 'Report for CJD litigation held in the High Court', (April-May, 1996:
London) quoted from Cooke, J. (1998). Cannibals, Cows, and the CJD Catastrophe (London:
Minerva): 31
49 Gordon, W. S. (1946) op. cit. note 47:517
50 Ibid.
51 Pattison, I. H. (1992) 'A sideways look at the scrapie saga: 1732-1991', S. B. Prusiner, J.
Collinge, J. Powell and B. Anderton (eds), Prion Diseases of Humans and Animals (New York:
Ellis Horwood): 16
52 Angus, Kenneth (1990) op. cit. note 39: 35-36
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During the war, most of veterinary research was curtailed, and work in several
areas of scrapie research had ceased.53 Only David R. Wilson at the Moredun was
able to continue his project on scrapie after 1939. Between 1939 and 1953, Wilson
conducted a variety of experiments into the means of scrapie infection.54 What he
found were some quite extraordinary features, from the conventional point of view
on the properties of viruses and bacteria.
Though he failed to isolate the infectious agent, his remarkable achievement
provided a benchmark for other scientists. Firstly, he reported that the agent was
filterable, which meant that it must be very small - smaller than bacteria.55 Secondly,
the agent was highly resistant to heat, formalin, phenol and chloroform.56 Third, the
scrapie agent remained viable in the desiccated state at 0° to 4°C for long periods; the
agent survived in dried brain tissue for a period of over two years.57 Fourth, exposing
infected brain samples to a considerable dose of ultraviolet light failed to inactivate
the scrapie infection. Lastly, the scrapie agent also survived steam treatment in an
autoclave, which usually kills most bacteria and viruses. These results implied that
normal disinfectants had little effect on the scrapie agent.58 The scrapie agent was so
unusual that Wilson hesitated to publish his results. Indeed, his main experimental
data have never been published. Instead, the data were circulated among small
numbers of researchers who were also concentrating on scrapie research.59 Moreover,
Wilson himself was not only hesitant about publishing his data, but was also under
enormous pressure from the ARC to come up with a vaccine against scrapie. He
failed in this aim, and his enormous contributions have since been forgotten and
53 Ibid., 45
54 ADRA (1942) Animal Diseases Research Association: Report 1941-1942 (Edinburgh: Moredun
Institute): 14
55 Wilson, D. R., R. D. Anderson, et al. (1950) 'Studies in scrapie', Journal of Comparative
Pathology 60: 267
56 Pattison, I. H. (1992) op. cit. note 51:16
57 Wilson, D. R., R. D. Anderson, et al. (1950) op. cit. note 55:278
58 Ford, Brian (1996) op. cit. note 35: 39-40
59 Fortunately, Wilson's experimental achievements and his data were recorded by his
colleagues, see Stamp, J. T., J.G. Brotherston, et al. (1959) 'Further studies on scrapie', Journal
ofComparative Pathology 69: 268-280
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ignored.60 According to Alan Dickinson, who was a colleague at the Moredun during
the 1950s:
D.R. Wilson did enormously significant founding work and he had a nervous
breakdown. He had a nervous breakdown because the Agricultural Research Council
were extremely critical that he hadn't produced a vaccine yet, and he had been
working on it for about two years. [...] It was a bandwagon: 'make a vaccine if it is an
infection, make a vaccine.' [...] The bureaucrats did not understand why someone
should be wanting to boil things.61
5. Intensive research projects in Edinburgh and Compton
In the 1950s, the scrapie epidemic was worsening on a global scale; in Canada
there was the first scrapie case in 1940;62 scrapie appeared in Australia in the summer
of 1951; the United States Department of Agriculture (USDA) issued a declaration of
a state of emergency with reference to scrapie in sheep in 1952;63 and the first
outbreak of scrapie in New Zealand occurred in 1952.64 Epidemiological
investigations revealed that every outbreak in those regions was closely related to
imported flocks from Britain. These countries therefore placed an embargo on British
sheep, and there was huge pressure to develop research on scrapie in order to
eradicate the disease.
Although there was an outbreak of scrapie in America, there were no laboratories
in the US set up to study scrapie. The British had the laboratories and the "USDA
[United States Department of Agriculture] found money left over from the Second
World War - a programme funded to insure that food procured for US troops abroad
was safe - to support the work."65 The USDA grant was allocated to the Institute for
60 Ibid., 40
61 Dickinson, Alan G. (1999) Interview with author (Dunbar: 15 September 1999)
62 Plummer, P. J. G. (1946) 'Scrapie - a disease of sheep', Canadian Journal of Comparative
Medicine 10:49-54
63 Anonymous (1952) 'Scrapie found in California sheep', Journal of the American Veterinary
Medical Association 121 (December 1952): 455; Wagner, A. R., H. E. Goldstein, et al. (1954)
'Scrapie-a study in Ohio' Journal of the American Veterinary Medical Association 124 (February
1954): 136-140
64 Brash, A. G. (1952) 'First outbreak of scrapie reported in New Zealand', New Zealand Journal
ofAgriculture 85: 305-306
65 Rhodes, Richard (1998) op. cit. note 46: 60
27
Background history of scrapie research, 1750-1960
Research on Animal Diseases (hereafter IRAD) at Compton and the Moredun
Institute. The ARC had a farm research centre at Compton, Berkshire, referred to as
the "Field Station" until the name was changed in 1963 to IRAD. The field station
was the first ARC research institute, and was designed to research mainly on cattle
diseases.66 The USDA grant initiated the first large-scale involvement of IRAD in
scrapie research. Before the involvement of IRAD, the Moredun Institute was the
only place conducting large-scale scrapie experiments. According to the Director of
the Moredun Institute, John Stamp, the aims were two-fold: "to determine whether a
virus is in fact present all the known methods of microbiological research are being
followed, while to investigate the possible latency factor a number of different breeds
of sheep are being tested, the former work at Moredun, the latter at the Agricultural
Research Council Unit at Compton".67
WhenWilliam Gordon moved down from the Moredun to take over as director at
Compton in 1942, he wanted to set up a large-scale scrapie experiment in the vast
dairy farms at Compton. With USDA funds, Gordon was able to launch this
programme. In 1954, William Gordon assembled between 30 and 57 sheep of each of
24 different breeds - 1,027 in all - in order to investigate their differential
susceptibility to scrapie. This experiment became known as the "24-breed
experiment". The result revealed an incidence of scrapie ranging from 78% in
Herdwicks to nil in Dorset Downs.68 This mammoth project continued until 1973,
even after Gordon's death.69 Moreover, the ARC agreed that Wilson's research
project in the 1940s should be extended, and this task was allocated to the IRAD at
Compton. However, before 1957 IRAD did not possess extensive facilities for
microbiological and biochemical research. When the ARC commissioned the institute
to launch an extended programme of microbiological work, Gordon set up four
departments for scrapie work: biochemistry (under Gordon Hunter), functional
66 Henderson,William (1981) op. cit. note 24:29-31
67 ADRA (1956) Animal Diseases Research Association: Report 1955-1956 (Edinburgh: Moredun
Institute): 24
68 Gordon, William S. (1964) 'Review of work on scrapie at Compton, England, 1952-1964',
Report ofScrapie Seminar (Washington: USDA): 19-40
69 Pattison, I. H. (1988) 'Fifty years with scrapie: a personal reminiscence', Veterinary Record
123(26-27): 662
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pathology (Richard Chandler), pathology (Pattison), and microbiology (David Haig).
Each department launched specific projects on scrapie.70
On the other hand, in Edinburgh under the leadership of Stamp, the Moredun
team launched another experimental project on scrapie, involving chemical,
microbiological and microscopic studies. As Stamp mentioned, the Moredun team
focused on the microbiological and chemical work, which was carried out by the
existing research teams in the institute.71 Furthermore, Stamp was also interested in
the genetic features of the disease, hence he planned to set up new project on genetic
research. One problem was, however, that the institute did not have good animal
facilities for genetic research. Traditionally, the primary project of the institute was
microbiological and virological research on various sheep diseases. Hence, Stamp
suggested setting up a collaborative team with the Animal Breeding Research
Organisation (hereafter, ABRO). ABRO was a part of the Institute for Animal
Genetics that was established by the Development Commission in 1921. Soon after
the establishment of the ARC, the institute came under ARC funding and control. In
1945, the Council and the Agricultural Improvement Council decided that it should
be concerned with fundamental genetic principles based on the results of a series of
long-term observations. In 1951, the Council decided to split the animal breeding
part and genetics part. Thereafter, the ABRO became an independent institute
responsible for animal breeding work.72 The institute was devised with six field
stations, and maintained approximately 900 cattle, 7,000 sheep, and 2,000 pigs. The
staff of ABRO were collectively engaged in a number of considerable farming
enterprises at the time.73 Consequently, Stamp considered ABRO a promising place
to launch the genetic research on scrapie.
In 1955, Stamp and H. P. Donald (who was a director of ABRO) agreed that they
should organise a collaborative research team to investigate the genetic features of
70 Gordon, William S. (1964) op. cit. note 68
71 ADRA (1956) op. cit. note 67: 24
72 Henderson, William (1981) op. cit. note 24:43-44
73 ABRO (1963) Animal Breeding Research Organisation - Report, 1963 (Edinburgh: Animal
Breeding Research Organisation): 7-8
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scrapie. This project was also supported by a grant of £ 54,000 from the USDA.74 John
Stamp stated the aim of project in the Moredun Institute's annual report in 1956:
Although the evidence of the transmissibility of scrapie is of first importance, the doubt
as to the living nature of the agent, linked with the considerable field evidence of a
breeding factor, make it essential to carry out a controlled breeding experiment to
determine whether in fact any genetic factors enter into the causation of the disease.75
The Moredun-ABRO joint project unit76 was led by a geneticist, Alan G.
Dickinson, a veterinarian Gilbert Young and a pathologist, Ian Zlotnik. Later, instead
of Young and Zlotnik, a Cambridge-graduate neuropathologist, Hugh Fraser, and
biologist George Outram became involved in the project.
Not surprisingly, the large scale projects in Edinburgh and Compton included
some overlapped subjects: each project included work on the microbiology,
biochemistry, pathology and genetics of scrapie (see the table 2).
Subject IRAD Moredun-ABRO
Director William Gordon John T. Stamp
MicrobiologyA7irology David Haig Derek Mould
Biochemistry Gordon Hunter John Brotherson
Pathology Iain Pattison Ian Zlotnik
Genetics William Gordon Alan G. Dickinson
Table 2: Overlapped subjects and researchers in IRAD and Moredun-ABRO
As a result, the ARC decided to set up a working party to oversee the research in
Edinburgh and Compton. The Technical Committee on Scrapie Research (also known
as the Scrapie Working Party) was set up in 1961. One of the members of the head
office of the Council, Scarisbrick, was appointed to the chairmanship.
74 Angus, Kenneth (1990) op. cit. note 39: 56
75 ADRA (1956) Animal Diseases Research Association, Report 1955-1956 (Edinburgh: Moredun
Institute): 26
76 Sometimes this team was called the ADRA (Animal Diseases Research Association)-ABRO
(Animal Breeding Research Organisation) joint project unit
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The working party also included many of those involved in the overlapping
research: from the Compton side, Gordon, Haig, Hunter and Pattison became
delegates; the Moredun side was represented by Stamp, Zlotnik, Brotherson, and
Mould. Between 1961 and 1969, the working party functioned as a regulatory body to
co-ordinate the whole project. The relationship between the two teams in Edinburgh
and Compton was maintained through the scrapie working party.
During the 1960s, the newly launched large-scale programmes in the UK
produced valuable research outcomes and speculations. As we shall discuss in
following chapter, the two research teams suggested quite opposite and conflicting
ideas about the nature of the disease. Although the research programmes discovered
unusual properties of scrapie, which could help to understand the mechanism of the
disease, the relations between the two centres would quickly became strained, and
eventually led to open controversy and rivalry during the 1960s and 1970s.
6. Summary
In this chapter, I have briefly reviewed the history of scrapie research between
1750 and 1960. Arguably, scrapie has a long history in Britain, and has caused serious
economic losses. Since scrapie was identified as an individual sheep disease by
pioneering veterinary researchers in the 1910s, there has been persistent pressure
from farmers and sheep breeders to pursue scientific investigations. Consequently,
privately funded research institutes were established, such as the Moredun Institute,
and the government also supported research on scrapie by founding the Agricultural
Research Council (ARC) in 1931. With a large-scale epidemic in the 1930s, scrapie
became recognised amongst veterinary scientists as one of the top priority research
subjects.
During the 1940s and 1950s, the Moredun Institute conducted a variety of research
projects on scrapie, and brought to light some puzzling features of the disease. David
Wilson's work and the louping-ill vaccine incident provided valuable experimental
data for subsequent researchers, and valuable primary knowledge for the
understanding of the disease. Furthermore, in the 1950s, the ARC decided to set up
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new research programmes on scrapie in Edinburgh and Compton. These projects
would produce valuable results and controversial hypotheses.
In sum, the whole process of disease recognition was closely associated with the
institutionalisation of research on the disease. In particular, the institutional settings
of veterinary and agricultural science played an important role in developing the
research on scrapie. In the early days, a scrapie-like disease was recognised in terms
of local knowledge. Knowledge of the disease was largely embodied in the crafts and
practices of local farmers and shepherds. However, with the professionalisation of
veterinary medicine, scrapie became recognised as an independent disease in sheep.
In the first half of the twentieth century, scrapie became one of the main veterinary
subjects. The whole process of disease recognition was, in fact, closely associated
with development and institutionalisation of veterinary medicine.
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Chapter 3 - Genetic research into scrapie at the Moredun
Institute, Edinburgh, 1964-1979
1. Introduction
In the 1960s, scrapie was regarded as a mysterious and arcane subject in
veterinary science, due to its extraordinary characteristics, such as long incubation
period, absence of immune reactions, and strong resistance of absent to physico-
chemical treatments. In 1961, there was an important experimental breakthrough; a
researcher at the Institute for Research on Animal Diseases (IRAD), Richard
Chandler, succeeded in infecting laboratory mice with the disease.1 This successful
transmission enabled scientists to conduct various experiments on the disease in the
laboratory. One particular group to benefit from this success was geneticists. For
genetics, laboratory animals have long been a crucial element the investigation of
gene action. Since the early twentieth century, when full-scale scientific studies on
scrapie began, the biggest obstacle was the impossibility of carrying out laboratory
studies. Due to the lack of appropriate laboratory animals, geneticists had to conduct
experiments in the field. Field experiments with sheep took a long time to produce
results. For this reason, the transmission of scrapie into laboratory animals was a
significant breakthrough.2 At long last, geneticists could now launch laboratory
experiments into the nature of scrapie.
One of the genetic research teams was based on collaboration between scientists
at the Moredun Institute and the Animal Breeding Research Organisation (ABRO) in
Edinburgh, a collaborative team led by a geneticist, Alan G. Dickinson. For nearly 20
years, Dickinson examined the genetic features of the disease, and produced an
1 Chandler, R. L. (1961) 'Encephalopathy in mice produced by inoculation with scrapie brain
material', The Lancet 1:1378-1379
2 Around the late 1950s, at least three teams of researchers carried out transmission
experiments in both Compton and Edinburgh: led by Richard Chandler (IRAD at Compton),
Ian Zlotnik (Moredun at Edinburgh), and Alan Dickinson (Animal Breeding Research
Organisation at Edinburgh). The race for transmission ended with Chandler's success.
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explanatory model of the nature of scrapie in the 1970s. He suggested that scrapie
infection occurs by means of a very small virus-like agent, but the replication of the
infection is dependent on the genetic properties of the host. During the 1970s, his
explanatory model achieved high levels of credibility within the research
community.
The aim of this chapter is to examine how Dickinson and his group built up their
experimental programme. In particular, I will outline the complicated series of
genetic-pathological experiments that Dickinson designed and carried out. The main
aim is to explain how Dickinson and his group at Edinburgh produced a genetical
and pathological explanation of the strain variation of the scrapie agent.
Furthermore, it will be shown how the Edinburgh researchers coped with
uncertainties in the field, and how the uncertainties were translated into something
approaching certainty through experimental results. Finally, this chapter also
describes how Dickinson used these results to formulate a hypothesis on the nature
of scrapie.
2. EarlyWorks of Dickinson: Genetic or Contagious Disease?
By the mid-fifties, some scientists were beginning to look into the genetic
dimension of scrapie. The genetic aspect of scrapie was a contentious issue in the
scientific community. This approach, in fact, was associated with public suspicion of
the disease: farmers had long held a suspicion that the disease might be inherited
rather than infectious. As seen in the previous chapter, since a scrapie-like disease
was reported in the eighteenth century, many writers speculated that it might be
caused by genetic problems, though their number declined in the wake of the mid-
nineteenth century interest in infectious disease. However, during the early years of
the twentieth century, in view of the failure to isolate a viral agent, and of the
anomalous properties of the hypothetical infectious agent, some scientists were now
reconsidering the possibility that scrapie was indeed caused by a genetic defect.
[Fraser, Hugh (1999) Interview with author (Edinburgh: 30 June 1999); Dickinson, Alan G.
(1999) Interview with author (Dunbar: 15 September 1999)]
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This view was zealously asserted by an Oxford-based scientist, Herbert B. Parry.
In particular, Parry stated that there was no evidence to suggest the spread of the
disease from affected animals to others of the same generation by contact, coitus or
contaminated environment.3 Parry claimed that scrapie was a genetic disease due to
a single autosomal recessive gene.4 His argument was supported by many sheep
breeders and some sceptics who did not believe in the viral origin of scrapie.
In addition, researchers in Compton conducted a series of field experiments on
sheep from the early 1950s. This indicated that host susceptibility to scrapie is
genetically determined. In other words, different genetic strains of sheep exhibit
differential susceptibility to the disease.5 Meanwhile, other workers at Compton,
Pattison and Mills, suggested that different strains of the disease itself existed,
suggesting that the virulence and clinical expression of the disease might vary
specifically, they identified two different strains: drowsy and scratching.6
In this context, other veterinary researchers saw a need at this juncture to
explore the genetic dimensions of scrapie. In 1955, a collaborative project in
Edinburgh between the Moredun Institute and the Animal Breeding Research
Organisation (hereafter, ABRO) was established to explore the possible genetic
dimension of the disease. This project was led by Alan G. Dickinson, a geneticist
trained at the University of Birmingham, who joined the staff of ABRO. As seen in
the previous chapter, the Moredun institute had a long tradition of scrapie research
since the 1920s. In 1955, the director, Russell Greig, retired from the directorship,
and the veterinary researcher, John T. Stamp, took over the position, stating that the
priority of research in the institute was to be scrapie research.7 The Moredun-ABRO
researchers launched animal breeding experiments to investigate whether scrapie
3 Parry, H. B. (1960) 'Scrapie: a transmissible hereditary disease of sheep', Nature 185 (4711):
441-443
4 Ibid., 442
5 For example, William Gordon's twenty-four breed experiment was designed to investigate
genetic susceptibility to scrapie with sheep in the field. Gordon, William S. (1964) 'Review of
work on scrapie at Compton, England, 1952-1964', Report of Scrapie Seminar (Washington:
USDA): 19-40
6 Pattison, I. H. and G. C. Millson (1961) 'Scrapie produced experimentally in goats with
special reference to the clinical syndrome', Journal of Comparative Pathology 71:101-108
7 Stamp, J. T. (1957) 'Address by Director of the Moredun Institute', Animal Diseases Research
Association: Annual Report and Accounts: 1956-1957 (Edinburgh: Moredun Institute): 18-25
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could indeed be explained as a genetically inherited condition, or whether it was
better understood as an infectious disease.8
Dickinson and Stamp obtained some suggestive experimental results in
opposition to the recessive gene theory. First, according to Stamp, the Moredun
Institute had evidence of infection by contact in sheep.9 Since 1952, the Moredun and
ABRO had maintained a brain pool affected by scrapie, which was called SSBP/1
(Scrapie Sheep Brain Pool). The SSBP/1 scrapie source had played a large part in
scrapie research. The source was originated in 1945 by David Wilson from three
natural cases, and had been passaged largely through Cheviot sheep.10 In order to
investigate the infectivity of scrapie, researchers in the Moredun inoculated material
obtained from SSBP/1 into goats and sheep. Then, if the normal sheep were mixed
with the experimentally scrapie-affected sheep, and had prolonged contact with a
day-old infected sheep, contact transmission of scrapie from sheep to goats occurred.
Second, other researchers at Moredun, MacKay and Smith,"also reported cases of
possible contact infection in goats. A scrapie-free goat was put with scrapie-
inoculated goats. A year later, the scrapie-free goatmanifested symptoms of scrapie
(scratching, lack of co-ordination). MacKay and Smith agreed that this occurrence of
scrapie without inoculation was a result either of the natural infection or of contact
infection of scrapie.12 This observation was contradictory to Parry's theory of a
recessive gene. Finally, in the meantime, Dickinson and Stamp investigated the
possibility of simple inheritance of scrapie in sheep. If a lethal recessive gene was
solely responsible for causing the disease, as Parry suggested, then a recognised
familial pattern should occur. If scrapie was due to a single recessive gene, then the
incidence of scrapie should be the same in the offspring of affected rams and
8 Stamp, J. T. (1962) Annual Report of Animal Diseases Research Association 1960-1961
(Edinburgh: Moredun Institute): 23
9 Stamp, J. T. (1962) 'Scrapie: a transmissible disease of sheep', The Veterinary Record 74 (12):
357-362
10 Dickinson, A.G., Smith, W. (1964) 'Adaptation of the SSBP/1 scrapie agent from sheep to
mice', Report of Scrapie Seminar, ARS 91-53 (Washington: Agricultural Research Service,
USDA): 251-252
11 J.M.K MacKay is a microbiologist, and B.S.W. Smith is a biochemist in the Moredun
Institute.
12 MacKay, J. M. K., W. Smith (1961) 'A case of scrapie in an uninoculated goat-a natural
occurrence or a contact infection?', The Veterinary Record 73(16): 394-396
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affected ewes. However, the experiment indicated that the offspring of affected
ewes had a high probability of developing scrapie, while the offspring of affected
rams had a much lower probability. This was inconsistent with the hypothesis that
scrapie was caused by a single autosomal recessive gene.13
Meanwhile, Dickinson and his colleagues at the Moredun-ABRO joint unit were
producing further evidence to indicate that scrapie was indeed both infectious and
contagious. Once Richard Chandler has shown that scrapie can be transmitted into
laboratory mice, Dickinson and Stamp built on experimental work with laboratory
mice. They investigated in more detail the phenomenon of contact transmission
from 1961.14 The main aim of this experiment was to demonstrate infection between
mice by contact. Scrapie-free were mice mixed with experimentally scrapie-infected
mice in the same cage. Consequently, some of the scrapie-free mice became infected
by scrapie, and developed the distinctive pathological features of the disease
(spongiform change in certain regions of brain). This suggested that, in this case at
least, scrapie was not a genetical disease, but a contagious one.
As a result, the Edinburgh researchers now became increasingly firm in their
conviction that scrapie is an infectious disease.15 It remained under just what sort of
infectious agent might be responsible, however. This was due to constant failure of
isolating the agent, and continued awareness of the anomalous properties of the
putative agent. Hence, scientists were continually reluctant to state that the agent of
scrapie was a virus. This reluctance in the scientific community can be seen in the
case of definition of the disease. At the time, many defined the disease as a 'slow
infectious virus', an idea suggested by an Icelandic veterinary researcher,
13 Stamp, John T. (1962) op. cit. note 8: 24; Dickinson, A.G., J.T. Stamp (1962) unpublished
work
14 Dickinson, A. G., J.M.K. MacKay, I. Zlotnik (1964) 'Transmission by contact of scrapie in
mice', journal of Comparative Pathology 74: 350-254
15 From their early works on scrapie, for instance, Greig (1950) and Wilson et. al. (1950) to
papers around 1960, most Moredun researchers held that scrapie was an infectious and
transmissible disease in sheep and goats. See Greig, J. R. (1950) 'Scrapie in sheep', Journal of
Comparative Pathology 60: 263-266; Wilson, D. R., R. D. Anderson, W. Smith (1950) 'Studies in
scrapie', Journal of Comparative Pathology 60: 267-282; Zlotnik, I., J.C. Rennie (1962) 'The
pathology of the brain of mice inoculated with tissues from scrapie sheep', Journal of
Comparative Pathology 72: 360-365; Stamp, J. T., J.G. Brotherston, I. Zlotnik, J.M.K. Mackay,
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Sigurdsson. Sigurdsson suggested that some diseases like Rida (scrapie in Iceland),
Visna and Maedi showed symptoms which developed very slowly.16 Although his
concept could not explain the whole anomalous mechanism of scrapie, the scientific
community was attracted to this novel concept, and it gained international support.
3. Investigating the involvement of host genes: developing a
standardised experimental system
As seen, Dickinson carried out these early and relatively simple experiments to
distinguish whether scrapie was an infectious or genetic disease. He had
established, at least to his own satisfaction, that scrapie is an infectious disease.
Around 1961, Dickinson and his colleagues pursued a more complex and long-term
experimental project to investigate some rather different aspects of the disease. At
the time, other scientists, especially at Compton, were endeavouring to study
biochemical aspects of the nature of the agent. However, Dickinson had a different
research aim from the others: he preferred to use pathological and genetic
techniques to investigate the ways in which the disease developed and progressed
in infected organisms.
Dickinson was interested in the fact that the incubation period of scrapie could
vary considerably from one individual of a given species to another. As a geneticist,
he was particularly interested in the possibility that this might be due at least in part
to variations in the genetic constitutions of the infected animals. Consequently,
Dickinson developed a series of experimental projects that were intended to explore
the possibility of genetic involvement.
The genetic investigation at the Moredun-ABRO unit was greatly aided by the
fact that scrapie could now be transmitted to laboratory mice, which had been
carried out serially and successfully by researchers in Compton then Edinburgh in
W. Smith (1959) 'Further studies on scrapie', Journal of Comparative Pathology 69: 268-280;
Stamp, J. T. (1962) op. cit. note 9
16 Sigurdsson, B (1954) 'Rida: a chronic encephalitis of sheep', The British Veterinary Journal
110:341-354
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1961.17 The successful transmission to laboratory animals was far more satisfactory
than working with the natural host of scrapie, i.e., sheep and goats. There are a
number of reasons why working with laboratory animals was more effective: first,
the progress of scrapie in sheep and goats is very slow, so experiments based on
measuring incubation periods would take a long time, whereas its progress in mice
is much quicker, greatly speeding up the experimental procedure. Second,
geneticists and other biomedical researchers had been maintaining and breeding
populations of mice in a variety of laboratories since the early twentieth century.18
Some of these had become quite inbred, and hence relatively genetically
homogeneous; indeed, scientists were increasingly exploiting this homogeneity for
standardising various experimental procedures. Consequently, geneticists already
knew a considerable amount about the genetic constitution and variability of some
of these various mouse stocks, and certainly more than they knew about the genetics
of even relatively pure bred farm animals such as the Moredun Institute's own flock
of Cheviot sheep. And finally, Dickinson and his colleagues plainly envisaged that
any investigation of the influence of host genetics on the development of scrapie
would involve the standard techniques of genetic investigation, i.e. controlled
breeding experiments. However, the relatively long life cycle of sheep and goats was
a major hindrance to pursuing such methods. In his directorial address in 1957,
Stamp remarked on the difficulties of conducting genetic research with sheep and
goats:
Although all this work [pathological and microbiological researches] suggests that the
cause of scrapie is a virus, we are still in conjunction with the Animal Breeding
Research Organisation, carrying on with our extensive genetical investigations for, as
many of you know, it is becoming increasingly difficult to differentiate a virus from a
17 Around the early 1960s, researchers both from Edinburgh and Compton reported that they
succeed in transmitting the agent into various laboratory animals: mice [Chandler, R. L.
(1961) op. cit. note 1], hamsters [Zlotnik, I (1963) 'Experimental transmission of scrapie to
golden hamsters', Lancet, ii: 1072], and rats [Chandler, R.L., & Fischer, J. (1963) 'Experimental
transmission of scrapie to rats', Lancet, ii: 1165].
18 Rader, Karen A. (1997) 'The origin of mouse genetics', Mammalian Genetics 8: 464-466;
Rader, Karen A. (1998) "'The mouse people": murine genetics work at the Bussey Institution,
1909-1936', Journal of the History of Biology 31: 327-354; Rader, Karen A. (1999) 'Of mice,
medicine and genetics: C.C. Little's creation of inbred laboratory mice, 1909-1918', Studies in
History and Philosophy ofBiology and Biomedical Science 30 (3): 319-343
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gene. Such genetical studies in sheep do however take many years and I, as well as you,
must be patient.19
While examining the effect of the genetic constitution of the mouse host on the
incubation time of scrapie, Dickinson was well aware that other factors might also
influence incubation time. For instance, it was well known that in many infectious
diseases the speed with which the disease developed was influenced by the dose of
infectious agent to which an organism was exposed.
If he was going to look at the influence of host genetics on the incubation period
of scrapie, then he had to ensure that any such peripheral effects were eliminated. In
effect, variation in the incubation period resulting from differences in the genetic
make-up of his experimental mice was the signal he wished to observe, while
variation in the incubation period resulting from variation in the dose of infectious
material would be noise in his experimental set up. Hence, in order to minimise
such noise, Dickinson took considerable pains to standardise the doses of infectious
material he injected into his mice.
Efficient means of measuring infectivity were made possible by the successful
transmission of scrapie into the laboratory mouse.20 The relatively short incubation
time made it possible for researchers to assay scrapie infectivity. In the early 1960s, a
group of researchers developed a method of titrating infectivity.21 Groups of 6-10
animals were inoculated with serial 10-fold dilution of the inoculum being tested. In
other words, a series of dilutions containing 0.1 per cent, 0.01 per cent and so on,
was made, and injected into animals. Then, every month the number of animals at
each dilution that developed the disease was recorded until all animals had died.22
At very high dilutions, it may be that no animals succumbed to disease. At very low
dilutions (i.e. higher concentrations) they might all do so. The dilution at which 50
per cent of the animals acquire the disease defined the unit of infective dose (IDso).
19 Stamp, J. T. (1958) 'Address by Director of the Moredun Institute', Animal Diseases Research
Association: Annual Report and Accounts: 1957-1958 (Edinburgh: Moredun Institute): 17
20 Chandler, Richard L. (1961) op. cit. note 1
21 Mould, D. L., Dawson, A. M., Smith, W. (1967) 'Determination of the dosage-response
curve of mice inoculated with scrapie', Journal of Comparative Pathology 77(4): 387-391
22 Kimberlin, R. H. (1976) Scrapie in the Mouse: a Model Slow Disease. (Durham: Meadowfield):
8
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By definition, 1 IDso unit is the dose necessary to give a 50 per cent probability of
causing disease in an animal. For example, if a 0.001 per cent dilution of infective
material results in the death of 50 per cent of animals, the original material before
dilution is known to contain 1,000 IDso units per gram.23
This method was called, "end-point titration", and it became a standard method
for assaying scrapie infectivity. The method was not without its drawbacks. As
Gordon Hunter, a leading biochemist in IRAD, claimed, "the biological titration of
the scrapie agent in mice is a tedious affair, and simpler methods of assay have been
continuously sought".24 Nevertheless, the accuracy of the method was regarded as
being beyond doubt. Moreover, the assaying titration was a necessary step for
conducting quantitative studies on scrapie. This new titration method is still
recognised as the standard and most accurate method by most researchers.
Dickinson's awareness of the involvement of host genetics was heightened by his
own efforts to refine this titration method. Dickinson claimed that "the optimum
type of animal for this purpose is one with minimum response time, minimum
genetic variability and maximum phenotypic stability to extraneous environmental
variables."25 Dickinson and his colleagues observed, when injecting scrapie into the
mice stock of Moredun mice, that there was a certain spread of variation in the
incubation period. They hypothesised that this was due to the genetic variation in
their mouse stock. Hence, they thought that if the variation of incubation could be
narrowed, then they could achieve an optimum type of laboratory mice for bioassay.
For this purpose, Dickinson selected nine different lines of mouse stock, of which
five were different standard inbred mice (SM, BSVS, RIII, LG, and C57BL)26 and four
were semi-inbred mice from Moredun. When equal doses of scrapie was inoculated
into each line of stock, they found that various ranges of incubation periods were
manifested. In the case of standard inbred mice, they displayed close similarities in
23 The BSE Inquiry (2001) The BSE Inquiry: Report Vol. 2 (London: The BSE Inquiry): 18
24 Hunter, G. D. (1974) 'Scrapie', Progress in Medical Virology 18: 294
25 Dickinson, A.G., Mackay, J.M.C. (1964) 'Genetical control of the incubation period in mice
of the neurological disease, scrapie', Heredity 19: 280
26 For short history of these different mouse strains and its various characters, see the full
database of Jackson laboratory. [Jackson Laboratory (1998) "Inbred Strain"
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response to scrapie: the incubation time shown was from 20.8 to 22.7 weeks. In
contrast, the semi-inbred mice showed significant and marked differences from each
other. This variation was taken to be evidence of residual heterozygosity.27 In this
experiment, Dickinson and MacKay concluded that "there was on average a wide
range of incubation periods between strains extending from 20 to 40 weeks, and this
aspect of the disease is evidently under a high degree of genetic control."28 From this
experiment, Dickinson was able to separate out a number of relatively inbred and
genetically homogeneous mouse lines, each of which showed a distinct and
relatively narrowly distributed spread of incubation period when inoculated with
standard doses of scrapie agent.
In the experiments just described, the variation in incubation time due to
variations in host genetics was in effect the signal they sought to isolate from the
background noise produced by other sources of variation. As a result of the
experiments, Dickinson produced a number of genetic mouse lines in each of which
the influence of host genetics on incubation time does not vary from one individual
to another. This type of mice could in effect be regarded as a standardised culture
medium in which the scrapie agent could be cultivated. By cultivating scrapie in
such standard laboratory mice, they were now in a position to look for other sources
of variation in the incubation period. As a result of this further standardisation of
their experimental system, Dickinson and his colleagues were now able to go to
perform yet more very fruitful experiments with scrapie.
4. Demonstrating strain variation in scrapie
Around 1961, Dickinson launched a long-term experimental project to detect
genetic variations in the disease itself. The basic question at the centre of his project
was distinct from other investigations on scrapie. There are several reasons why
Dickinson focused on the genetic variations of scrapie: first, among other things,
urww.inf0rmatics.jax.0r9; Rader, Karen A. (1997) op. cit. note 18; Rader, Karen A. (1998) op. cit.
note 18; Rader, Karen A. (1999) op. cit. note 18]
27 Dickinson, A.G., Mackay, J.M.C. (1964) op. cit. note 25: 287-288
28 Ibid., 288
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Dickinson had been struck by a phenomenon abeady demonstrated by other
researchers, who had reported clinically of different strains of the disease.
According to Pattison and Millson29, when sheep scrapie was transmitted to goats,
the infected animals two distinct sets of symptoms: one called 'drowsy', and the
other 'scratching'. The drowsy type had a shorter incubation period than the
scratching one. The two types of scrapie also differed in other ways. Notably, while
Chandler succeeded in transmitting the drowsy type into laboratory mice, attempts
to transmit the scratching type were unsuccessful.30
As a geneticist, Dickinson was interested in how differences between organisms
were determined and inherited. Consequently, he regarded the isolation of two
distinct strains as a fundamentally interesting feature of scrapie. He, therefore, set
out to see if he could elucidate this phenomenon further in the laboratory.
Specifically, Dickinson and his colleagues set out to see if they could isolate different
strains of scrapie in his laboratory mice. At the time, most scientists were using
physico-chemical methods to attempt to identify the agent of scrapie. He later
explains his own interests to the BSE inquiry in 1998:
[W]hen most people were saying: "we want to know what the nature of this (scrapie)
agent is," and I starting as a geneticist, said: "I think a more fundamental question is:
'what is the nature of agent variation?'" It is that distinction which still rumbles as
confusion through many documents, and has protruded into some of the evidence
given. It is a very important distinction. If you think about it, there are those who claim,
I think prematurely, that they know what the nature of the agent is in chemical terms.
The outstanding question is very much: "what are strain differences?" "What is the
nature of agent variation?"31
This research task was greatly facilitated by the high degree of standardisation
that he had already developed in his system of cultivating scrapie experimentally.
Having standardised both the dosage of infectious material and the media (i.e. the
inbred mouse strains) in which that material was cultivated, Dickinson was now in
position to identify any variations in the pathological manifestation of the disease
29 Pattison, I. H., G. C. Millson (1961) 'Experimental transmission of scrapie to goats and
sheep by the oral route', Journal ofComparative Pathology 71:171-176
30 Chandler, Richard L. (1961) op. cit. note 2; Chandler, Richard L. (1962) 'Encephalopathy in
mice', Lancet 1:107-108
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that might result from variations in the infectious agent. Consequently, his team at
Edinburgh conducted an extensive series of inoculation experiments, using scrapie
material from a variety of sources to see if such variation did indeed occur.
Dickinson's investigations into strain variation in scrapie were greatly facilitated
by the work of one of his colleagues at Moredun, Ian Zlotnik. Richard Chandler had
only succeeded in transmitting a single type of scrapie - the drowsy type in goats -
into laboratory mice. But in 1963, Zlotnik managed to transfer scrapie from Suffolk
sheep into mice. This proved to be quite different from Chandler's strain. The new
strain - named ME7 (Mouse Encephalopathy-7)32 - had a shorter incubation period,
and produced white matter vacuolation in the brain whereas Chandler's strain
produced grey matter vacuolation.
Following on this success, Dickinson and his colleagues developed a standardised
protocol for identifying and describing any variations in the patterns of neurological
lesions that might be caused by different strains of the disease, i.e., his method of
drawing up lesion profiles. Between the late 1950s and the early 1960s, researchers at
Moredun and Compton had investigated detailed pathological changes in the
scrapie-affected brain.33 From those studies, researchers had drawn up several
pictures of the pathological changes - particularly grey matter vacuolation -
occurring in the brain of affected mice. Dickinson and his team suspected that the
severity and distribution of vacuolation might vary from one strain of scrapie to
31 Dickinson, A. G. (1998) Transcript 31 of the BSE Inquiry, t31 (London: The BSE Inquiry): 4-5
32 The ME7 agent is one of scrapie strains that was isolated by Ian Zlotnik in 1963 [Zlotnik, I.,
J.C. Rennie (1963) 'Further observations on the experimental transmission of scrapie from
sheep and goats to laboratory mice' Journal of Comparative Pathology 73: 150]. This agent
originated from the brain and spleen of a natural scrapie in Suffolk sheep at Moredun. It has
some advantages for the purpose of genetic investigation: firstly, it produces clear-cut
pathological changes; secondly, it shows clear symptomatic signs of scrapie, e.g., jerky
movement, muscular tension of the body, and so forth. This agent has been used by the
Edinburgh group for twenty years, and became one of the important agents for genetic
investigations.
33 Zlotnik, I. (1957) 'Vacuolated neurones in sheep affected with scrapie', Nature 179 (6 April
1957): 737; Zlotnik, I. (1957) 'Significance of vacuolated neurones in the medulla of sheep
affected with scrapie', Nature 180(24 Aug. 1957): 393-394; Zlotnik, I. (1958) 'The
histopathology of the brain stem of sheep affected with natural scrapie', Journal ofComparative
Pathology 68:148-165; Zlotnik, I. and J. C. Rennie (1962) op. cit. note 14; Pattison, I. H. and K.
Smith (1963) 'Histological observations on experimental scrapie in the mouse', Research in
Veterinary Science 4: 269-275
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another. One of the pathologists in Moredun, Hugh Fraser,34 established a tool for
quantifying variations in the pathology, which is called "lesion profile". According
to Kimberlin, "by quantitising the severity of vacuolation in nine narrowly defined
areas of the brain, a sensitive system has been developed for studying the agent-
host interactions".35
Transverse sections of brain are stained, and scored on a 0-5 grading in such a
way as to eliminate subjective bias as far as possible. The scoring is based upon
simple observations of the pathological severity: mild, severe, moderate severe, and
so forth.36 Hugh Fraser and Alan Dickinson then defined scores for the lesion
density as follows:
Figure 1: The positions used for scoring the lesion density in scrapie in the mouse. 1:
medulla; 2. cerebellum; 3. mid-brain; 4: hypothalamus; 5: thalamus; 6: hippocampus; 7:
paraterminal body; 8 & 9: cerebral cortex.37
1: a few vacuoles, widely and unevenly scattered
2: a few vacuoles evenly scattered
34 Hugh Fraser is a veterinary pathologist; he did his first degree at the Royal Veterinary
College in London, and trained neurological disease at Cambridge. He had been involved in
scrapie research since the mid-1950s. At the time, Ian Zlotnik mainly undertook the
histopathological research at Moredun. In 1966, however, Zlotnik resigned from the head of
the neuropathology section in Moredun. In his place, Hugh Fraser joined the Moredun-ABRO
unit. He finished his PhD at the University of Edinburgh in 1971. He was head of
experimental pathology at NPU until retirement in 1995. In the series of genetic experiments
at the Moredun-ABRO unit, experimental pathology plays a crucial role in investigating the
host/agent relations. Since the mid 1960s, his role in the Moredun-ABRO unit and in NPU
was as significant as that of Alan Dickinson.
35 Kimberlin, Richard (1976) op. cit. note 22:14
36 Fraser, Hugh (1999) Interview with author (Edinburgh: 30 June 1999)
37 Ibid., 304
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3: moderate numbers of vacuoles, evenly scattered
4: many vacuoles with some confluence
5: dense vacuolation with most of field confluent38
These experimental methods proved highly successful. By the mid-sixties,
Dickinson and his colleagues were able to identify and isolate nine different strain of
the scrapie agent (ME7, 22A, 22C, 22L, 22M, 139A, 79A, 79V, and 80V: see Figure 2).
Each was characterised by a particular combination of incubation time, pathological
profile and preference for particular kinds of host mice. Moreover, each strain was
stable in these characteristics over successive inoculations from one mouse to
another.39
This experimental achievement involved an enormous standardisation of
method. Before the 1960s, scrapie research was hampered by natural variation in
experimental materials. The experimental transmission of scrapie into mice in 1961
by Richard Chandler was a major advance towards overcoming such problems. At
Moredun, Dickinson and his colleagues focused on standardising various aspects of
the experimental system: control of dose, measurement of infectivity, constructing
optimal inbred mice, measurement of incubation time, and lesion profile. These
systematic endeavours also enabled them to elicit very specific phenomena with a
high degree of predictability, reproducibility and discrimination. At this stage, in the
context of the Edinburgh group, the experimental work in scrapie research was
changed from an "art" for a few "golden hands" to a standardised, simplified, and
routine tool used by their own researchers.
38 Fraser, H., A.G. Dickinson (1968) 'The sequential development of the brain lesions of
scrapie in three strains of mice', Journal of the Comparative Pathology 78: 302
39 Although the actual experimental procedure looks simple, researchers had first to passage
each strain through many generations of mice in order to ensure genetical specificity. For
example, to obtain the short ME7 incubation period strain, Dickinson's team had to breed for
over 40 generations. They had used approximately 4,000 mice in about 400 experiments over
12 years. [Outram, G. W. (1976) 'The pathogenesis of scrapie in mice', R. H. Kimberlin (ed.),
Slow Virus Diseases ofAnimals and Man (Amsterdam: North-Holland Publishing Co.): 338]
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Figure 2: Origin of Various Scrapie Agents Isolated in the UK40
5. Elucidating the nature of the mouse genes responsible for variation
in incubation time
Having demonstrated the involvement of host genes in scrapie infection,
Dickinson's group began a series of experiments, published in 1968, which were
designed to further elucidate the nature of the host genes responsible for
determining the incubation periods of scrapie in mice.41 In this project, the key
variable observed was the scrapie incubation time. For this experiment, however,
they kept the strain of scrapie constant (i.e. working with the scrapie strain ME7
throughout), and instead manipulated the genetic constitution of the mice in which
the scrapie was cultivated. In other words, Dickinson and his colleagues were once
again taking variation in incubation time due to the host genome as the signal, and
eliminating the noise due to other sources of variation in incubation time.
40 Kimberlin, R. H. (1976) op. cit. note 22: 20
41 Dickinson, A. G., Veronica M.H. Meikle, H. Fraser (1968) 'Identification of a gene which
controls the incubation period of some strains of scrapie agent in mice', journal of Comparative
Pathology 78: 293-299
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From the previous experiment in 1964, they observed that the incubation periods
shown by the different mouse strains tended to fall into two distinct clusters: one
group being relatively long incubation and the other relatively short. They
speculated that mouse scrapie models could be divided into two groups: those
showing "operationally short" incubation periods, and those showing
"operationally long" ones. This had led Dickinson and his team to speculate further
about the nature of the gene involved. As a result of the selection and inbreeding of
the different lines of mice, and of the stability of the incubation period from one
generation to another, it could be assume that each mouse line was homozygous for
whatever genes were responsible for determining incubation period. The fact that
these homozygotic lines tended to fall into just two groups suggested that the
researchers were dealing with just two alleles of a single gene, which Dickinson and
his colleagues suggested calling Sine, which is an acronym for "Scrapie
incubation".42
Dickinson and Fraser set out to test whether or not this was the case. They
proceeded along classical Mendelian lines, i.e., if they were indeed dealing with two
alleles of a single gene, a simple series of cross-breeding experiments would
produce a classic pattern of combination of these alleles. In the experiment of 1964,43
Dickinson and Fraser selected two extreme strains of mouse line, which had long
and short incubation with the ME7 agent: the first of these, RID, was characterised
by producing a very short incubation time when infected with scrapie strain, ME7.
The RDI mouse stock demonstrates relatively short incubation periods with the ME7
strain of scrapie (20.8 - 21.5 weeks). If the single gene hypothesis was correct, this
strain should be homozygous for the short incubation allele of the Sine gene, which
Dickinson denoted s7. The second line, VM,44 was characterised by a long incubation
period (24.6 - 40.0 weeks). Again, if the single gene hypothesis was correct, the VM
mice should be homozygous for the prolonged incubation or p7 allele.
42 Outram, G. W. (1976) op. cit. note 39: 350
43 Dickinson, A.G., J.M.C. MacKay (1964) op. cit. note 25
44 A VM mouse was one of five partly inbred lines at Moredun (Dickinson, A.G., J.M.C.
MacKay (1964) op. cit. note 25: 281).
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Dickinson and his colleagues then crossed RIII with VM mice. In this case, if the
hypothesis about the genetic constitution of these two strains was appropriate, this
cross should produce a first filial generation (Fi) that was heterozygous for the two
alleles, i.e., its genotype would be s7p7. Then, when mice from the Fi generation
were infected with scrapie, they showed an incubation time that was unimodal and
intermediate between the two parental types (around 230 days). The results were
consistent with the hypotheses, so Dickinson took this result to indicate that the Fi
generation was heterozygotic for Sine, with no dominance shown by one or other
allele.
Moreover, they performed two backcrosses using the Fi generation, which also
produced results consistent with this genetic constitution. Firstly, the Fi generation
was mated with RIII mice (backcross 1: Bxi). If their hypothesis was correct, then this
would corresponded to crossing s7p7 x s7s7, and the progeny would be a mix of
s7p7 (i.e. Fi type) and s7s7. When mice from the progeny of this cross were infected
with scrapie, they did indeed show a spread of incubation times which spanned the
short and intermediate incubation times of RIII and the Fi generation. In other
words, the incubation period was distributed around 150-200 days. Secondly,
likewise backcrossing Fi generation with VM mice (Bx2), they would expect the
progeny to be a mix of Fi generation and VM type. When the progeny was infected
with the agent, it showed that the incubation period distribution had a bimodal
pattern (around 200 days and 300 days). In this case, the incubation period
conformed even more clearly to their hypothetical genotypes, falling into a clear
bimodal distribution corresponding to the VM and intermediate types.
Finally, when mice from the Fi generation were crossed with each other, the
incubation period of the resulting F2 generation appeared to be trimodally
distributed corresponding, as would be expected, to a mix of homozygous and
heterozygous mice.
More detailed results of the experiments are shown in Figure 3, below:
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Figure 3: Distribution of incubation periods in parental, F2 and backcross
generations45
All of this is consistent with the hypothesis that they were dealing with two
alleles of a single autosomal gene showing no dominance, and with two parental
types that were homozygous for one of these alleles. This conclusion was further
confirmed when the Edinburgh researchers looked at the pattern of pathological
changes in the brains of VM, RIII, and Fi mice infected with scrapie. The lesion
profile in the two parental mouse strains was different, while the lesion profile in
the Fi mice was intermediate between those produced in VM and RIII mice.46 As
seen in the Figure 4, the pathological pattern of the first generation (Fi) is an
intermediate form. This pattern is similar to the incubation period of Fi, which is
intermediate between two parental strains (VM and RIII mice).
45 Dickinson, A. G., Veronica M.H. Meikle, H. Fraser (1968) op. cit. note 41: 295
46 Ibid., 296
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Figure 4: The intensity of the ME7 scrapie lesion density in nine regions of the brain in
parental and Fi generations.47
In conclusion, the Edinburgh researchers found strong evidence that a single
host gene exerted a significant influence over the pathological development of
scrapie in mice. Dickinson and his colleagues state that "the name Sine is proposed
for it, and the two alleles which show no dominance are designated s7 for the one
which shortens the incubation period, and p7 for the one which prolongs it. The
distribution and intensity of brain lesions are shown to be quite distinct in the two
homozygotes, as represented by two mouse strains, and the heterozygote, as
represented by the Fi's cross".48
6. Demonstrating that the action of the host genes varies with different
strains of scrapie agent
In 1969, Dickinson initiated a further experiment to investigate how the Sine
gene influenced the scrapie incubation period. The previous experiment had shown
how Sine affected the incubation time of scrapie strain ME7. In the new experiment,
Dickinson looked to see if the same phenomena occurred when other strains of
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and p7. Dickinson again used the VM mouse for his p7p7 homozygote, but this time
replaced the RIII mouse with another strain, C57BL, that had since been shown to be
homozygous s7s7.49
With most strains of scrapie, the patterns of incubation time observed in the
three different mouse-lines (VM, C57BL, and Fi) were broadly similar to those
observed with ME7 - i.e. a long incubation in p7p7 mice, a short incubation in s7s7
mice and an intermediate incubation time in s7p7 mice. This is the case with scrapie
strains 22C50, 22L, 79A51, and 79V.
GENOIVPE OF MOUSE
• CS7BL (s7s7 J
▼ VM (p7p7)
x F, cross (s/p7)
200 300 400 SOO
INCUBATION PERIOD (days)
Figure 5: The variety of interactions between different strains of scrapie agent and the
alleles of Sine gene. The figure shows the incubation period of each agent in Fi mice
(s7p7) in relation to that found in the two parental strains, namely, C57BL (s7s7) and
VM (p7p7).52
However, Dickinson and his team also noticed a further and rather intriguing
phenomenon. With different scrapie strains, the precise degree of mixing of the
incubation period observed in heterozygous s7p7 mice varied. As you can see in
Figure 5, with the scrapie strain 22C, the incubation period in heterozygous s7p7
mice was closer to that in homozygous s7s7 mice than to that in homozygous p7p7
mice. In the case of 79A, by contrast, it was closer to the incubation in p7p7.
49 Dickinson, A. G., Veronica M.E Meikle (1969) 'Genetical control of the concentration of
ME7 scrapie agent in the brain of mice', Journal of Comparative Pathology 79:15-22
50 The 22C agent is obtained from the transmitted mice of C57 stock by 21st passage of Cheviot
sheep by Alan Dickinson [Dickinson, A. G. (1975) 'Scrapie in sheep and goats', R. H.
Kimberlin (ed.) Slow Virus Disease ofAnimal and Man (Amsterdam, North-Holland Publishing
Co.): 220]
51 The 79A agent is isolated from the drowsy type of goats, which is transmitted from scrapie
in the Cheviot sheep. When the scrapie in goats is transmitted into C57mice, then 79A strain
is obtained. The agent was isolated by Dickinson. (See Figure 2; ibid.,220)
52 Kimberlin, R. H. (1976) op. cit. note 22: 22
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Furthermore, with the 87A strain, the incubation time in heterozygous s7p7 mice
was identical with that in homozygous p7p7 mice.
Dickinson and his team interpreted this variability in terms of the genetic
phenomenon of dominance. Dominance is the tendency for one allele of a particular
gene to be expressed more strongly than another in heterozygous individuals. Thus,
in cases where the scrapie incubation period in s7p7 mice tended towards that in
s7s7 mice, as for instance with the 22C scrapie strain, Dickinson claimed that the s7
allele of Sine was partially dominant. On the other hand, in the case of scrapie strain
87A, where the incubation period in s7p7 mice was the same as in p7p7 mice,
Dickinson read this as indicating that the p7 allele of Sine was completely dominant.
Moreover, in the case of scrapie strain 79V, the p7 allele showed o^erdominance
where the incubation time in s7p7 mice exceeded that in p7p7. The Edinburgh group
were intrigued by the fact that the degree of dominance of the two alleles of the
mouse gene Sine varied depending upon what strain of scrapie the mice were
infected with.
Even more intriguing was the fact that, with scrapie agent 22A, the effects of Sine
alleles s7 and p7 were completely reversed. In C57BL mice, homozygous for s7, the
incubation period was longer than in VM mice, homozygous for p7 - the opposite of
what occurred with, for instance, scrapie strain ME7 (see Table 1). This implied that
the presence of the s7 allele of Sine appeared to prolong the incubation period where
the p7 allele tended to shorten it. Furthermore, in heterozygous s7p7 mice, the
incubation time was even longer than in homozygous s7s7 mice, i.e. the s7 allele
displayed over-dominance.
u - . 1i.--.ii




Table 1: Relative incubation periods in C57 and VM53
53 Dickinson, A.G., Veronica H.M. Meikle (1969) op. cit. note 49: 222. There are also clinical
differences between the two strains; mice injected with 22A agent displayed chronic
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Dickinson and Meikle speculated that there were two possible explanations for
these peculiar phenomena. On the one hand, it was possible that other host genes
besides Sine might play a role in determining the incubation period of some strains
of scrapie. On the other hand, it was possible that the different incubation time
effects were solely due differences in the various strains of scrapie agent and the
way they interacted with the host Sine gene. His next experiment was designed to
test whether the first of these hypotheses was true.
7. Eliminating the possibility that other mouse genes besides Sine are
involved
Dickinson was aware that his conclusions regarding the variance in dominance
relations between the different Sine alleles in the presence of different strains of
scrapie were entirely dependent on the truth of an important presupposition,
namely that no other mouse genes were involved, at least to any great extent, in
determining the incubation period of the scrapie agent. It was of course perfectly
possible that other host genes were involved, and were responsible for instance for
the displacement of the intermediate heterozygous incubation times towards one
homozygous extreme or the other, or for the apparent reversal of the influence of the
s7 and p7 alleles in the case of the scrapie strain 22A. Consequently, before
proceeding to reason further towards an explanation of these various phenomena,
around 1970, Dickinson and his technicianMeikle undertook a further experiment to
investigate whether or not other genes besides Sine might be implicated in
determining scrapie incubation time.54
In the previous experiment, Dickinson had only looked at the incubation period
of different scrapie strains in the parental mouse types, VM and C57BL, and in the Fi
generation produced by crossing these two mouse types. For each strain of scrapie,
progressive ataxia, in contrast with ME7-injected ones of the same stock, when the usual
syndrome was a progressive lethargy (Ibid., 216)
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these three mice populations had produced three distinctive incubation periods,
which Dickinson attributed solely to the influence of parental mouse genotypes,
s7s7, p7p7 and the heterozygote s7p7. If only the Sine gene was indeed involved,
then further crosses would produce F2 and further generations which would consist
of mixtures of the three genotypes s7s7, p7p7, and s7p7, and would consistently
produce the same trimodal distribution of incubation periods corresponding to these
three mouse genotypes. If, on the other hand, another mouse gene was involved in
determining the scrapie incubation period, then ordinary Mendelian recombination
would mean that the F2 and subsequent generations of mice would include a much
larger number of relevant genotypes. If scrapie was inoculated into these mice, it
would result in a distribution of incubation times that would not correspond to the
three earlier mouse genotypes, i.e., the two parental and the Fi genotypes.
The experiment was conducted as follows: Dickinson carried out the experiment
using VM and C57BL for p7p7 and s7s7 homozygotes, and inoculating these and
subsequent generations of mice with the ME7 and 22A strains of scrapie. They
claimed that "it was known from the previous work that the three genotypes s7s7,
p7p7 and s7p7 could be distinguished for the F2 generation in terms of the response
to ME7 scrapie and, if the same gene controls the response to the 22A strain, the
results for the F3 families should be predictable from the parental genotypes".55
Dickinson found that for both strains of scrapie, the distribution of incubation times
in the F2 and F3 generations of mice did indeed appear to follow a trimodal
combination of the incubation times observed in VM and C57BL and their Fi hybrid
(see the third diagram in Figure 5). The experimental results are as follows:
54 Dickinson, A. G., Veronica M.H. Meikle (1971) 'Host-genotype and agent effects in scrapie





























Fig. 5. Incubation period of two scrapie agents in inbred, F1( F2 and F3 mice following
intracerebral injection. Mice injected with 22A agent are shown as solid histograms,
those injected with ME7 are shown as open histograms. The Sine genotypes are given
adjacent to the appropriate modal groups.56
In conclusion, Dickinson and his colleagues saw this experiment as indicating
that only a single mouse gene, Sine, is responsible for determining the incubation
period of both the ME7 and the 22A strains of scrapie in mice. They went on to
confirm this result in a wide range of mouse stocks, including A2Gf/Lac,
BALB/cf/Lac, BRVRf/Sr, BSVS/Sr, C57BL/fa, C3Hf/Lac, DBA/2f/Lac, EM/Dk, LG/I,
LM/Dk, MM/Dk, NMRIf/Lac, RIII/Fa, SM/J, VM/Dk, and 129f/Lac. In no case were
results obtained that could not be explained by the single gene-two alleles
hypothesis.57
56 Ibid., 75. These results also confirmed the phenomena of absence of dominance with ME7 an
overdominance with 22A.
57 Dickinson, A.G., Veronica H.M. Meikle, unpublished work; Dickinson, A.G., Veronica
H.M. Meikle (1971) op. cit. note 54: 77. When many other experiments were conducted with
various scrapie agents investigating the pattern of incubation period, the main pattern was
identical to ME7 or 22A. No agent has been found with a shorter incubation in Fi than in
either parent or even as short as in the shorter parent.
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8. The replication site theory
By the mid-seventies, Dickinson and his colleagues at Edinburgh had
accumulated a very rich body of experimental knowledge and experience of the
scrapie agent and its behaviour in different lines of inbred mice. This included the
isolation and characterisation of a number of different strains of scrapie agent. Since
the early 1960s, the team had isolated at least 14 different strains of the agent.
Moreover, they identified a mouse gene, Sine, which was responsible for controlling
the scrapie incubation period, as well as identifying a number of lines of inbred mice
homozygous for one or other of the two alleles, s7 and p7. It also included strong
evidence that while the incubation time of some strains of scrapie was shortened in
mice carrying allele s7 and prolonged in those carrying p7, with other strains of
scrapie these effects of the mouse genotype were reversed. Finally, it included
strong evidence that the dominance relations between s7 and p7 in mice
heterozygotic for Sine varied in the presence of different strains of the scrapie agent.
At the time, Dickinson and his colleagues felt that they were in a position to
begin formulating a theoretical model of the interaction between the scrapie agent
and its host that would bring together and explain all those experimental results.
They began by considering the fact that genetically-determined aspects of the host
organism evidently played a significant role in affecting the rate at which the scrapie
agent could replicate and ultimately cause disease symptoms in the host. In
speculating what that role might be, they regarded the variability of the dominance
relations of the two alleles of the Sine gene as particularly suggestive. The
researchers believed that the variations in gene action were dependent upon allelic
interactions between the agent and the host genotypes (p7, s7 and s7p7).
The simplest kinds of dominance relations obtain in cases where one allele of a
gene codes for a faulty, and therefore inactive, version of an enzyme, while the other
allele codes for the active version. Organisms homozygotic for the faulty version of
the gene will be unable to produce an active version of that enzyme, so will lack the
function that it fulfils. On the other hand, organisms homozygotic for the normal
allele will be able to produce an active enzyme, and so will display that function. In
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the case of heterozygotes, a single copy of the functional gene exists, so they too will
be able to produce the active enzyme. In this case, the functional allele will display
dominance over the faulty one. The degree of dominance will then depend on
further factors. In cases where a single copy of the normal allele is sufficient to
produce enough of the relevant enzyme for full functionality, then heterozygous
organisms will be functionally identical to those with two copies of the normal
allele, thus complete dominance will obtain. On the other hand, in cases where the
functionality of the enzyme depends upon the quantities in which it is produced,
and where possession a single copy of the relevant gene results in the production of
less enzyme than in organisms possessing two copies, then functionality will be
compromised in the heterozygote and dominance will be incomplete.
In the case of the Sine gene, however, the dominance relations were rather more
complicated than could be explained on this simple activity/inactivity model. In
particular, the model cannot explain the phenomenon of ouerdominance exhibited in
the Sine gene under certain circumstances. Recall that in mice infected with scrapie
strains 22A and 79V, the incubation period in the heterozygote is longer than in mice
homozygous for the prolonged incubation allele (i.e. s7 in combination with 22A,
and p7 with 79V), rather than intermediate between the long and short incubation
homozygotes. Dickinson thought that this phenomenon was the most important
piece of information about the scrapie replication process. Dickinson's team
therefore reasoned that, in the case of the Sine gene, the proteins coded by the s7 and
p7 alleles must somehow be capable of interacting when both are present (i.e., in the
heterozygote), so as to bring about a scrapie incubation period that is longer than
when just one or other of the proteins is present.58 This overdominance, in other
words, indicates that the two-allele products do not act independently of one
another.59 According to Moira Bruce, one of Dickinson's collaborators:
I think that two proteins [as genetic products] cannot be acting independently. They are
interacting in some way. Two alleles of gene, each produces its own protein and that is
58 Dickinson, A.G., Veronica H. M. Meikle (1971) op. cit. note 54: 77
59 Dickinson, A. G. (1975) 'Host-pathogen interactions in scrapie', Genetics: Supplement 79: 390
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what you end up with; it's not just this product and that product acting independently,
which means that there is some sort of interaction between those two products.60
In considering how this interaction might occur and what it might involve,
Dickinson and his team set their genetic findings against a backdrop of more general
thinking about, and investigation into, the infectious nature of scrapie, its
pathological manifestations, and the immunological and biochemical properties of
the infectious agent.
Around the same time, there was a lot of interest in various kinds of anomalous
diseases, particularly what were seen to be virus-related diseases. The thing about
viruses is that they are not living organisms as such: they consist of a relatively small
genome of nucleic acid (DNA or RNA) wrapped in a protein coat. However, the
viruses do not possess the kind of metabolic machinery that enable living cells and
bacteria to undertake various vital functions, including self-replication. Rather,
viruses can only reproduce themselves by parasitising the metabolic machinery of
another living organism, and turning that machinery to production of new copies of
their own genome and coat proteins. It should be noted that the genomic and
protein structures of some viruses had been relatively well characterised by the
early 1970s. However, such work was also turning up a number of interesting
variants on the normal pattern of viral structure and activity. The recent discovery of
an infectious "viroid" was a good case in point. This was just a short length of naked
DNA, not even protected by a protein coat, which nonetheless was able to parasitise
plant cells and turn them to the work of replicating itself.61 This led some scientists
to speculate that the scrapie agentmight also be viroid.62
Dickinson and his colleagues speculated that the scrapie agent might be
something in effect intermediate between a viroid and a virus. The agent might
include a relatively small genome, which is replicated when the scrapie agent
replicates in the host. It might also include a protective protein coat, but this coat
60 Bruce, Moira E. (1999) Interview with author (NPU, Edinburgh: 9th June, 1999)
61 Diener, T.O. (1971) 'Potato spindle tuber virus IV', Virology 45 (2): 411-428
62 Diener, T. O. (1972) 'Is the scrapie agent a viroid?', Nature New Biology 235 (16 Feb.1972):
218-219; Diener, T. O. (1973) 'Similarities between the scrapie agent and the agent of the
potato spindle tuber disease', Annals ofClinical Research 5: 268-278
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could consist, not of specifically viral proteins, but of host proteins. In other words,
the genome of the infectious agent might not include the genetic information needed
to manufacture its own coat proteins. Rather the agent uses protein the genetic
instructions for which derive from the host genome. They called this putative new
infectious agent a "virino", to distinguish it from ordinary viruses.63 The virino's
own nucleic acids would be tightly complexed to the host protein. Thus, the virino
would not need to be a large size. The virino genome would then have only two
functions - the ability to use host processes for its replication, and the acceptance of a
coating of host molecules for its protection and infectivity.64 Dickinson and his
colleagues got the name "virino" from the Italian physicist, Enrico Fermi, who
suggested that a small nuclear particle shared some characteristics with the neutron.
He called this little neutron-like particle a "neutrino". Therefore, Dickinson calls the
infective agent of scrapie a virino. According to the science writer Richard Rhodes,
"[Dickinson] recalls Peter Medawar's quip to define his virino informally as 'bad
news securely wrapped in somebody else's protein'".65
The virino hypothesis is attractive because it serves to explain a number of the
anomalous pathological and biochemical properties of the scrapie agent. The
protective coat of host protein is consistent with its anomalous properties, including
its resistance to viricidal and antibacterial treatments, and the immunological
inertness that was one of basic themes of the original classification of slow
infection.66 According to James Hope, who worked with Dickinson:
The virino model more closely mirrored Sigurdsson's original insight - "one...suspects
that there is no effective immunity response in the slow infections, which seem to
progress unhampered for long periods of time until they kill. If immunity develops at
all, it must be a very ineffectual one. Perhaps the infectious agent is so well adapted to
its host, so well camouflaged, that it has to some extent eliminated its own species
63 Dickinson, A. G., G. W. Outram (1988) 'Genetic aspects of unconventional virus infections:
the basis of the virino hypothesis', Greg Bock & Joan Marsh (eds) Novel Infectious Agents and
the Central Nervous Systeml3 (Chichester: JohnWiley & Sons): 63-83
64 Dickinson, A. G. (1982) 'Scrapie: strategies, stalemates, and successes', Lancet 1 (29 May
1982): 1222
65 Rhodes, R. (1997) Deadly Feast: Tracking the Secrets of a Terrifying New Plague (New York:
Simon & Schuster): 164
66 Sigurdsson, B. (1954) op. cit. note 16
60
Genetic research into scrapie at the Moredun Institute, Edinburgh, 1964-1979
specificity in the immunological sense?" In the virino, the Sine gene product - a host
protein - provides the "camouflage."67
In this sense, the virino can explain why some anomalous features arise. For one
thing, the idea that the protective coat is made up of host proteins explains why
there is no observable immune response to scrapie infection. The immune system of
the host fails to recognise the scrapie agent as an invader, since the small amount of
foreign genomic material is wrapped in and protected by the proteins identical to
proteins proper to the host itself. For another thing, the idea that replication of the
scrapie agent involves commandeering the host's own protein, coded for by the host
genome, provides a way of thinking about the peculiar phenomena exhibited by the
host gene Sine.
The most peculiar and suggestive aspect of the behaviour of the Sine gene, as we
have seen, is the fact that under certain circumstances those alleles that lead to
prolongation of the incubation time of scrapie can exhibit overdominance over the
short incubation alleles, and that this implies some kind of interaction in the
heterozygote between the two different alleles or their protein products. Dickinson
and his colleagues claimed that this interaction might be explained if we suppose
that the host protein coded by Sine is involved in some way in the replication of the
infectious agent, and that the reproduction of the scrapie agent depends upon the
combination of a number of such protein molecules into multimers. In the case of
mice homozygous for Sine (whether s7s7 or p7p7), these multimeric structures
would be homomeric, i.e., they would consist of a number of identical protein
chains. However, in the case of heterozygous mice, these multimers would be
heteromeric, i.e., they would consist of two different kinds of protein monomers,
one coded by alleles s7 and the other by p7. In such cases, hypothesised Dickinson
and his colleagues, the functionality of the protein assemblages might be altered in
such a way as to bring about a particularly lengthy scrapie incubation period.
The simplest case of such interaction would of course occur if the host gene Sine
was actually responsible for providing the genetic template for the coat protein, and
67 Hope, J. (1994) 'The nature of the scrapie agent: the evolution of the virino', Annals of the
New York Academy of Sciences 724: 283-284
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the protein coat was itself the hypothetical multimeric structure. Differences in
incubation period between s7s7 and p7p7 homozygotes might then be explained if
the protein coat coded for by one allele could be produced or assembled into a
homomeric protein coat more quickly or readily than the protein coded for by the
other. More importantly, the phenomenon of overdominance might be explained if
for some reason it proved particularly difficult to combine the two different types of
coat protein, one coded by s7 and the other by p7, into a heteromeric coat structure.68
They speculated that agent replication must be very limited, otherwise the small
proportion of "quick" homomers would be sufficient to give heterozygote
incubation periods at least intermediate between the parental types, or even as short
as in the quicker homozygote.69 However, the experimental data indicated no such
case of shorter incubation time than the parental types.
The theory of the dependency of the infectious agent on the activities of the host
genome for its own replication also provided Dickinson with a way of thinking
about, and offering a speculative explanation for the relatively long incubation and
slow development of scrapie in the host. Dickinson supposed that some aspect of the
structural material or metabolic machinery necessary for replication of the scrapie
agent, and provided by the host, exists in relatively short supply in the host.
Dickinson called this the "replication site" of scrapie. Consequently, the scrapie
agent has to somehow colonise, and take control of the replication site to replicate
itself, but the speed at which this process can take place is limited by the availability
or assimilability of the replication site.
The idea of a limited availability of replication sites was confirmed by several
experiments. One of the main pieces of evidence came from a large series of
experiments in which two different strains of the agent had been shown to
68 Dickinson, A. G. (1975) op. cit. note 50: 390; Dickinson, A. G., H. Fraser (1975) 'Scrapie:
pathogenesis in inbred mice: an assessment of host control and response involving many
strains of agent' in V. T. Meulen & M. Katz (eds), Slow Virus Infections of the Central Nervous
System (New York: Springer-Verlag): 11; Dickinson, A. G., G.W. Outram (1979) 'The scrapie
replication-site hypothesis and its implications for pathogenesis', S.B. Prusiner & W. J.
Hadlow (eds) Slow Transmissible Diseases of the Nervous System 2 (London: Academic Press): 18
69 Dickinson, A. G., G.W. Outram (1979) op. cit. note 68:18
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compete.70 Mice of a particular Sine genotype were inoculated with a strain of agent
which has "slow" pathogenesis in that genotype, and then, after an interval, with an
operationally "quick" strain of agent. The interpretation of these experiments relied
on histological criteria to determine which of the agents killed the mice.71 Dickinson
and his colleagues observed that there was a kind of competition between the two
operationally different agents. The overall incubation period increased. For instance,
if the 22A agent was inoculated into RIII mice (22A in RIII mice produces a long
incubation), and after a certain interval the 22C agent was injected (22C with RIII
mice produces a short incubation), then they found that the 22A agent killed the
host. The researchers hypothesised that the replication site was being blocked by the
first-injected agent (22A), even though the second agent (22C) may be a much
quicker agent than the first one.72 In this experiment, it was concluded that the
slower agent (22A) was able to occupy all available sites so that the second agent
(22C) was excluded from participation in the disease, and must have been either
sequestered, excreted or degraded. This experiment implied support for the scrapie
replication site hypothesis. Dickinson and his colleagues claimed that "agent
competition is therefore envisaged as resulting from the agent injected first, having
had the opportunity to occupy some or all the available sites, and thus blocking the
access of agent injected later. The total efficiency of blocking achieved in the
experiment also indicates that the rate of site turnover is low."73
By the late 1970s, then, on the basis of this lengthy series of experiments, the
Edinburgh researchers had formulated a hypothetical account of the nature of the
scrapie agent and its means of replication that accounted for many of the peculiar
features of the disease. First, the agent included a small genome, of which several
distinct strains existed. This genome depended on the host organism's own genetic
machinery for its replication, which apparently took place at a limited number of so-
70 Dickinson, A. G., H. Fraser, V.M.H. Meikle, G.W. Outram (1972) 'Competition between
different scrapie agents in mice', Nature-New Biology 237 (21 June, 1972): 244-245
71 Ibid., 19
72 Dickinson, A. G., H. Fraser, I. McConnell, G.W. Outram, D. I. Sales, D. M. Taylor (1975)
'Extraneural competition between different scrapie agents leading to loss of infectivity',
Nature 253 (13 Feb. 1975): 556
73 Ibid., 556
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called replication sites. Second, the scrapie genome was protected by its close
association with protein molecules that were coded, not by the scrapie genome itself,
but by a host gene called Sine. This accounted both for the peculiar interactions
between different scrapie strains and different host genotypes, and for the striking
chemical resistance and immunological invisibility of the agent.
9. Summary
In this chapter, I have described a series of experiments performed by Alan
Dickinson and his colleagues at the Moredun-ABRO unit during the 1960s. The
experimental projects mainly dealt with genetic and pathological features of scrapie.
After constant failure of conventional physico-chemical attempts to isolate the
disease agent in the 1950s, some scientists proposed that scrapie was a hereditary
disease, due to a recessive gene. However, collaborative research at the Moredun
Institute and Animal Breeding Research Organisation (ABRO) from 1957 confirmed
that the disease was in fact a contagious disease.
Dickinson and Fraser launched a full-scale genetico-pathological project to clarify
the mechanisms of scrapie replication in the early 1960s. The new project suggested
a new way of understanding the disease. Whereas conventional approaches had
sought to isolate the disease agent, Dickinson's approach employed biological
methods to examine the nature of interactions between the agent and host genome.
Over nearly 15 years, their genetic and pathological work revealed many peculiar
characteristics of the agent. In particular, the researchers showed how one
autosomal host gene, called Sine, influences the process of scrapie replication. The
scrapie agent contained virus-like genetic information, but the agent hijacked the
host for the replication.74 Once the scrapie agent finds the right site for replication,
the host gene, Sine, produces protein which was the replicating scrapie genome.
That is why the host immune system fails to detect the invasion of the exogenous
74 Dickinson's concept of the replication site, and of the scrapie genome's appropriation of the
hosfs genetic machinery for its own replication, appears to have been informed by the
fundamental work of Francois Jacob and Jacques Monod during the 1960s and 1970s on the
regulation of gene action and transcription. See Hope, J. (1994) op. cit. note 67: 282
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agent. The scrapie agent was thus different from conventional viruses, leading
Dickinson to propose that it should instead be called a virino.
Since the first modern investigation on scrapie began in the 1910s, the scientific
community had been struggling to understand the disease. In this situation, the
Edinburgh researchers' experimental results were hailed as a remarkable
achievement.75 At the same time, however, other work was being conducted that
some scientists, at least, considered to be at odds with Dickinson's virino hypothesis.
In the next chapter, another line of experimental observations with biophysical and
molecular methods will be discussed.
75 Hunter, G. D. (1972) 'Scrapie: a prototype slow infection', The Journal of Infectious Diseases
125(4): 427-40
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Chapter 4 - Radiobiological Research at the Institute for
Research into Animal Diseases (IRAD), Compton, 1964-1978
1. Introduction
Whilst Dickinson and his team at the Moredun-ABRO unit carried out a series of
experiments to explore the genetic aspects of scrapie, another group of
microbiologists and biophysicists researched on scrapie at the Institute for Research
on Animal Diseases (IRAD), Compton. Their experimental results and speculations
on the nature of the puzzling disease were at odds with those generated by their
colleagues north of the border.
On the basis of radiobiological results, the research group at Compton speculated
that the scrapie agent might not contain genetic material, i.e. nucleic acid, which by
that time was generally regarded as the blue print of all life forms on earth. This
experimental result was contradictory to what Dickinson and his group claimed,
based on their genetico-pathological work. The experiment at Compton was led by
Tikvah Alper, a radiobiologist at London's Hammersmith Hospital, and Dr. D.A.
Haig and M.C. Clarke of the IRAD. Alper and her colleagues exposed samples of
scrapie-infected mouse brain to radiation in order to estimate the molecular weight
of the agent. This experiment relied on the so-called "target theory" in radiobiology,
which was based on the relationship between the intensity of the electron doses
needed to denature the agent and the size of the target molecule. The researchers
concluded from their experiments that the scrapie agent was much smaller than
conventional viruses, and that the agent might be able to replicate without itself
containing nucleic acid.1 Further series of experiments reinforced their support for
1 Alper, T., W.A. Cramp, D.A. Haig, M.C. Clarke (1967) 'Does the agent of scrapie replicate
without nucleic acid?', Nature 214(20 May, 1967): 764-766
66
Radiobiological research at the IRAD, 1964-1978
the latter conclusion.2 This conclusion was a striking departure from the
conventional idea that nucleic acid was essential for biological replication.3
In this chapter, I will describe the radiobiological experiments conducted by
Alper's group, and how they reached the conclusion that the agent did not contain
any genetic material. In the context of the 1960s, this radical claim met with hostile
reactions and criticisms. Nonetheless, the IRAD researchers proceeded to formulate
hypotheses about how the infectious process might occur without genetic material.
These hypotheses were intended to explain the anomalous features of the scrapie
agent.
2. The IRAD and early work on scrapie
The Institute for Research on Animal Diseases (IRAD) at Compton was
established in 1937 as one of the first field stations of the Agricultural Research
Council (ARC). The original aim of the field station was to conduct large-scale field
experiments on contagious diseases in cattle. A government committee had recently
argued that the best approach for conducting such studies was to establish a "farm
centre" under the direct control of the Council.4 In 1937, the ARC purchased the
Compton Manor Estate on the Berkshire Downs. The property consisted of 1,500
acres with suitable buildings and a herd of 400 diary cattle with a good health
history.5 The farm centre was established under the direction of Major G.W. Dunkin.
The Field Station had two main objectives: firstly, to provide isolated
accommodation for cattle and other farm animals; and secondly, to breed farm and
2 Alper, T. (1972) 'The nature of the scrapie agent', Journal of Clinical Pathology-supplement 6:
154-155; Alper, T., D.A. Haig, M.C. Clarke (1978) 'The scrapie agent: evidence against its
dependence for replication on intrinsic nucleic acid', Journal of General Virology 41: 503-516
3 Crick, F. (1970) 'Central dogma of molecular biology', Nature 227 (8 Aug.1970): 561-563
4 In 1936, a committee called the "Contagious Abortion Committee" under the Chairmanship
of Joseph Arkwright, investigated research on animal contagious diseases in many research
institutions. The committee published a report, called the "Major Committee Report", in
which they recommended setting up a farm centre to concentrate on research on animal
diseases, [see Henderson, William (1981) 'British agricultural research and the Agricultural
Research Council: a personal historical account', G.W. Cooke (ed.) Agricultural Research 1931-
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laboratory animals of known health history for experiments at Compton and to
provide a surplus of animals for other institutes.6 In 1963, the name of the field
station was changed to the present "Institute for Research on Animal Diseases".
Following the death of Major Dunkin in 1941, William Gordon, who was the main
figure in the famous "louping-ill incident"7 in the 1930s, was appointed Director. He
was very interested in scrapie research, and as soon as the opportunity arose in the
mid-1950s, as a result of renewed US and UK government concern, he resumed
scrapie research in Compton.8 In this context, in 1957, as described in the previous
chapter, Gordon conducted a large-scale experiment investigating the different
degrees of susceptibility and resistance to the disease. This experiment became
known as the "twenty four breed experiment".9
The institute consisted of four major departments: biochemistry, functional
pathology, microbiology and pathology. Apart from Gordon's susceptibility work,
each department conducted its own experimental projects on scrapie. First,
researchers in the pathology department carried out a relatively long-term project
on transmission of sheep scrapie into goats. In this project, Pattison and Mills not
only demonstrated that scrapie in sheep could be transmissible into goats,10 but also
showed, more interestingly, that scrapie in sheep and goats had two forms: drowsy
6 IRAD (1967) Agricultural Research Council, Institute for Research on Animal Diseases: Report
(Compton: IRAD): 7
7 Gordon, W. S. (1946) 'Advances in veterinary research: louping-ill, tick-bome fever, and
scrapie', The Veterinary Record 58(47): 516-525. For more detailed explanation of the accidental
experiment, see chapter 2, 'Background history of scrapie research, 1750-1960'.
8 Pattison, I. H. (1992) 'A sideways look at the scrapie saga: 1732-1991', S. B. Prusiner, J.
Collinge, J. Powell & B. Anderton (eds), Prion Diseases ofHumans and Animals (New York: Ellis
Horwood): 16; The commencement of scrapie research at Compton was decided when some
sheep exported from Britain developed scrapie in Canada, United States, Australia and New
Zealand. Those countries placed an embargo on British sheep, and this closure of export
markets created calls for control by Government. The scrapie research was set up as part of a
long-term programme, which had received financial support from the United States
Department of Agriculture (USDA) by Public Law 480 funds. For more detailed situation, see
the chapter 2.
9 Gordon, William S. (1964) 'Review of work on scrapie at Compton, England, 1952-1964',
Report of Scrapie Seminar (Washington: USDA): 19-40
10 Pattison, I. H., Gordon, W., & Millson, G. C. (1959) 'Experimental production of scrapie in
goats', Journal ofComparative Pathology 69: 300
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and scratching.11 Second, in the microbiology department, under David Haig, efforts
to cultivate the scrapie agent using cell-culture techniques were pursued with the
aim of characterising the agent more precisely.12 Third, a team in the biochemistry
department that was led by Gordon Hunter, tried a biochemical approach to its
purification.13 Fourth, one of the researchers in the functional pathology department,
Richard Gibbons, collaborated with Hunter to investigate the stability of the scrapie
agent.14
In the main, these four teams at the IRAD made little headway in their projects
during the late 1950s. However, a major experimental breakthrough was made with
the transmission of scrapie into small laboratory animals in 1961. Richard Chandler
was testing the relative susceptibility of three strains of mice to the agent of Johnei's
disease15. This familiarity with transmission experiments with laboratory mice, led
him to suggest injecting his three strains of mice with brain material from the two
types of goat scrapie. According to Michael Clarke, one of the researchers in David
Haig's department:
In the department of pathology which was headed by Ian Pattison, and Chandler was
working on Johne's disease and transmission to mice, and suggested to Pattison, I
think, that it might be worth trying transmission of scrapie material into mice, which
was what he did. And they put the scratchy and sleepy material, which Pattison had
identified, from goats into mice. And one of the two syndromes developed into
disease.16
As we saw in the previous chapter, this success in transmission stimulated
examination by other laboratories, particularly in Edinburgh. After that, researchers
in both Compton and Edinburgh could initiate large-scale research projects on
11 Pattison, I. H. and G. C. Millson (1961) 'Scrapie produced experimentally in goats with
special reference to the clinical syndrome', Journal ofComparative Pathology 71:101-108
12 Gordon, William S. (1964) op. cit. note 9: 24
13 Ibid., 24.
14 IRAD (1967) op. cit. note 6:19-20
15 The Johnei's (or Johne's) disease is a chronic debilitating intestinal disease of cattle. This
disease was discovered by German pathologist, H. A. Johne in 1894. Johne's disease occurs in
a wide variety of animals, but most often in ruminants. Ruminants are hoofed mammals that
chew their cud and have a 3-4 chambered stomach. Johne's disease has been reported in all of
the ruminants, but is most commonly seen in dairy cattle. It has been known to be caused by a
bacterium called Mycobacterium johnei. (Mycobacterium paratuberculosis)
16 Clarke, Michael (2000) Interview with author (31 May 2000: Institute of Animal Health,
Compton)
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scrapie in the laboratory. As Gordon Hunter acknowledged, the establishment of
scrapie in laboratory animals was the first step towards doing advanced
experiments. Soon after this success, Chandler and Hunter set out to show that
quantitative measurements of the amounts of scrapie agent in a given amount of
tissue could be made both on the basis of the length of the incubation period and by
normal viral-type titration, i.e., by diluting progressively until no disease appeared
after inoculation.17 Again, as discussed in the previous chapter, this technique of
titration with mice was regarded as one of major methodological advances of the
early 1960s. These advances made possible further lines of research at Compton. For
instance, using the mouse titration, David Haig and Michael Clarke in the
microbiology department, attempted to find antibodies for scrapie, but without
success.18
In another series of experiments, Hunter and Kimberlin found evidence that the
agent might be smaller than about 30nm. This result came from the filtration
experiments. Scrapie infectivity could not pass through filters with pores smaller
than about 30nm in size. This implied that the active scrapie agent was roughly
equivalent in size to small viral organisms like the picornaviruses.19 However,
biochemical methods failed to give any clear indication of the constitution of the
agent. At the same time, Richard Chandler attempted to visualise the agent using
electron microscopy.20 According to Gordon Hunter, only fragments of smooth
membranes could be identified among the main components of scrapie
preparations.21 Meanwhile, Gordon Hunter and Geoff Millson found evidence that
scrapie infectivity was closely associated with molecules that form an integral part
17 Hunter, G. D. (1993) Scrapie and mad cow disease: the smallest and most lethal living thing (New
York: Vintage Press): 64
18 Clarke, M. C. and D. A. Haig (1966) 'Attempts to demonstrate neutralising antibodies in
the sera of scrapie-affected animals', The Veterinary Record 78(19): 647-649
19 Hunter, G. D. and G. C. Millson (1967) 'Attempts to release the scrapie agent from tissue
debris', Journal of Comparative Pathology 77: 301-307; Hunter, G. D. (1993) op. cit. note 17: 64.
The picornavirus is among the most diverse and oldest known viruses. It was one of the first
viruses to be recognised by Loeffler and Frosch 1898. The viral genome consists of a single
strand of RNA with a protective coat made up of a few types of protein molecules.
20 Chandler, R. L. (1967) 'Cytopathology of scrapie in the rat: an electron microscopic study
of thalamic and hippocampal areas', Research in Veterinary Science 8(1): 98-102
21 Hunter, G. D. (1993) op. cit. note 17: 65
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of membrane structure - a conclusion they drew from their constant failure to isolate
and purify discrete particles with scrapie infectivity.22 These findings would later be
incorporated into a novel theory of scrapie put forward by the Compton researchers.
However, in the meantime, the head of the microbiology department, David
Haig, was devising a new experimental plan in association with Tikvah Alper, who
was in charge of a radiation unit at Hammersmith Hospital, London. This
collaborative work produced an extraordinary experimental result, and became a
turning point in the history of scrapie research.
3. Tikvah Alper and radiobiology
Tikvah Alper, one of the pioneers of British radiobiology, has an interesting
background. She was born in South Africa, the youngest daughter of a Russian-
Jewish political refugee. She majored in physics at Capetown University, and after
obtaining an MA, went to Germany to research into delta rays from alpha particles
under Lise Meitner, a German-Jewish woman physicist who was to play a major role
in the discovery of nuclear fission.23 Alper's paper on delta rays won the British
Association Junior Medal in 1933, and according to Jack Fowler, until the 1960s her
work on delta rays was still one of the few that provided evidence of cluster sizes.24
However, Alper could not obtain her PhD in Berlin because of the growth of anti-
semitic tendencies in Nazi Germany. Meitner and her work on the discovery of
nuclear fission vanished from view when she had to escape from the Nazi-regime.25
Alper, who was also Jewish, was unable to complete her research and returned to
South Africa, where she married a bacteriologist, Max Stern. While she was in South
Africa, she was offered the headship of the Biophysics Section of the newly
22 Hunter, G.D. & Millson, G. C. (1964) 'Further experiments on the comparative potency of
tissue extracts from mice infected with scrapie', Research in Veterinary Science 5:149-153
23 Fowler, J. (1995) 'In Memoriam: Tikvah Alper 1909-1995', Radiation Research 142(1): 111
24 Ibid., Ill
25 Because of the political situation in Germany, Meitner vanished from the list of these
engaged in discovering nuclear fission, and missed winning the Nobel Prize in 1945. Instead
of Meitner, her collaborator Otto Hahn won the Nobel Prize [Sime, Ruth Lewin (1996) Lise
Meitner: A Life in Physics (Berkeley, University of California Press)].
71
Radiobiological research at the IRAD, 1964-1978
established National Physics Laboratory. However, she circulated a petition against
Apartheid in 1951, and had to leave the laboratory and South Africa.
Alper had spent a two-year spell in Britain between 1946 and 1948. There she
had encountered the Cambridge physicist, Douglas Lea, one of the leading figures in
development of the target theory. The target theory was one of the important
theoretical frameworks in the emerging field of radiobiology, and provided a new
method of measuring the size of biological molecules.26 It was known that enormous
doses of X-rays applied to biological preparations would reduce the biological
activity of those preparations. Lea showed that ionising radiation operates on a
"target" basis such that a large molecule presents a correspondingly large target,
and so is more likely to be hit and deactivated than a smaller molecule.27 In other
words, according to Richard Rhodes, "the more intense the bombardment (needed
to deactivate a particular molecule), the smaller the molecule it would be".28 Alper
was impressed by Lea's work, and during her stay in Britain she undertook her own
experiments to apply the target theory to phage. These experiments, which led her
to introduce some significant qualifications into Lea's original theory, attracted a
certain amount of attention at the time.29
26 Lea, D.E. (1955) Action of radiations on living cells (Cambridge: Cambridge University Press);
Casarette, Alison P. (1968) Radiation Biology (Englewood Cliffs, NJ: Prentice Hall); Alper, T.
(1979) Cellular Radiology (Cambridge: Cambridge Univ. Press); Tubiana, M., Jean Dutreix,
Andre Wambersie (1990) Introduction to Radiobiology (New York: Taylor & Francis).
Radiobiology or radiation biophysics has a relatively short history. Pierre Curie performed
what might be considered the first radiobiological experiment when he used a radium tube to
produce an ulcer on his arm, and charted its progress and ultimate healing. By the 1950s,
radiobiology, especially experimental radiation biology, was gradually becoming established
as a relatively independent discipline. Most researchers in radiobiology had a physics
background26 The field has attracted engineers and physicists with a desire to contribute to
medicine and biological science. Alper and Lea both belonged to this group: she was one of
the most famous names in radiobiology, especially of those who came from medical physics
or radiation physics [Brown, Laurie M., Abraham Pais, Brian Pippard (1995) Twentieth
Century Physics (New York: American Institute of Physics press); Hill, A. V. (1956) 'Why
biophysics?', Science 124 (3234): 1233-1237; Hall, E. J. (1993) 'Nine decades of radiobiology: Is
radiation therapy any the better for it? - The Janeway Lecture 1992', Cancer 71(11): 3753-3766],
27 Hunter, G. D. (1993) op. cit. note 17: 65
28 Rhodes, R. (1997) Deadly Feast: Tracking the Secrets of a Terrifying New Plague. (New York:
Simon & Schuster): 121-122
29 Homsey, S. & Denekamp, J. (1997) 'Tikvah Alper: an indomitable spirit7, International
Journal ofRadiation Biology 71(6): 631-642: 634; According to Homsey and Denekamp, Lea and
his colleagues in Cambridge irradiated phage in dry conditions, such that only ionisations
72
Radiobiological research at the IRAD, 1964-1978
Consequently, when Alper moved to Britain in 1951, she was able to secure a
post at the MRC Experimental Radiopathology Research Unit at Hammersmith
Hospital. In that unit, she conducted further research on bacteriophage, one of the
most basic and simple models of a replicating life form available. Alper also came
into contact with the Compton research centre through a South African born
microbiologist, David Haig, who was struggling to isolate the scrapie agent by using
conventional virological methods such as the ultracentrifuge. In 1961, Haig met Max
Stern, who was a bacteriologist in the Wellcome laboratory, and husband of Tikvah
Alper. Stern suggested at the Veterinary Research Club in London that Tikvah Alper
could measure the size of the infective agent using radiation and applying target
theory.30 According to Alper, "when David Haig spoke about scrapie at a meeting of
veterinary research workers, Max (Stern) suggested that the size of the scrapie agent
might be found by the use of ionising radiation; and that was what started my
collaboration with David [Haig] and his colleague Michael Clarke".31 Clarke in turn
recalled that '[Haig] returned from this visit full of Alper's ideas about what might
be achieved - size and shape and composition of the agent.'32
This was a timely suggestion. Research into scrapie at Compton provided Alper
with an opportunity to extend the applicability of the target theory currently being
developed. Haig meanwhile was looking for other ways to tackle the problem of
scrapie, owing to his repeated failure to elucidate the nature of the agent by
conventional methods. Alper and Haig thus had a mutual interest in attempting to
estimate the size of the agent by means of radiobiologicalmethods. The collaborative
research into scrapie looked like a potentially fruitful way of fulfilling both their
interests.
within the phage were effective. From this experiment, they obtained a single exponential
survival curve, as expected from the simple target theory Lea developed. However, Alper
irradiated the phage in dilute suspension, and initially found that the survival curve was
sigmoid. She showed that the shape of the survival curve also depended on the time of
planting the phage after irradiation, and the indirect action of the radiolysis products of water
in the suspension media had an influence on the different results. This was not what Lea
expected, and he was not pleased. There were some debates between Alper and Lea.
30 Ibid.
31 Alper, T. (1993) 'The Scrapie Enigma: Insights from Radiation Experiments', Radiation
Research 135: 285
32 Clarke, Michael (2000) Personal communicationwith author (6th May 2000)
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The project commenced in 1964. As it was a collaborative work, there was a
division of labour between the two groups Clarke carried out the preparation of
materials at Compton, Alper irradiated the samples at Hammersmith then sent them
back to Compton where Haig inoculated them into mice. Each experimental process
took about a year. Alper irradiated the samples using the linear accelerator (8MeV)
in the Medical Research Council's Cyclotron Unit at Hammersmith Hospital, which
was the first such machine dedicated to medical and biological use.33 The aim of the
experiments was simple; they intended to estimate the size of the scrapie agent; its
molecular weight and diameter.34
4. Alper's radiobiological experiments with scrapie (1964-1969)
In this period, two series of experiments were conducted which depended upon
the principles of radiobiology. The first experiment was to follow the work of
Douglas Lea on the use of quantification of inactivation by ionising radiation to
determine target size. In the second experiment, exposure to ultraviolet (UV) light
was tried, in order to determine the degree to which the scrapie agent could
withstand UV radiation. In both cases, the infectious material came from mice brain
infected with "Chandler's strain" of the scrapie agent.
4.1. Estimating the size of the scrapie agent
Alper's first experiment involved applying the target theory to the scrapie agent
to obtain an estimate of its size. According to the target theory, molecular size and
weight can be estimated from the radiation doses needed to inactivate that molecule.
The size of a biomolecule is inversely proportional to the radiation dose required to
inactivate a given fraction of the population. The freeze-dried samples of scrapie-
33 This machine was installed in 1952, and switched off for the last time in 1984. It was used
for clinical and non-clinical research. As mentioned, it is the first 8 MeV-capacity accelerator
and this made the scrapie research possible [Bewley, D.K. (1985) 'The 8MeV linear accelerator
at the MRC Cyclotron Unit, Hammersmith Hospital, London', British Journal of Radiology 58:
213-217],
34 Alper, T., D.A. Haig, et al. (1966) 'The exceptionally small size of the scrapie agent',
Biochemical and Biophysical Research Communications 22: 278
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infected material were taken and exposed to various doses of radiation from the
linear accelerator at the Hammersmith hospital. Then, Haig's team injected the
samples into healthy mice to see if that material was rendered less or non-infectious,
and the results were compared to what was already known about the effects of the
same kind of radiation on other biological molecules and small molecular
assemblages including ribonuclease and various bacteriophages.35
Initially, they used doses up to 2 megarads, which would normally be sufficient
to inactivate the majority of infectious bacteria and viruses. However, they found
that these doses had no effect on the infectivity of the scrapie material.
Consequently, they exposed that material to larger doses of radiation from 2 to 25
megarads, and found that a minimum dose of around 5 megarads was needed to
render that material non-infectious, i.e. to inactivate the infectious agent.36
According to Clarke, who was participating in this project:
In the first experiment, doses of up to 2 megarads were used; 2.5 megarads was the
dose used in those days to sterilise heat labile material. No measurable loss of
infectivity was detected in any of the samples. Larger doses of irradiation were then
used and inactivation of infectivity obtained, a further experiment was conducted to
obtain a more accurate estimate of target size.37
For comparative purpose, Alper and her group already had much data on a
variety of molecular weights and sizes which were calculated by the target theory,
e.g. ribonuclease, lysozyme, bacteriophage R17 (RNA phage), bacteriophage T3. The
minimum dose of around 5 megarads for inactivation was about the same dose as is
35 Bacteriophages are small viruses, consisting of a protein coat plus either DNA or RNA, that
infect and replicate in bacteria. They are widely used in laboratory research into various
genetic processes, since their replication (or failure to replicate) can easily be observed in
bacterial cultures. Infection of a liquid suspension of bacteria with phage results in the
bacteria being lysed (basically, fragmented), with the consequence that the cloudy culture
turns clear. Phage preparations can also be spread onto a gel culture or 'lawn' of host bacteria,
and infection can then be seen as clear spots on the cloudy plate, making it possible to count
the number of phage particles in the original preparation. Inactivation experiments on
bacteriophage would be carried out be exposing a sample of the phage to radiation, then
adding it to a plate or suspension of host bacteria, usually E.Coli, to see if those bacteria
become infected or not. The properties of various phages, including molecular weight and
structure, are pretty well known.
36 Alper, T., D.A. Haig, M.C. Clarke (1966) op. cit. note 34:279
37 Clarke, Michael (2000) op. cit. note 32
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needed to inactivate bacteriophage T3, which is one of the smallest bacteriophages.
Alper and her colleagues took this as indicating that the scrapie agent was
approximately the same size as phage T3, i.e. between 1 - 2 x 105 daltons.38
4.2. Preliminary investigation with UV radiation
In view of the high resistance of the scrapie agent to ionising radiation, Alper
and her colleagues also decided to try a different kind of radiobiological
investigation of the properties of the agent - looking at the effects of UV radiation,
which was known to be bactericidal and viricidal, on the infectivity of the scrapie
agent. Alper and her collaborators exposed scrapie infected material to a range of
doses of UV from a low-pressure mercury lamp, which was known as a germicidal
lamp. This experiment was similar to the ionising one in that it used the same
methodology of irradiation, inoculation and titration of infectivity, but it differed
from the previous one in that it was not based on target theory, i.e. it was not
intended to measure the size of the scrapie agent. Rather, it was just about seeing
whetherUV had similar effects on the scrapie agent as on other infectious materials.
However, they found more surprising results than in the previous experiment.
To reduce phage T3 to 1% of infectious activity, a dose of 103 ergs/mm2 of UV
radiation from a standard germicidal lamp (wavelength 245nm) would suffice.
However, to effect a similar reduction in activity of scrapie material, a much larger
dose of radiation of more than 2.4 x 104 ergs/mm2 was required. In other words, the
scrapie agent was extraordinarily resistant to deactivation by UV light.39 The
researchers themselves were confused by this extraordinary outcome. Clarke
explains the situation at the time:
When there was an assay involved, I was looking at mice every week to score. So that
one can see a picture developing from fourteen or so weeks onwards up to thirty, the
mice developing scrapie, and one can get a feel for a comparison between one example
and another. So in the first experiment, I got a feeling early on that the irradiation that
had been used was not effective, because there was no reduction compared with the
controls. There are some months while the experiment is developing, when one has an
38 Alper, T. (1992a) 'New insight into the nature of scrapie from old radiation results', British
Journal ofRadiology, supplement 24:1
39 Alper, T., D.A. Haig, M.C. Clarke (1966) op. cit. note 34: 281
76
Radiobiological research at the IRAD, 1964-1978
opportunity to think about the implications of what has actually been happening. It
was Tikvah Alper who suggested, because we got no reduction with the first
experiment using ionising radiation, that we should try ultraviolet light. Ultraviolet
light of wavelength 245 was known to be viricidal or bactericidal. It was a common
enough thing to use at that time, and so we did the experiment and we got no
inactivation.40
How to explain these results? Germicidal UV light of the kind used in this
experiment was generally understood to inhibit the infectivity of viruses and
bacteria by disrupting the structure of nucleic acids. Alper and Haig suggested a
possible hypothesis, that scrapie infection might not involve replication of nucleic
acids. In the paper of 1966, they claimed that "the agent may be able to increase in
quantity without itself containing nucleic acid".41 As an additional argument in
support of this very unorthodox proposal, they pointed to the previous experiment,
which suggested that the scrapie agent had a molecular weight of 1-2 x 105 daltons.
This is very small, and so would be in keeping with the view that the scrapie agent
has a relatively simple structure which perhaps does not contain nucleic acid.
4.3. Further UV experiments
In 1967, Alper and her collaborators launched a further experiment using ultra¬
violet light. One aim of the experiment was to reconfirm the extraordinary
characteristics of the agent that had been observed in the previous experiments.
Particularly, they intended to throw more light on the question of the involvement
of nucleic acid in the replication of the scrapie agent. But this time the material was
exposed to two different wavelengths of UV light of 254nm and 280nm, understood
to have different effects on biological molecules. In radiobiology, the wavelength of
254nm is understood to disrupt nucleic acids, while that of 280nm disrupts proteins.
The first half of this experiment looked at the effects of UV of around 254nm, and
compared the effect on scrapie material with the effects on organisms that are
known for their high resistance to UV light. These are coliphage "fr" (a
bacteriophage) and Micrococcus radiodurans (a bacterium which is understood to
have a very effective mechanism for repairing DNA damage due to UV light). Both
40 Clarke, Michael (2000) op. cit. note 16
41 Alper, T., D.A. Haig, M.C. Clarke (1966) op. cit. note 36: 283
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are rendered largely non-infectious or inactive by doses of 1-2 x 104 ergs/mm2, i.e.
their genome is damaged and their ability to replicate is almost entirely destroyed.
Alper and her colleagues also compared the effect on the scrapie agent with genetic
marker Nbi, which was known to be somewhat more resistant to UV light.42 By
contrast, doses up to approximately 5 x 104 ergs/mm2 of UV light at 254nm had no
effect on the infectivity of the scrapie agent (see Figure 1). This meant that radiation
that was understood to have a seriously damaging effect on nucleic acids did not
affect the scrapie agent. It was, therefore, in keeping with the hypothesis that
infectivity and replication of the agent do not involve nucleic acids.
Figurel: Effects of UV light in the range 254-265mA.43
In the second half of this experiment, Alper and her colleagues looked also at UV
light of 280 nm, which was known to deactivate proteins. If the replication of the
scrapie agent was to depend on the integrity of a protein, it would be expected that
42 In general, genetic markers are short pieces of the genome of some organism or other that
can readily be measured by titration with appropriate reagents. In the case of Nbi, it was
found that it resisted to UV treatment, and had a very effective repairing mechanism. This
was reported by M. H. Patrick and C. S. Rupert in 1967. [Patrick, M.H.& Rupert, C.S. (1967)
'The effects of host-cell reactivation on assay of UV-irradiated Haemophilus influenza
transforming DNA', Photochemistry and Photobiology6 (1): 1-20]
43 Alper, T., W.A. Cramp, D.A. Haig, M.C. Clarke (1967) op. cit. notel: 756
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irradiation by UV light would be at its most effective at about just such a range.44
Alper looked at the effects of doses of this light of up to 7 x 104 ergs/mm2 on various
viruses, enzymes and genetic markers, all of which were found to be severely
reduced or deactivated by such light. The effect of similar doses of UV 280nm on the
infectivity of the scrapie agent was not strong, but did seem to indicate a small
degree of reduction in infectivity at high doses.45 This result is shown in Figure 2,
below:
Figure 2: Effects of UV light in the range 280-285mA.46
Alper and her collaborators tentatively suggested that this might indicate that the
scrapie agent was suffering some protein damage leading to a reduction in
infectious activity. In further support of this view, they pointed out that the closest
deactivation curve to that for scrapie agent was found with the enzyme aldolase, a
large protein of molecular weight 1.4 x 10s, i.e., pretty close to what they estimate for
the scrapie agent.47
47 According to Setlow, R.B. & Doyle, B. (1957), it had highly resistant characteristics against
UV light. [Ibid.]





Radiobiological research at the IRAD, 1964-1978
In conclusion, Alper and her colleagues did not make any strong claim about
what they thought that the scrapie agent was. In particular, they were careful not to
say they thought it was a protein. However, they did venture the suggestion that
their evidence indicated that it did not depend on a nucleic acid fraction for its
replication. According to Alper, in view of "the evidence that the agent appeared
effectively transparent to 'germicidal' UV, we were bold enough to suggest that the
agent must be capable of replication without depending on the integrity of a nucleic
acid moiety".48
Alper and Haig's sceptical view on nucleic acid in the agent was bucking the
trend of conventional wisdom. They and their collaborative team were fully aware
of the potentially explosive implication of their conclusions. Consequently, they
were anxious not to appear dogmatic, and instead adopted a position of open-
minded empiricism. Michael Clarke explains the situation:
At that time I think as a group, we were open to views of others, and we tried not to
establish a hypothesis. We reported what we found, and the indication from our work
was that the agent might not contain nucleic acid. We didn't know what it was. We
were reporting our findings, which indicated it might not be nucleic acid.What one has
to take along with this, were the other factors that were known to be associated with
the disease - its pathology; its lack of cellular response, no antibody response, but it is
transmissible. And it appeared to be very small. What was it? We didn't know. Other
people produced hypotheses of one sort or another. I think if you read our papers, we
didn't actually suggest what it might be, we just suggested what it wasn't; and that it
wasn't nucleic acid. But in some of the experiments that we did, I think, by implication,
because we compared it with proteins, we suggested that protein might be an
important component of it, other than nucleic acid.49
As seen in the quotation above, they claimed they were only reporting their
experimental results, rather than offering speculative explanations for those results.
But their willingness to accept that those results might contradict some of the most
fundamental principles of biological theory - notably the "central dogma" that all
life forms are coded by nucleic acid genomes - says much about their disciplinary
priority. As Alper described in a letter to Haig, the work was an "essay in classical
48 Alper, T. (1993) op. cit. note 31: 285
49 Clarke, Michael (2000) op. cit. note 16
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radiobiology".50 The central dogma was not highly significant for her in interpreting
the experimental results; instead, she read the data on the basis of her own
radiobiological principles. If radiobiological experiments failed to provide evidence
of nucleic acids, Alper had no difficulty accepting that nucleic acids might not be
present. This extraordinary result, and the implications Alper drew from it, initiated
a controversy on the nature of scrapie that endured during the late 1960s and early
1970s.
4.4. The UV action spectrum of scrapie
In the 1960s, the only UV radiation device used in England was the 15-watt
capacity germicidal lamp. Consequently, Alper and her colleagues had only been
able to conduct fairly crude experiments with light of around 145 and 280nm.
However, she was keen to look at the effects of more specific and intermediate
wavelengths of UV light on the scrapie agent. In 1970, one of the prominent French
radiobiologists, Raymond Latarjet51 in the Institut du Radium in Paris, also known to
Tikvah Alper, wrote to her saying that his colleague had developed new systems for
irradiating at particular wavelengths. Collaboration between Alper and Latarjet
followed on from there.
At the time, the Paris institute had a 500W high-pressure mercury lamp. This
meant they could conduct experiments at various high energy levels, and more
importantly, using different wavelengths of UV lights they could achieve finer
control over the wavelength of the radiation generated. Alper took scrapie material
over to Latarjet's laboratory, where it was exposed to UV at different wavelengths,
and brought it back to Compton for inoculation research.52
50 Clarke, Michael (2000) op. cit. note 32
51 Raymond Latarjet is regarded as one of the fathers of modem photobiology in France. He
was one of the founding members of the Comite Internationale de Photobiologie in 1950, and
became the president of the organisation between 1960 and 1964. He died in 1998. (Setlow,
Richard B. (1998) "Raymond Latarjet 1911-1998" American Society for Photobiology Newsletter
27 (4) [online: www.photobiology.org/Newslttr/asp_nl69.html])
52 Clarke, Michael (2000) op. cit. note 16
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Figure 3: Left: action spectra for a number of viruses and virus core nucleic acids.
Right inactivation of scrapie agent (x) relative to the distribution of action spectra for
viruses and virus core nucleic acids (shaded area).53
Using Latarjet's device, they exposed the material to wavelengths of 237, 254, 267,
and 280nm. Alper, Latarjet and other colleagues could then compare the "action
spectrum" of the scrapie agent with other known absorption spectra. Action spectra
describe the extent to which ultraviolet light with different wavelengths tends to
inactivate infectious organisms. In general, biological entities containing nucleic acid
show a common pattern of action spectra, with a maximum inactivation with UV
wavelengths of 260 to 270nm, and in the case of most viruses, a minimum in the
range 235-245nm,54 as can be seen in the shaded area in the left figure of Figure 3.
The result for scrapie material was quite different with a marked increase rather
than a reduction of inactivation at 237nm, and no peak at around 260-270nm.
Alper and her colleagues took this as further confirmation that the scrapie agent
was radiobiological^ quite dissimilar to conventional viruses. In particular, Alper
concluded that it was impossible to reconcile the behaviour of the scrapie agent with
the presence of nucleic acids. As Alper recalled in 1993, "these results were excellent
53 Alper, T. (1992a) 'New insight into the nature of scrapie from old radiation results', British
Journal ofRadiology, supplement 24: 34
54 Latarjet, R., B. Muel, D.A. Haig, M.C. Clarke, T. Alper (1970) 'Inactivation of the Scrapie
Agent by Near Monochromatic Ultraviolet Light', Nature 227 (26 September, 1970): 1342
82
Radiobiological research at the IRAD, 1964-1978
confirmation of the non-involvement of nucleic acid in scrapie replication".55 Thus
where the previous experiments led to the speculation that the scrapie agent is much
smaller than most normal infectious agents, and perhaps that it contained no nucleic
acid structure, after this experiment, what had been mere speculation became
confident belief that scrapie agent could replicate without depending upon nucleic
acid.
5. Building hypotheses to explain results: the 1967 gold rush
Whilst Alper and Haig's team reported unusual characteristics of the scrapie
agent from their radiobiological experiments, some researchers rushed to produce
their own versions of speculation on the nature of the agent. In this sense, 1967 was
the year of the gold rush as a number of Alper's colleagues at Compton sought to
explain her results.
Soon after Alper and Haig's team reported their results of radiobiological data,
other researchers in the pathology department, Iain Pattison and Katherine Jones,
suggested that a small protein might be responsible for transmitting the disease.
They claimed to have discovered the scrapie agent from the tumours of mice, and
from nucleoprotein material from normal mice. Moreover, the causal agent of the
tumours (allergic encephalomyelitis), identified as a basic polypeptide, had a
resemblance of the scrapie agent. From this result, Pattison and Jones speculated "if
the possibility is considered that the scrapie agent is present in an inhibited form in
normal tissue and in a released form in scrapie tissue, such unmasking would
provide an alternative explanation to self-replication."56 However, this bold claim
was dismissed as due to laboratory contamination. According to Gordon Hunter in
1992, Pattison, like so many others, overstated his case, while cross-contamination
was obviously quite inadequately controlled.57 Later, Pattison himself described the
55 Alper, T. (1993) op. cit. note 31: 283-292
56 Pattison, I. H., Katharine M. Jones (1968) 'Detection of the scrapie agent in tissues of
normal mice and in tumours of tumour-bearing but otherwise normal mice', Nature 218 (6
April 1968): 102-104
57 Hunter, G. (1992) 'The search for the scrapie agent', S. B. Prusiner, J. Collinge, J. Powell and
B. Anderton (eds), Prion Diseases ofHumans and Animals (London: Ellis Horwood): 27
83
Radiobiological research at the IRAD, 1964-1978
situation, although he still believed in the validity of the experiment: "this
suggestion was impartially reviewed in the Nature-Times News Service of April 8,
1968, but was disbelieved by almost all workers in the scrapie field, the consensus
being that our results could be explained by laboratory contamination."58
Meanwhile, in a paper of 1967, Gibbons and Hunter pointed out that Alper's
radiation experiments provided evidence that the agent should not be considered to
be a virus, a nucleic acid, a protein or polysaccharide.59 Instead, they formulated a
theory that the disease occurred by the self-copying process of a membrane. The
researchers inferred the significant role of the cell membrane from various chemical
experiments, and from their own endeavours to isolate pure infectious particles
from scrapie samples by differential centrifugation techniques. Despite fifty
attempts to extract the isolated form of the agent, they found that infectivity was
always associated with membrane debris.60 They suggested that the scrapie agent
could not be purified because of the tenacious attachment of cellular debris,
particularly fragments of membrane, which are usually rather resistant to chemical
and physical treatments, owing to protection by the lipid layers. The membrane
theory could also explain other anomalous aspects of scrapie. The self-copying
capacity of membranes could explain how the agent replicated in the absence of
nucleic acid. Hunter and Gibbons also postulated that the membrane played a role
in protecting the infective particles from immune detection, hence the lack of
immune response. Furthermore, the researchers were able to produce evidence that
was consistent with the membrane theory in terms of the operational size of the
agent: the size was the same as the smallest membrane debris.61
58 Pattison, Iain (1988) 'Fifty years with scrapie: a personal reminiscence', Veterinary Record
123(26-27): 664. Michael Clarke also expressed the view Pattison's evidence for the protein
theory was too weak to put forward a hypothesis. [Clarke, Michael (2000) op. cit. note 16]
59 Gibbons, R. A., G.D. Hunter (1967) 'Nature of scrapie agent', Nature 215 (2 Sept. 1967):
1041-1043
60 Hunter, G. D. and G. C. Millson (1967) 'Attempts to release the scrapie agent from tissue
debris', Journal ofComparative Pathology 77: 301-307
84
Radiobiological research at the IRAD, 1964-1978
6. Radiobiological evidence in support of the membrane theory
Stimulated by this hypothesis, Alper and her collaborators launched a new
radiobiological experiment in the late 1970s.62 In radiobiology, it had long been
known that cells are more sensitive to ionising radiations in the presence of oxygen
than in anoxia. The role of oxygen was established by radiobiologists, and it was
they who determined the "oxygen enhancement ratio" (OER) for living cells which
is of the order of 3 in general. According to Latarjet, simpler systems like isolated
nucleic acid are about equally sensitive in the presence and absence of oxygen in
aqueous media (OER=l).63 Interestingly, the presence of oxygen during irradiation
greatly enhances the damaging effect of ionising radiation on biological membrane.
This means, for instance, that a preparation of lysosomal enzymes and membrane
components will lose its biological activity more readily when irradiated in the
presence of O2 than without. This was demonstrated by D.K. Watkins, who showed
that that for sub-membrane system including lysosomes, the oxygen enhancement
ratio was in the region of 10-20.64
Alper saw this a further means of investigating the properties of scrapie agent,
and seeing how it compares to other infectious agents. Consequently, in 1978, she
looked at the OER in a variety of bacteria, viruses transforming DNA, enzymes and
lysosomes.65 She found that in viruses, i.e., where the nucleic acid was surrounded
by a protein coat, the OER was approximately 1 (OER=l) or less than 1 (OER <1).
61 Kimberlin, R. H., G.C. Millson, et al. (1971) 'Biochemical and histopathological changes in
the brains of mice inoculated with scrapie by the intraperitoneal route', Journal of Comparative
Pathology 81:469-477
62 Alper, T., D.A. Haig, M.C. Clarke (1978) op. cit. note 2
63 Latarjet, R. (1979) 'Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease, and kuru
by radiations', S. B. Prusiner and W. J. Hadlow (eds), Slow Transmissible Diseases in the Nervous
System (New York: Academic Press) 2: 391
64 Watkins, D. K. (1970) 'High oxygen effect for the release of enzymes from isolated
mammalian lysosomes after treatment with ionizing radiation', Advances in Biological and
Medical Physics 13: 289-306
65 Alper and her colleagues presented a variety of data which showed the presence of oxygen
when molecules were irradiated provided protection against damage to their functions, e.g.,
bacteriophage S13, bacteriophage Ti, DNA of uXm, transfer-RNA, escherichia coli, transforming
DNA, Lysozyme, Ribonuclease, Lysosomes and scrapie [Alper, T., D.A. Haig, M.C. Clarke
(1978) op. cit. note 2: 513],
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However, in the case of the scrapie agent, as in the case of lysosome, the ratio was
about 12 (OER=12).
Test system Test of damage OER
Bacteriophage S13 Loss of infective activity 0.50
Bacteriophage Ti Loss of infective activity 0.35
DNA of 0X174 Loss of infective activity 0.56
Poly-uracil Loss of pheylalanine synthesising ability 0.74
Transfer-RNA E. coli Loss of transfer activity 0.47
Transforming DNA Loss of transforming activity 0.8-1.1
Lysozyme Loss of enzyme activity 0.80
Ribonuclease Loss of enzyme activity 0.74
a-Chymotrypsin Loss of esterase activity 0.43
Lysosomes Release of p-glucurocidase 10-20
Scrapie Loss of infectivity 12
Table 1: Ratios of radiation doses
Alper took this as evidence that replication of the scrapie agent involves some
kind of membrane system or component. In addition, it appears that Alper had now
obtained details of the UV absorption spectrum of endotoxin, which is a constituent
of bacterial membrane. She noted that this was apparently similar to the UV action
spectrum for scrapie agent that she and Latarjet had obtained in 1970. Alper also
took this as evidence that scrapie replication involved a membrane component.
Alper and her collaborators said that "this provides support for the original
'membrane hypothesis' of Gibbons and Hunter, and that this support is augmented
by the apparent similarity between the absorption spectrum for endotoxin (a
constituent of bacterial membrane) and the action spectrum for scrapie".67 Overall,
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From the experiment in 1978, Alper and her colleagues concluded that the
replication of scrapie was neither due to a nucleic acid core nor to protein, but rather
involved replication of a plasma membrane. As Gibbons and Hunter claimed in
1967, "one may take advantage of our ignorance of the way membrane is
synthesised to suggest that it may in fact be produced by a self-copying process not
directly involving nuclear DNA, and that a foreign membrane fragment may
become incorporated and later copied."68 Alper thought Gibbons and Hunter's idea
was supported by her experimental data. Furthermore, during the 1980s, many
experimental results revealed the role of membranes and its mechanisms of growth
and division.69 The development of research on membranes led her conclude that
healthy cell might incorporate fragments of foreign disease-carrying membrane,
which would be copied. Thus, the replication process of the agent is dependent
upon the growth and division of the cell membrane. From the viewpoint of their
hypothesis, nucleic acid is not necessary to replicate the infectious agent.
Unfortunately, the scientific community failed to pay attention to this hypothesis.
This failure of recognition amongst scientists was partly because Alper and her
colleagues omitted to institutionalise this approach, as I will discuss in the next
chapter.
During the 1970s, the Agricultural Research Council refused to fund any more
research on scrapie at Compton, and the group could not continue their
collaborative projects any more. Then, in the early 1970s, Alper retired from the
directorship of MRC Experimental Radiopathology Research Unit at Hammersmith.
Nevertheless, Alper herself continued to focus on the radiological research on
scrapie. Tikvah Alper died in 1995, and her co-workers changed to other research
topics, eventually retiring from scientific practice.
68 Gibbons, R. A., G.D. Hunter (1967) op. cit. note 64:1042
69 Palade, G.E. (1983) 'Membrane biogenesis: an overview', Methods Enzymology 96: XXIX-LV
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7. Summary
In this chapter I have described a series of experiments by Tikvah Alper and her
colleagues at the Hammersmith Hospital and IRAD. During the 1960s, many
research groups launched a variety of experimental projects aimed at understanding
the mechanism of scrapie. Several research groups in IRAD in particular
energetically studied the disease by using conventional biomedical methods.
However, these were not successful. Conventional methods evidently did not work
for investigating scrapie. In this context, David Haig and Tikvah Alper launched a
new project to estimate the molecular size and weight of the agent using
radiobiological methods. They found not only that the agent was very small, but also
that it was resistant to UV irradiation. They concluded that reproduction of and
infection by scrapie could not involve nucleic acids. This unusual property of the
scrapie agent baffled researchers.
Soon after these experiments, scientists in IRAD put forward their own
hypothetical explanations for the extraordinary characteristics of the agent. Alper
and Haig found that their experimental results were compatible with one of the
suggested hypotheses, the membrane theory, that was put forward by Hunter and
Gibbons. Their theory could explain how replication might occur without involving
nucleic acid, by locating the scrapie agent in a self-replicating plasma membrane.
Since Alper and her colleagues reported the exceptional properties of the scrapie
agent in 1967, the results started a controversy raging in the scrapie research
community. Their results met with considerable criticism, because the conclusions
implied deviation from the conventional wisdom of biology, the 'central dogma'.
Moreover, the conclusion of their work were also at variance with what Dickinson's
group at the Moredun-ABRO unit had shown, namely, strain variation of the agent.
The two ideas were the subject of controversy during the 1970s, and no consensus
was reached. In the next chapter, I will discuss how the controversy developed, and
how each side criticised and reinterpreted the competing theories and data. In
addition, I will also examine the outcome of the controversy between two theories at
the end of the 1970s.
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Chapter 5 - How controversy ends:
Disputes on the nature of scrapie and their closure, 1967-1980
1. Introduction
In the previous chapters, I have introduced two cases of experimental projects on
scrapie during the 1960s, and have shown how the researchers reached apparently
contradictory conclusions on the nature of the scrapie agent. One group assumed on
the basis of genetic experiments that the scrapie agent must contain an informational
molecule.1 The other group demonstrated that the agent was resistant to various UV
lights, and concluded that it did not contain a nucleic acid genome.2 Both
speculations were based on carefully controlled experimental programmes. Soon
after each group brought out their experimental data, relations between the two
groups quickly degenerated into hostility and controversy that raged through the
1970s. However, the dispute came to an end with the extraordinary intervention of
the governing body, the Agricultural Research Council (ARC), in the late seventies.
On the whole, the scientific community and policy makers inclined to the more
conventional conclusion of the first group. The radical interpretation of the second
group faced too much antipathy and was passed over by the scientific community in
the end.
In this chapter, I shall discuss the overall course of the controversy. I analyse
how the scientific community reacted to the conflicting laboratory results. Moreover,
1 Dickinson, A. G., Veronica M.H. Meikle, H. Fraser (1968) 'Identification of a gene which
controls the incubation period of some strains of scrapie agent in mice/ Journal of the
Comparative Pathology 78: 293-299; Dickinson, A. G., Veronica M.H. Meikle (1971) 'Host-
genotype and agent effects in scrapie incubation: change in allelic interaction with different
strains of agent/ Molecular and General Genetics 112: 73-79; Dickinson, A. G., G.W. Outram
(1979) 'The scrapie replication-site hypothesis and its implications for pathogenesis/ S. B.
Prusiner & W. J. Hadlow (eds) Slow Transmissible Diseases of the Nervous System 2: 13-31
(London: Academic Press)
2 Alper, T., W.A. Cramp, D.A. Haig, M.C. Clarke (1967) 'Does the agent of scrapie replicate
without nucleic acid?', Nature 214 (20 May, 1967): 764-766; Alper, T. (1972) 'The nature of the
scrapie agent/ Journal of Clinical Pathology-supplement 6: 154-155; Alper, T., D.A. Haig, M.C.
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I will show that the conflicting theories on scrapie were closely associated with
distinctive laboratory cultures and traditions, and that the contradictory ideas were
sustained by cultural elements specific to each laboratory, including directorial style,
social relations within the laboratory, career structures, and so forth. Finally, I shall
analyse the ending of the controversy by the intervention of the ARC. In the process
of the closure of dispute, the alignment of interests amongst influential scientists and
administrators played an important role in deciding between the two factions. I shall
investigate how non-scientific factors played a role in building scientific consensus.
2. Scrapie research and the wider biological community
2.1. Reception of the two lines of research
As we have seen, in the 1960s and 1970s, a collaborative research group of the
Moredun and Animal Breeding Research Organisation (ABRO) in Edinburgh
speculated that the agent of scrapie could be a virus-like entity - a view that was
consistent with their success in isolating various strains of the agent. They also
argued that some extraordinary characteristics of the disease (e.g. long incubation
period, absence of immune reaction, resistance to chemical treatments and so forth)
could be explained by the peculiar genetic interaction between the host and the
virus-like agent, which they labelled a virino.
At the same time, another group reached an incompatible conclusion that
derived from radiobiological experiments. Tikvah Alper and David Haig's group in
the Institute for Research on Animal Diseases (IRAD) at Compton showed that UV
radiation of a wavelength that specifically damages nucleic acids does not deactivate
scrapie agent. They concluded that the agent is either much different from
conventional viruses, or that the agent may be able to replicate itself without
containing nucleic acids. This ignited a firestorm of controversy in the small field of
scrapie research. The groups behind the conflicting speculations failed to reach any
agreement on the issue. Rather, the differences and conflicts were intensified and
sustained during the 1970s.
Clarke (1978) 'The Scrapie Agent: Evidence Against its Dependence for Replication on
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For the Edinburgh group, the phenomenon of strain variation, so important in
their genetic-pathological work, seemed inexplicable in the absence of a small core
of nucleic acids. On the other hand, from Alper's point of view, the radiobiological
evidence against the presence of a genome seemed compelling. Both sets of results
were derived from established methods, and the validity of the data was generally
accepted by the scientific community. However, many scientists gradually came to
favour the approach of the Edinburgh group as offering the more plausible
explanation, since the virino theory was compatible with what was known of other
infectious agent. Alper's non-viral membrane theory, on the other hand, provoked
considerable interest but also ambivalence, because it departed so far from the
central dogma of biology, i.e. the assumption that all living things contain nucleic
acid genomes.
Alper's papers of 1966 and 1967 met with immediate scepticism from the wider
scientific community. When Alper and Haig attempted to publish their
extraordinary results, journals were initially reluctant to publish; this was why their
findings first appeared in Biochemical and Biophysical Research Communication, where
many people were probably not aware of it.3 Moreover, the report of more detailed
experimental results in Nature was initially turned down by the referees. According
to Hornsey and Denekamp, an outraged letter to the Editor convinced him of the
importance of the paper, and with the proofs couriered across London it was
published two weeks later.4 The paper in Nature met with considerable publicity and
criticism. There was a flood of correspondence, so much so that the Hammersmith
Hospital mailroom refused to deliver the mail to the MRC building, and Alper and
Cramp had to collect it themselves.5
While the wider scientific community were generally prepared to accept the
soundness and interest of Alper's radiobiological data, they were much more
sceptical about the theoretical speculations she built on those results, i.e. that there is
Intrinsic Nucleic Acid', Journal of General Virology 41:503-516
3 Clarke, Michael (2000b) Interview with author (31 May 2000: Institute of Animal Health,
Compton)
4 Hornsey, S. & Denekamp, J. (1997) 'Tikvah Alper: an indomitable spirit', International
Journal of Radiation Biology 71(6): 631-642; 638
5 Ibid., 639
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no nucleic acid in the scrapie agent. The scientific community attentively considered
Alper's idea: scientific journals such as the Lancet and Nature printed editorials,6 but
the tone of these showed that they were cautious about accepting the idea as a
whole. In Nature, the editorial ran as follows:
It is worth recalling that even if the infective agent lacked nucleic acid, it is conceivable
that the process of infection and of replication might be fitted into the now accepted
framework of how protein synthesis in cells is regulated.7
Alper and Haig's speculations were also interesting enough to capture public
attention.8 The Sunday Times headline on the front page, along with the news of the
beginning of the Cultural Revolution in China, was "Sheep give clue to mystery of
life".9 Alper's colleagues at IRAD evidently agreed with this optimistic appraisal, as
their eagerness to hypothesise alternative means of replication makes clear.10 In
other words, the general mood in IRAD was enthusiastic about the radiobiological
results.
Despite the media attention and local enthusiasm, however criticisms of Alper's
results also mounted. A group of researchers in the MRC Research Unit in
Demyelinating Diseases at Newcastle, E. J. Field and D. H. Adams, reproduced
Alper and Haig's experiment in order to scrutinise its validity.11 They reported that
the result was fully confirmed. The authors claimed, however, that there were
difficulties in accepting Alper's far-reaching conclusions. Adams thought that such a
radical departure from conventional virus theory was not essential to explain the
6 Lancet (1967) 'The scrapie agent7, Lancet I (30th September 1967): 705-706; Nature (1967)
'What is scrapie?', Nature 214 (20th May 1967): 755
7 Nature (1967) op. cit. note 6
8 Evening Standard (1967) 'New life form is discovered', The Evening Standard (27 January
1967); Oxford Mail (1967) 'In search of the smallest killer of all', The Oxford Mail (27 January
1967)
9 Silcock, Bryan (1967) 'Sheep give clue to mysteries of life', The Sunday Times (22 January
1967): 1, 4
10 Hunter, G. D., R.H. Kimberlin, et al. (1968) 'Scrapie: a modified membrane hypothesis',
Journal of Theoretical Biology 20: 355-357; Pattison, I. H. & Jones, K.M. (1967) 'The possible
nature of the transmissible agent of scrapie', The Veterinary Record 80(1): 2-9; Kimberlin, R. H.
& Millson, G. C. (1967) 'Some biochemical aspects of mouse scrapie', Journal of Comparative
Pathology 77: 359-367
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many exceptional properties of the scrapie agent, if certain assumptions were made
concerning the nature of the viral coat.12 Moreover, Field and Adams reinterpreted
the same data of Alper and Haig: even if the size of the agent was exceptionally
smaller than any other conventional viruses, the rejection of nucleic acids must be
treated with caution. They observed that small circular DNA (0.8 x 106 molecular
weight) had been demonstrated in M. lysodeikticusP The duplication of the Alper-
Haig data was successful, but they clearly showed that the data could be read in a
different way.
Some other commentators also cast doubt on the validity of Alper's work, and
thought her conclusions should be treated with caution. Carleton Gajdusek and Joe
Gibbs, American medical researchers on kuru, a disease found in local tribes of
Papua New Guinea with similar pathological characteristics, wrote, "it is the
mystery which has been engendered by erroneous laboratory data and by the
premature interpretation of UV inactivation results."14 Moreover, in 1974, Gajdusek
and Gibbs attacked Alper and Haig again:
Unfortunately, some early studies of the physical properties of the scrapie vims were
naive and were received rather uncritically with the resulting, sometimes
sensationalistic speculation as to its physical structure and mechanism of replication.15
Although Gajdusek and Gibbs cast strong doubt on the validity of Alper's work,
they failed to establish what was wrong with the experiment. Their challenge was
only based on disbelief of the data. This type of criticism had no influence on Alper's
efforts to persuade the scientific community. At the time, many regarded her results,
based as they were on standard radiobiological method, as shown, and therefore
thought that refuting her experimental data was an unlikely proposition. She was
regarded as one of the founding members of British radiobiology, so her authority
on radiobiological knowledge seemed to be unchallengeable.
11 Field, E. J., F. Farmer, et al. (1969) 'Susceptibility of scrapie agent to ionizing radiation',
Nature 222 (5 April, 1969): 90-91
12 Adams, D. H. & E. A. Caspary (1967) 'Nature of scrapie vims', British Medical Journal iii (15
July): 173
13 Field, E. J., F. Farmer, et al. (1969) op. cit. note 11: 91
14 Clarke, Michael (2000a) Personal communication with author (6May 2000)
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In the meantime, when Dickinson and his team concluded that strain variation
provided fundamental evidence for the fact that the agent contained a genetic
informational molecule in 1968,16 his speculations were generally well received by
the scientific community. This was partly because strain variation was taken for
granted as a conventional phenomenon by researchers at the time. Even Alper's
group remarked that it could be acceptable. According to Clarke, strain variation
"no great surprise to me at all, because after all as with most microbiological agents,
there are many different strains, so it wouldn't have been very surprising."17
2.2. Alper loses support
For Dickinson, the bottom line was that a small informational molecule must
control the basic mechanisms of scrapie infection. For Alper and Haig, on the other
hand, it was unthinkable that there was a virus with such a small size and
extraordinary resistance to UV light: the scrapie agent could not be a virus as far as
radiobiological principle was concerned. That was the fundamental point on which
they disagreed. Nevertheless, many researchers began to endorse Dickinson's
conventional stance. Although many of Alper's fellow scientists agreed with her
speculation, some of them were also not convinced by her conclusion that the
scrapie agent contains no nucleic acid, and so tried to find other ways of explaining
her results. They thought that departure from conventional viral knowledge was too
premature and risky.
In the mid-1970s, some researchers put forward counter-evidence against the
radiobiological data of Alper-Haig. One of Haig's colleagues in IRAD, Richard
Kimberlin, attempted to measure the size of the infective molecule by using a
different method from that used by Alper and Haig.18 Kimberlin thought that the
membrane structures and the agent might be separated by ultrasonic methods. The
disrupted particles were passed through a variety of filters to measure their size.
From this experiment, he found that the ultrasonicated and filtered membranes
15 Ibid.
16 Dickinson, A. G., Veronica M.H. Meikle, H. Fraser (1968) op. cit. note 1
17 Clarke, Michael (2000b) op. cit. note 3
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indicated that the operational size was in excess of 5 x 107 daltons.19 This was
considerably larger than of Alper and Haig's estimate of 1.5 x 105 daltons.
Kimberlin attempted to reconcile his result with Alper's. He speculated that the
scrapie activity was dependent on the integrity of a system that consists of two main
components: one component was small and radiation insensitive, as Alper and Haig
identified in 1967. The other was much larger, and could sustain damage by ionising
radiation. Although Alper concluded that the agent was much smaller than any
conventional viruses, Kimberlin suggested that the very small component that Alper
and Haig identified might contain scrapie-specific information. Furthermore, he
contemplated that the large component might play a role in protecting the core from
heat, radiation and other chemical treatments.20 His suggestion offered to reconcile
the UV properties of scrapie with the presence of nucleic acid including the
existence of protection or of repair mechanisms.21
Kimberlin's speculations showed that he was sympathetic to the assertion of the
existence of scrapie-specific genetic information, put forward by Dickinson. In effect,
he sought to reconcile Alper's non-viral view with the existence of nucleic acid.
Interestingly, around the same time, as Kimberlin reached the conclusion of multi-
structure of the agent, he turned his interests from the biochemical approach to the
pathogenesis of scrapie. He thus moved closer towards Dickinson's framework,
because Dickinson's group had identified themselves with pathogenetic research on
scrapie.22 Kimberlin became one of the strongest supporters for Dickinson's virino
18 Kimberlin, R. H., G.C. Millson, et al. (1971a) 'An experimental examination of the scrapie
agent in cell membrane mixture', Journal ofComparative Pathology 81: 383-391
19 Ibid.
20 Kimberlin, R. H. (1976b) Scrapie in the Mouse: a Model Slow Disease (Durham: Meadowfield):
61
21 Ibid., 65
22 Fraser, H. and A. G. Dickinson (1970) 'Pathogenesis of scrapie in the mouse: the role of the
spleen', Nature 226 (2 May. 1970): 462-463; Outram, G. W. (1976) 'The pathogenesis of scrapie
in mice', R. H. Kimberlin (ed.), Slow Virus Diseases of Animals and Man (Amsterdam: North-
Holland Publishing Co.): 325-357; Dickinson, A. G. & H. Fraser (1975) 'Scrapie: pathogenesis
in inbred mice: an assessment of host control and response involving many strains of agent',
Meulen,V.T. & Katz, M. (eds), Slow Virus Infections of the Central Nervous System: Investigational
Approaches to Etiology and Pathogenesis - Workshop on Slow Virus Infections (New York: Springer-
Verlag):3-14. It is evident that pathogenesis is a subfield of general scrapie research, but
particularly for Dickinson's group, it represents their research as a whole. When the
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theory, and he would go on to join the newly established institute under Dickinson's
leadership in 1981.
In addition to Kimberlin's experimental result, one of Alper's collaborators in
Paris, Raymond Latarjet, revised her non-genome conclusion.23 Latarjet duplicated
and extended the radiobiological experiments that Alper and Haig had done. He
reported an interesting feature of his radiobiological work: ribosomes, and relatively
small nucleic acid molecules displayed a very similar UV inactivation spectrum to
the scrapie agent. He thus confirmed Alper's findings of 1970, that the scrapie action
spectrum did not show a peak at 267nm and a minimum at 240nm, at which all
viruses and nucleic acid cores of viruses had shown greatly reduced effectiveness.24
However, Latarjet also claimed in his new study that the spectrum of ribosomes
indicated that scrapie was not the only exceptional case.
From this experiment, he revised Alper's conclusion, suggesting instead that
nucleic acid was not necessarily absent from the scrapie agent, but is merely of very
small size and coated with protein molecules. Latarjet remarked as follows in his
paper:
...Before accepting [Alper's] revolutionary hypothesis, we must carefully examine
whether the experimental action spectrum found for scrapie is absolutely incompatible
with nucleic acid genome. One point is certain: if the genome is a nucleic acid, it must
be embedded within a chemical complex in such a way that the non-nucleic acid
component of the complex participates, by its absorption, in the inactivation of
infectivity.25
Latarjet was once one of the enthusiasts for the Alper-Haig speculation, and he
participated in their extended experiment with his equipment in Paris. Yet, after he
revisited the Alper-Haig hypothesis, Latarjet came to a conclusion that scrapie might
consist of very small nucleic acids within protein complexes.
Moredun-ABRO unit was extended as a unified research centre on scrapie and CJD in 1981,
the centre been renamed as the ARC-MRC Neuropathogenesis Unit.
23 Latarjet, R. (1979) 'Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease, and kuru
by radiations', S. B. Prusiner and W. J. Hadlow (eds), Slow Transmissible Diseases in the Nervous
System (New York: Academic Press) 2: 387-407
24 Latarjet, R., B. Muel, D.A. Haig, M.C. Clarke, T. Alper (1970) 'Inactivation of the scrapie
agent by near monochromatic ultraviolet light7, Nature 227 (26 September, 1970): 1341-1343
25 Latarjet, R. (1979) op. cit. note 23: 404
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From the experimental results and revised speculations discussed above, during
the mid-seventies, researchers' attitudes on the nature of scrapie gradually shifted
towards Dickinson's idea. Furthermore, such modifications of Alper's original
conclusion implied that there was also an on-going endeavour to reconcile Alper's
non-viral theory with conventional ideas about infectious agents. Although the
consensus gradually inclined toward the conventional interpretation, Alper and her
group persisted their view that there is no nucleic acid. Kimberlin and Latarjet also
conceded that there is no strong evidence that there is any nucleic acid: the
experimental data of Kimberlin and Latarjet were not enough to demonstrate
conclusively that there was a nucleic acid genome.
3. Institutional culture
Notwithstanding how the work of the two parties was received by the wider
community, Dickinson and Alper persisted in disagreeing over the significance of
their respective findings. In this context, the two parties found themselves at
loggerheads in several conference meetings. According to Dickinson:
Four or five times we discussed at public meetings. She (Alper) used to say [her work]
proves that it can't be a nucleic acid. And I used to stand up and say, 'these days, they
[Alper and her colleagues at Compton] either establish that we cannot be dealing with
any nucleic acid, or they extend our understanding of the properties that nucleic acids
can have, and they have to say that is the situation.' And she used to stand up and call
me 'Phlogiston Dickinson'.26
The controversy between the Edinburgh and Compton groups was based on their
pursuit of two distinctive experimental systems, each its own intrinsic standard of
measurement, criteria of evaluation and interpretation. Each party of scientists
believed that the experimental system they used was the best way of revealing the
mechanism of scrapie disease. Thus, Dickinson's team focused on a long-term
genetical and pathological project. In contrast, Alper and her colleagues only
concentrated on radiobiological results. Moreover, from their different experimental
perspectives, Dickinson and Alper took very different views, of the significance and
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implications of the available evidence, which they interpreted as supporting
divergent conclusions about the nature of the scrapie agent. Significantly, this
polarisation of opinion was not a logically necessary consequence of the methods the
two groups adopted or the results they produced. Kimberlin and Gajdusek, for
instance, were able to take up positions that effectively reconciled Alper's and
Dickinson's findings.
Consequently, we can raise a question concerning the two bodies of laboratory
work: why did two conflicting beliefs persist without ever reaching any
fundamental agreements? In order to explain this, we need to look not just at the
different experimental approaches the two groups adopted, but also more generally
at the distinct laboratory cultures within which they worked.
3.1. Institutional rivalry
In the late 1950s, both the Moredun-ABRO collaboration in Edinburgh and IRAD
in Compton received 5-10 year grants from the US Department of Agriculture
(USDA) under US Public Law 480.27 In both Edinburgh and Compton, various
approaches on scrapie were launched without any overall co-ordination and
guidance. The work in Edinburgh and Compton overlapped. As Clarke remarks, "if
you look at the literature, you would see there is some overlap with things that were
going on: they were trying cell culture by MacKay at Moredun, just as we [Haig and
Clarke] were at Compton. Mould at Moredun was doing biochemical studies, and
we were doing biochemical studies here. And you can see that similar kinds of work
were going on at both sites."28 Concerned about lack of direction and duplication of
effort, the governing body of the two research institutes, ARC, decided to set up a
working party in order to oversee the whole situation of research in Edinburgh and
Compton, after taking advice from the director of the Wistar Institute in America,
26 Dickinson, Alan G. (1999) Interview with author (15 September 1999: Dunbar, Scotland)
27 Dickinson, A. G. (1998b) Statement to the BSE inquiry, s74 (London: BSE Inquiry); Pattison,
Iain (1988) 'Fifty years with scrapie: a personal reminiscence', Veterinary Record 123(26-27):
661-666
28 Clarke, Michael (2000b) op. cit. note 3
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Hilary Koprowski.29 As a result of his advice, the Technical Committee on Scrapie
Research (generally known as the scrapie working party) was set up in 1961 under
the chairmanship of Scarisbrick from the head office of ARC.
However, the relationship between the two teams was not eased by the working
party. Due to the overlapping of projects and their respective vested interests, the
relationship between them became competitive. One of the researchers in Moredun,
Hugh Fraser, explains the situation in his interview. He says, "the relation was
competition. You might say there was almost antipathy between Scotland and
Compton."30 The competitive nature of the relationship was fired by the
confrontational characters of the two directors, John Stamp and William Gordon.
Gordon was once a researcher in Moredun until he moved to Compton. Both had
strong personalities, and were fascinated with scrapie. In the late 1950s, they were at
loggerheads. Even the working party decided to exclude the two directors from the
regular meetings. They were urged to wait outside the committee room. Instead,
senior scientists from both groups took their seats: David Haig, Iain Pattison, and
Gordon Hunter from the Compton side; while Moredun was represented by Ian
Zlotnik, virologist John Brotherson, and chemist Derek Mould.31 The meetings only
intensified the rivalry and personal dislike. In his interview, Clarke outlined the
acrimonious character of the relationship between them:
As well as rivalry, there was I think, it was fair to say, some dislike. I can remember a
meeting at Compton, in which Alan Dickinson spoke, and Ian Pattison was, I think,
upset with Dickinson. When Dickinson came to talk to me afterwards, I remembered
feeling it necessary to apologise to Dickinson for what had occurred, and he just
shrugged it off. I think there were certain feelings of dislike as well as rivalry.32
Dickinson also expresses a poor view of Pattison's scientific ability in his
interview. He says that "he [Iain Pattison] was a very good histologist, but the
29 Hilary Koprowski was a medical scientist. In 1957, he became the director of the Wistar
Institute, Philadelphia remaining there for 25 years. He made the research centre a leading
light in the investigation of cancer and viral diseases. Garfield, E. (1982) 'A tribute to Hilary
Koprowski: scientist, musician and friend', Current Comment 29 (19 July 1982): 5-10
30 Fraser, Hugh (1999) Interview with author (30 June 1999: Science Studies Unit, Edinburgh)
31 Hunter, G. D. (1993) Scrapie and Mad Cow Disease: the Smallest and Most Lethal Living Thing
(New York: Vintage Press): 96
32 Clarke, Michael (2000b) op. cit. note 3
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moment he got into a laboratory and tried to do laboratory work it was, Pattison was
the first person to claim that formaldehyde didn't inactivate infectivity, in a
publication. But everybody knew this, of course. Wilson knew it."33 Gordon Hunter
witnessed other personality conflicts in the meeting: "[Iain Pattison's] vibrant
clashes with Ian Zlotnik dominated the early meetings of the working party. Each of
them considered that the other was stealing his results".34
There was, as Gordon Hunter remarked, obviously continuous tension and
hostility between the Moredun and Compton contingents. In 1966, when Iain
Pattison claimed to have purified and made progress towards the identification of
the agent,35 most members of the party attributed his results to cross-
contamination.36 The mistrust and disputes raged on, and not only caused Pattison
to retire in 1973, but also brought about the closing down of the working party in
1969. The working party was officially wound up by the Joint Consultative
Organisation (JCO), which was a newly established policy-making organisation at
the top of the ARC. However, many witnesses agreed that it had already collapsed
around 1966.37 The result of the closing down was catastrophic: there was no
guidance for co-ordination for the whole project. In fact, the working party was the
only formal place to discuss and co-ordinate the work conducted in the two centres,
and its collapse meant that there was no longer any official route for communicating
between different sectors of the overall research programme. Meanwhile, each
research group began to publish their own versions of speculations on the nature of
scrapie around 1967. This indicated that the field was entering into a period of open
competition. In this situation, a positive exchange of data and opinion could hardly
33 Dickinson, Alan G. (1999) op. cit. note 26. The relevant publication was Pattison, I.H. (1965)
'Resistance of the scrapie agent to formalin', Journal ofComparative Pathology75:159-164
34 Hunter, G. D. (1993) op. cit. note 31: 96; Dickinson alludes here to the experimental results
of work done by David Wilson in the 1940s. As discussed in chapter 2, Wilson conducted a
series of experiments and found that the agent was resistant to various biochemical
treatments, including formalin. However, he did not publish the result, choosing instead to
circulate them to the community.
35 Pattison, I. H., Katharine M. Jones (1968b) 'Detection of the scrapie agent in tissues of
normal mice and in tumours of tumour-bearing but otherwise normal mice', Nature 217 (136):
102-104
36 Fraser, Hugh (1999) op. cit. note 30; Clarke, Michael (2000) op. cit. note 3; Hunter, G. D.
(1993) op. cit. note 31; Dickinson, Alan G. (1999) op. cit. note 26
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be expected to come about. This climate of hostility, mistrust and cut-throat
competition played an important role in reinforcing the entrenched opposing views
on the nature of scrapie.
3.2. Laboratory culture
If rivalry and competition between the two parties played a certain role in
encouraging their intransigence, we must also consider a specific point connected
with the development of that rivalry, namely the strikingly distinctive cultures of
the two laboratories. On the face of it, the rivalry and competitiveness between the
contenders could be attributed to personal relations and the unique personalities
involved. However, in this instance, the roots of the hostility that evolved go deeper
than the merely personal level. The laboratory culture itself, including directorial
styles, traditions, shared norms and specific research goals, helps to explain the
antagonism pervading the relationship.
3.2.1. IRAD: Management by competition
IRAD was established as one of the first ARC institutes in 1937. When the scrapie
research programme was set up in 1958, the institute had plenty of resources. It was
one of the main ARC research institutes, with huge facilities. However, as far as
scrapie was concerned, IRAD was not a specialised centre for sheep diseases.
Actually, the institute was established for the purpose of studying cattle disorders
and developing vaccines, e.g. Brucella abortus vaccine.38 When William Gordon
became the director in 1942, his managing style had a major influence on the whole
laboratory culture of IRAD. As Henderson claimed, there was a definite change
from the original concept of a Field Station providing animals and accommodation
for the extension of others' work, to that of developing a research institute in its own
right and a centre of excellence in its own subject.39 Gordon dominated the
37 Hunter, G. D. (1993) op. cit. note 32: 97
38 Henderson, William (1981) 'British agricultural research and the Agricultural Research
Council: a personal historical account7, Cooke, G.W. (ed.), Agricultural Research 1931-1981: A
history of the Agricultural Research Council (London: Agricultural Research Council): 29
39 Ibid., 30
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fundamental character of the institute. His style encouraged self-directed and
autonomous research on animal diseases, especially scrapie.
For the twenty-five years of Gordon's directorship, all the on-going experimental
projects in IRAD were not necessarily coherent with one another: individual
researchers pursued their own interests. There were not even any formal meetings
for the discussion and overall organisation of research projects. Michael Clarke
summarises the situation:
As far as I am aware, [Gordon] never had formal meetings with his senior scientific
staff. They just got on, and did whatever was needed to be done. These people were
appointed, and they went on and they did whatever. Occasionally, there would be
visiting groups here who would look at what was going on, they would comment on it,
but they did more or less as they liked.40
However, this style of research management did not always work well. The
diversified system caused problems. Under Gordon's directorship, the relationship
between researchers in the institute was not co-operative. Rather, he tended to
encourage competition. Even when different researchers shared the same aim,
establishing the chemical nature of scrapie, for instance, the laboratory culture led to
rivalry between the researchers. Hugh Fraser witnessed the situation at IRAD:
There were, I think, people at Compton working separately from one another, I don't
think that Pattison had any relationship with Hunter, they worked quite separately.
Kimberlin worked of course with Hunter and then became independent, but Pattison
was very much isolated and worked separately. There was also Haig who had
collaboration with Tikvah Alper's work which was at Hammersmith, and Pattison had
a capacity to contaminate material, one of the biggest problems in this whole area.41
However, despite allowing his researchers to choose their own topics, this did not
mean that they worked on entirely unconnected topics. On the contrary, the
competitive atmosphere fostered by Gordon was based on a shared vaguely
articulated idea of what the big problems were that awaited solution. One such
problem was the physicochemical nature of the scrapie agent. This obscure goal tied
the heterogeneous researchers together. Indeed, researchers who did not share their
40 Clarke, Michael (2000) op. cit. note 3
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colleagues' views about what topics to address could find themselves subject to
quite considerable pressure or exclusion by their colleagues.
Richard Kimberlin's case shows what happened if one became derailed from the
common goal of research. Kimberlin started his career as a member of the
biochemistry department. He carried out his project with Gordon Hunter and Geoff
Millson. However, around the early 1970s, he began to develop an interest in the
pathogenesis of scrapie, which was the main subject of the Edinburgh group. He
was fascinated with Dickinson's work in Edinburgh, and decided to launch an
independent project in Compton. However, the response from others there was
discouraging. Kimberlin describes the circumstances surrounding his decision in the
BSE Inquiry:
I was very much in favour of moving to Edinburgh because it just seemed to be a
logical progression of my career. [...] And partly because actually at Compton I had
really split off from the mainstream of the work at Compton. The focus of the scrapie
programme at Compton was always very much onto the nature of agent [...] And I
moved off much more into areas of biology, pathogenesis rather than the nature of the
agent. And with the change in climate which became very palpable. [...] The work I
was doing was a little bit out of the mainstream, and I could see a potential threat here,
so in order to continue my interests in pathogenesis it made a lot of sense to move up
to Edinburgh.42
As we have seen, Kimberlin eventually made that move. To summarise the
peculiar culture of IRAD: firstly, under William Gordon's directorship, each
researcher was encouraged to pursue any subject that interested him/her. Secondly,
relatively good resources were also provided for the self-directed experimental
projects. Traditionally, IRAD was one of the main research centres of the ARC, so
the ARC provided good experimental facilities, and USDA sponsored the scientific
research on scrapie in the institute. Thirdly, the competitive ethos between
researchers was prevalent at the time. Due to the lack of research direction and a
tendency to pursue their own interests, scientists could conduct their scientific
research without constraint, rather than research for a specific practical purpose.
41 Fraser, Hugh (1999) op. cit. note 30
42 Kimberlin, Richard (1998) Transcript of oral hearing: day 40, t40 (1 July, 1998: The BSE
Inquiry): 28-29
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Lastly, it should be noted that there was a shared goal of research: defining the
biochemical nature of the scrapie agent.
3.2.2. Moredun-ABRO unit: collaborative research
The research team in Edinburgh, on the other hand, had a very different culture
from IRAD. The Moredun research institute was established in 1926 for the purpose
of researching mainly on sheep diseases. The institute was one of the first institutes
established by the private sector in agricultural science. It was supported by a group
of Scottish landowners and sheep farmers.43 This meant that the main research
priority was, to some extent, associated with practical issues: especially, researching
on sheep diseases was considered as the main subject. According toWilliam Martin,
the director of Moredun since 1977, "the Animal Diseases Research Institute, now
the Moredun Institute, was set up by landowners and farmers in Scotland to
promote investigation into the diseases of livestock. The institute does have a
diagnostic and specialist function with regard to livestock disease, which is available
to farmers through veterinary surgeons, the Scottish College of Agriculture, the
Veterinary Investigation Service and others. It does not function on behalf of, and is
independent from, the Ministry of Agriculture and the ARC, as it was then
known."44 From this remark, we can see that the basic principle of the institute was
concerned with practical issues facing the Scottish farming industry, as a non¬
governmental institute.
The practical interests of the institute pervaded the research into scrapie. The
Moredun-ABRO unit had oriented its research towards pathogenesis of the disease:
in particular, they examined how the disease replicated in the host. Whereas the
Compton scientists aimed to elucidate the physicochemical nature of the agent, the
Edinburgh group saw such questions as distracting from the more urgent practical
question of how to tackle the disease. Kimberlin, for one identified this as a
fundamental divergence between the two groups:
43 Henderson, William (1981) op. cit. note 38:12
44 Martin, William (1998) Transcript oforal hearing: day 3, t3 (11 March, 1998: The BSE Inquiry):
35-36
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At least to me it was fundamental. The point is that when one is thinking from a
practical standpoint about the implications of a new disease, it is extremely difficult, in
fact I think it is almost impossible, to dwell too much on the areas of confusion about
the nature of the agent, because on that basis you might actually make wrong scientific
judgement about what type of policy measures would be appropriate [...] so I was far
less concerned with all the various hypotheses about the nature of the agent. How these
diseases develop, I was much more concerned with the biology of them, how they
behave and the kind of scenarios that we had to assume, taking a worst case stance to
do that, which was necessary to minimise the consequences of the new disease.45
Another characteristic of the culture of the Edinburgh group can be found in
directorial style. During the 1960s and 1970s, John Stamp, a veterinary researcher,
was the director of Moredun. Like William Gordon, he was fascinated with scrapie,
and wanted to promote scrapie research. However, compared with Gordon, he was
an opposite character. Stamp sought to co-ordinate the research in his institute. He
contacted ABRO to start a collaborative project on genetical aspects of scrapie in
1955. He believed that a certain guideline for research was necessary. When he
agreed to collaborate with setting up the Moredun-ABRO unit, he intended to
provide a basic direction of research: genetic research in order to unmask the
relationship between the host and the pathogen. Under this direction, Alan
Dickinson, the leader of the unit, was promoted and encouraged to conduct long-
term genetic-pathological experiments.46
From the unit, is establishment in the late 1950s, the researchers practised under a
coherent culture of research. This was possible because the group was relatively
smaller than the Compton group. As discussed, the research groups in IRAD
pursued whatever they were interested in, and their research into scrapie followed a
number of different lines. By contrast, the Moredun-ABRO unit had one direction:
pathogenesis of the scrapie agent. According to Hugh Fraser, Dickinson's unit was
run on a relatively small budget, so economy demanded that the research be tightly
focussed.47 Under such constraints it was unlikely that the pursuit of different
interests in the unit would be possible. During the late 1960s, and the whole 1970s,
the Edinburgh researchers carried out one consistent experimental project.
45 Kimberlin, Richard (1998) op. cit. note 43:10-12
46 Stamp, J. T. (1957) 'Address by Director of the Moredun Institute', Animal Diseases Research
Association: Annual Report and Accounts: 1956-1957 (Edinburgh: Moredun Institute): 18-25
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In addition, under the leadership of Dickinson, the group shared all the
information they needed within the group, and the relationship between researchers
was co-operative. The role of each researcher was quite functionally defined in the
Moredun-ABRO unit: the whole research process was devised in terms of distinct
but related functions; for instance, there was a pathology section, a genetics section
and an animal breeding section. The Moredun researchers did in fact manage to co¬
ordinate their efforts and share information effectively within a division of labour.
In every respect, the Moredun-ABRO laboratory culture was quite contrary to that
prevailing at IRAD. Whereas the IRAD researchers were competitive, the unit
embodied a coherent and co-operative culture.
From this discussion of the Moredun-ABRO unit, several interesting points can be
noted: firstly, the Moredun institute was established by the private sector,
specifically, sheep farmers in the 1920s. For this reason, the research orientation was
directed towards practical issues rather than pure scientific issues. Secondly, the
directorial style of John Stamp was completely different from that of his counterpart,
Gordon: Stamp specified what the Moredun-ABRO collaboration was to focus on,
while Gordon let his researchers get on with whatever they wanted. Thirdly, the
research unit under Dickinson's leadership worked in a coherent and stringent
culture, partly as a result of their small budget which determined the research goal
of the research team.
4. Cultural divergence and scientific disagreement
So far, I have shown that there were clear cultural differences between the two
groups. Those cultural differences reinforced and sustained the personal animosities
and interpretative differences between the groups. As seen, the culture at Moredun-
ABRO unit was one of collaboration around a single question, namely the
pathogenesis of scrapie. Thus while they approached the problem from a variety of
perspectives including classic pathology and genetics, any theories of the nature of
the disease that the team developed needed to be acceptable to colleagues working
47 Fraser, Hugh (1999) op. cit. note 30
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in these various areas. Thus the nature of the Moredun collaboration means that the
researchers there de facto took a broadly holistic biological view of the disease. By
contrast, while the Compton researchers also approached the problem of scrapie
from a number of perspectives including some very novel ones such as radiobiology,
they did so not as collaborators but as competitors. Consequently, their perspective
on scrapie tended to be relatively narrowly rooted in their own speciality and
techniques.
This was a key point of divergence between the two groups, with implications for
how they evaluated each other's work. Thus Dickinson was critical of Gordon's way
of approaching the disease, which he considered simplistic. In his interview,
Dickinson remarks that "Bill Gordon understood things only in very simple terms,
and if you do that you can jump to very big conclusions, because you don't need to
bother about the data."48 He was similarly critical of Alper's conclusion that there is
no nucleic acid in the agent which he attributed to an unwarranted reliance on an
excessively narrow range of radiobiological methods. Dickinson likened Alper's
assertion to the belief, common during the 1930s, that viruses were proteinaceous.
This was a misunderstanding based upon half-truth that "put the cart before the
horse by ignoring the virus's real genome."49 In the 1930s, Wendell Stanley claimed
that genetic information of the tobacco mosaic virus was not nucleic acid, but
protein.50 Dickinson argued that Alper and her colleagues made the mistake as
Stanley did. He claimed that "Stanley was just the Ticky [Alper] of those days."51 It is
this broader perspective that led Dickinson and his colleagues to dismiss the
Compton work as failing to take into account biological phenomena such as strain
variation.
48 Dickinson, Alan G. (1999) op. cit. note 26
49 Dickinson, Alan G. (1982) 'Scrapie: strategies, stalemates, and successes', Lancet (29 May
1982): 1221-1223; Actually, this article was written in order to criticise Staley Prusiner, when
Prusiner suggested his proteinaceous nature of the agent in 1982. However, for criticising
Alper's work, Dickinson used the same example of Wendell M. Stanley in his interview with
author.
50 Stanley, Wendell M. (1935) 'Isolation of a crystalline protein possessing the properties of
tobacco mosaic virus', Science 81: 644-645
51 Dickinson, Alan G. (1999) op. cit. note 26
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Alper and her Compton colleagues, on the other hand, were less inclined to take
account of broader biological considerations. They acknowledged the existence of
strain variation, but did not see this as relevant to how they interpreted their own
experiments. Thus according to one of Alper's colleagues, Michael Clarke: "people
have shown with the experiment what Gordon had done with twenty different
breeds of sheep. [...] So it was no surprise." They tended to dismiss any attempts to
integrate their own physicochemical findings into a wider biological understanding
of how the scrapie agent might function as excessively speculative. Instead, they
concentrated on their own experiments and the immediate inference to be drawn
from them, without placing them in a wider context of biological thinking. In his
interview, Clarke goes on to claim that "I take the view that people can speculate as
much as they like. But these are the experiments that we did, and this is how we
interpreted it. You can speculate as much as you like, you can suggest it is green
cheese if you like. It is very difficult to prove that it is not."52
Moreover, it should be noted that the highly competitive ethos at Compton
actually encouraged risky claim-making. There was a strong motivation for
individuals to get ahead, acquire prestige by making a big breakthrough.
Consequently, novelty was to be welcomed, particularly if it brought publicly. In
this respect, the fact that Alper's claim that scrapie agent does not involve nucleic
acid might herald a major innovation in biological thinking was seen at Compton as
very much in her favour. Thus even if other biologists were much more cautious, the
Compton researchers immediately invested heavily in Alper's claims by making
their own bold speculations on how nucleic-acid-free replication might occur. Again,
this contrasts with the situation in Edinburgh, where collaborative efforts tended to
entail a more conservative approach to novelty, and where there was a greater
tendency for new findings to be integrated into existing knowledge.
Consequently, the cultural differences between the two research groups tended
to consolidate the unyielding character of their relationship. Their divergent
institutional cultures, including directorial style, structures of collaboration and
competition, and distribution of responsibilities and rewards, supported very
52 Clarke, Michael (2000b) op. cit. note 3
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different attitudes towards theoretical claim making, the pursuit of novelty and the
need to maintain a broad biological perspective. These cultural divergences led in
turn to mutual distrust and disdain between the two groups, and to a further
hardening of attitudes that further reinforced their scientific disagreements.
5. Closure of the controversy: administrative intervention
If the heterogeneous culture of the two institutes had such influence on
knowledge production, we can then go on to ask, how are such entrenched
disagreements ever to be settled? The rivalry between the contenders was never
resolved, nor did their controversial speculations show any sign of reconciliation.
However, the controversy came to an end with the intervention of the Agricultural
Research Council. In the 1970s, the ARC set up a special committee to solve the
current problems of scrapie research. The intervention process had a dynamic
impact on resolving the whole controversy. It brought about a systematic
restructuring of scientific research procedure in the UK from the level of the ARC to
scrapie laboratories.
5.1. Restructuring scientific research system in the UK
During the 1970s, the whole scientific research structure in Britain entered a new
phase. In 1971, a Green Paper was published under the title "a framework for
government research and development", which included a report by Lord
Rothschild on "the organisation and management of government R & D".53 This was
the groundbreaking Rothschild report. Lord Rothschild reported that scientific
research in Britain should be based on the principle that applied R&D- that is R &
D with a practical application as its objective - must be done on a
customer/contractor basis.54 It was regarded as the first attempt to privatise scientific
research. The report caused a huge controversy at the time, and had a great impact
53 Great Britain, Lord Privy Seal (19719 A Framezvork for Government Research and Development,
Cmnd 4841 (London: HMSO, 1971)
54 Quotation from Henderson, William (1981) op. cit. note 38: 93
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on the scientific community as a whole.55 From that time on, basic principles of
government-sponsored scientific research would be revised.
For agricultural sciences, the impact of the report was also huge: it challenged the
basis upon which scientists had developed British agricultural research since the
establishment of the ARC in 1931. According to Timothy Dejager, by advocating
greater intervention by the "users" of research, Lord Rothschild attempted to alter
the principle by which science was linked to practice, consequently threatening the
autonomy of scientists in their choice of problems.56 The ARC was established on the
basic principle that scientific research should produce practical benefits, but should
also leave scientists free to pursue research interests without the constraints
imposed by immediate economic needs and agendas set by the government.
However, the Rothschild report required the ARC to revise its fundamental
principles.
The main agenda of the reorganisation was to focus on centralisation of the
funding system in terms of the "planning-by-committee method".57 The ARC had
already begun to more in this direction, joining with MAFF to set up a Joint
Consultative Organisation (JCO), consisting of five boards (animal, arable crops &
forage, horticulture, engineering & buildings and food science & technology).58 The
JCO sought to impose order on dispersed committees and working parties in order
to redirect the whole system of scientific research. The master plan of setting up the
JCO was suggested by Kenneth Mather. Under the five boards of the JCO, each
agricultural sector had its own committees. Research on sheep was dealt with by the
Sheep Committee of the animal board. This committee was chaired by John Stamp,
the director of the Moredun Institute.59
Predictably, in this context, the organisational transformation had a major
influence on the contending institutes in the controversy, especially the Council-
55 For more detailed studies on the impact of the Rothschild report on science, see Williams,
Roger (1973) 'Some political aspects of the Rothschild affair7, Science Studies 3: 34-46
56 Dejager, Timothy (1993) 'Pure science and practical interests: the origins of the
Agricultural Research Council, 1930-1937', Minerva 31(2): 129
57 Dickinson, A. G. (1998b) op. cit. note 27: 6
58 Henderson, William (1981) op. cit. note 38:100
59 Ibid., 101
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directed institute, IRAD. The IRAD was an archetypal institute of the Council. Thus,
it embodied the basic principle of the Council, which ensured independence of
researchers' interests, in its laboratory culture. The research style at Compton, in
particular, was thus likely to be vulnerable to changes demanded by the Rothschild
report, which posed a potential threat to maintaining the on-going research projects
at Compton.
By contrast, the scrapie programme of the Moredun-ABRO unit was less swayed
by the new regime. Although the unit was connected to the ARC-funded ABRO, it
was also linked to the Moredun Institute, which was established by the private
sector and was not under direct control by the Scottish Office. The independence of
the institute also secured it from being controlled by the Ministry of Agriculture,
Fisheries and Food (MAFF).60 Moreover, Dickinson's team sought to tackle practical
issues: for instance, during the late 1960s, there had been a health scare concerning a
link between multiple sclerosis (MS) and scrapie. Consequently, the Edinburgh team
received about £5,000 from the Multiple Sclerosis Society for research on linkage
between MS and scrapie.61 Thus the Edinburgh scrapie research was supported not
just by the government through the ARC, but also by other potential "users" or at
least interested parties, such as the ABRO and the MS Society. This would be looked
on favourably in light of the Rothschild principles. The big shake up in science, in
the policy and therefore in the science community itself, gradually pervaded the
domain of scrapie research. The Rothschild regime could potentially have had a
devastating effect on the less practical aspects of research laboratories. In particular,
the IRAD group could be seen as being more vulnerable to disruption.
5.2. Experimental fiascos: credibility crisis in IRAD
The collapse of the scrapie working party in 1969 occurred in this context, and
seems to have had a negative impact on policy makers at the ARC. Many were
inclined to attribute the failure of the working party to disputes over Pattison's work
60 Martin,William (1998) op. cit. note 45: 35
61 Dickinson, A. G. (1998b) op. cit. note 27: 10; Wildy, Peter (1976) Report of the advisory
committee on scrapie, ARC 196/77 (Advisory Committee on Scrapie: Agricultural Research
Council): 3
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at IRAD. As we have seen, Iain Pattison reported in 1968 that he had identified the
scrapie agent, and that it consisted of protein particles without nucleic acids.62 Most
members of the working party, including members from IRAD, were inclined to
doubt the validity of the experiment. One of the insiders of IRAD, Michael Clarke,
describes the situation:
There wasn't general agreement between Pattison, Haig, and Hunter as to the
interpretation of the data. I think one would say that the small number of cases that he
was working with, didn't leave people with very much confidence as to its validity.
Just as with some of the other work that Pattison did at the time, deliberately
contaminating material to try and show that the cases of scrapie that he was getting
were not from contamination. Pattison produced evidence that he could recover the
scrapie agent from the tumours of mice, and from nucleoprotein material from normal
mice. So he believed at the time that the agent was present in all of these animals.63
Many people in the working party believed that Pattison overstated his case.
They saw this claim as being not only unsubstantiated, but also believed his findings
to be caused by cross-contamination of the experimental material. According to the
recollection of Gordon Hunter, Pattison's colleague in IRAD:
On the basis of experiments with an electro-osmometer, where cross-contamination
was obviously quite inadequately controlled, he claimed that the scrapie agent was a
basic protein. This was easily disproved in general terms, since basic proteins isolated
from scrapie brain under fairly mild conditions contained no biological activity
whatsoever.64
The disputes amongst members of the working party on the issue of cross-
contamination marred the meetings, and the working party itself came to a
somewhat precipitate end. It caused considerable damage to the credibility of IRAD,
and overshadowed other researchers' work there. Some generalised that much of
the work that issued from Compton, especially the more controversial claims,
62 Pattison, I. H., Katharine M. Jones (1968b) 'Detection of the scrapie agent in tissues of
normal mice and in tumours of tumour-bearing but otherwise normal mice', Nature 217 (136):
102-104; Pattison, I. H. & Jones, K.M. (1967) op. cit. note 10
63 Clarke, Michael (2000b) op. cit. note 3
64 Hunter, G. D. (1992) 'The search for the scrapie agent', S. B. Prusiner, J. Collinge, J. Powell
and B. Anderton (eds) Prion Diseases ofHumans and Animals (London: Ellis Horwood): 26
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"probably results from frustration, or those were sensationalistic speculations".65
Tentatively, it is plausible to suppose that these events may have contributed to the
sceptical reception of Alper and Haig's work in the late 1960s.
Unfortunately, another similar event occurred in IRAD in the mid-1970s: the so-
called, polyadenylated RNA story.66 This concerned a research project to detect
DNA in the scrapie agent devised by a PhD student. In the mid-seventies, this
research student claimed to have discovered DNA elements in the agent by
estimating and monitoring changes in the quantity of polyadenylated RNA in the
scrapie affected brain sample.67 Many people were excited by this development, and
presented this result at a major international conference in 1979.68 However, this
result could never be duplicated. Many researchers tried to reproduce the result, but
no one ever succeeded in doing so. Eventually, the finding was disregarded, and the
student left the institute. This event showed the typical laboratory culture of IRAD:
competition and the pursuit of one's own interests. Clarke summed up the situation
in his interview:
[There were two PhD students in the biochemistry department.] Robert Somerville was
looking for a protein, and Chris Corp was supposed to be looking for a nucleic acid. I
think that was the general sort of division of work. But every week, it was Somerville,
he was up and the next week, it was Corp who was up. There was a sort of rivalry
established, and in part encouraged, between the two to make progress. In the event,
various bits and pieces of work were done, and small nucleic acids were, I think, found.
Chris Corp came up with these changes in polyadenylated RNA, which seemed to
Hunter and Kimberlin as a great breakthrough. [...] As a paper, [...] I didn't think was
sufficiently advanced for it to be published. And I got David Haig to say, "no", because
Corp wanted to publish this. I was already perhaps a bit concerned. I mean there were
indications that something was not right with some of this work. When Corp went off
to the States to show them how to do it, I think he was largely unsuccessful. Alistair
Lax was appointed to extend the polyadenylated RNA story, and he was unable to do
so, he could not repeat any of the work. Chris Corp was then brought back into the
65 Clarke, Michael (2000b) op. cit. note 3
66 Dickinson, A. G. (1998b) op. cit. note 27; Kimberlin, Richard (1998) op. cit. note 43; Clarke,
Michael (2000b) op. cit. note 3; Hunter, G. D. (1993) op. cit. note 32:41
67 Corp, Chris R., Richard H. Kimberlin (1976) 'Polyadenylated ribonucleic acid in normal
and scrapie-infected mouse brain', Biochemical Society Transactions 4 (6) 1132-1133;
Polyadenylated RNA is a class of RNA, which has a long polyadenylated chain. It includes
most messenger RNAs.
68 Hunter, Gordon G. (1979) 'The enigma of the scrapie agent: biochemical approaches and
the involvement of membranes and nucleic acids', Prusiner, S.B. & W.J. Hadlow (eds), Slow
Transmissible Diseases of the Nervous System 2 (New York: Academic Press): 365-386
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work to reproduce it, and at the end of the day, none of this work could be reproduced.
And there was an internal inquiry about all. [Eventually,] he resigned.69
Unfortunately, this event had even more devastating effects, as far as the
credibility of the institute was concerned. It came at a really bad time, when the
whole research system of the ARC was being transformed following the new
direction indicated by the Rothschild report. The work in IRAD was being
scrutinised by the Joint Consultative Organisation (JCO). According to Clarke, "at
one of the meetings, the results of some of the work and failure to reproduce [...]
some of the work was discussed, and it was clear, I think that already support for
the sort of scrapie work at Compton was coming to an end. I think that Jack Payne,
he was then director, he was unhappy about it. He was glad to see it ended. So 1981,
I think that the work [scrapie research] came to an end. But it was partly failure of
polyadenylated RNA".70 Gordon Hunter also recalled the devastating situation at
the time:
Shortly afterwards, I had to give the opening paper at a major slow virus meeting in
Paris, and I had to make the sad announcement that work with our previous
collaborator X must all be disregarded. But I was able to show how our subsequent
work, involving Alistair Lax, Geoff Millson, and others, had repaired the damage. [...]
But it was too late. The ARC ordered our programme to stop, and Alan Dickinson had
the British field to himself at last.71
This series of experimental failures influenced the whole credibility of IRAD in
the field. This could be one of the key elements in understanding why the
exceptional results reported by Alper and Haig were gradually disregarded by
scientists during the 1970s. Finally, the Council decided to close down the scrapie
programme in IRAD at the end of the 1970s. The controversy on the nature of
scrapie was brought to an end through institutional intervention.
69 Clarke, Michael (2000b) op. cit. note 3
70 Ibid.
71 Hunter, G. D. (1993) op. cit. note 31:107
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6. How controversy ends
This crisis of credibility was not the sole reason why the scrapie research at
Compton was closed down. But it came at a time when scrapie research was being
reorganised, and it fatally undermined any claim that Comptonmight have to retain
some of that research. Around 1976, the JCO suggested establishing a scrapie
advisory committee for the purpose of revising the whole research programme. This
recommendation from the JCO was not only motivated by the fallout from
Rothschild, but also by USDA concern about possible links between scrapie and
CJD.72 In addition, there was another outbreak of scrapie in Britain. In the early
1970s, the scrapie outbreak caused quite serious economic losses. It is estimated to
have cost Swaledale breeders alone as much as 1.7 million pounds during the five
years 1971-1975.73
At a meeting of the ARC, in 1977, the Council decided to set up the Scrapie
Advisory Committee.74 Peter Wildy, a pathologist at the University of Cambridge,
was appointed chair of the committee. The members of the committee consisted in
part of senior researchers from IRAD, ABRO and Moredun. Other members came
from outside the scrapie research community: ARC, MAFF, and MRC sent their
delegates to monitor the meetings.75 One of the main agenda items of the committee
was the issue of liaison with the Medical Research Council. The advisory committee
agreed that a joint CJD-scrapie research programme should be established, in
72 The USDA (US Department of Agriculture) ban on meat from scrapie-infected and scrapie-
exposed animals, and there was a growing interest in diseases of the human central nervous
system which had perceived similarities with scrapie. The USDA concern was based upon
observations that some chronic degenerative features of scrapie had similarities with certain
neurological diseases such as Creutzfeldt-Jakob Disease (CJD) and Kuru. Although there was
no evidence that scrapie caused these disorders in human beings, the fear of a possible link
escalated at the time. [ARC (1976) Meeting of the Council, ARC 311/76 (12 October 1976: ARC):
10; ARC (1976) Research on scrapie of sheep, ARC 240/76 (12 October 1976: ARC): 1; Anderson,
Malcolm (1998) Statement to the BSE inquiry, s72 (London: BSE Inquiry)]
73 Wildy, Peter (1977) Report of the Advisory Committee on Scrapie, ARC 196/77 (12 October 1977:
ARC): 6
74 ARC (1977) Meeting of the Council, ARC 220/17 (11 October 1977: ARC)
75 The members were as follows: F. Brown (Animal Virus Research Institute), A. Dickinson
(ABRO), D. Haig (IRAD), G. Hunter (IRAD), R. Kimberlin (IRAD), S.A. Hall (MAFF),
Katherine Levy (Medical Research Council), C.A. Mims (Guy's Hospital Medical School), J. T.
Stamp (Moredun), and J. Watson (MAFF).
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collaboration with the Medical Research Council (MRC).76 The committee also
agreed that the best way to do this collaborative work between ARC and MRC
would be by combining scrapie research from Moredun and Compton into a single
institute, and extending it to include CJD. Finally, the committee agreed that the two
existing programmes of scrapie research in Edinburgh and Compton should also be
transferred into one location. In the proposal, Edinburgh was suggested as the main
candidate location for the new centre.77
This proposal for consolidating the scrapie work in Edinburgh seems to have
been drawn up by Dickinson and Kimberlin. This, at least, was the view of
opponents such as Clarke, who complains that Dickinson and Kimberlin were able
to by-pass the committee by submitting their proposals direct to the chair of the
committee.78 Certainly, there are strong reasons to think that opinion within the
ARC was weighted in Dickinson and Kimberlin's favour. Dickinson's genetic and
pathological orientation was in keeping with the views of prominent figures in ARC
and MRC. An indication of this can be found in a document of the MRC. In the
document we read that, "the [Neurosciences] Board had noted Dr. Dickinson's high
reputation for research on scrapie, and they were confident he could provide the
scientific leadership for a programme of research on slow agents."79
Dickinson's reputation was reinforced by a web of powerful connections within
the agricultural and medical research communities. Firstly, one of the central figures
of decision making at the top level of the ARC, Kenneth Mather, had been a director
and mentor of Dickinson's PhD work in the University of Birmingham. The work of
his group in the biometric genetics unit of the University of Birmingham became
significantly influential for geneticists. Dickinson was one of the members of that
group. During the 1970s, as a member of the Council, Mather played a role in
76 Wildy, Peter (1977) op. cit. note 73: 7
77 Wildy, Peter (1978) ARC & MRC laboratory for slow infections and CNS degenerative disease:
proposal for a coordinated programme by the Agricultural Research Council and the Medical Research
Council for basic research on slow-virus diseases and models for studying the dementias, ARC 150/78
(9 May 1978)
78 Clarke, Michael (2000a) op. cit. note 14
79 MRC (1980) Proposal for a joint ARC/MRC Neuropathogenesis Unit, MRC 80/590 (23 November
1980: ARC): 1
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making the master plan for the reorganisation of the ARC.80 Dickinson's plan of
genetic research on scrapie and CJD was compatible with the scientific orientation
that Mather had pursued. Another interesting figure who had a close connection
with Dickinson was John Jinks. When the scrapie advisory committee was built up,
John Jinks was also a member of the Council. During the period 1967-85, he was also
a member of fifteen of the visiting groups which the council sends periodically to
inspect the institutes which it finances. Within the council, he was an influential
figure in making policy. In 1984, Jinks became the Secretary and Deputy Chairman
of the Agriculture and Food Research Council (ARC changed its name in 1981).81
Significantly, he too had worked alongside Dickinson in Birmingham, and he was
second co-author of Dickinson's first scientific paper in 1956.82
When the proposal of establishing a new MRC and ARC joint research
programme at Edinburgh was put forward, Dickinson and Kimberlin were "given
encouragement to proceed to detailed proposals by the Secretaries of both the ARC
(Sir Ralph Riley) and the MRC (Sir James Gowans)."83 In particular, Dickinson had a
good working relationship with James Gowans, an immunologist who was
constantly involved in the new research programme in Edinburgh.84 In his interview
Dickinson states, "Jim Gowans - I told you how much I admired him."85 Finally, if
the list of members of the Council meeting, which decided to establish the scrapie
advisory committee in 1976, is checked carefully, then it may be seen that many
people were sympathetic to the Moredun-ABRO unit, including John Stamp (the
director of Moredun), J.B.W. King (the director of ABRO) and Kenneth Mather. On
the other hand, the only delegate who had a connection to IRAD was Wilham
Henderson, the former director of IRAD between 1967 and 1972. In this context, the
network of interests seemed more in favour of the Edinburgh side.
80 Henderson, William (1981) op. cit. note 38: 50. He was a director of the Unit of Biometrical
Genetics, the University of Birmingham, between 1950 and 1965.
81 Mather, Kenneth (1988) 'John Leonard Jinks, 1929-1987', Biographical Memoirs of Fellows of
the Royal Society 34: 342
82 Dickinson, A. G., J.L. Jinks (1956) 'A generalised analysis of diallel crosses', Genetics 41: 65-
78
83 Dickinson, A. G. (1998b) op. cit. note 27:12
84 Gowans, James L. (1996) 'The lymphocyte: a disgraceful gap in medical knowledge',
Immunology today 17 (6): 288-291
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More generally, from the overall decision-making process of establishment of
new research centre, we can think about this process in scientific as well as political
terms. Specifically, when seen from the point of view of Dickinson and Kimberlin's
political backers within the ARC and MRC, there were compelling scientific reasons
for favouring their proposals over any suggestion that scrapie work should continue
at Compton. The kind of pathological and genetic approach that Dickinson and
Kimberlin took towards scrapie was in keeping with the scientific orientation that
predominated within the upper echelons of the ARC and MRC. As seen above,
Dickinson's scientific position was close to Mather, Jinks and Gowans. In effect, it
corresponds closely to what might be regarded as ARC orthodoxy.
By contrast, the novel radiobiological work undertaken at IRAD fell somewhat
outside this orthodoxy. In addition, the fact that the IRAD work had resulted in two
rather embarrassing experimental fiascos had presumably led many in the ARC to
feel that they had made an unsuccessful gamble by investing in this work. Dickinson
made much of this when he wrote to John Rook of the ARC, outlining the reasons
why the ARC and MRC had decided to consolidate their scrapie research in
Edinburgh. Among the five reasons he listed were: In a letter to John Rook of the
ARC, Dickinson explained five elements of the rationale for establishing the new
centre in Edinburgh:
As you know, the major objective was achieved by late 1980 with the commitment of
both Councils to the venture, and with the following elements having contributed to
the decision:
1. Findings by Edinburgh group were highly relevant to the MRC.
2. A building was available in Edinburgh, which would only need straightforward
modifications.
3. Part of the Compton group (those working mainly on pathogenesis) wanted to
regroup in Edinburgh
4. The Compton group working on the biochemical nature of the agent had made little
progress over two decades, and inspired little confidence for the future.
5. The latter point was reinforced by the Compton "nucleic acid" fiasco in 1979-1980,
which convinced the outsiders on the Scrapie Advisory Committee to recommend
starting the NPU and to set a termination date for work at Compton.86
85 Dickinson, Alan G. (1999) op. cit. note 26
86 Dickinson, Alan (1981) A letter to John Rook, YB 81/9.23/1.1 (London: The BSE Inquiry)
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Interestingly, in his letter, Dickinson pointed out the experimental fiasco in
Compton as one of the rationales for regrouping all the scrapie research projects.
This confirms the view that this event played a fatally negative role in undermining
the credibility of the Compton group at that time. This also seems to have been the
view of some key members of the scrapie advisory committee. Katherine Levy, a
member of the MRC neuroscience board, and participant in the scrapie advisory
committee as an MRC delegate, later told the BSE Inquiry, "I do know that there was
work at Compton on the nature of the agent, which I think I am correct in saying
had been rather spectacularly unsuccessful."87
This emerging consensus could explain why committee delegates from IRAD
were powerless to resist the process of redirection in favour of Edinburgh, whilst
Dickinson and Kimberlin put forward a new project, which could be a potential
threat to the scrapie programme at Compton. As Hunter recollected, the debacle
unfortunately coincided with a period of contracting budgets, and the Agricultural
Research Council closed down the Compton scrapie programme.88 Hugh Fraser
comments on what other researchers thought about research at Compton:
We consider there to have been an extraordinary waste of resources at Compton, where
massive amounts of money and massive facilities have been available by the ARC to
Compton with absolutely nothing to show. I think, Professor Peter Wildy, very good
friend of ours in Edinburgh, professor of pathology in Cambridge who actually said
that 'look Dickinson and your colleague, I think you are right, and your work has been
successful.'89
Such were the general feelings amongst researchers including administrators
from the ARC and MRC at the time.
Finally, in 1980, senior staff of the MRC, including Katherine Levy, visited
Compton and Edinburgh to assess their suitability as sites for the unified research
centre. The MRC made a decision that the new centre should be located at
87 Levy, Katherine (1998) Transcript of oral hearing: day 22, t22 (1 July, 1998: The BSE Inquiry):
113
88 Hunter, G. D. (1992) 'The search for the scrapie agent7, S. B. Prusiner, J. Collinge, J. Powell
and B. Anderton (eds) Prion Diseases ofHumans and Animals (London: Ellis Harwood): 29
89 Fraser, Hugh (1999) op. cit. note 30
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Edinburgh.90 Shortly afterwards, the scrapie advisory committee and the ARC
committee agreed to establish the Neuropathogenesis Unit in Edinburgh. Alan
Dickinson was appointed as the first director of the unit.91 Accordingly, it was
arranged in principle that the Compton facilities and researchers were to transfer
into the new site. In fact, the programme in Compton was terminated, not
transferred. Only two researchers from Compton, Richard Kimberlin and Sue Collis,
moved to Edinburgh. What happened to other prominent scrapie researchers? The
rest of the researchers, including Hunter, Haig, and Clarke, decided to remain in
Compton. They had two alternatives: either changing their research project or
retiring. David Haig decided to retire from his scientific practice. This meant that the
whole project with Alper also officially came to an end. Gordon Hunter with his
group continued their research on scrapie, but it gradually died out during the
1980s. Some researchers became involved in other research projects. Michael Clarke,
for instance, participated in another research project on bovine diarrhoea virus.
The whole process of restructuring by the ARC can be seen as precipitating an
institutional intervention in the controversy between Edinburgh and Compton. To
sum up, the question of why the Committee selected Edinburgh, not Compton, as
the place for the new centre, can be answered in terms of the dominating values and
interests within key sections of the scientific community. It soon became apparent
that the controversy between the two groups had arisen not just over different
scientific hypotheses: inherent tensions and rivalries were exacerbated by different
and incompatible laboratory cultures. The decision to close the radiobiological work
on scrapie at Compton and concentrate instead on pathological and genetic work at
Moredun/ABRO was in effect a decision to stick with safe science. Key policy¬
making bodies in the agricultural and medical science committees took the view that
the IRAD style was not cost-effective and too risky, and that the IRAD teams had
failed to make sufficient progress in scrapie research. By contrast, the Edinburgh
research was seen to be safe, predictable, and generally in keeping with other work
in the biological science.
90 Dickinson, A. G. (1998b) op. cit. note 27:12
91 ARC (1980) A meeting of the Council, ARC 190a/80 (14 October 1980: ARC)
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7. Conclusion
In this chapter, I have described the development and progress of the controversy
between the Edinburgh and Compton groups on the nature of the scrapie agent.
When Alper and her colleagues published a series of radiobiological experimental
data, claiming that nucleic acids were not involved in the replication of scrapie, a
controversy sprang up. As a result of the radiobiological data, many fellow
researchers in Compton put forward various heretical speculations on the nature of
scrapie, from self-replicating protein to membrane replication theory. However,
those speculations faced criticisms from other scientists. Around the same time, the
Edinburgh group of researchers put forward a somewhat more conventional line of
speculation: virino theory, which offered an explanation of the peculiar behaviour of
the pathogen and its interaction with the host organism. The dispute between the
two groups intensified. As we have seen, the two research groups not only failed to
find a common ground from which to consider their respective findings, but
descended into growing antagonism, due as much to the different experimental
cultures that they represented as to any inherent contradictions between their
results.
In fact, the confrontation was not only centred on scientific issues, such as the
nature of the agent, but was also associated with competitive/rival relations between
the two research groups. This is the key thing that the difference between the highly
individualised and competitive character of work at IRAD, which encouraged the
researchers to make bold speculations on rather limited information, compared to
the more collaborative work at Moredun-ABRO unit, which led the researchers to
make more cautious speculations based on a wider range of biological
considerations. It is evident that the workers in each institution feel a reciprocal
contempt for their opposite members, which deepened the hostility between them.
More interestingly, the controversy, which looked as though it were heading for
endless confrontation, was brought to an end with the dramatic intervention of the
ARC, an administrative body. Combined with a big transformation of the ARC itself,
the field of scrapie research was reorganised by the ARC. In this situation, the ARC
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and its scrapie advisory committee underpinned the Edinburgh-centred
reformation. Eventually, the research programmes at Compton were terminated.
Alan Dickinson's research at Edinburgh continued to be carried out in the newly
established research centre, namely, the Neuropathogenesis Unit.
The whole process of controversy and its ending provide an interesting insight
into how science is practised. In this case, two cultural styles were in conflict, and
escalated the intensity of the controversy between scientists. Throughout the
controversy, Edinburgh succeeded in producing knowledge that conformed more
closely to views held elsewhere in the scientific community. As seen, the
pathological and genetic approach of Dickinson and Kimberlin was in keeping with
the scientific orientation that predominated within the ARC and MRC. On the other
hand, IRAD failed in satisfying the scientific criteria that the community shared at
the time. In particular, the IRAD team embodied a high-risk culture of technical
innovation and bold claim-making which resulted in the production of speculative
and in some cases very insecure knowledge claims. Furthermore, this was at odds
with the scientific orientation and preference of the upper ranks of the ARC and
MRC.
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Chapter 6 - Research into unconventional slow viruses in the
United States, 1957-1980
1. Introduction
In the American context, research into scrapie presents a quite different picture
from in Britain. Scrapie was not the main research priority for American scientists.
Rather they were interested more in other neurological diseases like kuru,
Transmissible Mink Encephalopathy (TME), and CJD, for which scrapie came to
serve as a useful laboratory model. Scrapie was first noticed in the US in 1947.
According to Hourrigan, who worked in the US department of Agriculture (USDA),
the first case was reported in Michigan. It was immediately traced to imported
British sheep.1 Since scrapie was not endemic in the US, the main response by the
USDA was simply to launch an eradication programme, in the expectation that
future importation of the disease could be prevented or controlled. The USDA was
interested in sponsoring further research into the disease, but the US did not have a
strong tradition of research into the diseases of sheep and goats. Since Britain had a
much stronger tradition of research on the topic, the USDA simply decided to fund
work in Britain.2 This financial support from the USDA resulted, as we have seen, in
promoting scrapie research in Britain, and many researchers conducted large-scale
experiments there during the 1960s.
By the mid-1970s, however, scrapie research was under way in a number of
American laboratories - not so much as a subject of important in its own right, but
because it was seen as a way to gain insight into a larger family of viral diseases for
which it provided a useful experimental model. In this chapter, I will describe how
scrapie came to be seen in this light. In particular, I will point to the convergence of
1 Hourrigan, J. L. (1965) 'The scrapie eradication program', D. C. Gajdusek, C. J. Gibbs Jr. and
M. Alpers (eds) Slow, Latent, and Temperate Virus Infections. (Bethesda, National Institute of
Health): 263. Between 1947 and 1964, scrapie was diagnosed in 138 flocks in 26 US states.
However, in Britain the scale of outbreak was much larger [Hourrigan, J.L. (1964) 'Scrapie in
the United States and the scrapie eradication program', Report of scrapie seminar held at
Washington D.C. (27-30 January, 1964) (Washington, USDA): 340-360],
2 Pattison, I. H. (1988) 'Fifty years with scrapie: a personal reminiscence', Veterinary Record
123(26-27): 661-666
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scientific interests around the concept of "unconventional slow viruses", and the role
of scrapie in the formation and institutionalisation of that concept.
2. American pathway of research into scrapie-like diseases
The initial American interest in scrapie-like diseases derived not from scrapie
itself, but from concern with human neurological diseases such as Kuru. One
American researcher's contribution in particular should be focused on: Carleton
Gajdusek. He was a paediatrician and virologist, who graduated from the Harvard
medical school. While he was studying for his postgraduate degree in Caltech, he
studied physical chemistry under Max Delbruck and Linus Pauling, the Nobel
laureate chemist. From Caltech, he returned to Harvard for work in microbiology
under John Enders, another Nobel laureate famous for his successful cultivation of
poliomyelitis virus in the test tube in 1954. In 1951, Gajdusek moved to the National
Institutes of Health (NIH) when his "over-ambitious projects and outlandish
schemes" were accepted by one of the prominent NIH scientists, Joseph Smadel.3 His
project was basically the "study of child growth and development and disease
patterns in primitive cultures". Between 1952 and 1954, Gajdusek was investigating
rabies, plague and arbovirus in Iran, Afghanistan, Turkey; viruses in South America,
New Britain, and Papua New Guinea; and epidemic haemorrhagic fever in Korea.4 In
1955, he was invited by the Australian Nobel laureate, Macfarlane Burnet, to study
influenza-virus genetics and infectious hepatitis virus in the Walter and Eliza Hall
Institute of Medical Research in Melbourne.5
In 1957, while he was in Australia, he had a chance to visit Papua New Guinea to
research into diseases of children. Here, he encountered a native tribe, called the
Fore. Some of their members, Gajdusek found, were suffering from a mysterious
disease called kuru. Immediately, he was fascinated with this human neurological
3 Gajdusek, D. Carleton (1976) 'Autobiography', Nobel e-Museum, The Official Web Site of The
Nobel Foundation, (www.nobel.se/medicine/lauretes/1976/gajdusek-autobio.htmh
4 Ibid.; Rhodes, Richard (1997) Deadly Feasts (New York: Simon and Schuster): 32
5 Gajdusek, D. Carleton (1981) 'Introduction', Judith Farquhar & D.C. Gajdusek (eds) Kuru:
Early letters and field-notes from the collection of D. Carleton Gajdusek (New York: Raven Press):
xxii
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disease, and launched a pathological, epidemiological and virological examination of
the disease. With his mentor in NIH, Smadel, he set up a new laboratory to launch a
project concerning the transmission of kuru into laboratory animals, when he
returned from Papua New Guinea in 1961. In 1965, he showed that the disease could
be transmitted into other mammalian species like mice and chimpanzees. This
showed that the disease is transmissible. Furthermore, Gajdusek and his colleagues
discovered the transmission link between the local cannibalistic ritual and the fatal
disease. For this discovery concerning "new mechanisms for the origin and
dissemination of infectious diseases" of the local people in Papua New Guinea,
Gajdusek won the Nobel Prize in Physiology and Medicine in 1976.6
William Hadlow, who qualified in animal and human pathology at Ohio State
University, also played an important role in developing research into scrapie-like
diseases in the US. He worked in a department of pathology in the University of
Minnesota. In 1952, he was hired by Carl Eklund, who set up his laboratory at the
Rocky Mountain Laboratory (RML), Montana. In the early days, he studied arbovirus
infection. In 1958, his experience as a pathologist was noticed by the NIH, and they
sent him to Britain to study scrapie for two years as a part of the new, USDA-
sponsored, eradication programme. The USDA did not have anyone who had any
experience with scrapie. Moreover, there was no laboratory set up to study scrapie in
America. Consequently, the USDA decided to support British scrapie researchers,
and send an American researcher to study the disease in Britain.
While Hadlow investigated pathological changes of scrapie-affected brains at the
Institute for Research on Animal Diseases (IRAD) at Compton, he encountered the
photomicrographs of kuru-affected brain in an exhibition at the Wellcome Museum
of Medical Science in London. He found that the two diseases had a lot of
pathological similarities. According to Jennifer Cooke on 28 June 1958, Bill Jellison,
who was a colleague in the RML, visited Hadlow on his way home from a scientific
meeting in Eastern Europe:
Jellison casually mentioned to Hadlow an exhibition he had seen in London the
previous day, which had included "a strange brain disease of a primitive people in
6 Goodfield, June (1985) Quest for the Killers (Boston: Birkhauser)
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New Guinea". Intrigued, Hadlow journeyed to London, to the Wellcome Museum of
Medical Science. On the first floor, Hadlow was drawn to large colour photographs
that told the story of kuru. The display also showed the neurohistologic changes in the
brain of kuru victims. It suddenly hit him. The kuru brains had holes in the neurones,
just like those in scrapie brain.7
In an article he published shortly afterwards in the Lancet, Hadlow claimed that
the pathological patterns of scrapie and kuru were strikingly similar, and that both
diseases might be classified as belonging to the same family.8 Gajdusek was alerted
by this argument, and he became interested in the disease in sheep and goats as a
possible model for kuru.9
Another American who took an early interest in scrapie was Carl Eklund. He was
trained as a chemist and medical virologist. During his postdoctoral days, at the
Rockefeller Institute he studied arbovirus, which can cause serious and potentially
fatal inflammation of the brain (encephalitis). During the mid 1950s, he was single-
handedly determined to study poliovirus in the Rocky Mountain Laboratory (RML),
Montana. According to Hadlow, when his studies on the arboviruses were drawing
to a close, he became fascinated by observations then being made on scrapie.10 In
1961, he set up one of the first research laboratories into scrapie at the RML,11 and
investigated the behaviour of the scrapie agent in the host. Eklund thought that this
was the first basic step towards the investigation of the disease in the USA.12
Interestingly, although these researchers became interested in the disease in sheep
and goats, the initial priority of research was not scrapie at all. They had their own
research subjects, and each came from a predominantly virological background;
Gajdusek was a paediatrician and virologist; Gibbs was a virologist; Eklund was also
a medical virologist; and Hadlow worked in virus research in his early career.
Compared to British researchers, who were mostly recruited by agricultural research
7 Cooke, Jennifer (1998) Cannibals, Cows, and the CJD Catastrophe (London: Minerva): 38
8 Hadlow,William (1959) 'Scrapie and kuru', Lancet ii (5 September 1959): 289-290
9 Gajdusek, D. Carleton (1981) op. cit. note 5: xxvi
10 Hadlow,William J. (1979) 'A memorial tribute to Carl M. Eklund', Slow Transmissible
Diseases of the Nervous System I. Prusiner, S.B., W.J. Hadlow (eds) (New York: Acadmic Press):
xvii-ix
11 Ibid.
12 Eklund, C. M., R. C. Kennedy, et al. (1967) 'Pathogenesis of scrapie virus infection in the
mouse', Journal of Infectious Diseases 117:15-22
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institutes, American scientists came to scrapie research chiefly through an interest in
the pathological similarities between scrapie and other neurological diseases such as
kuru. Since William Hadlow suggested that both diseases had strikingly similar
pathological features in 1959, American researchers began to consider scrapie as a
useful model for explaining the nature of other mysterious neurodegenerative
diseases.
Another significant factor was the theoretical contribution of an Icelandic
pathologist, Bjorn Sigurdsson. He examined a local sheep disease in Iceland called
"rida". Since the mid-1930s, four different chronic diseases had appeared in Icelandic
sheep, namely pulmonary adenomatosis, maedi (progressive pneumonia), visna and
paratuberculosis. Sigurdsson made a detailed study of these diseases, and from his
observations suggested a new concept for categorising the mysterious acute diseases.
Sigurdsson introduced his new concept, "slow virus", in the lecture delivered in
London in March 1954.13 This concept attracted much interest, because there were
many chronic, long-incubation diseases which could not be explained by the
conventional virus theory. The unconventional slow virus was as yet a largely
hypothetical group of viruses, defined chiefly to accommodate the baffling
characteristics of scrapie. But the inclusion of kuru in that group opened up what
appeared to be a very promising direction of research into other virus diseases that
infect humans (i.e. kuru) but could also be studied in animals (i.e. scrapie). This was
an unexplored but very promising area for medical scientists, especially virologists.
Many medical scientists in America believed that kuru and scrapie were
representations of a new and special type of viral diseases. The fact that those
unconventional diseases might be caused by a virus was huge boost to virology.
13 Sigurdsson, B. (1954) 'Rida: a chronic encephalitis of sheep: with general remarks which
develop slowly and some of their special characteristics', The British Veterinary Journal 110:
341-354
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3. Slow virus research laboratories in America
3.1. Rocky Mountain Laboratory (RML), Hamilton, Montana
Since the early 1960s large-scale research on scrapie-like disease was carried out in
the Rocky Mountain Laboratory at Hamilton, Montana. The laboratory was an
outpost of the National Institute of Allergy and Infectious Diseases, National
Institutes of Health (NIH). The facility itself was established with research into the
deadly tick-borne disease known as Rocky Mountain spotted fever. Around the turn
of the century, many early settlers in the Montana foothills of the rugged Bitterroot
Range of the Rocky Mountains were plagued with a disease known as "black
measles", or "spotted fever". In order to examine this disease, Public Health and
marine hospital service personnel and scientists from the Hygienic Laboratory
undertook their field research in Montana. This was the origin of the RML as a
Montana State laboratory in 1921.14 Then the laboratory was purchased by the
Federal government, and became a public research laboratory that was one of three
specialised facilities of the Public Health Service (PHS) throughout the country.15
During the 1920s, researchers developed a vaccine against the agent of spotted
fever,16 and the RML became a national vaccine factory. In addition to typhus and
spotted fever vaccines, the facility also produced a yellow fever vaccine for the
military during the Second World War.17
In 1937, the institute was redesigned as the Rocky Mountain Laboratory and
assigned to the Division of Infectious Diseases, NIH. In 1955, the RML became a part
of the National Institute of Allergy and Infectious Diseases. One of the main figures
in slow virus research in America, William Hadlow, started his career in the institute
in 1952. In 1958, the USDA asked him to visit the IRAD at Compton, England, to
study scrapie. As mentioned, while he was staying at the Compton laboratory, he
made an important claim that scrapie and human neurological disease, kuru, had
14 Harden, Victoria A. (1990) Rocky Mountain Spotted Fever: history of a twentieth-century disease
(Baltimore. The Johns Hopkins University Press): 140
15 Harden, Victoria A. (1986) Inventing the NIH: Federal biomedical research policy, 1887-1937
(Baltimore, The Johns Hopkins University Press): 1967
16 NIAID (1998) 'NIAID history7, National Institute of Allergy and Infectious Disease website
(www.niaid.nih.gov/final/history/history.htm)
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many similar pathological features. When he returned to the RML, his boss Carl
Eklund suggested he set up a new project of scrapie research at RML, beginning in
the autumn of 1961.18 Eklund played an important role in extending research on
scrapie and its related diseases. According to Hadlow's memorial tribute:
During the years that followed, his primary concern was always to gain a better
understanding of the disease. And this required information on the temporal features
of vims replication before any conclusions could be drawn about its pathogenesis.19
The early task of scrapie research was to establish "a more suitable assay system
for the agent".20 While Hadlow was visiting at Compton, he obtained samples of
scrapie-affected sheep brains, and this sample became the first source for scrapie
research in America. They also obtained mouse-adapted agents from IRAD at
Compton around the same time.21 Eklund and Hadlow could now conduct
transmission experiments using the same laboratory mice (RML Swiss mice) as had
been used in Eklund's studies on the arboviruses. With the Chandler's strain, they
successfully transmitted the agent into their mice stock, and the quantitative studies,
which Eklund considered so vital to progress in understanding scrapie, became
possible.22 By using their mouse model of scrapie, they conducted detailed studies on
pathological changes in various organs (e.g. lymphocytic tissues, spleen, spinal cords
and brain) and of the time taken for the agent to replicate in these various organs.23
During the 1960s, subsequently, Eklund and Hadlow extended their methodology to
other slowly progressing viral diseases of animals including TME, Aleutian disease
in mink (AD), and progressive pneumonia of sheep. They thought that those viral
diseases could be categorised in the same class of slow viruses.24
17 Harden, Victoria A. (1990) op. cit. note 14:186
18 Hadlow, William J. (1979) op. cit. note 10: xvii
19 Ibid., xviii
20 Ibid., xvii
21 This agent was transmitted into mice by Richard Chandler in 1961, so it was called the
Chandler's strain. This strain of agent played a significant role in promoting research in
America. During the 1970s, the strain was the only source for every experiment.
22 Hadlow, William J. (1979) op. cit. note 10: xvii
23 Eklund, C. M., R. C. Kennedy, et al. (1967) 'Pathogenesis of scrapie virus infection in the
mouse', Journal of Infectious Diseases 117:15-22
24 Eklund, C.M., Hadlow, W.J., Kennedy, R.C. et al (1968) 'Aleutian disease of mink:
properties of the etiological agent and the host responses', Journal of Infectious Diseases 118 (5):
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During the 1970s, the main task of the scrapie project in RML continued to focus
on virological approaches, including using biochemical approaches in an attempt to
characterise the putative virus. Their approach can be seen as conventional virology.
According to Richard Race, who was a colleague of Eklund and Hadlow since 1970:
we worked on scrapie pretty heavy until about 1979; most of our work involved
animals and just studying the natural disease and the pathogenesis in natural hosts, for
example, sheep. We had a lot of sheep and goats around here at that time. And we did
a lot in trying to determine what tissues were infected, and how much agent was in
those tissues by doing bioassays in mice. That was kind of the emphasis until about
1980, and then Bill Hadlow left at about that time.25
Around 1974, the scrapie research team at RML also launched a series of
biophysical experiments in an attempt to isolate the scrapie agent. Stanley Prusiner, a
young neurologist from San Francisco who will play an important part in the story,
participated in this project. It was mainly based on the ultracentrifugation method in
order to isolate a pure form of the agent, but it turned out to be largely fruitless
work. After the death of Eklund and retirement of Hadlow, there was a lull. This
period was not to last, however. In the early 1980s, scrapie research in the RML was
resumed by a successor of Hadlow, Bruce Chesebro, and his colleagues such as
Byron Caughey, Richard Race, and Suzzette Priola. Since then, the RML has made
many valuable contributions to biochemical and virological research on scrapie.
3.2. The Laboratory of Central Nervous System Studies, NIH
As mentioned, Gajdusek's early interests were centred on kuru. He set up his
project on the basis of conventional virological principles. Trained under prominent
poliovirus researchers such as Enders and Smadel, he applied the basic techniques of
virological research to researching the disease in Papua New Guinea. Initially,
Gajdusek thought the disease must be a genetic disorder, because he had failed in
510-523; Eklund, C.M. & Hadlow, W.J. (1969) 'Pathogenesis of slow viral diseases', Journal of
the American Veterinary Medical Association 155 (12): 2094-2099; Lopez, C., Eklund, C.M.,
Hadlow, W.J. et al. (1971) 'Tissue culture studies of the virus of progressive pneumonia, a
slow infectious disease of sheep', Proceedings of the Society for Experimental Biology and Medicine
138 (3): 1035-1040; Eklund, C.M. & Hadlow, W.J. (1937) 'Implications of slow viral diseases of
domestic animals for human disease', Medicine 52 (4): 357-361
25 Race, Richard (2000) Interview with author (14 August 2000: RML, Hamilton, Montana)
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early attempts to transmit kuru into animals. However, his virological interest was
renewed by Hadlow's argument that kuru could be the same type of disease as
scrapie, with a similar long incubation period and spongiform changes in the brain.26
From Hadlow's point of view, Gajdusek's approach to kuru was based on the wrong
model. Gajdusek was testing for kuru on the assumption that it was a normal virus
and an acute infection, which shows symptoms within days or weeks after
exposure.27 In a personal communication between Gajdusek and Hadlow in 6 July
1959, Hadlow pointed out that kuru could also have a long incubation period like
scrapie. Gajdusek was instantly alerted to the possibility of long incubation periods,
because they had only observed their test animals for a few weeks after inoculation.28
This led him to change his view of kuru from an acute infectious disease to a slow
infectious one. Gajdusek wrote about the situation as follows:
The real question is not how we came to speculate that the disease might be infectious
or that cannibalism might be involved in its spread. [...] Much more compelling for us
than popular speculations about cannibalism was Dr. William Hadlow's suggestion, in
1959, that scrapie, an infectious chronic disease of sheep and goats, was clinically and
pathologically quite similar to kuru; this suggestion led us to consider scrapie as a
model for the kuru situation.29
At the same time, the USDA invited some British scrapie researchers to take part
in a "scrapie tour" in 1959. Many prominent researchers like Herbert Parry, William
Gordon, John Stamp and Alan Dickinson joined the tour.30 Moreover, in 1960 the
USDA held a scrapie conference in Washington. According to Vicent Zigas, one of
Gajdusek's colleagues at NIH, "Carleton's most stimulating news was that he was
very impressed with the scrapie conference in Washington. [...] He discussed the
analogy with Kuru with Hadlow extensively, and planned the inoculation of
monkeys and chimpanzees".31
26 Hadlow, William (1959) op. cit. note 8
27 Rampton, S., J. Stauber (1997) Mad cow USA (Common Courage Press): 49
28 Goodfield, June (1985) op. cit. note 6:25
29 Gajdusek, D. Carleton (1981) op. cit. note 5: xxiv
30 Dickinson, Alan G. (1999) Interview with author (15 September 1999: Dunbar, Scotland)
31 Zigas, Vincent (1990) Laughing Death: the untold story of Kuru (Clifton, NJ: Humana Press):
295
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In June of 1961, Gajdusek made a trip to a laboratory in Keldur, Iceland to study
the theory of slow viruses, which was suggested by Sigurdsson in 1954. Paul
Paulsson, who was the director of the laboratory, showed him their work on the
Icelandic form of scrapie, rida, and other slow infections of sheep. Also he visited the
Moredun Institute at Edinburgh and the Compton laboratory. In this trip, Gajdusek
observed that the prominent research centres in Iceland and Britain conducted
transmission experiments into laboratory animals. He wrote later, "I came back with
the conviction that we had to pursue urgently such inoculations and long-term
observations of animals, especially primates."32 Moreover, he obtained a pocketful of
sealed test tubes ofmouse-adapted scrapie inoculant from Compton.
Following the model of slow virus and scrapie sources from Compton, he
persuaded Joseph Smadel to let him launch a new series of tests, potentially a long-
term and expensive project, using monkeys and chimpanzees. He had already
recruited an experienced London-based neuropathologist, Elizabeth Beck, to study
the Kuru brain. His new project was impossible without the support of Smadel.
Smadel's role in establishing the new laboratory was crucial. The author of Deadly
Feasts, Richard Rhodes, describes Smadel's support for Gajdusek's research: "Smadel
controlled important resources, and he proceeded to draw on those resources to
facilitate Gajdusek's work. He solicited a grant of a thousand dollars from the
National Foundation for Infantile Paralysis for his protege...and he started lobbying
medical journals to publish a first report on kuru that Gajdusek and Zigas had
drafted and sent along to establish their priority in discovering the disease."33 The
laboratory for the study of slow, latent and temperate virus infections was
established under the National Institutes of Neurological Disorders and Stroke
(NINDS) in 1961. When Gajdusek set up scrapie research with Smadel, Smadel
recruited a virologist, Joseph Gibbs Jr. While Gajdusek was working in the highlands
of Papua New Guinea, Gibbs inoculated thousands of laboratory animals with
scrapie, kuru and other human neurological diseases.
32 Gajdusek, D. Carleton (1981) op. cit. note 5: xxv
33 Rhodes, Richard (1997) op. cit. note 4: 40
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The main research aim in the early days was simple: transmission of kuru into
experimental animals. In 1962, Gibbs and his colleagues ground up brains of kuru
victims and injected these into a monkey, then into chimpanzees in 1963.34 At last,
Gajdusek's team successfully transmitted kuru agent into primates in 1966.35 This
meant that kuru was shown to be transmissible and infectious. His team also showed
that cannibalism among the Fore could be blamed for the spread of kuru.36 Moreover,
they claimed that kuru, CJD and scrapie belonged to the same family.37 Those
experimental achievements on the so-called subacute progressive degenerative brain
diseases secured Gajdusek a Nobel Prize for Medicine in 1976.38 This event closed
one era of experimental work in Gajdusek's laboratory.
Their research aim was gradually shifted to achieving a physicochemical
understanding of the agent. In 1976, they attempted to purify the agent by using
pressure cell disruption and zonal centrifugation.39 While during the early days
Gajdusek and his collaborators centered on the issue of understanding the general
virological character of the disorders, since winning the Nobel Prize his team in NIH
had expanded to examine other features of the disease. The laboratory itself was
expanded and recruited some prominent researchers such as Paul Brown from
Harvard Medical School, and an expert on biophysics, Robert Rohwer.
Furthermore, Gajdusek's team entered into collaboration with prominent French
radiobiologist Latarjet to pursue radiobiological methods in studies of the agents not
34 Goodfield, June (1985) op. cit. note 6: 28
35 Gajdusek, D.C., Gibbs, C.J., Alpers, M. (1966) 'Experimental transmission of a Kuru-like
syndrome to chimpanzees', Nature 209 (25): 794-796; Beck, E., Daniel, P.M., Alpers, M.,
Gajdusek, D.C., Gibbs, C.J. (1966) 'Experimental "kuru" in chimpanzees: a pathological
report', Lancet 2 (7472): 1056-1059
36 Gibbs, C.J. Jr. & Gajdusek, D.C. (1970b) 'Kuru: pathogenesis and characterization of virus',
American Journal of Tropical Medicine & Hygiene 19(1): 138-45; Gajdusek, D.C. (1971) 'Slow
virus diseases of the central nervous system', American Journal of Clinical Pathology 56(3): 320-
32
37 Gibbs, C.J. Jr., Gajdusek, D.C. et al. (1968) 'Creutzfeldt-Jakob disease (spongiform
encephalopathy): transmission to the chimpanzee', Science 161(839): 388-9; Beck, E., Daniel,
P.M., Matthews, W.B. et al. (1969) 'Creutzfeldt-Jakob disease. The neuropathology of a
transmission experiment', Brain 92(4): 699-716
38 Melnick, Joseph L. (1976) 'The 1976 Nobel Prize for physiology or medicine', Science 194
(4268): 927-929
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just of scrapie but also of kuru and CJD. Gajdusek estimated the size of kuru, CJD
and scrapie agent by using ionising radiation. As we have seen, Alper and Haig had
already done this type of experiment with the scrapie agent in the late 1960s.40 It is
interesting, therefore, that Gajdusek apparently rejected Alper and Haig's view that
radiobiological results indicated that replication of the infectious agents did not
involve nucleic acids. Latarjet himself had been involved in Alper's project in 1970.41
However, Gajdusek like Latarjet concluded that the genetic information of all three
viruses (Kuru, CJD and scrapie) was considerably smaller than that of any other
known viruses of mammals.42 In other words, he continued to suppose that the agent
of scrapie was virus.
3.3. Institute for Basic Research in Developmental Disabilities (IBR), New
York
During the 1970s, another group of scientists became interested in scrapie-like
diseases. They were located in a newly established state-operated institute, called the
New York State Institute for Basic Research in Developmental Disabilities (IBR). This
laboratory, on the other hand, was established to examine the causes of
developmental disabilities, provide laboratory and clinical service, and prepare
materials for public and professional education in 1967.43 The institute was initially
operated by the Department of Mental Hygiene of the New York State. However, in
1977 the Office of Mental Retardation and Developmental Disabilities took control of
the institute. When the institute was established in the late 1960s, the main research
39 Siakotos, A.N., D.C. Gajdusek, et al. (1976) 'Partial purification of the scrapie agent from
mouse brain in by pressure disruption and zonal centrifugation in sucrose-sodium chloride
gradients', Virology 70 (1): 230-237
40 Alper, T., D.A. Haig, M.C. Clarke (1966) 'The exceptionally small size of the scrapie agent',
Biochemical and Biophysical Research Communications 22: 278-284; Alper, T., W.A. Cramp, D.A.
Haig, M.C. Clarke (1967) 'Does the agent of scrapie replicate without nucleic acid?', Nature
214(20 May, 1967): 764-766
41 Latarjet, R., B. Muel, D.A. Haig, M.C. Clarke, T. Alper (1970) 'Inactivation of the Scrapie
Agent by Near Monochromatic Ultraviolet Light7, Nature 227(26 September, 1970): 1341-1343
42 Gibbs, C.J. Jr., D.C. Gajdusek, R. Latarjet (1978) 'Unusual resistance to ionising radiation
of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie', PNAS 75 (12): 6268-70
43 New York State Archives (2000) 'Guide to the organization and history of state
government', New York State Archives Internet Document
(www.archives.nysed.gov/holding/guide/part4.htm): 10
134
Research into unconventional slow viruses in the US, 1957-1980
area was focused upon diseases in the central nervous system such as autism,
poliomyelitis, Alzheimer's disease,44multiple Sclerosis (MS),45 and Batten disease.46
At this institute, one researcher in particular played a role in establishing the new
project on research into scrapie-like disease. Richard Carp is a veterinarian and
virologist from the University of Pennsylvania. In 1968, he set up his laboratory in
the IBR in order to examine general diseases of the central nervous system (CNS).
Before he came to the institute, he was dealing with the poliovirus. At the time, he
encountered scrapie as a neurological disorder, and he realised that it offered a good
opportunity to pursue another line of experimental research into an infectious
neurological condition. In other words, his fascination in scrapie was a part of his
broad interests in infections diseases of the CNS. He explains this in his interview:
It just seemed like a very interesting area to investigate when I was starting out. I
worked originally on polio, which is a very quick virus, and then I worked on Simian
virus 40 for a while which is another virus that you can assay reasonably quickly -
about 12 or 14 days. And I thought this was quite a challenge because here we had
something that took many months to assess. And it was very interesting, and also [...] I
had come to an institute that was really geared toward central nervous system
disorders, so it seemed to me one of the more interesting of the CNS diseases.47
44 Alzheimer's disease is a progressive, neurodegenerative disease characterized by loss of
function and death of nerve cells in several areas of the brain, leading to loss of mental
functions such as memory and learning. Alzheimer's disease is the most common cause of
dementia.
45 Although multiple sclerosis (MS) was first diagnosed in 1849, the earliest known
description of a person with possible MS dates from fourteenth-century Holland. An
unpredictable disease of the central nervous system, MS can range from relatively benign to
somewhat disabling to devastating as communication between the brain and other parts of
the body is disrupted. The name "multiple sclerosis" signifies both the number (multiple) and
condition (sclerosis, from the Greek term for scarring or hardening) of the demyelinated areas
in the central nervous system.
It is believed that, currently, there are approximately 250,000 to 350,000 people in the United
States with MS diagnosed by a physician. (NINDS (2000) 'Multiple sclerosis: hope through
research', National Institute ofNeurological Disorders and Stroke website
(www.ninds.nih.gov/health_and_medical/pubs/multiple_sclerosis.htm))
46 Batten disease is a fatal, inherited disorder of the nervous system that begins in childhood.
In some cases, the early signs are subtle, taking the form of personality and behavior changes,
slow learning, clumsiness, or stumbling. There is no specific method of treatment.
47 Carp, Richard (2000) Interview with author (27 July 2000: the Institute of Basic Research,
New York)
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Around the late 1960s, Carp found that British scientists were conducting large-
scale projects on scrapie, and he began to correspond with Hugh Fraser, who was a
prominent scrapie researcher in Edinburgh. In 1971, Carp made a trip to Britain to
visit scrapie research centres. The main aim of the trip was to look into the trends of
scrapie research in the United Kingdom. During the trip he became very interested in
the research methods and style of the Edinburgh group. He was most interested in
genetic aspects of scrapie, and the Edinburgh group of scientists provided valuable
data and methodology for research. According to him:
Ifs not just the trip that is involved in this, I also read the papers and the work that the
Edinburgh group did seemed to me to correspond to the standpoint that I guess I had.
My interest in polio had originally been in genetic aspects of the disease, not the virus.
And so I guess I was most interested in the genetic aspects of scrapie. And that was
certainly being carried forward very expertly by the Edinburgh group.48
Since then the IBR and the Edinburgh group have maintained strong collaborative
ties in their research. The Edinburgh group has provided basic ideas and
experimental materials to the IBR. The IBR group needed a model for the principles
and methods to pursue in their newly established project. In return, the IBR have
exchanged experimental data and group members. This made for a strong alliance
between the Edinburgh and American group.
The scrapie research group in the IBR during the early 1970s was not particularly
productive, whereas Gajdusek's and the RML produced much experimental data.
Carp and his colleagues tried to find scrapie-related effects on the behavior of blood
cells. They produced evidence to show that in the case of scrapie-infected mice, the
level of the white blood cells known as polymorphs was lowered.49 However,
according to Gordon Hunter, it became obvious that the results were not
reproducible.50 As Hunter remarked, the seventies was a period of false trails,
48 Ibid.
49 Licursi, P.C., P.A. Merz, G.S. Merz, R.I. Carp (1972) 'Scrapie-induced changes in
percentage of polymorphornuclear neutrophils in mouse peripheral blood', Infection and
Immunity6: 370-376
50 Hunter, G. D. (1992) 'The search for the scrapie agent 1961-1981', S. B. Prusiner, J. Collinge,
J. Powell and B. Anderton (eds) Prion Diseases of Humans and Animals (New York, Ellis
Horwood): 27.
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because mariy scientists conducted various experiments and sometimes they
published premature data without sufficient repetition.51
Despite the frustration of such false dawns, the group in Staten Island introduced
distinctive projects which were different from other scrapie research centres in the
US. Like the Edinburgh group, Richard Carp thought that elucidating the
relationship between the host (genetic factor) and exogenous factor (viral
component) was more important than the physico-chemical nature of the agent,
which was the main focus of interest during the 1970s in the US. Where Carp's
project differs from the Edinburgh project was in adding some conventional
virological research methods. For instance, exposure of PAM cells, a spontaneously
transformed mouse cell line, to brain homogenates from mice infected with scrapie
caused a relative decrease in total cell yield. Carp believed that scrapie caused the
reduction of cell division.52 This type of approach integrated the scrapie research into
a broader programme of research into disease of the CNS in general. During the
1970s, Carp and his team at the IRAD were also pursuing virological research into
multiple sclerosis.53 In other words, the research project into scrapie was a part of a
bigger project of studying other neurological disorders. However, the whole research
orientation changed when one of his laboratory staff, who specialised in electron-
microscopy, Pat Merz, discovered the first visualised form of the what was believed
to be the infectious particle, famously known as "Scrapie-Associated Fibrils
(SAFs)".54 Since then, research on scrapie became their main priority of research.
si Ibid., 27-29
52 Carp, R.I., Merz, G.S., Licursi, P.C. (1976) 'Scrapie in vitro: agent replication and reduced
cell yield', Infection & Immunity 14(1): 163-167
53 Carp, R.I., Licursi, P.C., Merz, G.S. (1975) 'Multiple sclerosis-induced reduction in the
yield of a mouse cell line', Infection & Immunity 11(4): 737-41; Carp, R.I., Merz, G.S., Licursi,
P.C. (1976b) 'A small virus-like agent found in association with multiple sclerosis material',
Neurology 26 (6 PT 2): 70-1; Carp, R.I., Warner, H.B., Merz, G.S. (1978) 'Viral etiology of
multiple sclerosis', Progress in Medical Virology 24:158-77
54 Merz, P.A., R.A. Somerville, et al. (1981) 'Abnormal fabrils from scrapie-infected brain',
Acta Neuropathologica 54 (1): 63-74. This finding was regarded as one of the major
breakthroughs in this field. I will discuss this issue later
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3.4. Department of Veterinary Science, University ofWisconsin, Madison
Veterinary research at the University of Wisconsin, Madison has long been
strongly associated with local farming interests. As with other research schools in the
US, the Madison research group did not initially focus on scrapie, but on another
disease in mink called Transmissible Mink Encephalopathy (TME). As is becoming
clear, scrapie research in America shows a different developmental pathway from
Britain: the majority of scrapie researchers came on board as an extension of other
research interests, e.g. virological, or medical interests, whereas British research on
scrapie derived from agricultural demands. In the Madison, however, local
agricultural interests played an important role in promotion of the research. The state
of Wisconsin has a nickname, "the dairy state". Also the University of Wisconsin,
Madison (UW-Madison) has provided many valuable resources for local farmers,
and developed revolutionary techniques of pest management, fertilizer application,
irrigation, crop rotation, animal insemination and disease control.55 This means that
the agricultural industry were able to influence academic research. Following such
strong demands from the agricultural sector, UW-Madison specialised particularly in
bovine-related research.
Alongside the strong tradition of research on bovine diseases, some members of
the department were also interested in diseases in mink. In fact, the United States
accounted for about a third of the world's total mink production, and Wisconsin is
the largest producer of commercially-raised mink pelts in the country.56
Consequently, it is not surprising that the department has a strong tradition of
research into mink-related diseases. One of the mink diseases was TME. It was
thought that the disease was caused by a virus-like agent that produces a
spongiform-like change in brain.57 TME is a rare disease, but caused enormous
economic losses in the commercial mink industry. According to Rampton and
Stauber, in 1961 the disease struck five ranches in Wisconsin, killing between 10% to
55 Rampton, S., J. Stauber (1997) op. cit. note 27: 86
56 Ibid., 86
57 Marsh, R.F. & Hanson, R.P. (1969) 'Physical and chemical properties of the transmissible
mink encephalopathy agent', Journal of Virology 3(2): 176-80,1969
138
Research into unconventional slow viruses in the US, 1957-1980
30% of the animals on each ranch. Other incidents occurred in 1963 in Idaho, in
Canada and Wisconsin.58
Robert Hanson and Richard Marsh were the central figures of research on TME.
Robert Hanson is an UW-Madison-graduated virologist who had a position in the
department of veterinary medicine. Initially he was interested in Newcastle Disease
Virus (NDV),59 but during the 1960s his interest was expanded into neurological
disease in mink, due to the TME outbreak in the Wisconsin fur industry. With his
doctoral student, Richard Marsh, he examined the host range, neuropathology, and
physicochemical properties of this slow and unconventional presumed viral agent.60
Hanson's colleagues in Wisconsin, Dieter Burger and G. R. Hartsough conducted
aetiological studies on the outbreak of TME in 1963, and found that there were
spongiform-like holes, similar to scrapie-infected sheep. In the conference held in
Washington in 1964, they reported their findings, and suggested that it could be a
scrapie-like disease.61 At the same time, they heard the news from Gajdusek's
laboratory in Washington that they had succeeded in transmitting kuru into
chimpanzees.62 They also attempted the same type of experiment to transmit TME
into monkeys.63
From 1969, Marsh and Hanson undertook a comprehensive study aimed at
identifying the physical and chemical properties of the TME agent. They found that
TME was chemically indistinguishable from the scrapie agent.64 During the early
1970s, Hanson and Marsh investigated various forms of TME neuropathogenesis,
58 Rampton, S., J. Stauber (1997) op. cit. note 27: 87
59 Newcastle disease is a serious and commonly fatal disease of chickens caused by a
paramyxovirus. Other avian species are also infected, but usually with less severe
consequences. Man is also susceptible. In most developing countries Newcastle disease is the
most important infectious disease affecting village chickens. Newcastle disease continues to
pose a severe threat to the poultry industry in spite of the availability of several vaccines.
60 Yuill, t. M. and B. G. Easterday (1996) 'Robert Paul Hanson', Biographical Memoirs 70:147
61 Burger, D. & Hartsough, G.R. (1965) 'Transmissible Encephalopathy of Mink', D.C.
Gajdusek, C.J. Gibbs Jr., & M. Alpers (eds) Slow, latent, and temperate virus infections
(Washington: USDA): 197-305
62 Gajdusek, D.C., Gibbs, C.J., Alpers, M. (1966) op. cit. note 35
63 Eckroade, R.J., Zu Rhein, G.M., Marsh, R.F., Hanson, R.P. (1970) 'Transmissible mink
encephalopathy: experimental transmission to the squirrel monkey', Science 169(950): 1088-90
64 Marsh, R.F. & R.P. Hanson (1969) 'Physical and chemical properties of the transmissible
mink encephalopathy agent', Journal of Virology 3:176-180
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attempted to characterize the agent, and made comparisons with the scrapie agent.65
From those studies, they concluded that TME could be good animal model to
investigate other similar human and animal diseases such as kuru, CJD, and
scrapie.66 At the same time, in collaboration with Edinburgh researcher Richard
Kimberlin, Marsh discovered that hamsters were also susceptible to both TME and
scrapie, and had a much shorter incubation time than mice, developing higher levels
of infectivity (over 10,000 infectious units per gram of brain) than any other test
animals.67 By succeeding in infecting hamsters with TME and scrapie, they were able
to establish a second animal model that would play an important role alongside the
mouse scrapie model in subsequent research.
Although Richard Marsh focused on physicochemical features of TME and
scrapie-related diseases, the UW-Madison team shared the view, articulated by
Robert Hanson, that it is necessary to unite molecular and epidemiological concepts
and techniques as a seamless continuum in the study of the host-virus-environment
interaction. Acting on this principle, during the 1970s, Richard Marsh in particular
led the TME research team in UW-Madison, and attempted to reveal the
physicochemical nature of TME and scrapie. After constructing the hamster model as
faster, more economical and biochemically friendly, Marsh collaborated with UC
Riverside pathologist, Joseph Semancik, and launched a series of purification
experiments in order to isolate the purified form of the scrapie agent.
65 Marsh, R.F., Burger, D., Eckroade, R., Zu Rhein, G.M., Hanson, R.P. (1969) 'A preliminary
report on the experimental host range of the transmissible mink encephalopathy agent7,
Journal of Infectious Diseases 120(6): 713-9; zu Rhein, G.M., Eckroade, R., Marsh, R.F. (1971)
'Experimental transmissible mink encephalopathy (TME) in mink, monkey, and hamster.
Electron microscopic studies', Journal of Neuropathology & Experimental Neurology 30(1): 124;
Hanson, R.P., Eckroade, R.J., Marsh, R.F., Zu Rhein, G.M., Kanitz, C.L., Gustafson, D.P.
(1971) 'Susceptibility of mink to sheep scrapie', Science 172(985): 859-61
66 Marsh, R.F. (1972) 'Animal model of human disease: kuru, Creutzfeldt-Jakob disease (slow
virus infections). Animal model: transmissible mink encephalopathy, scrapie-like disease of
mink', American Journal ofPathology 69(1): 209-12
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4. Research trends in the 1970s
As discussed above, there were four major research laboratories conducting
scrapie-like disease research in the United States during the 1970s. Researchers of
scrapie-like diseases began from different medical and veterinary interests and
backgrounds. However, by the mid-1970s the different lines of American research
that I have discussed had all converged under the umbrella of research into
"unconventional slow viruses". Moreover, researchers shared similar aims even if
the detailed contents of the experiments were various. They mainly focused on the
isolation of the scrapie agent using a range of biochemical and biophysical methods.
It is interesting to note the role-played in this convergence by the adoption of the
loosely defined term, "unconventional slow viruses". This loosely defined, fuzzy
concept played an important heuristic role in the construction of new scientific
knowledge. According to a medical historian, liana Lowy, such loosely defined
imprecise terms may facilitate the constitution and the maintenance of heterogeneous
interactions between distinct groups of scientists pursuing otherwise distinct
research project and methodologies. Lowy suggests that such loose concepts may
serve as "boundary concepts", a notion she develops from Susan Leigh Star's term,
"boundary object". For Star, boundary objects are material objects that are
conceptualised in ways "which are both plastic enough to adapt to local needs
[...and] robust enough to maintain a common identity across sites".68 This plasticity
enables different groups of scientists to pursue quite disparate lines of research, and
to conceptualise the object of that research in quite different ways, which nonetheless
67 Kimberlin, R. H. & R. F. Marsh (1975) 'Comparison of scrapie and transmissible mink
encephalopathy in hamsters I: biochemical studies of brain during development of disease',
Journal of infectious disease 131(2): 97-103
68 Star, Susan Leigh, James R. Griesemer (1989 [1998]) 'Institutional ecology, "translations",
and boundary objects: amateurs and professionals in Berkeley's Museum of Vertebrate
Zoology, 1907-39', Biagioli, B. (ed) The Science Studies Reader (London: Routledge): 509. For
details, see Lowy, liana (1992) "The strength of loose concepts - boundary concepts, federative
experimental strategies and disciplinary growth: the case of immunology', History of Science
30: 371-396. Lowy's argument tends to be read as implying that loose and imprecise concepts
themselves served to determine map of scientific practice in general. However, such an
idealistic reading is not intended here. As will be seen, with regard to the case of the
unconventional slow virus, the imprecise concept was adopted by scientists because it served
their own interests in collaboration and cooperation.
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claiming to be working on the same thing. It may also permit communication and co¬
operation between these disparate groups in pursuit of common interests such as
institutional solidarity or large-scale funding. Lowy extends this notion to include
"boundary concepts" - purely conceptual constructs without immediate material
referents, but which nonetheless make possible similar federative claims to be
pursuing a common scientific interest.
The concept of "unconventional slow viruses" is a case in point. The vagueness of
the term itself makes clear that this is indeed a loose concept, as too does the lack of
specificity of the criteria for membership of this class of diseases. General family
resemblance, in terms of aetiological and pathological characteristics, suffered for a
disease to be included in this class. Thus at the height of this concept's currency
during the 1960s and 1970s, it included a wide range of conditions - amyotrophic
lateral sclerosis (ALS),69 Aleutian disease of mink,70 and multiple sclerosis, as well as
scrapie, kuru and CJD - some of which would subsequently be confirmed as viral
conditions while other would be recategorised as quite other forms of disease.71 The
69 ALS is a progressive neurodegenerative disease that attacks nerve cells in the brain and the
spinal cord. The progressive degeneration of the motor neurons in ALS eventually leads to
their death. It is often referred to as "Lou Gehrig7s disease".
70 Aleutian disease (AD) was described in ranch-raised mink in 1956. The disease was so
named because it was first found in mink with the Aleutian coat color gene. It has since been
demonstrated that all color phases of mink are susceptible to the disease. Aleutian disease
progresses slowly, taking up to one year before the mink manifests any symptoms. This has
been shown to be caused by Aleutian Mink Disease Virus, or ADV, which is a parvovirus that
infects mink, ferrets, raccoons, skunks, and possibly other Mustelidae.
71 Kurland, Leonard T. (1965) 'Amyotrophic Lateral Sclerosis: a reappraisal', D.C. Gajdusek,
C.J. Gibbs Jr., & M. Alpers (eds) Slow, latent, and temperate virus infections (Washington:
USDA): 13-22; Hirano, Asao (1965) 'Pathology of Amyotrophic Lateral Sclerosis', D.C.
Gajdusek, C.J. Gibbs Jr., & M. Alpers (eds) Slow, latent, and temperate virus infections
(Washington: USDA): 23-38; Gibbs, Jr., C.J. & Gajdusek, D.C. (1965) 'Attempt to
demonstrate a transmissible agent in kuru, amyotrophic lateral sclerosis, and other subacute
and chronic progressive nervous system degenerations of man', D.C. Gajdusek, C.J. Gibbs Jr.,
& M. Alpers (eds) Slow, latent, and temperate virus infections (Washington: USDA): 39-48; Field,
E.J. (1965) 'Some observations on the clinical immunology of multiple sclerosis', D.C.
Gajdusek, C.J. Gibbs Jr., & M. Alpers (eds) Slow, latent, and temperate virus infections
(Washington: USDA): 187-194; Gorham, J.R., Leader, R.W. et al. (1965) 'Some observations on
the natural occurrence of Aleutian disease', D.C. Gajdusek, C.J. Gibbs Jr., & M. Alpers (eds)
Slow, latent, and temperate virus infections (Washington: USDA): 279-286; Leader, R.W.,
Gorham, J.R., Hanson, J.B., Burger, D. (1965) 'Pathogenesis of Aleutian disease of mink', D.C.
Gajdusek, C.J. Gibbs Jr., & M. Alpers (eds) Slow, latent, and temperate virus infections
(Washington: USDA): 287-296; Helmboldt, C.F., Kenyon, A.J., Dessel, B.H. (1965)'The
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concept of a family of unconventional slow viruses was thus not dictated by any
unequivocal natural occurrences. Nor was the inclusion of a disease in that family
even anything more than provisional and negotiable. Rather, acceptance of the
concept, even as merely a working hypothesis, involved a leap of scientific faith - as
is evident how Gajdusek's decision to pursue further virological research into kuru
on the strength of Hadlow's observation, regarding it histological similarity to
scrapie.72 That so many scientists, working on such a wide range of diseases, were
willing to take such a leap of faith must lead us to ask just what they saw as the
advantages of such a move.
What were the advantages to be gained through developing the concept of
unconventional slow viruses? A part of the answer may be that, in this context in the
US, the various researchers all benefited from being part of a larger programme by
pursuing this federative strategy. Rather than working in relative isolation on
obscure diseases of Papuan New Guinea cannibalism (kuru) or the livestock of
Wisconsin mink farmers (TME and AD) or sheep farmers in European countries
(scrapie), they could now claim to be studying a family of diseases that embraces all
these conditions. Indeed, the same family of diseases might also be extended to
include other diseases ofmuch greater human importance. The most ambitious claim
to extend the concept to other diseases in order to gain advantages is found in
Gajdusek's Nobel lecture in 1976, when he suggested that the concept of slow viruses
might help to account for human chronic diseases from Parkinson's disease to
Alzheimer's disease. He claimed that:
The suspicion has been awakened that many other chronic diseases of man may be
slow virus infections. Data have gradually accumulated both from the virus laboratory
and from epidemiological studies, which suggest that multiple sclerosis and
Parkinson's disease, desseminated lupus erythematosis and juvenile diabetes,
polymyositis and some forms of chronic arthritis may be slow infections with a masked
and possible defective virus as their causes. The study of kuru was carried on
simultaneously with a parallel attack on multiple sclerosis, amyotrophic lateral
sclerosis, and Parkinson's disease; in addition, other degenerative dementias such as
comparative aspects of Aleutian mink disease (AD)', D.C. Gajdusek, C.J. Gibbs Jr., & M.
Alpers (eds) Slow, latent, and temperate virus infections (Washington: USDA): 315-328
72 Rampton, S., J. Stauber (1997) op. cit. note 27:48
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Alzheimer's disease, Pick's disease, Huntington's chorea and parkinsonism-dementia
were also studied.73
The construction of the concept of unconventional slow viruses thus made it
possible for scientists working on a variety of relatively obscure diseases of limited
social and economic importance to claim that, potentially at least, their individual
and collective efforts might hold the promise of significant improvements in human
health and welfare. Such a claim brought immediate advantages to the researches, in
terms of their own sense of the importance of their work, and their ability to sell that
work to funding bodies. It did so, moreover, in ways that enabled the various
researches to build on their previous scientific achievements, which also developing
new lines of research that permitted greater cooperation and convergence.
One of the benefits of the "strength of weak concepts" is that they permit the
continuance of distinct lines of research. The conceptual convergence around the
loose concept of "unconventional slow viruses" permitted the continuance of
methodological diversity in various research teams in the US. Under that concept,
they were able to pursue often distinct lines of research, even perhaps based upon
different disciplinary predispositions, including virological, pathological and genetic
research. However, it is important that all these teams shared the assumption that
what they were working on was some kind of virus. Virology, especially work on the
physico-chemical constitution of viruses, was one of the most exciting and
productive areas of development in American biomedical sciences at the time,
including the polio triumph, and investment in the search for cancer viruses. It is
notable, in this respect, that many of the slow virus researchers came from poliovirus
research. For instance, Joseph Smadel sponsored Gajdusek's project, and Gajdusek
himself trained under prominent poliovirus researchers like John Enders and
Macfarlane Burnet. Moreover, Richard Carp of IBR and Carl Eklund of RML had
previously conducted poliovirus research. The slow virus researchers tended to
replicate the methods that had proved so fruitful in poliovirus and cancer virus
research for their new project. This tendency can be found in the methods they used,
73 Gajdusek, D.C. (1977) 'Unconventional viruses and the origin and disappearance of kuru',
Science 197 (4307): 948
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e.g. Gajdusek's transmission experiments with primates, Carp's cell culture
experiments, Eklund's bioassay methods of scrapie research, and so on. All of these
were based on virological methods that had figured in poliovirus research in the
1950s.
Furthermore, by the mid-1970s, all the slow virus research teams were also
beginning to shift a greater or lesser proportion of their research resources to look at
the physico-chemical properties of the putative slow viruses using a variety of
approaches including biochemistry. In particular, each group in the field launched
their own project to isolate the infectious agent of scrapie. One clear example of this
approach was Prusiner and Hadlow's team in the RML, who launched a series of
purification experiments between 1974 and 1979. By using various methods of
ultracentrifugation, his team gradually isolated small infectious particles from
infected cells. Furthermore, other American teams adopted other established and
novel techniques of virus research in their efforts to isolate the scrapie agent,
including biochemical methods at Madison, electron microscopy at IBR, and
radiobiology at NIH. Critically, the availability of increasingly standardised research
tools in the form of mouse and hamster scrapie, facilitated a certain amount of
collaborative exchange and movement between the various research groups
involved. In other words, it helped to further consolidate and extend the federative
strategy outlined above. Although the concept of the family of diseases was loosely
defined, the methodologies that were used to investigate the nature of the putative
agent became increasingly standardised.74 The establishment of these standardised
methodologies also provided a route by which others from outside the established
slow virus networks. For instance, a Canadian scientist, Hyun J. Cho, who had used
ultracentrifugation techniques to isolate the Aleutian Disease Virus in Mink, now
launched a project to isolate scrapie agent. This brought him into contact with the
Wisconsin group, who also had an interest in Aleutian Disease, and who sent him
samples of scrapie-infected hamster tissues. Cho affirmed that he had succeeded in
74 As Joan Fujimura points out in her work on the history of cancer research during the post¬
war era, standardised tools and methodologies played a key role in transforming biology into
an experimental and analytic science. For more details, see Fujimura, Joan H. (1996) Crafting
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isolating 14 nm virus-like particles from the scrapie-infected mouse brain.75 At that
time, many researchers were anxious to find infectious particles of scrapie agent. This
was great news for researchers in this field, and the particles became known as "Cho
particles". Subsequently, he went on to collaborate with the Compton researchers in
the UK, though his findings were eventually invalidated by work at Compton, where
researchers found the same particles in a normal brain.76
Another example of the standardised centrifuge experiment deserves mention.
Around the same time, in Riverside, California, efforts to isolate the scrapie agent
were made by Terry Malone, who was a PhD student of Joseph Semancik. The team
collaborated with Richard Marsh and used complicated centrifugation methods and
chemical treatments such as ammonium sulphate precipitation, enzymatic digestion,
and gel electrophoresis.77 As a result, they obtained two exciting experimental results
Firstly, many scrapie experts believed that the scrapie agent was hard to separate
from cell membrane fragments due to the stability of the intimate association of the
agent with the membrane. However, Malone and her colleagues' work showed that
prolonged centrifugation could produce membrane-free scrapie agent. In other
words, such prolonged centrifugation can break the membrane structure, and
smaller particles can be separated from the membrane. This was a very strong blow
to the membrane theory. Secondly, this membrane-free agent was tested with
enzymes such as D-Nase, which could break DNA structure and inactivate it, R-Nase
for denaturing RNA, and Protease-K for digesting amino-acid chains. As a result of
these enzymatic treatments, scrapie infectivity after exposure to D-nase was
significantly decreased. However, R-Nase and Protease-K did not produce such a
Science: a sociohistory of the quest for the genetics of cancer (Cambridge, MA: Harvard University
Press)
75 Cho, H.J., A.S. Greig (1975) 'Isolation of 14-nm virus-like particles from mouse brain
infected with scrapie agent', Nature 257(5528): 685-686
76 Cho, H. J., A. S. Greig, et al. (1977) 'Virus-like particles from both control and scrapie-
affected mouse brain', Nature 267(2 June, 1977): 459-460; Hunter remarks that "Cho had
probably been somewhat unlucky in that some preparations from scrapie brain did seem to
contain a lot more of the particles than did normal brain." (Hunter, Gordon (1992) op. cit. note
53: 28)
77 Malone, T. G., R. F. Marsh, et al. (1978) 'Membrane-free scrapie activity', Journal of Virology
25(3): 933-5; Marsh, R. F., T. G. Malone, et al. (1978) 'Evidence for an essential DNA
component in the Scrapie agent', Nature 275 (5676): 146-7
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significant decrease. This meant that there was a DNA component that could interact
with D-Nase, and was vital for the agent to function. Thus, they concluded that the
scrapie agent contains an essential DNA component.78 This groundbreaking news
also became controversial later.79
Finally, I would like to make one more point about how standard methodologies
facilitate collaboration. It is notable that the collaborative networks of scrapie
research also spanned the Atlantic. For example, there was collaboration on genetic
and virological research between Kimberlin from Edinburgh and Marsh from
Wisconsin in the mid 1970s, which would lead to the hamster model of scrapie and
TME.80 Interestingly, what is most striking is that collaboration and exchange of
personnel also occurred between US groups and the Compton group in the UK. This
contrasts with the British context, because relations between Edinburgh and
Compton were very tense. As seen in the previous chapters, this was a result of
fundamental disagreement over the nature of the agent and a competitive concern to
formulate empirically and theoretically tight aetiological theories of scrapie,
supported by divergent methodological approaches and institutional styles of
practice. This effectively prevented collaboration between the British research teams.
In contrast, while American researchers generally did not accept the controversial
claims put forward by the Compton researchers regarding the non-involvement of
nucleic acids in replication of the scrapie agent, they nonetheless had no difficulty in
collaborating with the Compton team. This was because the American researchers
were more interested than the Edinburgh researchers in the physico-chemical
methods being pursued at Compton and in the kinds of data they produced; and
because, unlike the Edinburgh team, they were able to dissociate those methods and
78 Marsh, R. F., T. G. Malone, et al. (1978) 'Evidence for an essential DNA component in the
Scrapie agenf, Nature 275 (5676): 147
79 Later many researchers doubted her experimental result because nobody was able to repeat
this work. At that time, she and her colleagues believed in the validity of her work. According
to Hunter's recollection, it took a period of years before the claims were withdrawn. This is an
interesting example for investigating why many scientists were enthusiastic about her work
initially, but subsequently came to regard it as the premature conclusion of a junior worker. I
will discuss this later.
80 Kimberlin, R. H. & R. F. Marsh (1975) op. cit. note 67; Marsh, R. F., R. H. Kimberlin (1975)
'Comparison of scrapie and transmissible mink encephalopathy in hamsters II: clinical signs,
pathology, and pathogenesis', Journal of Infectious Diseases 131(2): 104-110
147
Research into unconventional slow viruses in the US, 1957-1980
data from the more controversial theoretical claims put forward by the Compton
researchers.
5. Conclusion
As I have shown, there was a clear pattern of scrapie research in the US. Most
researchers in America accepted a loosely defined concept of scrapie as an
"unconventional slow virus", even though some researchers were doubtful of the
concept. However, this imprecise concept could be adapted to refer to variety of local
experiments, and facilitated cooperation between heterogeneous researchers.
Consequently, various groups of scientists who were initially interested in different
subjects gradually accepted the concept to describe their own work, chiefly because it
enabled them to forge collegial links with other scientists and to make claims for the
importance of their collective endeavour that went far beyond what they could claim
individually.
This convergence around the concept of unconventional slow viruses was
followed by a significant degree of methodological convergence. In general, scrapie
tended to be adopted as the preferred laboratory model for research in this area. At
the local level, they came increasingly to share standardised methods of purification
and chemical treatment to isolate the putative agent of scrapie. Particularly the
technique of ultracentrifugation was seen as a good indication of the convergent
pattern of research in the US. In sharing such methods and research patterns,
American researchers' work could overlap. For instance, Cho's group, Marsh-
Semancik's group, and Prusiner's group appeared to have overlapping methods:
centrifugation, sedimentation, gel electrophoresis, enzyme treatments, and so forth.
By the late 1970s, some scientists such as Cho and Malone were claiming to have
found the core particle of the agent, though such claims remained to be confirmed.
It is worth briefly contrasting the American situation with that in Britain. First,
unlike in Britain, where research had focused on scrapie in its own right, in the US,
scrapie was incorporated as a convenient laboratory model for research into a more
general if rather vaguely defined family of diseases, the unconventional slow viruses.
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Secondly, American research in this area was sustained, not because of the economic
importance of any one disease in that family, as was the case with scrapie in Britain,
but primarily because it built on the success of virology, and held out the possibility
that that success may be extended to include other diseases. In other words, whereas
scrapie research in Britain derived from agricultural demands and governmental
responses, slow virus research in the US was initiated by the driving force of
virological success.
The successful development of poliomyelitis vaccine in 1955 was widely regarded
as a triumph of the virological approach in medical science. Huge amounts of money
were invested and a large number of scientists involved. Consequently, the
poliovirus research became a standard model for virology, and some scientists
expected the success could be extended into other areas.81 In this regard, it is notable
that many researchers in the slow virus field worked or trained in the field of
poliovirus research. It is not a coincidence that the most prominent poliovirus
scientists, e.g. Enders, Smadel, Bernet, and Koprowski, were involved in the slow
virus research directly and indirectly. Hilary Koprowski was also involved in setting
up the scrapie advisory committee in Britain in 1958 and participated in the scrapie
workshop at Washington in 1964.82 Moreover, many researchers in this field came
from the poliovirus research: as mentioned, Gajdusek was initially funded by the
National Foundation for Infantile Paralysis shows the clear relationship between the
two fields. He was trained by Enders, Smadel, and Bernet. Carp and Eklund also
conducted poliovirus research before coming to the field of slow viruses.
81 There are many historical studies on poliovirus in America. Gould, Tony (1995) A summer
plague: polio and its survivors (New Haven: Yale University Press); Wilson, Daniel J. (1998) 'A
crippling fear: experiencing polio in the era of FDR', Bulletin of the History of Medicine 72 (3):
464-495; Benison, Saul (1976) 'Poliomyelitis and the Rockefeller Institute: social effects and
institutional response', Theory and practice in American medicine (New York: Science History
Publications): 85-103; Blume, Stuart & Geesink, Ingrid (2000)'A brief history of polio
vaccines', Science 288 (5471):1593-1594; Grimshaw, Margaret (1995) 'Scientific specialization
and the poliovirus controversy in the years before World War II', Bulletin of the History of
Medicine 69 (1): 44-65; Grimshaw, Margaret (1996) The poliovirus controversy in the years before
World War II: shaping America's medical science approach to human disease (PhD thesis: University
California, Los Angeles). And also on Britain, Hardy, Anne (1997) 'Poliomyelitis and the
neurologists: the view from England 1896-1966', Bulletin of the History of Medicine 71 (2): 249-
272
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The broadly virological consensus supported that feature of American scrapie
research that contrasts most markedly with the British scene, namely the tendency
for research to converge around a single set of concepts and methodologies. In
Britain, as we have seen, relations between the two main groups of scrapie
researchers quickly became strained and antagonistic. This was a consequence of a
number of factors, including the very different disciplinary backgrounds from which
the two groups came to scrapie research, and the different laboratory cultures they
embodied. Also important, however, was the fact that scrapie was plainly a matter of
considerable economic and social significance in Britain. Consequently, neither
group needed to ally itself with others to assert the importance of its work. Rather,
within a framework of unified research council administration with close links to
central government and other policy bodies, there was a great deal at stake on
maintaining the distinctiveness and ideally the dominance of one's own approach.
As we have seen, this lay at the heart of the opposition between the Compton and
Edinburgh groups over their divergent theoretical, methodological and cultural
approaches to scrapie research. It is notable, however, that such factors did not
hinder collaboration with American researchers. On the contrary, both British groups
exchanged data, material and personnel quite freely with their American colleagues,
just as the American centers exchanged such resources freely among themselves. In
this broader international context, there was more to gain and less to lose by
stressing convergence over divergence, and eclecticism over purity. This was
certainly the case within the diversified setting of American researcher institutions,
where a generalized commitment to virological methods was sufficient to motivate a
remarkable convergence of different groups around the key topic of scrapie. But the
same generalized interest in scrapie also made possible collaboration with British
scientists, since it did not impinge on the particularly local interests that were
responsible for the tensions and hostilities within the British system.
82 Gajdusek, D.C.& Gibbs Jr., C.J., Alpers, M. (1965) Slow, latent atrd temperate vims infections
(Washington: USDA)
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Chapter 7 - Formulating the prion hypothesis: Stanley
Prusiner's work, 1972-1982
1. Introduction
In the early 1970s, a medical doctor from San Francisco, Stanley Prusiner, set up
his own research laboratory to examine the chemical make-up of the scrapie agent.
Although he was a relatively latecomer in the research field, he performed quite
large-scale experimental work. Between 1974 and 1979, Prusiner conducted several
experiments to purify the scrapie agent in collaboration with researchers in the
Rocky Mountain Laboratory, Hamilton (RML). During this period, although he was
not successful in isolating it in purified form, he did manage to obtain a partially
purified form of the scrapie agent using centrifugation methods.
After completing the collaborative project with the RML researchers, he
developed new methodologies for characterising the biochemical structure of the
agent. In 1982, Prusiner published an article in Science magazine. The title was
"Novel proteinaceous infectious particles cause scrapie" and here, for the first time,
he called these particles "prions."1 This eight-page long article caused an uproar in
the scientific community. Many people read this paper as propounding a novel but
heretical notion in the field of biological theory. For this reason, researchers and
commentators furiously attacked this idea, believing it to violate the consensus that
the only molecules capable of containing and replicating genetic information are
nucleic acids. At the time, many people in the field interpreted Prusiner's article as
arguing that transmissible disorders of the central nervous system, such as scrapie in
sheep, Creutzfeldt-Jakob disease (CJD) and kuru in humans, could be caused by
naked protein particles without nucleic acid. Stanley Prusiner, however, never
acknowledged that this was what he had meant to convey. Notwithstanding this,
some claimed that this idea could provide a significant clue to understanding one of
1
Prusiner, Stanley (1982a) 'Novel proteinaceous infectious particles cause scrapie', Science
216(9 April 1982): 136-144
151
Formulating the prion hypothesis: Stanley Prusiner's work, 1972-1982
the most troublesome diseases in America, Alzheimer's. The resulting dispute
between Prusiner and prion sceptics has continued for two decades.
In this chapter, I will describe how Prusiner first developed his basic experimental
system for purifying scrapie agent with his collaborators at the RML. While many
commentators consider the 1970s as a period of "false trail" or a "failure of
purification", it was a significant time for Prusiner, who was able to generate
systematic data from his large-scale physicochemical experiments. To conduct these
systematic experiments he had to collaborate with other established groups of
scientists. I will discuss how collaboration with scientists in the RML worked and to
what extent the collaboration played a role in developing Prusiner's research career.
His procedures for characterising the so-called "sedimentation profiles" of the
scrapie agent will be elucidated and, from these profiles, how he came to speculate
that the agentmight be a hydrophobic protein.
In the later sections of this chapter, I will describe how Prusiner went on to
elaborate his experimental system, in particular his methods of scrapie bioassay, in
ways that greatly increased the efficiency of his experimental methods overall. Using
these methods, Prusiner was able to produce yet more data on the biochemical
characteristics of the scrapie agent, culminating in his high-profile publication in
Science in 1982. I will conclude by discussing Prusiner's strategy of proposing the
name "prion" in this paper, and by stressing in particular how he chose the name as
a means of prioritising the importance of his own biochemical findings while
carefully avoiding committing himself to any more general speculations about the
biological nature of the agent.
2. Setting up a laboratory and collaboration with the RML
Between 1969 and 1972, Stanley Prusiner, who graduated from University of
Pennsylvania, began his research career in San Francisco. He worked for the National
Institutes of Health (NIH) as an intern on a Public Health Service (PHS) assignment
instead of doing military service in the Vietnam War. He joined a laboratory of
biochemistry where Earl Stadtman, a pioneer in the elucidation of the mechanism by
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which enzymes are regulated, was a director. Stadtman became a mentor of Prusiner,
and with him, Prusiner investigated glutaminases in E. coli in the lab. According to
Prusiner's recollection, he learned an "immense amount about the research process;
developing assays, purifying macromolecules, documenting a discovery by many
approaches, and writing a clear manuscript describing what is known and what
remains to be investigated."2 During the 1970s, his work mainly focused on
developing economical bioassay methods for enzymes, and how to purify the
enzymes.3 It seems that the skills he acquired in Earl Stadtman's lab played an
important role in developing his research, as he acknowledges.4 After completing his
internship for the NIH, he began a residency in the University of California, San
Francisco (UCSF) in the department of neurology. In this period, he encountered a
female patient who was diagnosed as having Creutzfeldt-Jakob disease (CJD), which
was known as a fatal neurological disorder in humans. According to his Nobel
Lecture, this was the beginning of Prusiner's interest in this subject:
In July 1972, I began a residency at the University of California San Francisco in the
Department of Neurology. Two months later, I admitted a female patient who was
exhibiting progressive loss of memory and difficulty performing some routine tasks. I
was surprised to leam that she was dying of a "slow virus" infection called Creutzfeldt-
Jakob disease (CJD) which evoked no response from the body's defenses. Next, I
learned that scientists were unsure if a virus was really the cause of CJD since the
causative infectious agent had some unusual properties. The amazing properties of the
presumed causative "slow virus" captivated my imagination and I began to think that
defining the molecular structure of this elusive agent might be a wonderful research
project. The more that I read about CJD and the seemingly related diseases—kuru of the
Fore people of New Guinea and scrapie of sheep—the more captivated I became.5
In 1974, Prusiner was offered an assistant professorship in the department of
neurology, UCSF. He decided to set up a laboratory in order to examine the
mysterious human disorder, CJD. However, he chose to work not on CJD itself, but
2 Prusiner, Stanley B. (1997) 'Autobiography', Nobel e-Museum, The Official Web Site of The
Nobel Foundation (www.nobel.se/medicine/laureate/1997/prusiner-autobio.html): 2
3 Prusiner, S. B., Milner, L. S., Long, C. W., Myers, M. L. (1971) 'Vacuum manifold for rapid
assay of enzymes using radioactive tracers and ion exchange chromatography', Revieiu of
Scientific Instruments 42 (4): 493-494
4 McManus, Rich (1998) 'Nobelist Prusiner draws homecoming crowd', NIH Record (11
March, 1998: www.nih.gov/news/NIH-Record/ll_03_98/story 02.htm): 1
5 Prusiner, Stanley B. (1998) 'Prions', PNAS 95:13363
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on the supposedly similar disease of sheep, scrapie. He thought that this was "a
wonderful problem for a chemist". In his interview with Discovery magazine in 1986,
he claimed that "it had been attacked by pathologists, physicians, veterinarians.
Those who tried to unravel the chemistry of the disease hadn't taken a very careful
approach. I spent much of my time thinking about how I was going to do this
problem. When I finished, I set up a lab here. I got some money from the neurology
department, but not a lot."6 There is an interesting anecdotal story related to his
failure to secure an NIH grant. He recollects that the NIH said, "who the hell are
you? You know something about enzyme chemistry, but you know nothing about
virology, and nothing about scrapie, and you never trained with anybody."7
Prusiner was a latecomer to the field of scrapie research, and the small field was
already occupied by many prominent researchers. For this reason, there was
relatively small room to launch his project in the field. However, the territory of
biochemical studies of scrapie was less developed as yet, because the area was
known to be quite risky and not so productive at that time. For the past twelve years
many researchers had tried and failed to achieve any clean data regarding its
chemical structure. Thus, relatively small number of scientists was interested in this
research area.
Prusiner had to overcome prejudice against a purely chemical approach, so he
took a virology course in order to acquire virological knowledge of scrapie. More
importantly, Prusiner realised that collaboration with current scrapie researchers was
crucial to participate in the field. Consequently, he contacted researchers in the
Rocky Mountain Laboratory (RML), William Hadlow and Carl Eklund. They were
already well-established researchers in this field, and the RML was working on the
laboratory-standard scrapie agents, obtained from Compton, England.8 Furthermore,
6 Taubes, Gary (1986) 'The game of the name is fame. But is it science?', Discovery (December
1986): 31. This article was written for the purpose of criticising Prusiner's strategy of doing
science in 1986, in the peak-time of the prion controversy. So it is not an impartial source.
However, it contains a rare interview with Prusiner, so I used it primarily as a source of
Prusiner's own quotes about his experimental work.
7 Ibid., 31.
8 Since William Hadlow visited Compton laboratory in the early 1960s, they were able to
maintain the scrapie agent, particularly as isolated by Chandler in 1961, in their laboratory in
Hamilton, Montana. This agent was the main experimental material used by the majority of
laboratories in the US during the 1970s.
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the laboratory maintained a large animal stock for experimental purposes. For
Prusiner, the RML was thus the ideal place to obtain the actual scrapie agent and
conduct animal experiments. The RML researchers also had a great deal of
experience and knowledge of scrapie, on which Prusiner was able to draw.
According to him, Hadlow and Eklund taught him an immense amount about
scrapie, and helped him initiate studies on the sedimentation behaviour of the
scrapie agent.9
Collaboration can work well when both parties match their interests reciprocally.
According to the analysis of a historian of science, Jane Maienschein, collaborations
typically occur for one or more of three overlapping reasons: co-labouring,
producing greater credibility, and creation of community.10 The case of collaboration
between Prusiner and the RML team can be seen as exemplifying this analysis. The
collaboration began with Prusiner's contact with William Hadlow, and involved co-
labouring between animal and biochemical work. The RML team also had some
reasons to collaborate with Prusiner. Although Prusiner was a newcomer and had
not much experience in dealing with scrapie, he was an expert in biochemistry and
enzymology. From William Hadlow's point of view, the collaboration fulfilled the
need for a biochemist for their new project. In the early 1970s, the RML launched a
new project to isolate the agent. However, the RML team mainly consisted of
veterinarians and virologists, so they needed a biochemist. According to Richard
Race, who was a young researcher in the RML at that time and now retired,
"basically Stan [Prusiner] did all of the physicochemical treatments. What we did
here, he would come out, get the tissues, take them home [San Francisco], work them
up and then send them back out, and then we would inoculate the mice to determine
where the infectivity had gone".11 The RML researchers dealt with mouse stocks and
inoculation experiments, which were more or less related to conventional biological
and virological work. On the other hand, Prusiner's lab was dealing with physico-
chemical treatments: centrifugation, sedimentation, enzymatic treatments, and
chemical treatments.
9 Prusiner, S.B. (1997) op. cit. note 2
10 Maienschein, Jane (1993) 'Why Collaborate?', journal ofHistory ofBiology 26 (2): 167
11 Race, Richard (2000) Interview with author (14 August 2000: Hamilton, Montana)
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For Prusiner, there was another reason to collaborate with the RML. He was a
relative beginner in the field and frustrated by not being able to raise research funds
for his own project. He probably needed to gain credibility from this small but highly
esoteric scientific community. As Maienschein suggests, collaborations among
different individuals may produce greater credibility, because each brings to the
project his or her own credentials and acceptability in a different research
community.12 Hadlow and his team in RML had already been established as one of
the main scrapie research groups in the world, whereas Prusiner had only just set up
his lab and failed to raise an NIH grant. As Prusiner stated, he collaborated with the
RML team to "rebut the disapproval ofmy first NIH application on scrapie".13 This is
a clear example of gaining credibility by virtue of collaboration with another group.
3. Isolating the agent: sedimentation profile
Many writers only discuss the 1970s, during which period Prusiner was
collaborating with the RML, as a period of trial and failure to isolate the scrapie
agent. For instance, in his brief historical review, Gordon Hunter dubs this period
"the period of false trails (1973-1981)".14 Moreover, most historians focus on the post-
prion era since 1982.15 Prusiner's work at this time, meanwhile, is regarded as merely
the preliminary stage to devising his famous "prion" theory. However, I do not think
this does him justice. Actually, Prusiner's experimental work in this period played a
crucial role in shaping his later ideas. His sedimentation profiles and
physicochemical treatments led him to question the conventional suppositions about
the presence of an informational molecule in the scrapie agent.
12 Maienschein, Jane (1993) op. cit. note 10:167
13 Prusiner, Stanley B. (1997) op. cit. note 2: 3
14 Hunter, Gordon (1992) 'The searching for the scrapie agent: 1961-1981', Prusiner, S.B., J.
Collinge et al. Prion Diseases in Humans and Animals (London: Ellis Horwood): 23-29
15 Many writings on mad cow disease focus on the period after 1982, regarding this period as
just a kind of pre-history of prion paradigm. Such claims can easily be found in several
writings, see Rhodes, R. (1997) Deadly Feast: Tracking the Secrets of a Terrifying New Plague.
(New York: Simon & Schuster); Rampton, S., J. Stauber (1997) Mad Cow USA (Common
Courage Press); Cooke, J. (1998) Cannibals, Cows, and the CJD Catastrophe (London:
Minerva); Brouwer, Eve (1998) 'Sheep to cows to man: a history of TSEs', Scott C. Ratzan (ed.)
The Cow Crisis: Health and the Public Good (London: UCL Press): 26-34
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As mentioned earlier, during the 1970s the main goal of American scrapie
researchers came increasingly to be isolating the scrapie agent, though there were
some huge obstacles, including long incubation period, difficulties of separating it
from the cellular structure, and no visual evidence of the agent. From my survey,
during the 1970s there were six major research groups doing scrapie work in North
America: IBR in New York, RML in Montana, University of Wisconsin, Madison,
Gajdusek's lab in NIH, Bethesda, Cho's group in Canada and Prusiner's lab in San
Francisco. Five of these six groups launched similar projects for purifying the agent
and examining its chemical structure.16 Consequently, for Prusiner and his
collaborators in Montana, purification of the scrapie agent was the right agenda with
respect to the mainstream tendency in America. In this collaborative work, Prusiner
showed an "almost monomaniacal zeal to isolate the scrapie agent".17
The process of purification was, and still is, one of the hardest tasks amongst
scrapie researchers. The scrapie agent is obtained from infected brain tissues in
which a wide variety of proteins, plus DNA and RNA are present. Since 1961, many
attempts have been made to purify scrapie from cellular material on an assumption
that the scrapie agent exists as a discrete particulate structure. However, as Richard
Kimberlin, a scrapie expert in Edinburgh, remarked in 1976, these attempts had
consistently failed, to the point where most workers in the field now believed that
the original assumption may be wrong. This led researchers to suppose that it is
usually very intimately bound up with membrane structure.18 Indeed, some British
scientists even hypothesised that it is an integral part of the membrane structure, and
suggested the so-called "membrane theory". Consequently, the problem of isolating
the agent increasingly came to be seen by researchers in the UK and US alike as one
of purification of the agent from cell membrane fragments.
Prusiner's collaboration with the RML team marked a significant shift in his own
way of working. Hitherto he had worked on developing quick and efficient methods
16 Only one of them, the Institute for Basic Research (IBR) in New York, was focusing on
biological and pathogenic characteristics of scrapie at the time. However, even they had a
small project to detect the scrapie agent by electro-microscope and chemical treatments. For
more details, see the previous chapter on research into unconventional slow virus in the US.
17 Taubes, Gary (1986) op. cit. note 6: 31
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of bioassay for measuring enzyme activity. By contrast, the Prusiner-RML work
involved a much slower form of bioassay (i.e. titration of the agent in mice) that took
a year to conduct. This represented a significant investment of time and effort in
whatmight prove an unsuccessful attempt to purify the agent, and is an indication of
Prusiner's commitment to the scrapie work. During his collaboration with the RML
team, Prusiner used as many as 250,000 laboratory mice.19
The basic procedure of purification is as follows; Prusiner worked with
homogenized samples of spleen and brain from scrapie-infected mice. This
homogenate consisted of a wide range of cell components of different sizes and
chemical constitution, including, presumably, the scrapie agent. Prusiner and his
colleagues' basic method was to separate this mixture into different fractions using
the established method of differential centrifugation. (See Figure 1)
differential centrifugation
Repeated cefibifugxtion at progressively
higher speeds will fractionate ceil
homogenates into their components.
Centrifugation separates ceil components on the basic of site and density. The larger
and denser components experience the graatest centrifugal force and move most
rapidly. They sediment to form a pellet at the bottom of the tube, while smaller, less































Figure 1: Differential centrifugation20
This centrifugation and sedimentation process was well established as a standard
process for separating different sub-cellular components from homogenised cells.
The homogenate, which contains all kinds of cell fractions, is placed in test tubes and
rotated at different speeds and for different durations in a centrifuge. Once the
samples have been centrifuged, the cellular homogenate is divided into two parts;
18 Kimberlin, Richard (1976) 'Experimental scrapie in the mouse: a review of an important
model disease', Science Progress 63: 466
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the larger and denser components are sedimented to form a pellet (P) at the bottom
of the test tubes, while the smaller and lighter components remain in suspension in
the supernatant.21
The different fractions of scrapie-infected brain and spleen were then tested for
the presence of the scrapie agent using the standard method of titration of infectivity
in mice, as discussed in earlier chapters. The resulting picture of the variation of
infectivity across the different sedimentation fractions was called the sedimentation
profile. By identifying those fractions in which scrapie infectivity was concentrated,
and by then subjecting those fractions to further fractionation and again testing for
infectivity, Prusiner hoped ultimately to produce what would effectively be a pure
preparation of the scrapie agent.
This was essentially a very hit-and-miss procedure, involving trial-and-error to
discover what speeds and durations of centrifugation were most effective in
sedimenting out different components of the homogenate, and it involved a huge
amount of tedious and repetitive work. In the end, however, after five years of work
and the sacrifice of 250,000 mice, Prusiner and his collaborators were able to identify
a particular fragment of the homogenate - called P5, the pellet produced by the fifth
sequential centrifugation of a sample of homogenate - that contained 50-80% of the
infectious activity of the original material.
The production of this homogenate fraction P5 marked an important stage in the
development of Prusiner's research. Prusiner did not suppose that P5 consisted of
pure scrapie agent, but he regarded it as a partial purification that went significantly
beyond anything that had been achieved previously. A wide variety of cellular
components were removed by the sequential centrifugation, and P5 consisted of
particles smaller than mitochondria and larger than soluble proteins - including,
Prusiner supposed, the scrapie agent.22 Importantly, P5 was devoid of cellular
membrane fragments, showing for the first time that the scrapie agent could be
obtained in a form that was not bound up with cellular membranes.
21 Albert, Bruce, Dennis Bray et al. (1998) Essential Cell biology (London: Garland Publishing):
161
22 Prusiner, S. B., W. J. Hadlow, et al. (1978) 'Partial purification and evidence for multiple
molecular forms of the scrapie agent', Biochemistry 17(23): 4993-9
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One of the implications of Prusiner's claim to have produced membrane-free
scrapie agent was that the membrane hypothesis could no longer be sustained. As
shown in chapter 4, researchers at Compton, England, had hypothesised that
replication of the agent might depend on its close association with intact and
functional plasma membrane. This idea was suggested by two prominent
biochemists at Compton, Gordon Hunter and Richard Gibbons in 196IP Around the
same time, David Haig and Tikvah Alper supported this hypothesis by showing
their experimental results of the irradiation of the scrapie agent.24 Prusiner's
demonstration of infectivity in membrane-free preparations of the agent was at odds
with this hypothesis. Moreover, his claim to have produced such a membrane-free
preparation was reinforced by additional experimental work. Some of his samples of
mouse scrapie homogenate were subjected to treatment with ultrasound and 0.5%
DOC (sodium deoxycholate) before centrifugation. The former has been used for
breaking cellular membranes with high frequency sound,25 and the latter was known
as a detergent disrupting cellular membranes.26 This treatment, Prusiner argued,
ensured that no functionally intact plasma membrane was present in these samples.
If the membrane hypothesis was true, the sedimentation profile of these samples -
i.e. the pattern of infectivity in the various sedimentation fractions - should have
differed markedly from that in non-treated homogenate. However, Prusiner showed
that treatment with ultrasound and DOC made little difference to the sedimentation
profile. The work of Prusiner and his collaborators showed that infectivity, in other
words, was independent of the presence of intact plasma membranes. As a result of
their experiments, the membrane hypothesis was shown to be inadequate to explain
the complicated mechanism of the disease.
Perhaps more importantly for Prusiner, the production of fraction P5 now
provided him with a preparation of the scrapie agent on which he could perform
23 Gibbons, R. A. and G. D. Hunter (1967) 'Nature of scrapie agent', Nature 215 (2 Sept. 1967):
1041-1043
24 Alper, T., W.A. Cramp, et al. (1967) 'Does the agent of scrapie replicate without nucleic
acid?', Nature 214 (20 May, 1967): 764-766
25 Albert, Bruce, Dennis Bray et al. (1998) op. cit. note 20:160
26
Prusiner, S. B., W. J. Hadlow, et al. (1977) 'Sedimentation properties of the scrapie agent',
PNAS 74 (10): 4659
160
Formulating the prion hypothesis: Stanley Prusiner's work, 1972-1982
further biochemical research in the absence of any protective or otherwise confusing
influence arising from its intimate association with the plasma membrane.
4. The hydrophobic character of the scrapie agent
Having obtained this partially purified form of the scrapie agent, Prusiner
launched experiments to examine its physicochemical make-up. One of the most
unusual properties of the scrapie agent is its remarkable heat stability. Several
investigators had attempted to inactivate the infectivity of the agent by heating, but
these attempts had shown that the agent is completely stable at temperatures as high
as 80 degrees.27 Prusiner repeated this heating experiment with his partially purified
samples. The results were striking. For one thing, he confirmed that the agent is
remarkably heat resistant. Moreover, when the agent was heated, the size of the
agent as measured using sucrose gradient centrifugation appeared to increase.
Prusiner proposed two interpretations of these phenomena. One possible
explanation for the heat resistance is that the scrapie agent is similar to a parvovirus,
which is known to be more stable than most other biological molecular structures to
heat. In fact relatively few biological particles are stable in the situation of heating,
and most conventional viruses are destroyed. Parvoviruses, which are small single-
stranded DNA viruses, are the most heat-resistant. Similarity to a parvovirus would
also explain other properties of scrapie agent such as its resistance to nuclease
digestion if, like parvoviruses, it consists of single-stranded DNA protected by a
protein and/or lipid coat.28 But importantly, similarity to a parvovirus would not
explain the apparent increase in molecular weight on heating.
Consequently, Prusiner proposed a more novel explanation, based on wider
speculations about the biochemical character of the scrapie agent. He started from
what was generally known about the strong tendency for the agent to associate itself
27 Gordon, W. S. (1957) 'The opening discussion to Palmer's paper', Die Veterinary Record 69
(7, Dec. 1957): 1324-1327; Millson, G. C., G. D. Hunter, et al. (1976) 'The physico-chemical
nature of the scrapie agent', R. H. Kimberlin (ed.) Slow Virus Diseases of Animals and Man
(Oxford: North-Holland Publishing Co.): 243-266
28 Prusiner, S. B., W. J. Hadlow, et al. (1978) 'Sedimentation characteristics of the scrapie
agent from murine spleen and brain', Biochemistry 17 (23): 4992
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with cell membranes. Cell membranes consist of a phospholipid bilayer, with a
hydrophobic (water-hating) middle layer and hydrophilic (water-loving) outer layer.
In an aqueous environment, the hydrophobic lipid chains of phospholipid molecules
tend to be forced together, while the hydrophilic phosphate components tend to face
outwards, where they can form hydrogen bonds with water. This produces a
particular three-dimensional structure, called a phospholipid bilayer, which is the
basic structure of cellular membranes.
Figure 2: Schematic drawing of a phospholipid bilayer in water; the water-hating tails
avoid the water and water-loving components face the water.29
Prusiner suggested that the strong association of scrapie agent with such
membranes might be explained if it had a hydrophobic surface, such that it would
tend to avoid water by inserting itself into the hydrophobic mid-layer of the
membrane. The same hydrophobic property could also be invoked to explain the
increase in size of membrane-free infectious particles on heating. In an aqueous
environment, hydrophobic particles will tend to aggregate together. Indeed, Linus
Pauling, who won the Nobel Prize for his protein work, had shown that these sorts of
hydrophobic interactions increase on heating.30 Consequently, Prusiner speculated
that the increase in size of particles of scrapie agent on heating could be due to their
increasing aggregation as a result of hydrophobic interactions. Indeed, he went on to
propose that the agent itself might be a hydrophobic protein.
Prusiner also pointed out that a number of the other peculiar properties of the
scrapie agentmight be explained if it turned out to be a hydrophobic protein:
29 Ibid., 351
30 Pauling, Linus (1960) The Nature of the Chemical Bond (Ithaca: Cornell University Press)
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first, the unusual stability of the agent to heating is consistent with such a view since
hydrophobic interactions are stabilised at high temperature. Second, the association of
the scrapie agent with membrane fraction is understandable since hydrophobic
proteins can readily insert themselves into membranes. Third, not unlike experiences
with the scrapie agent, many hydrophobic proteins have been found to be exceedingly
difficult to purify with retention of activity. Fourth, the scrapie agent like many
lipoproteins appears to exhibit minimal antigenicity in contrast to apolipoproteins,
which are often good antigens. Fifth, the apparent discrepancy in the size of the agent
as determined by ultrafilteration and by ionising radiation might be due to the ability
of the agent to undergo aggregation and dissociation as a consequence of its
hydrophobic surface.31
In other words, this hypothesis seems to answer many mysterious problems of the
scrapie agent: heat stability; strong membrane association; difficulty of purification;
absence of antigenic reaction; difficulty in determining the size of the agent.
Prusiner's idea that the scrapie agent might be a hydrophobic protein was highly
speculative, being based, not on any direct observational data, but rather on the
various peculiar properties of the agent that such a hypothesis would help to explain.
It was also distinctly at odds with prevailing views about the biology of infectious
agents in general, which are generally assumed to include some kind of nucleic acid
genome. Consequently, Prusiner's arguments found little support from other
researchers at that time. Although he later remarked, "I had anticipated that the
purified scrapie agent would turn out to be a small virus, and was puzzled when the
data kept telling me that our preparations contained protein but not nucleic acid",32
at the time, his experimental data were insufficient to support any strong claim that
there was only protein in the agent. The same data could have been interpreted
differently by other people who had different views. Other researchers continued to
suppose that the agent was most probably some kind of single-stranded virus. For
instance, Laura Manuelidis, one of the leading CJD experts at the Yale medical
school, still believes that the agent has quite similar properties to such viruses.33
Furthermore, some researchers such as Gordon Hunter and Richard Kimberlin
31 Prusiner, S. B., W. J. Hadlow, et al. (1978) op. cit. note 22: 4998
32 Prusiner, S.B. (1997) op. cit. note 2
33 Manuelidis, L. (1996) 'In the community of dinosaurs: the viral view', L. Court and B.
Dodet (eds) Transmissible Subacute Spongiform Encephalopathies: Prion Diseases (Paris: Elsevier):
375-390
163
Formulating the prion hypothesis: Stanley Prusiner's work, 1972-1982
thought that the hypothetical hydrophobicity of the agent was not a primary issue
compared to phenomena such as strain variation which implied the presence of
nucleic acid in the agent. Both Kimberlin and Hunter pointed out that this
phenomenon of increasing size with heating might indicate the existence of
glycoprotein as a component of the agent.34 Nonetheless, as we shall see, Prusiner
was evidently strongly attracted by the subject of the hypothesis of hydrophobic
protein, and would devote an increasingly large proportion of his time and other
resources to pursuing it.
5. End of the RML collaboration and Prusiner's methodological
innovation
The first phase of Prusiner's work on scrapie came to an end when the NIH
decided to close down the collaborative research with the RML. This was partly
because the collaborative research consumed so much of the Institute's resources,
and partly because the NIH had decided to reorientate research at the RML. Prusiner
remarked that "we rapidly went through our ten thousand mice and even if we were
handed money on a silver platter, we couldn't go on like that." According to Richard
Race, the closing down of the project was due to a new orientation of research in the
RML. Though the quotation is slightly long, it gives a good explanation of why the
project was closed down in 1979:
It broke down for political reasons in the late 1970s. There was kind of a change in the
hierarchy at NIAID [the National Institute of Allergy and Infectious Diseases, which is
a governing institute of the Rocky Mountain Laboratory]. We had a new scientific
director, and they did not believe that the level of collaboration was mutual enough to
warrant us using our facility to do all of the animal work. So they basically said we
don't want to be doing Dr. Prusiner's animal work. Unless this was more of
collaboration on a scientific level, we don't think that we should be involved to the
extent that we are. So that kind of shut that part down...[It was] because they wanted
the facility; the facility is limited, so if other people needed it who were here, they
wanted it for the people that were here, not for people that were around the world.
Today there are dozens of people who would love to collaborate with us just because
we have the expertise to do the animal work. But we have enough in house people
34 Hunter, G. D., R. H. Kimberlin, et al. (1973) 'Viral and non-viral properties of the scrapie
agent', Annals ofClinical Research 5 (5): 262-7
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working directly on the problem that are NIAID people that want to use the facility, so
that is the way that it is done.35
About this time, Prusiner also had other troubles to contend with. His post in the
Howard Hughes Medical Institute (HHMI) of UCSF was not renewed. However,
fortunately, Prusiner recollects, "the tenure decision was reversed and I was able to
continue my work. Although my work was never supported by HHMI again, I was
extremely fortunate to receive much larger funding from the R. J. Reynolds Company
through a program administered by Fred Saitz and Maclyn McCarthy, and shortly
thereafter from the Sherman Fairchild Foundation under the direction of Walter
Burke. While the vast majority of my funding always came from the NIH, these
private sources were crucial in providing funds for the infrastructure which was the
thousands of mice and hamsters that were mandatory."36 In 1978, when the NIH
decided to close the scrapie project down in the RML, Prusiner and his collaborators
thought they should publish their provisional data. The volume was published in
1979.
With the ending of the RML work, Prusiner was effectively deprived of facilities
for conducting bioassays of the various scrapie materials that he had been isolating
and subjecting to other kinds of physico-chemical treatment. However, his new
funds from R. J. Reynolds Company and the Sherman Fairchild Foundation now
enabled him to plan new facilities at UCSF. Since he was starting from scratch in
planning these facilities, he was also aware that the bioassay method employed at
RML - i.e. titrating the infectivity of scrapie material in mice - was both slow and
uneconomical in the sense that it required huge numbers of mice. In the late 1970s,
however, Prusiner was able to devise new bioassay methods that improved
enormously on the earlier method both in terms of speed and economy.
35
Race, Richard (2000) op. cit. note 11
36 Prusiner, S.B. (1997) op. cit. note 2: 3. This is the very interesting story of how he raised
funds from the big tobacco company, R. J. Reynolds, and from the Sherman Fairchild
Foundation, which was founded by a big airline company, AMR. Every year the foundations
provide huge amounts of money for medical research. Although the process of getting funds
is an interesting story for social scientists, it is hard to obtain information about private funds.
Thus, I merely mention the fact that he got funding from those leading private companies
during the 1970s.
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In 1975, Richard Kimberlin and Richard Marsh in the veterinary school of
University of Wisconsin, Madison, collaborated to transmit scrapie and
Transmissible Mink Encephalopathy (TME), another scrapie-like disease of minks,
into Syrian hamsters.37 From this experiment, Kimberlin and Marsh had noticed that
the incubation period was much shorter than in mice.38 In an article in 1977,
Kimberlin suggested that hamster-adapted scrapie could be an alternative model for
research. He argued in the article:
We suggest that this scrapie model may be of general use in checking the validity of
key findings from studies of mouse scrapie. We also suggest that 'Chandler' scrapie in
hamsters offers some unique advantages to scrapie research, studies alone or in
addition to some of the models of mouse scrapie...two particular advantages of this
hamster scrapie model are the high infectivity titres in brain in the clinical stage of the
disease, and the very short incubation period after intracerebral infection.39
Prusiner was evidently impressed by the possible short incubation period of
scrapie in hamsters. While he was in contact with Richard Marsh around 1978 and
1979, Prusiner conducted his own investigations, which showed that the incubation
period was only 60 days on average in hamsters, whereas the average incubation
period of mouse scrapie was around 150 days.40
Prusiner's interest in hamster scrapie related to his research priorities. For
scientists who took a more widely biological view of scrapie, including an interest in
the processes of pathogenesis, hamster scrapie was an interesting novelty, but did
not herald a particularly significant new line of research. Rather, for such workers,
there was more to be gained by continuing to work with mice. Mouse scrapie was
already characterised in considerable detail, including how it varied in different
37 Kimberlin, R. H., R. F. Marsh (1975) 'Comparison of scrapie and transmissible mink
encephalopathy in hamsters I: biochemical studies of brain during development of disease',
Journal of infectious disease 131(2): 97-103
38 Marsh, R. F., R. H. Kimberlin (1975) 'Comparison of scrapie and transmissible mink
encephalopathy in hamsters II: clinical signs, pathology, and pathogenesis', Journal of
Infectious Diseases 131(2): 104-110
39 Kimberlin, R. H., C. A. Walker (1977) 'Characteristics of a short incubation model of
scrapie in the golden hamster', Journal ofGeneral Virology 34: 302
40 Prusiner, S. B., S. P. Cochran, et al. (1981) 'Determination of scrapie agent titer from
incubation period measurements in hamsters', S. Wayne, J., M. N. Hart, J. Stein-Streilein, W.
R. Duncan and R. E. Billingham (eds) Symposium on Hamster Immune Responsiveness and
Experimental Models of Infectious and Oncologic Diseases, (New York: Plenum Press): 385-399
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strains of mice and using different strains of the scrapie agent. Consequently, it was
seen to offer more scope for studying the biological processes of disease transmission
and progression. In the case of hamster scrapie, on the other hand, only one strain of
scrapie had been isolated, and little had been done to characterise the processes of
pathogenesis.41 Thus, the scope for further research was limited with this animal
model.
By contrast, Prusiner was not interested in the biology or pathology of the disease,
but only in the biochemistry of the agent at the time. Consequently, he was inclined
to regard the host, be it mouse or hamster, as little more than a laboratory medium in
which to conduct his bioassays of the agent. From this perspective, the fact that the
hamsters delivered results more quickly than mice was a good enough reason to
develop this method. A researcher in the RML, Suzette Priola, explains the
differences between the two models: "we have a strain of hamster scrapie that goes
very quickly. This is one advantage. It just takes 90 days to do an experiment. As
opposed to the shortest natural model, experimental mouse model, which is 150
days. So, the advantage is usually time. In terms of doing pathogenesis or looking at
where it is in the animal, mice are usually used more, because you can use more of
them."42 Undoubtedly, there is a huge advantage in using the hamster model for
bioassay purposes: much shorter incubation period than mouse scrapie.
Moreover, the decision to use hamsters also enabled Prusiner to adopt another
methodological innovation. It was his new method of titrating infectivity. Since
Richard Chandler transmitted the agent into mice in 1961,43 the titration of infectivity
in mice had employed the so-called "end-point method". This method involves
making a sequence of dilutions of the scrapie material, inoculating them into mice,
and observing at what dilution 50% of the mice become infected. From this, it is
possible to estimate the concentration of infectious particles in the original sample.
Figure 3 shows the process of titrating infectivity by this method.
41
Kimberlin, R. H., C. A. Walker (1978) 'Evidence that the transmission of one source of
scrapie agent to hamsters involves separation of agent strains from a mixture', Journal of
General Virology 39: 487-496
42 Priola, Suzette (2000) Interview with author (RML, Hamilton, MT: 11 August 2000)
43 Chandler, R. L. (1961) 'Encephalopathy in mice produced by inoculation with scrapie brain
material', The Lancet 1:1378-1379
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This method has advantages and disadvantages. Although it takes a long time, it
was thought to produce an accurate indication of how much infectious substance is
in the sample. This has been widely accepted as the standard bioassay method, not
just for scrapie but also for viruses. On the other hand, this method is both wasteful
and slow: wasteful, because several dilutions of each sample of scrapie material have
to be tested in batches of mice, and slow, because the incubation time of the disease
increases as the concentration of infectious material decreases. The end-point
titration works with low concentrations, i.e. low enough to infect only 50% of the
mice into which they are inoculated, at which point incubation can take as long as a
year. Prusiner became aware of these disadvantages of the old method when he
conducted his collaborative project with the RML researchers. He claimed that
"although end-point titration in mice was an improvement over work in sheep and
goats, this method of measuring the scrapie agent was still slower and more
cumbersome than the methods used by Pasteur in his studies of viruses almost a
century earlier."44
Figure 3: Titration - A known mass of material is homogenised in a saline solution to
produce a 1 % suspension. After mixing, an aliquot is removed and diluted tenfold, to
produce a 0.1% solution. This procedure is repeated until the required dilution is
reached. Aliquots of the required dilutions are then injected into experimental animals.
The dilution (titre) which produces 50 % affected animals is the ID50 dilution, referred to
as 1 unit of infectivity. This can also be expressed in terms of the equivalent weight of
the starting material. 45
In 1978, Prusiner and his colleagues developed an alternative to the end-point
titration. As early as 1963, Gordon Hunter observed an inverse relationship between
44
Prusiner, Stanley (1984) 'Prions', Scientific American 251 (October 1984): 50
45
BSE Inquiry (2001) The BSE Inquiry: Report Vol. 2 (London: The BSE Inquiry): 29
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concentration and incubation time, and suggested that this might provide an
alternative method of measuring concentration.46 If a standardised graph of the
relationship between concentration and incubation time could be drawn, then it
would be possible to calculate the concentration of infectious agent in any scrapie
sample by simply measuring the incubation time. This would have the advantage
that mice would only need to be inoculated with a single undiluted sample of scrapie
material, so it would be far less wasteful of mice. Moreover, if that sample contained
a relatively high concentration of scrapie agent, the time taken to deliver a result
would be much shorter than at the low concentrations needed to conduct an end-
point titration. However, Hunter and his colleagues were unsure about the accuracy
of this method.47 Soon after the trial in Compton, further tests in Edinburgh
confirmed that it was inaccurate.48
Learning of this work in the course of this research into hamster scrapie, Prusiner
investigated whether the incubation period might provide a better means of
estimating the concentration of infectious material in hamsters than in mice. He
confirmed that as in mice it is possible to correlate concentration with incubation
period. With higher doses of the agent shorter incubation periods were observed.
This inverse proportional (linear) relation could be systematically specified, such that
the titre of a sample could be calculated from the incubation time of that sample (see
Figure 4). He showed that, with relatively high concentrations of scrapie agent, that
concentration could be measured in as little as 60 days and using only four
hamsters.49 Results could be achieved very rapidly with this method, and the number
of laboratory animals used could be readily reduced. Previously, researchers would
have to observe 60 laboratory mice for at least a year to determine the concentration
46
Hunter, G. D., G.C. Millson, et al. (1963) 'Observations on the comparative infectivity of
cellular factions derived from homogenates of mouse-scrapie brain', Research in Veterinary
Science 4: 543-549
47 Ibid., 548
48 Dickinson, A. G., V. M. Meikle, et al. (1968) 'Identification of a gene which controls the
incubation period of some strains of scrapie agent in mice', Journal of Comparative Pathology
78(3): 293-299; Dickinson, A. G. and V. M. E. Meikle (1969) 'Genetical control of the
concentration of ME7 scrapie agent in the brain of mice', Journal of the Comparative Pathology
79:15-22
49 Prusiner, S. B., S. P. Cochran, et al. (1982) 'Measurement of the scrapie agent using an
incubation time interval assay', Annals of Neurology 11(4): 353-8
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with the end-point titration. However, using Prusiner's methods, they could assay a
sample with just four animals in 60 days.
Figure 4. Incubation time titration50
However, others objected that this method included many potential sources of
error. As soon as Prusiner gave publicity to the effectiveness of incubation time
titration, researchers in the Institute of Basic Research (IBR), New York, scrutinised
its validity, and showed error might occur unless other variables were controlled by
means of end-point titration.51 The director of the microbiology department in IBR,
Richard Carp, urged that incubation time titration is efficient but it is not always
accurate. He continues, "the fact that sometimes the treatment of the material that
goes in it at a -1 or -2 dilution, can affect the relationship between incubation period
and end-point titration...if you modify that treatment with a different detergent or a
different solvent, or something that is different, then I think that you can upset that
relationship between incubation period and titre and get a false reading on the total
titre."52 This problem of inaccuracy being caused by uncontrolled variables seems to
be widely accepted. Even Richard Race in RML, a former Prusiner collaborator
during the 1970s, pointed out that where a linear curve between dose and incubation
time obtained, then the method would be fine. But if a non-linear curve was
established, it would not be possible to interpret what is going on.53 From these
arguments, it can be summarised that Prusiner's novel method may be effective with
50 Ibid., 53
51 Somerville, R. A., R. I. Carp (1983) 'Altered scrapie infectivity estimates by titration and
incubation period in the presence of detergents', Journal ofGeneral Virology 64: 2045-2050
52 Carp, Richard (2000) Interview with author (IBR, New York: 27 July, 2000)
53 Race, Richard (2000) op. cit. note 11
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respect to saving time and money, but that caution needs to be exercised when
judging the accuracy of the results. However, Byron Caughey, who is a biochemist in
RML, argues that the method is acceptable where fairly rough-and-ready estimates
of infectivity performed under standardised conditions will suffice:
It all depends on the kind of information that we need. If we need a quantitative
assessment, a quantitative comparison of the amount of infectivity there, we prefer the
endpoint dilution assay, though it is much more expensive and time consuming. The
incubation time assay can be helpful and useful under certain circumstances, where
you have a very well established standard curve between the actual endpoint dilution
titre and the incubation period. But any time you are crossing species barriers or
permuting the agents or manipulating it so that you create a different set of conditions
or you are working in a different species, or anything like that where the standard
curve may not work anymore; or you simply manipulated your samples in certain
ways, biochemically, so that you don't know if the standard curve applies any more,
you have to go back to the endpoint dilution assay. So, as often as possible, when it is
really critical to get a quantitative comparison of titres, for whatever purpose, we
prefer to use the endpoint dilution.54
Nonetheless, Prusiner judged incubation time titration to be quite adequate for his
own needs, and adopted it as his standard method of scrapie bioassay. This
methodological innovation proved to be a key factor in Prusiner's ability to make an
impact on research into the biochemical nature of the scrapie agent. Between 1978
and 1982, he and his team were able to perform large numbers of experiments,
generating a large body of data that would eventually enable them to make novel
claims about the nature of the agent. At the interview with Gary Taubes in 1986,
Prusiner claimed that over the next two or three years, "we did more experiments on
the biochemistry of scrapie than everyone else in the history of scrapie combined."55
6. Biochemical investigations
Meanwhile, Prusiner was exploring other ways ofmoving forwards from the only
partially successful attempts to isolate the scrapie agent that he had pursued at RML.
After termination of the collaborative project, he set out alone to work on his own
project. He met Richard Marsh in Wisconsin, and he went to Gajdusek, who won the
54 Caughey, Byron (2000) Interview with author (RML, Hamilton, MT: 11 August 2000)
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Nobel Prize with kuru research in 1976. According to Prusiner's colleague, Stephen
DeArmond, "he did everything possible to learn how to approach the problem."56
During the late 1970s, he attempted to extend his network and knowledge
enthusiastically. Particularly, in 1978 and 1980, he "pilgrimaged to the Eastern
Highlands [of Papua New Guinea] to add kuru to his quiver"57. On this trip, he
worked up clinical studies on fifteen kuru patients with Gajdusek and Mike Alpers.
Above all, however, Prusiner was intrigued by the suggestions he had already
made as a result of the RML work, that the scrapie agent is primarily or even
exclusively proteinaceous in character. In 1979, he began to pursue a variety of
biochemical experiments to throw further light on the involvement of proteins and of
nucleic acids in the infectious activity of the scrapie agent. He considered the method
of preparing a partially purified preparation of scrapie agent that he had developed
with the RML researchers to be good enough to provide material for such
experiments, and his aim now shifted to characterising this partially purified agent
biochemically.
Around 1979, Prusiner set about testing the effects of a wide range of biochemical
reagents on the scrapie agent, and specifically observing how various reagents
affected the infectivity of the agent. Thanks to his new technique of hamster
incubation time bioassay, Prusiner was able to carry out this broad programme of
testing very quickly, enabling him to publish a paper in Science as early as 1982. This
paper would establish Prusiner as a key figure in research into scrapie and related
diseases.
6.1. Testing for the involvement of protein
The basic idea of these experiments is quite simple; if you treat the scrapie agent
with chemical detergents which can break or disrupt the amino-acid chains of
protein, and if the results show that the activity of the agent has vanished, then you
may logically conclude that proteins are a functional component of the agent. In
biochemistry there are various chemical detergents and enzymes for denaturing
55 Taubes, Gary (1986) op. cit. note 6: 33
56 DeArmond, Stephen (2000) Interview with author (UCSF, San Francisco: 17 August 2000)
57 Rhodes, Richard (1997) op. cit. note 15:163
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proteins. The standard enzyme for denaturing proteins is protease-K. This enzyme is
a non-specific protease, in other words, it can digest any amino-acid chain. Protease-
K is a very effective enzyme for neutralising proteins. Prusiner aimed to test whether
the scrapie agent involved proteins by using this detergent. The result was clear:
when you put protease-K in the sample of scrapie, it lost its infectivity.
The second experiment involved chemical modification by diethyl pyrocarbonate
(DEP). DEP also inactivates proteins by modifying proteins chemically. With DEP the
scrapie agent was also inactivated. In addition, if the inactivated agent was treated
with hydroxylamine, which reverses the chemical effect of DEP on protein,
infectivity was restored. The third line of evidence is a treatment with a reagent,
sodium dodecyl sulfate (SDS). SDS is a detergent widely used in experimental
biology for solubilising membrane and protein assemblies. Particularly, this
detergent disrupts most protein-protein interactions and lipid-protein interactions.58
When the scrapie agent was exposed to this detergent, the infectivity was abolished.
The fourth evidence that protein is an essential part of the agent involved exposure
to chaotropic ions - another reagent that inactivates proteins. Low concentrations of
the ions were shown to inactivate the agent. The fifth experimental result involved
the use of phenol, a potent denaturant of protein. Phenol, in general, is useful to
isolate nucleic acids, because it can remove proteins, while leaving nucleic acids
intact. Again, with phenol, the agent was inactivated. The sixth biochemical
experimental evidence involved exposure to urea, which is the soluble waste product
of the breakdown of proteins and amino acids in mammals and other animals. It is
also known to deactivate proteins. Prusiner and his team again observed that the
scrapie agent lost its infectivity when exposed to urea.59
Prusiner went on to declare that "from all of these studies with chemical reagents
that denature proteins but permit isolation of biologically active nucleic acids, we
conclude that denaturation of a protein within the scrapie agent leads to inactivation
of the infectious particles."60 This means that scrapie infectivity depends on the
58 Darnell, J., H. Lodish, D. Baltimore (1986) Molecular Cell Biology (New York: Scientific
American Books): 582-583.
59 Prusiner, Stanley (1982a) op. cit. note 1
60 Ibid., 139
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presence of an intact protein, which he locates within the scrapie agent - i.e. he
assumes that the various protein denaturing agents he uses are acting on the agent
itself, and not on some kind of agent-protein complex.
6.2.Testing for the involvement of nucleic acids
Prusiner's next step was to explore whether nucleic acids were involved in
replication of the agent. From the conventional molecular biological view, all
biological entities depend on nucleic acid-based genomes for their replication.
Prusiner conducted a series of basic experiments to determine whether this was true
in the case of scrapie agent. He treated the partially purified scrapie agent with a
variety of nucleases - micrococcal nuclease, nuclease P, deoxyribonucleases I and II,
ribonucleases A and Ti, and phosphodiesterases I and II - all of which break down
nucleic acids and would be expected to lead to inactivation of the agent if a nucleic
acid is involved in replication. Despite these attempts to inactivate the agent by
means of nuclease treatment, he could not find any positive evidence of inactivation
of the agent. The experimental phenomena could be explained by two possible
interpretations. One was that nucleic acid was not involved in scrapie infectivity. On
the other hand, as Prusiner mentioned in the paper, the same phenomena might be
observed if the nucleic acids were protected by viral protein coats which the
nucleases could not penetrate.61
Prusiner also invoked other experimental evidence to reinforce his preference for
the former hypothesis - notably the radiobiological findings of Tikvah Alper, David
Haig and Michael Clark, which had led them to conclude that the agent did not
contain nucleic acids.62 Prusiner also conducted similar experiments in collaboration
with James Cleaver of the medical school in UCSF. Prusiner and Cleaver obtained a
similar result to Alper's.63
Another experimental result that underpinned Prusiner's scepticism about nucleic
acid was an experiment with psoralens. Psoralens are photo-sensitisers used for
identifying DNA/RNA structures in cells and micro-organisms. Psoralens are known
61 ibid., 140
62 Alper, T., W.A. Cramp, et al. (1967) op. cit. note 24
63 Prusiner, Stanley (1982a) op. cit. note 1:140; Prusiner, Stanley (1984) op. cit. note 44: 53
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to be able to pass through the protein coat of such organisms and reach nucleic acids.
When exposed to UV light the psoralens then bind with the nucleic acid and
inactivate it. According to Prusiner, psoralens have several advantages in searching
for a nucleic acid genome: (1) low reactivity with proteins; (2) penetration of viral
protein and lipid coats; and (3) formation of stable covalent linkages on photo-
activation.64 However, Prusiner found that exposure to psoralens produced no loss of
scrapie infectivity. In addition, Prusiner exposed the scrapie agent to a number of
other chemicals - zinc ions, and hydroxylamine - that were known to disrupt or
modify nucleic acids. However, neither of these led to deactivation of the scrapie
agent.
These experimental results were all consistent with the same conclusion as that
reached by Tikvah Alper and her colleagues in 1967, i.e. that scrapie agent does not
contain nucleic acid. However, Prusiner was very cautious when he came to draw
conclusions from his own research. In particular, he was careful not to exclude other
possible explanations for those experimental phenomena. He argued that his
findings were consistent with two possible models of the replication of the scrapie
agent. The first possibility was that the agent contained a nucleic acid, but that this
nucleic acid-based genome was protected by a protein or lipo-protein coat. The
second possible model Prusiner suggested was that the agent was devoid of nucleic
acid. In this case, the protein component of the agent must somehow code for its own
biosynthesis.65 As Prusiner himself stated, this latter hypothesis "contradicted the
'central dogma' of molecular biology."66 As we have seen, there are good reasons to
suppose that Prusiner himself favoured this hypothesis. But he was too sensible to
associate himself too closely with such a controversial view in a high profile
publication. Consequently, in his 1982 Science which , he simply proposed the two
alternative explanations of the data, adding that "there seems to be little advantage
in championing one model over another."67
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Figure 5: Examinations of chemical nature of the agent68
6.3. Prion: new name of the agent
While refusing to commit himself to controversial hypotheses about the absence of
DNA in the scrapie agent, Prusiner did use his 1982 Science article to put forward
some bold claims that would secure him considerable visibility in the field of scrapie
research, and indeed in the field of infectious diseases more generally. For Prusiner,
the scrapie agent was a novel infectious pathogen that could not be included in any
conventional classification. In his article he states the difficulties in classifying of the
agent, "rigid categorisation of the scrapie agent at this time would be premature."69
But also argued that its biochemical and physical properties identified it as a "novel
infectious entity". He claimed, "its [the scrapie agent] resistance to procedures that
attack nucleic acids, its resistance to inactivation by heat, and its apparent small size
68 Prusiner, Stanley (1984) op. cit. note 44: 54
69 Ibid., 142
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all suggest that the scrapie agent is a novel infectious entity."70 For the categorisation
of this new pathogen, Prusiner suggested a new name for the agent.
Prusiner's decision to suggest a new name for the agent work reflected a wider
sense among scrapie researchers that they were working on something peculiar and
important. This is in turn apparent in a general interest in inventing a new
classification for the agent. Between the late 1970s and early 1980s, several attempts
were made to give the agent a proper name. In 1979, the Edinburgh-based
researchers including Alan Dickinson, Richard Kimberlin and George Outram,
suggested calling it a "virino", a name which suggests that it is related to viruses but
that highlights its peculiarities, especially its small size.71 Other scientists in the field
called it a "slow (unconventional) virus". Prusiner and his team took the opportunity
of their 1982 Science article to suggest a different name for the infectious agent which
made no reference to any supposed viral characteristics, but instead pointed to
particular biochemical properties of the agent. Stanley Prusiner suggested calling it
"prion" [pronounced pree-on]. According to him, "prions are small proteinaceous
infectious particles which are resistant to inactivation by most procedures that
modify nucleic acids. The term "prion" underscores the requirement of a protein for
infection; current knowledge does not allow exclusion of a small nucleic acid within
the interior of the particle".72 In this quotation, there is no specific definition of the
prion - just a mention that proteins are a necessary component for infection.
When he planned to publish this paper and was thinking about what to call the
agent, Prusiner and his team reviewed the first manuscript of the article and
discussed the naming. One of his post-doctoral research fellows, David Bolton says,
"as I recall, each of the internal reviewers had some comments and criticisms. Stan
may or may not have altered the manuscript based on these. I do recall that the term
'prion' was chosen during that period, and that Paul Bendheim originally suggested
the term 'prian' for proteinaceous infectious agent. Stan liked the basic idea but
70 Ibid., 141
71 Dickinson, A. G., G. W. Outram (1979) 'The scrapie replication-site hypothesis and its
implications for pathogenesis', S. B. Prusiner and W. J. Hadlow (eds) Slow Transmissible
Diseases of the Nervous System (London: Academic Press) 2:13-31
72
Prusiner, Stanley (1982a) op. cit. note 1:141
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changed it to prion based on the similarity to subatomic particle names".73 In an
interview with science writer Gary Taubes in 1986, Prusiner said that, considering
the way the word sounded, he had decided to transpose the "O" and the "I" in
proteinaceous infectious particle, in order to make itmore "terrific".74
It should be stressed that this new name served to set Prusiner apart from other
researchers in two respects - first, in refusing to use terms including "unconventional
slow virus" and "virino", and in avoiding any allusion to viruses in the name he
chooses, Prusiner clearly distances himself from any supposition that the scrapie
agent is necessarily similar to viruses. And secondly, in identifying prions as "small
proteinaceous particles", he quite clearly stressed the essential role of proteins in the
infectivity of the scrapie agent.
In his article in 1982, Prusiner did not say that prions consist solely of protein, i.e.
he still did not rule out the possibility that nucleic acids are somehow involved in
their replication. However, what he did do by calling them prions, and by thereby
emphasising the functional importance of proteins in their action, was to play up the
importance of his own research which had established that functional importance.
Another interesting feature of Prusiner's idea is that instead of putting forward a
complete hypothesis about how the agent might replicate in the absence of a nucleic
acid genome, or how it might account for other peculiar features of scrapie, he only
provided a new name. At the time many scientists who were involved in scrapie
research attempted to explain the perplexing characteristics of the disease with their
own hypothetical ideas. Prusiner was more cautious and more astute. Acceptance of
the term "prion" did not depend upon the truth of any complete theoretical
speculations. Whatever the ultimate speculation of the nature of scrapie, the term
prion could still serve to denote the causal agent.
7. Summary
In this chapter we have described how Prusiner began to be involved himself in
scrapie research in the early 1970s. During the early years, he attempted to purify the
73 Bolton, David (2000) Personal communication (16 November 2000)
74 Taubes, Gary (1986) op. cit. note 6: 30
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agent by using the centrifugation method. The collaborative work with the RML
researchers led him to achieve a partially purified form of the agent. Although this
experimental project was regarded as a failed attempt to isolate the agent, he gained
valuable experimental data and a valuable new technique for producing
experimental material.
He then went on to develop a new faster and more economical bioassay technique
with the hamster model of scrapie. This in turn enabled him to test the effects of a
wide range of chemicals on his partially purified scrapie agent in a very short time,
and to produce a considerable amount of biochemical data. On the basis of those
experimental data Prusiner produced a high-profile publication in Science in 1982 in
which he put forward some quite striking evidence for the involvement of protein in
scrapie infectivity, and an equally striking failure to find evidence of the involvement
of nucleic acids. This high profile publication also provided him with a platform
from which to suggest that scrapie represents a new category of infectious agent for
which he proposed the name "prion". He claimed that the precise nature of the
infectious agent was not yet known, but it was characterised by precisely those
phenomena that Prusiner had just demonstrated, namely the key role of protein and
the lack of effect of biochemical reagents that would normally disrupt nucleic acids.
As we will see in the next chapter, these claims not only established Prusiner's place
on the map of scrapie research, but also precipitated a prolonged controversy over,
and prompted further research into, the nature of these putative prions.
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Chapter 8 - Prion controversy, 1982-1997
1. Years of Upheaval
1.1. Beginning of warfare
The publication of Stanley Prusiner's article in Science 19821 prompted immediate
controversy among experienced scrapie researchers. As we have seen, Prusiner
proposed two possible explanations for his results: firstly, that prions contained
undetected nucleic acids; and secondly that prions were devoid of nucleic acids
entirely. Although Prusiner did not rule out the first possibility, the research
community was astonished that he could seriously propose that the agent might not
contain nucleic acids. This was clearly an unorthodox approach, because it was a
violation of Francis Crick's original "central dogma" of molecular biology, namely
that biological informationmust be encoded in nucleic acid molecules.2
The first criticism came from a British scrapie researcher, Richard Kimberlin, in
the Neuropathogenesis Unit (NPU) at Edinburgh. In a short paper in Nature,3
Kimberlin pointed out that Prusiner's experimental evidence for the absence of an
informational molecule in the agent could nonetheless be compatible with the
existence of scrapie-specific nucleic acids. For instance, the failure of various reagents
to inactivate the agent could be read as meaning that those reagents and enzymes
had not gained access to the putative informational molecule.4 Instead of using
Prusiner's term "prion", Kimberlin thought that another neologism, "virino",
previously suggested by his colleagues Alan Dickinson and George Outram, would
be preferable for describing the possible character of protein-wrapped scrapie-
specific nucleic acid. He also warned that scientists need not rush outside the bounds
1 Prusiner, Stanley (1982) 'Novel proteinaceous infectious particles cause scrapie', Science 216
(9 April 1982): 136-144
2 Keyes, M. E. (1999) "The prion challenge to the 'central dogma' of molecular biology, 1965-
1991: part II: the problem with prions', Studies in History and Philosophy of Biological and
Biomedical Sciences 30(2): 186





of conventional thinking in order to account for the behaviour of the scrapie agent.5
A few weeks later, in an unsigned editorial in the Lancet,6 Alan Dickinson stated that
Prusiner's novel idea was premature as conventional viruses were wrongly thought
by many people to be essentially protein in the 1930s. Furthermore, Prusiner's idea of
the possible absence of a scrapie-specific genome could not account plausibly for the
"various ramifications of the occurrence of different strains of scrapie."7 In fact, these
two papers were orchestrated reactions to Prusiner's argument. Kimberlin and
Dickinson from NPU collectively agreed that Kimberlin should write the Nature
article, and Dickinson should do the Lancet editorial without signing his name to it.8
Soon after their criticisms were published, Prusiner recognised the style of
Dickinson's writing, and Dickinson "got a rocket", as he put it, from Prusiner.9 It was
published in the Lancet shortly afterwards.10 In the letter, Prusiner expressed his
scepticism about the Edinburgh group's twenty-year achievements, questioning the
value of their work on the strain variation of the scrapie agent. He claimed in the
letter "to suggest that isolation of a few strains of the scrapie agent in laboratory
rodents for pathogenesis studies is an important achievement is questionable. These
strains may describe a few biological characteristics of the scrapie agent, but they do
not define or constrain the possible molecular structures of this unusual infectious
particle."11 This volatile confrontation was a sort of declaration of war against the
Edinburgh group. When Prusiner criticised the existence of strain variations directly,
he was crossing the Rubicon with regard to criticising the mainstream studies. His
challenge was the first salvo of a long warfare between the prion-group and prion-
sceptics.
Underlying the disagreement between Prusiner and the NPU researchers was a
deeper divergence in their preferred methods and styles of investigation. This had
already attracted comment from George Outram, one of Dickinson's colleagues in
5 Ibid., 107
6 Anonymous Editorial (1982) 'Scrapie: strategies, stalemates, and successes', The Lancet (29
May 1982): 1221-1223
7 Ibid., 1222
8 Dickinson, Alan G. (1999) Interview with author (15 September 1999: Dunbar)
9 Ibid.
10 Prusiner, Stanley B. (1982) 'Research on scrapie', Lancet (28 August 1982): 494-495
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NPU. He claimed that the prevailing experimental attitude was to use a mouse strain
of the shortest incubation period; researchers would then proceed to apply every
conceivable sophisticated procedure of modern biochemistry, immunology and
molecular biology to it. However, he argued, "the danger with this approach is that
in order to get meaningful answers the right questions must first be asked, [...] such
a method would be the study of variation."12 Outram's preferred approach was to
focus more upon general biological phenomena, not upon a few molecular
particulars.
The NPU group's achievements of the previous twenty years were generally
appreciated by other groups of scientists. However, Prusiner's counter-claim in the
letter to the Lancet shows no such appreciation of the preceding work. His main
research priority was totally different from that of the mainstream researchers at the
time: "elucidating the molecular structure was paramount for progress in this
field",13 he claimed. This was precisely the opposite direction from that chosen by
others. This was a collision of different principles: the biological and the biochemical
approach. One of the leading pathologists in NPU at Edinburgh, Hugh Fraser, said,
"I was very critical [of Prusiner's idea]. I think I was critical because it was based on
the ignorance of disease. It was based on unawareness, I would say ignorance, lack of
awareness of our work!"14 Another researcher in NPU, Moira Bruce, also felt upset
when Prusiner ignored their achievements. She said, "he ignored whole, very well
established series of observations about the strain variation. He ignored the most
important bit of information, that of the nature of the agent from a biological
perspective. I think we were very sceptical [about Prusiner's idea]. Plus, I think there
was a bit of feeling that this was a sort of an upstart somebody had come into the
field from nowhere, and who was he to tell us what the agent was. However, it
wasn't just that. It was because the hypothesis just wasn't adequate for what we
11 Ibid., 494
12 Outram, G. W. (1980) 'Mouse scrapie: Black-box models and the slow encephalopathies', in
F. C. Rose and P. O. Behan (eds) Animal Models ofNeurological Disease (Bath: Pitman Medical):
360
13 Prusiner, Stanley B. (1982) op. cit. note 10:494
14 Fraser, Hugh (1999) Interview with author (Edinburgh: 30 June 1999)
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knew about the biology of the disease."15 This difference between the prion group
and the prion sceptics was clear. The philosophical gap between the groups would
persist for two decades.
1.2. Mapping the battlefield
Soon after the exchange in Nature and Lancet, the battlelines were clearly drawn
between Prusiner's group and the prion sceptics. The majority of scrapie researchers
belonged to the sceptics' faction. Around the early 1980s, at least eight leading
groups of scientists studied scrapie and its related disease.16 It should be made clear
here that the prion sceptics are not a homogeneous group or camp of scientists.
Although they sometimes shared their main ideas on the nature of the agent, they
sometimes took different positions. Thus, the term 'prion sceptics' means those who
fundamentally disagreed with Prusiner's idea of a protein-only agent. The leading
group of the sceptics was the Edinburgh group at NPU. Their experimental
demonstration of strain variation was the most powerful scientific evidence to
persuade others that the agent could be classified as virus-like. Most research camps
appreciated the evidential strength of the Edinburgh group's work; due to variations
of the agent, they believed that the agent must contain nucleic acid, even though its
size and unusual properties seemed to indicate the opposite, i.e., that no nucleic acid
was present. However, the prion sceptics sometimes put forward widely differing
ideas on the nature of the agent. In a review paper by Richard Carp and his
colleagues in 1985, though they agreed with Dickinson and Kimberlin's theory that
the agent included nucleic acid, and disagreed with Prusiner's idea, they took a
theoretical position called "the filamentous virus hypothesis".17 At the time, seven
15 Bruce, Moira E. (1999) Interview with author (NPU, Edinburgh: 9 June 1999)
16 The Neuropathogenesis Unit (NPU, Edinburgh), Heino Diringer's group in the Koch
Institute (Berlin), Laura Manuelidis group in the Yale Medical School, Richard Carp's group
in the Institute of Basic Research (IBR, New York), Gajdusek's group in the national institute
of neurological disorders and stroke (NINDS, Bethesda), Richard Hadlow's group in the
Rocky Mountain Laboratory (RML), Richard Marsh's group in the University of Wisconsin,
Veterinary School (Madison), and Prusiner's group in UCSF.
17 Carp, R.H., P.A. Merz et al. (1985) 'Nature of the scrapie agent: current status of facts and
hypotheses', Journal of General Virology 66:1357-1368
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out of eight groups of scientists were critical of Prusiner's idea. In fact, Prusiner was
isolated in the field of scrapie research.
Almost everyone involved with scrapie and its related diseases became Prusiner's
adversaries. His new idea was considered "biological heresy". Moreover, other
scientists dismissed his alleged prion theory as simply "a fairy tale." According to
science writer Jennifer Cooke, "his many detractors at the time labelled Prusiner, and
his heresy, as 'the P words'...he had created a new scientific word to fit a scientific
entity that was still unknown. And for that he attracted a lot of publicity - a third 'P'
word which resulted in grant money."18 Even Prusiner's former collaborator, Richard
Race, did not believe in his concept and its theoretical implication. He said, "it was
heretical, this is nuts. It is crazy. But over the years my attitude is maybe it is, but we
need better evidence."19
2. Dispute between the prion-group and prion-sceptics
2.1. Discovery of PrP, protease-resistant-protein
According to Richard Rhodes, Prusiner's decision to privilege the proteinaceous
nature of the scrapie agent was a form of gambling - a risky game he would win only
if further research into scrapie-related proteins proved fruitful.20 The payoff spilled
rapidly from his lab in the months that followed. One of his post-doctoral
researchers, David Bolton, reported in Science that the purified scrapie protein had
been found. 21 At the time, Prusiner's aim was to identify, isolate and purify the
proteinaceous particles that he called prions, and that he plainly suspected might
themselves be the agents of scrapie infection. He and his team had already managed
to produce partially purified scrapie agent, but they were still looking for ways to
18 Cooke, Jennifer (1998) Cannibals, cows and the CJD catastrophe (Random House Australia:
Sidney): 106
19 Race, Richard (2000) Interview with author (RML, Hamilton, MT: 14 August 2000)
20 Rhodes, Richard (1997) Deadly Feast: Tracking the Secrets of a Terrifying New Plague. (New
York: Simon & Schuster): 162-164
21 Bolton, D. C., M. P. McKinley, et al. (1982) 'Identification of a protein that purifies with the
scrapie prion', Science 218(4579): 1309-1311
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improve on this.22 Specifically, they now endeavoured to separate out the prion
protein from the various hamster proteins that contaminated their scrapie material.
In 1982, Prusiner and his team decided to make use of the fact that the scrapie
agent is known to be resistant to proteases. If samples of partially purified scrapie
materials from infected hamster brains were treated with protease, most or all of the
hamster proteins would be digested, leaving just the scrapie agent plus perhaps a
few other hamster proteins intact.23 By then comparing the digested brain material
from scrapie-infected hamsters with similarly treated material from non-infected
hamsters, it should be possible to identify those proteinaceous components that were
unique to infected materials.
This work was undertaken by Frank Masiarz, who was the head of post-doctoral
research in Prusiner's laboratory. However, his methods were not sufficiently
discriminatory to reveal whether or not any intact proteins remained in the protease-
digested hamster brain samples. In order to visualise such proteins, Masiarz first
treated the undigested brain samples with a radiolabelling agent. After digestion
with protease he then ran the preparation through a polychloride gel, which
separates proteins chromatographically by molecular weight - if any intact proteins
did indeed remain, it should then have been possible to identify them as distinct
bands of radio-labelled material. However, Masiarz did not produce any results that
he considered clear enough to be worth reporting. Only when Masiarz was about to
leave the laboratory did he show Bolton, who decided to take over Masiarz's project,
his notebooks. According to Bolton in his interview:
when I went back through one of his notebooks, there was something that looked
different between the scrapie sample and the normal sample. And it was sort of fuzzy
band. So I asked him about it, and I said, you know this looks like you have got
something here. And he said that no, that it wasn't really reproducible, and we had
problems, it wasn't consistent between the things...Frank was pretty pessimistic. But
when I looked at it, it looks to me very promising.24
22 It is notable that Prusiner increasingly called this partially purified scrapie preparation a
"purified prion" preparation at the time.
23 Prusiner, Stanley (1982) op. cit. note 1
24 Bolton, David (2000a) Interview with author (31 July 2000: IBR, New York)
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Bolton explained that the problem was very technical. Masiarz was labelling
proteins with the Bolton-Hunter reagent, which is a particular kind of reagent that
labels free-amino groups. The preparation of digested proteins contained so much
such residual material that the background radioactivity practically obscured any
remaining intact protein. Bolton said, "the problem was that most of the reagent,
most of radioiodine doesn't get incorporated with the protein, but it stays in the
solution. Thus when you look at the bottom of the gel, there's a tremendous
background of non-specific radiation just from the reagent itself. This makes it very
hard to see some of these things that are going on at the small molecular weight
end."25 However, Bolton was able to devise a way of separating out the intact protein
from any residual labelling agent that might be getting in the way. He treated the
protein preparations with sodium dodecylsulfate (SDS) and quinine hemisulfate to
precipitate out the intact proteins. These could then be separated from the solution of
labeled amino groups by centrifugation and washing with acetone. From this
treatment, he could get much cleaner resolution in gels. When this separated material
was rim on a polychloride gel, a very clear band of protein showed up.
Having shown by this relatively crude means that it was possible to isolate intact
proteins from scrapie-infected brain material after digestion with protease, Bolton
then went on to perform a similar experiment, but using a much more precise
method of differentiating the different protein components. He again treated scrapie
infected and non-infected partially purified brain preparations with protease-K. He
then separated out any remaining intact proteins by gel electrophoresis - a quite
precise method for not only separating out different proteins, but for calculating their
molecular weight by measuring how far they move along the gel. As in the previous
experiment, some proteins in the scrapie-infected sample remained intact and
showed up as a clear band on the electrophoresis gel. On the other hand, no protein
was found in brain material from non-infected hamsters (see Figure 1). 26 Bolton
25 Ibid.
26 Bolton, D. C., M. P. McKinley, et al. (1982) op. cit. note 21:1310
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concluded that the scrapie infected brain material contained a protease-resistant
protein of molecular weight 27-30 K. Bolton called this PrP 27-30.27
Figure 1: Protease-Resistant Protein (PrP) Radioiodinated and separated by SDS-
Polyacrylamide Gel Electrophoresis.28
Bolton, like Prusiner, was cautious in drawing more general conclusions from this
experiment, stating only that "since this protease K-resistant protein has not been
found in purified fractions from normal hamster brains, we conclude that the protein
is specifically associated with scrapie infection".29 Notably, Bolton and Prusiner did
not yet go so far as to say that it is the scrapie agent.
On the other hand, having identified PrP and discovered something of its
properties, Prusiner and his team were now able to adapt this method to produce
significant quantities of purified PrP. By taking samples from scrapie-infected
hamster brains, digesting the proteins with proteases in the presence of SDS,
spinning down and wash the precipitate, then running it through a polychloride gel
to separate out the PrP, they were able to produce sufficient quantities of purified
PrP on which to conduct further research. Moreover, this was a very quick
procedure: the protein could be detected and quantified within one day after
radiolabelling. Prusiner wrote that the implication of this finding was that the
isolation of PrP represented a substantial decrease in the time required to gain
information about the structure of the prion. Having a handle on one component of
27 McKinley, M. P., D. C. Bolton, et al. (1983) 'A protease-resistant protein is a structural
component of the scrapie prion', Cell 35(1): 57
28 Ibid., 58




the prion gave cause to hope that the discovery of any other components would
follow in the not too distant future.30 This became the basis of their next round of
experiments
2.2. Prion protein gene (1985)
Having purified the protein PrP, Prusiner was now in a position to pursue further
research into its role in scrapie infection. In particular, Prusiner was interested in
testing his hypothesis that PrP was itself the agent, and that it propagated itself by
catalysing its own manufacture in the cell. If that was the case, then it ought not to be
possible to find any evidence that PrP was being manufactured by translation from
either the host genome or a viral genome. If he could rule out genetic translation, this
would place him in a much stronger position to suggest that the scrapie agent is a
self-replicating protein. Consequently, he devised an experiment to test whether or
not there was any evidence of PrP being manufactured by normal genetic means in
infected hamster brains. For this work, Prusiner looked beyond the confines of the
scrapie research community. He drew on the expertise of Leroy Hood of Caltech and
Charles Weissmann of the University of Zurich. They were known amongst medical
students as "gods of molecular biology".31 Leroy Hood was a pioneer in cloning
techniques for sequencing DNA. He was also one of the first advocates of, and a key
player in, the Human Genome Project. Charles Weissmann is an expert in gene
cloning and gene splicing. In 1980, he was the first scientist to make bacteria produce
a facsimile of human interferon.32 He was a founder of the Institute of Molecular
Biology at Zurich in 1965. Weissmann accepted Prusiner's suggestion of
30 Prusiner, S. B., D. F. Groth, et al. (1985) 'Prions - structure, biology, and diseases', K.
Maramorosch and J. J. McKelvey (eds) Subviral Pathogens of Plants and Animals: Viroids and
Prions (New York: Academic Press): 369
31 Taubes, Gary (1986) 'The game of the name is fame. But is it science?', Discover (December,
1986): 50
32 Lane, Neal F. (1997) 'Double helixes and double-edged swords: cloning and the conundrum
of scientific success', National Press Club
(22 April 1997: www.npf.gov.od/lpa/forum/lane/nl497/npc.htm)
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collaboration, because he became fascinated with scrapie when he heard Prusiner's
talk on the subject in Perth, Australia in 1982.33
Generally, molecular biological orthodoxy states that DNA sequences in the genes
provide a template for the transcription of so-called complementary DNA (cDNA).
This in turn provides a template for transcribing messenger RNA (mRNA). And the
messenger RNA in turn provides a template for reading off the sequence of amino
acids that make up a protein. Prusiner's aim was to see if it is possible to identify any
polynucleotides in scrapie-infected brain material that might correspond to these
stages in the manufacture of PrP. This was a complex process that involved a number
of experimental steps.
First, in 1984, the Hood and Prusiner team successfully produced a number of
fairly short amino acid chains, oligopeptides, from PrP.34 These were particular
sequences of amino-acids which, taken together, would almost certainly be unique to
PrP. Knowing these amino-acid sequence, they were then able to work backwards to
specify what nucleotide sequences in mRNA would code for these.35 However, the
problem was that there is redundancy in the coding, i.e. most amino acids can be
coded by more than one nucleotide sequence. Consequently, working backwards
from oligopeptides to nucleotide sequences leads to the specification of a rather large
number of mRNA sequences, each of which could code for the respective
oligopeptide chains of PrP. Prusiner undertook the rather laborious task of
chemically manufacturing all of these different candidate oligonucleotide sequences
so-called icosamers (i.e. functionally equivalent structural variants). Prusiner needed
to find out if any of these candidate mRNA sequences were identical to mRNA that
actually occurs in cells where scrapie is replicating and hence where PrP is being
manufactured. If he could find such mRNA in vivo, then it would show that PrP is
synthesised from genetic information, and would refute his self-replicating protein
hypothesis.
33 Brown, Phyllida (1999) 'Charles Weissmann: another new challenge', Current Biology 9(17):
R625
34 Prusiner, S. B., D.F. Groth, et al. (1984) 'Purification and structural studies of a major




In order to start looking for this mRNA in scrapie-infected cells, Prusiner had
meanwhile initiated another set of procedures. He inoculated hamsters with scrapie.
Some time later, when he judged that scrapie replication, and by implication PrP
production, would be proceeding at a maximum rate, he removed and homogenised
their brains. He now extracted mRNA from this brain material, using a standard
biochemical procedure. This mRNA would include polycleotides coding for all
proteins that were currently being produced. If PrP production depends upon a PrP-
specific mRNA, then this should be included in the mixture. Using molecular
biological cloning techniques, Prusiner used this mixed mRNA to produce an equally
mixed preparation of cDNA. Again, if PrP is coded by a gene, then this cDNA
mixture should include PrP-specific cDNA.
This cDNA was then transferred into E.coli. This involved a fairly random
procedure, in which a culture of E.coli was bathed in a solution of the cDNA, and
some of the E.coli bacteria picked up some of the bits of cDNA and incorporated
them into their own genomes. The bacteria were then plated out and grown on agar,
so that individual bacteria grew into distinct colonies which could in turn be cultured
on separate plates. By this means, Prusiner produced what he called a gene "library"
of E.coli cultures, each of which might include in its genome one or more of the
cDNA strands prepared from the mRNA from scrapie-infected hamsters. If there
exists a PrP-specific cDNA, then some of these E.coli cultures should contain it.
However, this library was not catalogued, i.e. Prusiner had no prior way of knowing
which if any of the E.coli cultures contained which of the many kinds of cDNA he
had extracted from the hamster cells. Rather, his "library" was just a random
selection of cDNA-carriers.36
The next step was that Prusiner's team had to find out if any of the candidate PrP-
specific mRNA sequences that they had manufactured corresponded to the hamster-
derived cDNA in any of the E.coli cultures that made up this "gene library". For this
purpose, Prusiner cloned radioactively labelled mRNA from each of his candidate
PrP-specific mRNA preparations. He then mixed each of these mRNA samples with




samples from each E.coli culture in his hamster cDNA library. If any of the mRNA
preparations was complementary to any of the hamster cDNA incorporated into the
E.coli genome, then the labelled mRNA would bind with the respective E.coli culture.
As a result of this screening procedure, Prusiner found that some of his PrP-
specific mRNA did indeed bind to the E.coli genome in some of his cultures, i.e. these
mRNA sequences were indeed complementary to cDNA derived from scrapie
infected hamsters. Contrary to what he expected, Prusiner had demonstrated that
PrP was manufactured in scrapie-infected hamster cells by a process of translation
from information coded in a nucleic acid genome. Moreover, he had now cultured
and identified a strain of E.coli that actually carried the relevant stretch of genome (or
rather the cDNA that was the first transcription product of that genome).
It should be noted, though, that at this stage Prusiner still did not know exactly
where this cDNA originated from in scrapie-infected hamster cells. It might be
transcribed from the hamster's own genome, or it might be transcribed from an
exogenous genome, e.g. one belonging to a putative scrapie virus. Thus, he needed to
do a further series of experiments to identify which genome it originated in. From the
strain E.coli carrying the relevant piece of cDNA, Prusiner's team were in turn able to
prepare a cDNA probe, i.e. a preparation of cloned and marked cDNA, that they
could use to look for related genomic material in other preparations. Prusiner used
this cloned cDNA probe to look for PrP-specific nucleic acid sequences in
centrifugally purified preparations of scrapie agent, i.e. his "purified prion"
preparations. He was unable to find any such material. This implied that PrP is not
encoded by a nucleic acid genome present in the agent itself. Prusiner took this as
further proof against the suggestion that the scrapie agent is a virus. However, when
Prusiner used his cloned cDNA probe to examine the hamster genome, he found that
it was indeed complementary to a section of DNA in the genome itself, i.e. they had
now identified a hamster gene that codes for PrP. Moreover, they showed that this
gene is present in non-infected as well as infected hamster cells, i.e. it is a part of the
normal hamster genome.37




All this of course constituted strong evidence against Prusiner's original theory
that the scrapie agent is a self-replicating protein, since he had shown that PrP, the
protein he considered most likely to play this role, was a product of the hamster's
own genes. Prusiner and his colleagues took six months to make sense of this "self-
inflicted apparent disproof of his theory".38 Bolton, a Prusiner researcher at that time,
says, "the impression I get is that they were quite perplexed about this gene showing
up. If you read the articles, Weissmann seems uncomfortable with how you mesh
this being a normal gene with it being a prion."39
If this work effectively refuted Prusiner's self-replicating protein hypothesis,
however, it did raise further interesting questions about PrP. Specifically, if the PrP
gene is present in both non-infected and infected hamster cells, why does the PrP
protein only show up in the latter? In other words, there still appeared to be some
association between PrP and scrapie infection, and Prusiner now wanted to know
what this might be. Consequently, Prusiner's next experiment involved looking to
see if a different technique from that used by Bolton to isolate PrP from infected cells
might indicate that it is only present in non-infected cells. For this, he used an
immunological technique. He produced marked antisera which would bind to and
reveal the presence of PrP. When he used these antisera on extracts from non-
infected brain, they bound to a protein. This technique thus indicated that a molecule
immunologically identical to PrP occurs also in non-infected hamsters.40 However,
when the same immunological marker was used on extracts of non-infected hamster
brain that had been treated with protease-K, it failed to bind to anything. This
indicated that whereas PrP from scrapie-infected brain is resistant to digestion by
protease, the immunologically identical molecule from non-infected brain is not
resistant.41 Prusiner regarded this as highly suggestive - specifically, it suggested that
the PrP gene codes for a protein that can exist in two different forms, one of which
occurs in non-infected cells and is susceptible to protease digestion, and another that
38 Taubes, Gary (1986) op. cit. note 31:50
39 Bolton, David (2000a) Interview with author (31 July 2000: IBR, New York)
40 Bendheim, P.E., Barry, R.A., et al. (1984) 'Antibodies to a scrapie prion protein' Nature 310
(2 August 1984): 418-421; Barry, R.A., Mckinley, M.P., et al. (1985) 'Antibodies to the scrapie
protein decorate prion rods' The Journal of Immunology 135 (1): 603-613
41 Oesch, B., D. Westaway, et al. (1985) op. cit. note 37
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occurs in infected cells and is protease-resistant. Since both proteins were
presumably coded by the same gene and were immunologically identical, Prusiner
and his team supposed that they must comprise identical amino-acid sequences.
Consequently, he cautiously hypothesised that their different chemical properties
must be due to post-translation differences in molecular conformation, i.e. to
difference in the way the protein chain was folded that were not determined by
genetic information.42
Around 1986, Prusiner also changed what PrP stands for, from protease-resistant
protein, i.e. the form specifically found in infected cells, to prion protein,
encompassing both forms of the protein coded by the PrP gene. At the same time, he
introduced the new terminology PrP0 and PrP50 to distinguish what he now called
"cellular and scrapie prion proteins".
In conclusion, Prusiner's experimental results effectively disapproved Prusiner's
own initial hypothesis that the scrapie agent is simply a self-replicating protein
associated with and perhaps even identical with PrP. However, he has nonetheless
managed to salvage something of his protein hypothesis by raising further
interesting questions about the role of PrP in scrapie infection. Although the prion
protein gene produces both the normal and pathological forms of the protein,
Prusiner and Weissmann suggested after long speculation that the protease-resistant,
disease-associated from of PrP was responsible for scrapie-like diseases. And while
he might not yet have been in position to formulate this view explicitly, it appears
that he was already entertaining a suspicion that infection might proceed through the
conversion of PrP0 into more PrP50.43
2.3. Is prion protein infectious? Counter-evidence (1986-1990)
Despite Prusiner's impressive technical accomplishments in identifying and
isolating PrP and the gene that coded for it, other scientists remained sceptical about
the theoretical conclusions he drew from his work, and specifically about his claims
42 Meyer, P.K., M.P. McKinley et al. (1986) 'Separation and properties of cellular and scrapie
prion proteins', PNAS 83: 2310-2314
43 Prusiner, S. B., M. Scott, et al. (1990) 'Transgenetic studies implicate interactions between
homologous PrP isoform in scrapie prion replication', Cell 63 (16 November 1990): 673-685
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that PrP was a key factor in scrapie infectivity. Furthermore, prion-sceptical scientists
continued to conduct research that appears to support their scepticism.
At the same time as Prusiner was pursuing the PrP gene, a group of scrapie
researchers in the Rocky Mountain Laboratory (RML), led by Bruce Chesebro,
launched a similar project to scrutinise the troublesome protein, including finding a
gene that codes for PrP in mice. The RML had good facilities for experimentation
with molecular biology, and they found the same gene in mice.44 The experimental
process was nearly the same as what Prusiner's team did withWeissmann. With the
same small amino acid sequences from scrapie protein that were isolated by Prusiner
and Hood's team in 1984, Chesebro's team synthesised a mixture of oligonucleotides
for use as a hybridisation probe to analyse mRNA populations derived from infected
and uninfected animals. As a result of this investigation, like Prusiner, they
concluded that the gene for the normal and pathological proteins was identical, and
there was no evidence for any unique messenger RNA (mRNA) associated with
scrapie infectivity. And like Prusiner, they drew possible implications from this
finding. Firstly, it could be seen as evidence against the view that scrapie-specific is
responsible for the infectivity of scrapie. Secondly, if expression of this protein is
associated with scrapie, then Chesebro and his team speculated that it could be a
post-transcriptional or a mutational modification.45
More interestingly, Chesebro's team failed to find any PrP-specific mRNA in
mouse spleen. The PrP-specific mRNA appeared only in scrapie-affected brain, not in
the spleen or in the liver at all. According to many pathogenetic studies of scrapie,
the agent was known to replicate initially in spleen.46 If PrP is really the infective
agent, why was PrP-related mRNA not found in spleen? Chesebro concluded that
PrP 27-30, which was the candidate infectious agent for Prusiner's group, might not
44 Chesebro, B., R. Race, et al. (1985) 'Identification of scrapie prion protein-specific mRNA in
scrapie-infected and uninfected brain', Nature 315(23 May 1985): 313-333
45 Ibid., 332
46 Kimberlin, R. H. (1979) 'Early events in the pathogenesis of scrapie in mice: biological and
biochemical studies', S. B. Prusiner and W. J. Hadlow (eds) Slow Transmissible Diseases of the
Nervous System (New York: Academic Press) 2: 33-54; Outram, G. W. (1976) 'The pathogenesis
of scrapie in mice', in R. H. Kimberlin (ed.) Slow Virus Diseases of Animals and Man
(Amsterdam: North-Holland Publishing Co.): 325-357
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be specific for the infectious scrapie agent.47 This experimental result cast doubt on
Prusiner's observation in 1985.
Shortly afterwards, Laura Manuelidis at the Yale Medical School - a worldwide
CJD expert, came up with an interesting experimental result showing that the prion
protein might not be linked to the infectivity of scrapie.48 Manuelidis' team set out to
reassess the effect of treatment with protease-K on scrapie infectivity. Other
researchers had already shown that protease-K significantly reduced scrapie
infectivity,49 whereas Prusiner's claims rested on the assumption that the infectious
agent resists protease-K treatment. Manuelidis now showed that protease treatment
of CJD brain material does indeed produce a protease-K resistant form of PrP as
Prusiner's team observed. But at the same time, Manuelidis also observed that this
treatment reduces infectivity by more than 90%.50 Furthermore, she found that in CJD
preparations, the major protein equivalent to PrP 27-30 in Prusiner's experiment,
could be separated from infectivity under mild non-denaturing conditions, while
Prusiner's group suggested that the infectivity was inseparable from PrP.51 Also,
Manuelidis and her colleagues later reported that when they attempted to separate
different molecules from the infected brain samples, they found that the most
infectious part was not PrP but a fraction containing other proteins and nucleic
acids.52 These studies suggested that PrP in itself is unlikely to be the replicating
component of the infectious agent. Instead, she claimed that the agent was like a
virus and had its own informational molecule. Many viruses, she said, are hardy and
even resist treatment with enzymes that digest genetic material. These viruses like
the polioviruses are packed inside a protein shell that protects them. ''Think of all the
47 Chesebro, B., R. Race, et al. (1985) op. cit. note 44: 332
48 Manuelidis, L., T. Sklaviadis, et al. (1987) 'Evidence suggesting that PrP is not the
infectious agent in Creutzfeldt-Jakob disease', EMBO Journal 6(2): 341-347
49 Millson, G. C., G. D. Hunter, et al. (1976) 'The physico-chemical nature of the scrapie
agenf, R. H. Kimberlin (ed.) Slow Virus Diseases of Animals and Man (Oxford: North-Holland
Publishing Co.): 243-266; Lax, A.J., Millson, G.C., Manning, E.J. (1983) "Involvement of
protein in scrapie agent infectivity' Research in Veterinary Science 34:155-158
50 Manuelidis, L., Valley, S., Manuelidis, E.E. (1985) 'Specific proteins associated with
Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants' PNAS
82: 4263-4267
51 Manuelidis, L., T. Sklaviadis, et al. (1987) op. cit. note 48: 345
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viruses out there that have to get through the gastrointestinal tract/' she said, "they
have to deal with all sorts of lousy environments."53
Also in 1989, more good news for the sceptics came from Edinburgh. Richard
Kimberlin reported his experimental results. As other Edinburgh researchers had
done, he had based his experiments on the biological measurement of incubation
time and pathological changes.54 Prion sceptics continued to point out that Prusiner's
suggestion that the scrapie agent is an infectious protein seems to be incapable of
accounting for the significant and problematic fact of strain variation in scrapie,
which implies that the scrapie agent must possess its own genome. This objection
was reinforced when Kimberlin and his colleagues published new work on strain
variation. Kimberlin and his colleagues studied the transmission of different strains
of scrapie from mice to hamsters and then back to mice. In this experiment, each
strain of the agent maintained its distinctive pathogenic identity when the agent was
transferred between different species like mice and hamsters. Kimberlin claimed that,
in spite of the species barrier, the scrapie agent maintains its genomic character when
it jumps to another species. From this experiment, Kimberlin speculated that "it is
likely that the scrapie genome is a very small 'regulatory' nucleic acid which may not
code for protein (hence the need for a 'protective' host-coded protein such as PrP). A
major criterion for recognising candidate genomes is that there should be sequence
differences according to the strain of agent."55 In other words, while the scrapie agent
may rely on the host genome to manufacture its protein constituents, the strain is not
decided by the gene of the animal that is infected, but is carried by the infective
agent.56 This was at odds with Prusiner's hypothesis that the scrapie agent is simply a
protein coded by the host genome, and further reinforced the view that the agent
52 Sklaviadis, T.K., L. Manuelidis, E. E. Manuelidis (1989) 'Physical properties of the
Creutzfeldt-Jakob disease agent', Journal ofVirology63 (3): 1212-1222
53 Kolata, Gina (1994) 'Viruses or prions, an old medical debate still rages', New York Times (4
October 1994)
54 Kimberlin, R. H., C.A. Walker, et al. (1989) 'The genomic identity of different strains of
mouse scrapie is expressed in hamsters and preserved on reisolation in mice', Journal of
General Virology 70: 2017-2025
55 Ibid., 2018
56 Deader, S. (1996) Lethal Legacy: BSE-Search for the Truth (London: Bloomsbury): 52
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must have a genome of its own. Indeed, Kimberlin actually included the phrase
"genomic identity" in the title of his 1989 paper.
As a result of these experimental results, the prion sceptics remained
unconvinced, and could point both to Prusiner's failure to link PrP unequivocally to
infectivity, and to his failure to account for strain variation and its conservation when
transferred across different species. Meanwhile, as more and more energy and
resources were invested in scrapie research, the stakes grew higher, and between
1986 and 1989, the scrapie research community was embroiled in their most bitter
clashes in the history of the prion controversy. Each camp presented their
experimental achievements to refute their opponents. However, the dispute was
moving beyond a rational debate. Throughout these experimental exchanges, the
relations between the two sides were becoming increasingly acrimonious. For
instance, at the CIBA Foundation meeting in 1988, there was a major confrontation
and the controversy between the prion group and prion sceptics was intensified. It
was too intense to make a transcript of the dialogue, so the meeting organisers
stopped recording and turned off the microphone. George Carlson says, "I was
amazed, I never saw anything like that. The personalities were amazing. You had
people yelling at each other at meetings...I mean it is mind-boggling, absolutely
mind-boggling. The animosity between groups, it was very controversial."57
2.4. Transgenic experiments (1989-1991)
Meanwhile, Prusiner's lab in San Francisco launched an ambitious series of
experiments adopting yet another set of new experimental techniques from the
cutting edge of molecular biology, namely the construction of transgenic organisms,
which he intended to further elucidate the role of PrP and its gene in scrapie and
other diseases. The project was led by a Scottish molecular biologist, Mike Scott, and
a new postdoctoral researcher, Karen Hsiao. During his search for the hamster PrP
gene, Prusiner's team had developed techniques for cloning the cDNA
complementary to that gene. It was a small step to being able to produce and clone
the gene itself. Moreover, techniques had recently become available for inserting
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such cloned genes into the embryos of various organisms including mice.58
Consequently, Prusiner's team were now able to create a strain of transgenic mice
that carried the hamster PrP gene.59 The transgenic mice were created by injecting the
PrP gene into the male pronucleus of a fertilised mouse egg. The injected eggs were
then transferred into pseudopregnant mice. According to Jean Manson and Nadia
Tuzi, "this approach generates transgenic mice in which the transgene is integrated
randomly into the murine genome. Although the expression level and distribution of
PrP cannot be controlled with this transgenic approach, its use has yielded many
interesting and informative TSE models."60
This elegant method provided a powerful means of developing whole-animal
models to study the function of specific genes and the proteins they encode. In
Prusiner's lab, they now used this transgenic mouse to investigate the species
specificity of particular strains of scrapie.61 When Prusiner inoculated ordinary mice
with purified scrapie agent of a strain that had been continuously passaged through
hamsters, it took 500 days for symptoms to manifest themselves. However, when he
inoculated the same hamster-passaged scrapie agent into the transgenic mice
carrying the hamster PrP gene, the incubation time is reduced by 140 days on
57 Carlson, George (2000) Interview with author (9 August 2000: the Mclaughlin Research
Institute, Great Falls, Montana)
58 The method developed rapidly during the 1980s. According to a historian of molecular
biology, Michel Morange, the technique ushered in the age of contemporary molecular
biology. [Morange, Michel (1998) A history of molecular biology (Cambridge: Harvard
University Press)]
59 This method was devised in 1973 by two researchers, F. Graham and A. Van Der Erb.
[Graham, F.L. and A.J. Van der Erb (1973) 'A new technique for the assay of infectivity of
Human Adenovirus DNA', Virology 52 : 456-467] However, the main progress of transgenic
technique developed with the creation of transgenic animals in 1980. A Yale biologist, Frank
Ruddle, injected mouse embryos a few hours old with foreign DNA that then integrated into
their chromosomes. [Gordon, J.W., G.A. Scangos, et al.(1980) 'Generic transformation of
mouse embryos by mocroinjection of purified DNA', PNAS 77: 7380-7384] After several
rounds of cell division in vitro, the embryos were implanted into surrogate mothers, which
twenty days later, gave birth to a total of seventy-eight pups, two of which had integrated the
foreign DNA into most of their cells. [Morange, Michel (1998) op. cit. note 58:202]
60 Manson, J.C. and N.L. Tuzi (2001) 'Transgenic models of the transmissible spongiform
encephalopathies', Expert Reviews in Molecular Medicine (11 May, 2001: www-
ermm.cbcu.cam.ac.uk/01002952h.htm): 3
61 Sofroniew, M. V. and K. Staley (1991) 'Transgenic modelling of neurodegenerative events
gathers momentum', Trends in Neuroscience 14(12): 513
198
Prion controversy, 1982-1997
average and then remained constant.62 Prusiner and his supporters interpret this in
terms of their theory that the scrapie agent is a variant form of PrP that catalyses its
own production from ordinary PrP. Specifically, they supposed that there are
genetically determined differences between hamster and mouse PrP, and that
hamster PrP^ will more readily convert hamster PrP0 than mouse PrP°. If that was
the case, it might be expected that incubation of hamster-passaged scrapie would be
quicker in mice that carried hamster PrP genes, and consequently manufactured
hamster PrP protein, than in mice that did not. This was indeed the result that
Prusiner and his team produced, and they took this as evidence in support of the
prion theory. From Prusiner's point of view, the transgenic mice indicated that
hamster PrP^ in the inoculum was the sole cause of the disease, and that it acts as a
template for the conversion of the hamster PrP° (HaPrP°) protein in the transgenic
mouse into more HaPrP^.63 As Charles Weissmann pointed out, within the
framework of the "protein-only" hypothesis, these results were significant in
showing that hamster-derived prion more readily converts the transgenic hamster
PrP° than endogenous murine PrP° into the PrP^ form.64
Another significant experimental outcome was also reported by one of Prusiner's
post-doctoral fellows, Karen Hsiao. She had for some time had an interest in
Gerstmann-Straussler-Scheinker (GSS) syndrome, a rare inherited CJD-like human
neurodegenerative disease that Gajdusek suggested in 1981 might also belong in the
category of scrapie-like slow virus diseases.65 Hsiao sequenced the PrP gene from
GSS cases and found that it carries a mutation, i.e. it codes for a variant of the PrP
62 Prusiner, S. B., M. Scott, et al. (1990) 'Transgenetic studies implicate interactions between
homologous PrP isoform in scrapie prion replication', Cell 63 (16 November 1990): 673-685
63 Hunter, N. (1991) "Scrapie and GSS—the importance of protein" Trends in Neurosciences
14(9): 389
64 Weissmann, C. (1991) 'Spongiform encephalopathies: the prion's progress', Nature
349(6310): 570
65 GSS is one of the TSE diseases in humans. In 1936, two neurologists, Gerstmann and
Straussler, and a neuropathologist, Scheinker, first described a family with unusual
neurodegenerative symptoms. It is an extremely rare disease. This strikes only one in about
10 to 100 million people. Some of its pathological features resemble those of Alzheimer's
disease. [Masters, C.L., D.C. Gajdusek, C.J. Gibbs (1981) 'Creutzfeldt-Jakob disease virus
isolation from the Gerstmann-Straussler syndrome', Brain 104: 559-558]
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protein.66 She observed that one of the DNA sequences in the human prion gene was
mutated from proline to leucine at position 102, and speculated that this was the
cause of the rare inherited disease, GSS.67 Hsiao constructed a transgenic mouse
containing the GSS prion gene (GSS PrP) that harboured the same mutation. The
mutated transgenic mouse died from spongiform neurological disease at around 166
days without prior exposure to scrapie or GSS. This means that the transgenic mice
developed neurodegenerative symptoms spontaneously. This spontaneous disease in
the transgenic mice suggested strongly that the disease was indeed caused by a
variant form of PrP, in this case one that was actually coded by the PrP gene.
Prusiner and Hsiao suggested that GSS is an "inherited prion disease".68
These transgenic experiments, and in particular Hsiao's GSS experiment, made a
considerable impression on others both within the scientific community and more
widely. A neurobiologist at Johns Hopkins University School of Medicine, Donald
Price, said, "I think ifs really extraordinary. A single mutation in a transgene, when
put in a mouse, can cause clinical disease and brain pathology."69 Many Prusiner
supporters think that Hsiao's work provided vital data to persuade other scientists to
believe the protein-only idea. In an interview, Stephen DeArmond, a neuropatholgist
in Prusiner's camp, claimed that due to this experiment, the prion theory gained
momentum:
So, now indirect evidence for the protein-only hypothesis is building more and more.
Momentum is gaining. So, now mutations, and then subsequently, all at about the
same time, a number of laboratories show that mutations at different points accounted
for other forms of CJD as well as other types of GSS-type disorders, and insertions
occasionally did it also. So, again, the information is mounting.70
As he claimed, other scientists began to take an increasing interest in the
possibility that other neurodegenerative disorders might have similar genetic basis,
66 Hsiao, K. and S. B. Prusiner (1990) 'Inherited human prion diseases', Neurology 40(12):
1820-7
67 Hsiao, K., H. F. Baker et al. (1989) 'Linkage of the prion protein missense variant to
Gersmann-Straussler Syndrome', Nature 338(6213): 342-345
68 Hsiao, K. and S. B. Prusiner (1990) op. cit. note 66
69 Marx, J. (1990) 'Human brain disease recreated in mice', Science 250(4987): 1509
70 DeArmond, Stephen (2000) Interview with author (UCSF: 18 August 2000)
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including fatal familial insomnia (FFI) that was currently classified as a prion
disease.71 Prusiner and his colleagues centred on these genetic diseases passionately.
The transgenic experiments by Scott and Hsiao implied that the so-called prion
diseases could be generated from genetic defects, not from virus-like infection. One
of Weissmann's colleagues in Zurich, Adriano Aguzzi, summed up its positive
implications. He says "the familial cases make it much more difficult to argue on the
side of a virus. You can have close to 100% penetrance in these families - meaning if
they have the mutation, they usually get the disease. So then you'd have to argue
that there's some ubiquitous virus which infects everybody but will produce disease
only in the patients who have the mutation. It's kind of acrobatics."72
In view of the attention and acclaim that this transgenic work was receiving,
Prusiner now felt sufficiently confident to explicitly state the view that he had
hitherto only hinted at, namely that prion is an infectious protein, without any
nucleic acid component. From these encouraging experimental results, Prusiner
formalised his idea of a protein-only agent. Since he suggested the novel concept of
prion in 1982, he had never put forward the protein-only theory as his own preferred
theoretical position for explaining his overall work. In 1991, however, he finally
excluded the possibility of viral factor in the agent.73 It was the first instance where
he clearly talked about a prion as being protein only. He was now confident enough
to claim the absence of any viral informational molecule from the agent. Prusiner
thought he had enough data to exclude such a possibility.
71 Fatal Familial Insomnia (FFI) was first reported in 1982. This disease is similar to CJD, but
shows more striking pathology; the thalamus, a large nucleus in the centre of the brain, was
so markedly affected that it had collapsed and almost disappeared. The FFI patient has a
sleep disturbance that rapidly progressed to a complete inability to sleep or to respond to
most sleeping pills. [Ridley, R. M. and H. F. Baker (1998) Fatal Protein: the story of CJD, BSE
and other prion diseases. (Oxford: Oxford University Press): 87] Interestingly, it is a family-
based disease. In 1986, a neuropathologist, Pierluigi Gambetti, and his colleagues in the
University Hospitals of Cleveland reported a large North Italian kindred having as many as
29 affected individuals among 288 family members spanning six generations. [Lugaresi, E., R.
Medori et al. (1986) 'Fatal familial insomnia and dysautonomia with selective degeneration of
thalamic nuclei', New England Journal ofMedicine 315: 997-1003]; For a more detailed review on
prion research into FFI, see Aguzzi, A. and C. Weissmann (1996) 'Sleepless in Bologna:
transmission of fatal familial insomnia', Trends in Microbiology 4(4): 129-31
72 Mestel, Rosie (1996) 'Putting prions to the test', Science 273 (5272): 187
73 Prusiner, S. B. (1991) 'Molecular biology of prion diseases', Science 252(5012): 1515-22
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This claim was now well received by many fellow scientists. Since Prusiner
introduced his powerful transgenic technique to the field of scrapie research, his
work gained more credit and publicity from many scientists and the general public.
The changing public mood can be seen in some reactions of the mass media. In 1991,
the New York Times reported Prusiner's transgenic work under the heading "heretical
theory on brain diseases gains new ground".74 Around the same time, there were also
some positive responses from his fellow scientists. Science magazine reported
Prusiner's achievements with transgenic mice, thereby supporting Prusiner's prion
theory.75 A molecular biologist in St. Mary's hospital in London, John Hardy, claimed
that "this [Hsiao's] experiment should finally dispel the doubts of those who
believed that a nucleic acid must be involved in the pathogenic process."76
The prion sceptics remained unconvinced, however. For one thing, they
challenged the interpretation that the prion camp had placed on Hsiao's experiment.
In particular, they were able to point out that the similarities between the
neurodenerative disease suffered by Hsiao's transgenic GSS mice and transmissible
diseases such as scrapie were limited. In scrapie, infection was characterised by the
presence of a protease-resistant form of PrP. If the pathology of transgenic GSS PrP
mice was similar to that caused by scrapie infection, it ought to be possible to isolate
a similarly protease-resistant form of PrP from their brains. Hsiao and Prusiner had
tried but failed to do so. Likewise, if GSS was indeed a prion disease, it ought to be
possible to transmit that disease from transgenic GSS PrP mice to ordinary mice, but
while Hsiao and Prusiner had attempted to do so, they failed. 77 Richard Carp, a
leading prion sceptic, sees this as a serious flaw in the evidence, and stresses that
"there has been a whole string of situations, where they transmit material, the Karin
Hsiao mouse, where they had the 102 mutation, but if they put it into normal mice
74 Blakeslee, Sandra (1991) "Heretic theory on brain diseases gains new ground" New York
Times (8 October, 1991): C12
75 Marx, J. (1990) op. cit. note 69; Marx, J. (1991) 'Prion proposal proved?', Science 251(4997):
1022-1023
76 Hardy, John (1991) 'Prion dimers: a deadly duo?', Trends in Neurosciences 14 (10): 423
77 Hsiao, K. K., M. Scott, et al. (1990) 'Spontaneous neurodegeneration in transgenic mice
with mutant prion protein', Science 250(4987): 1587-90
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they get nothing. So, there has been no instance where artificially produced PrP has
been infectious."78
The prion sceptics were not satisfied simply to point out gaps in Prusiner's
aetiological arguments, however. In 1991, one of the prion sceptics at Edinburgh,
Nora Hunter, published a paper outlining an alternative theory of the significance of
PrP, which she argued provided a more adequate account of the theoretical
evidence.79 It was not necessary to regard the PrP protein as the infectious agent
itself, or even as a component of the agent. Rather, the phenomena could be better
explained if it was understood to be a receptor molecule, present in the host cells and
involved in the process of infection by and replication of a scrapie virus, but not itself
infectious. This idea of PrP protein as a receptor was underpinned by a recent study
of the poliovirus receptor (PVR) protein,80 which had shown that transgenic mice
expressing human poliovirus receptor became susceptible to poliovirus. A similar
theorisation of the PrP protein could account for much of what was shown about its
involvement in scrapie infection.
Thus, where Prusiner had explained Scotfs transgenic studies of cross-species
infection in terms of the host genome coding for a version of the agent itself, the
receptor molecule theory offered an alternative explanation. Strains of the disease
passaged through a particular species might be expected to adapt to the particular
version of the PrP protein receptor found in that species. The presence of hamster
PrP in the transgenic mice would thus facilitate replication of the hamster scrapie
virus, with the result that incubation would be quicker than in mice that did not
possess hamster PrP. The receptor allows the hamster-passaged scrapie to infect
transgenic mouse cells that are normally resistant because this hamster scrapie agent
does not fit with the mouse PrP protein.81
This alternative view was supported by Hunter's allies. One of the American
prion-sceptics, Robert Rohwer, an assistant professor of microbiology at the
University of North Carolina at Chaple Hill, agreed with this view of the prion
78 Carp, Richard (2000) Interview with author (IBR, New York: 27 July 2000)
79 Hunter, N. (1991) op. cit. note 63
80 Ren, R., F. Costantini et al. (1990) 'Transgenic mice expressing a human poliovirus
receptor: a new model for poliomyelitis', Cell63 (2): 353-362
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protein as a receptor. In an interview with the New York Times in 1991, he claimed
that "in my view, this protein is a virus receptor that helps determine host
susceptibility. The fact that there is only one protein and many strains of the disease
implies there's got to be some nucleic acid somewhere."82
Meanwhile, in the case of Hsiao's transgenic GSS PrP theory, Hunter suggested
that the pathology experienced by the transgenic PrP mice need not be attributed to
the action of a variant form of PrP at all. Hunter pointed out that the transgenic GSS
PrP mice carried more than 60 copies of the mutant PrP gene.83 Consequently,
without any detectable PrP in the sample and transmission, the neurodegeneration
that occurred in these mice might simply be attributed to the fact that the mice were
producing too much PrP, whereas Prusiner and Hsiao believed that one mutant
caused the disease.
Whatever gaps there might be in Prusiner's aetiological arguments, and whatever
room there might be for alternative explanations of the phenomena, however,
Prusiner's transgenic work had at least succeeded in making PrP and its gene into
one of the key foci of interest in research into scrapie and related diseases. The
impact of Prusiner's transgenic experiments was enormous, and almost all research
groups working in this field have since constructed their own transgenic models.
2.5. Unfinished war
Meanwhile, Prusiner was opening up another line of research into the role of PrP
in scrapie and other diseases. Since Prusiner's team found two forms of prion
protein, i.e., protease-soluble and resistant form, in 1985, he and his team had
speculated about just how these two forms might differ from one another, and how
an understanding of that difference might throw light on the processes of infection
and pathogenesis. During the late 1980s, some researchers cautiously suggested that
this might be only a matter of changes in the shape of the protein molecule. In
general, genetic information determines the sequence of amino acid that make up the
81 Ibid.
82 Blakeslee, Sandra (1991) "Heretic theory on brain diseases gains new ground" New York
Times (8 October, 1991): C12
83 Hunter, N. (1991) op. cit. note 63: 389
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basic structure of a protein. After assembly this amino acid chain then folds itself into
a stable shape or conformation. Prusiner and others speculated that the protease-
soluble and -resistant forms of PrP might represent different conformations of the
same basic molecule. They suspected that the process of infection, i.e. of transforming
PrP0 into PrP30, might be simply be a matter of switching between one conformation
and another.84
In 1991, Prusiner began to collaborate with a young protein and pharmaceutical
chemist, Fred Cohen, in UCSF. Cohen was an expert in the chemistry of protein
folding. Prusiner and Cohen began to investigate chemical difference between the
pathological form (PrP30) and the normal form (PrP0). Since Linus Pauling elucidated
the general structures of proteins, particularly the helical form (known as a-helix)
and sheet form (known as p-sheet), in the 1930s, techniques for studying protein
structure had advanced enormously.85 Fred Cohen and Prusiner now adopted
another novel technique to analyse structure of the proteins: Fourier transform
infrared (FTIR) Spectroscopy.86
84 Oesch, B., D. Westaway, et al. (1985) op. cit. note 37; Chesebro, B., R. Race, et al. (1985) op.
cit. note 44; Meyer, P.K., M.P. McKinley et al. (1986) op. cit. note 42; Caughey, B. B., A. Dong,
et al. (1991) 'Secondary structure analysis of the scrapie-associated protein PrP27-30 water by
infrared spectroscopy', Biochemistry 30: 7672-7680
85 Since Pauling's research into proteins in the 1930s, protein chemistry had progressed
slowly. In 1972, Christian Anfinsen won the Nobel Prize in chemistry for his 1960 work at the
NIH, which was a significant breakthrough in protein chemistry. His work showed that the
final three-dimensional form of a protein is determined solely by its amino-acid sequence.
During the 1970s and 1980s, many protein chemists have paid attention to the protein folding
process. In the 1970s Michel Goldberg of the Pasteur Institute in Paris found that in many
cases simple protein molecules clumped together into insoluble aggregates. This aggregate
form of protein came to central stage protein chemistry in the 1980s. With regard to
development of prion theory, the research progress of protein misfolding seems to be closely
related. For more details on the review of the history of prion chemistry, particularly protein
folding studies, see Thomasson, W. A. B. (2000) 'Unraveling the mystery of protein folding',
FASEB (www.faseb.org/opar/protfold/protein.htmb: Taubes, Gary (1996) 'Misfolding the
way to disease', Science 271 (15 March 1996): 1493-1495
86 FTIR spectroscopy is a quite new technology, exploits the fact that particular functional
groups present in proteins, and especially highly polar bonds, resonate at around the
frequency of infra-red light. This machine can record the interaction of infrared radiation with
samples, measuring the frequencies at which the sample absorbs the radiation and the
intensities of the absorption. Consequently, by studying the IR absorption spectra of protein
molecules, it is possible to identify the presence of such bonds, and thereby to elucidate the
structure of the molecule This technique was introduced to the field of scrapie research by
researchers in RML in 1991. [For more detailed explanation of the FTIR, see Griffith, P.R.,
J.A. de Haseth (1986) Fourier transform infrared spectrometry (New York: John Wiley);
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Using this technique, Cohen and Prusiner's team found that the normal prion
protein was rich in a-helix but was devoid of p-sheet, whereas the pathological
protein was high in p-sheet.87 The team thus revealed a major morphological
difference between the cellular isoform (normal form) and the scrapie isoform
(pathological form). Cohen says in his interview, "the difference was a tremendous
diminution in a-helical structure on going from the PrP0 isoform to the PrP5^ isoform.
And an even greater increase in p-structure going from the cellular isoform to the
scrapie isoform. So here was one consequence, but two structures that were
dramatically different."88 This result confirmed that the difference was not derived
from the DNA codes, but from conformational changes in the protein.
Figure 2: Two models of tertiary structures of PrPc and PrPSc.89 The left model is the
normal PrP with helical structure (a-helix); the right model clearly shows its difference
from the normal form of PrP. Some of a-helix structures are changed into p-sheet.
Meanwhile, Prusiner had a collaborative project with Weissmann to produce
further evidence that they considered to support the conformation change theory.
They had found a way of altering and thereby inactivating the PrP gene. Mice
homozygous for the inactivated gene, called PrP-knockout mice, did not produce
PrP. When these mice were inoculated with scrapie, they remained healthy for over a
Caughey, B., R. Race et al. (1988) 'In vitro expression of cloned PrP cDNA derived from
scrapie-infected mouse brain: lack of transmission of scrapie infectivity', CIBA Foundation
Symposiuml35: Novel Infectious Agents and the Central Nervous System: 197-208]
87 Baldwin, M. A., K-M. Pan, et al. (1994) 'Spectroscopic characterization of conformational
differences between PrPc and PrPsc: an a-helix to b-sheet transition', Philosophical Transactions
of the Royal Society of London, Series B. 343(29 Mar. 1994): 435
88 Cohen, Fred (2000) Interview with author (UCSF, San Francisco: 22 August 2000)
89 Prusiner, S.B. (1996) 'Molecular biology and pathogenesis of prion diseases', Trends in
Biological Science 21: 483
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year, whereas mice carrying the normal gene fell ill within around 120 days.90
Prusiner argued that this showed that the scrapie prion could not propagate in the
absence of the normal protein, a finding that he interpreted as supporting his view
that propagation was a matter of conversion of normal into pathological PrP.
Weissmann said, "the findings described in this paper in accordance with the
'protein-only' hypothesis and together with the large body of evidence amassed by
Prusiner and his colleagues provide strong support for this model."91
time after inoculation / davs
Figure 3: Scrapie resistance of mice with disrupted PrP genes Prnp0/0 (PrP knockout)
and Prnp+/+(PrP containing) mice remaining symptoms-free at different times after
inoculation with mouse scrapie prions.92
Weissmann and Prusiner's results were announced in September 1993, at a two-
day meeting on prion diseases hosted by the Royal Society of London. At this
meeting, Weissmann told an interviewer that "the weight of the evidence is quite
heavily in favour of the prion hypothesis."93 Not all those participating in the
meeting would have agreed, however. At the same meeting, the troublesome issue of
strain variation was again raised by a paper from the Edinburgh group. For the last
three decades, the Edinburgh scientists had kept showing the existence of different
90 Weissmann, C., H. Bueler, et al. (1994) 'Susceptibility to scrapie in mice is dependent on
PrP0, Philosophical Transactions of the Royal Society of London, Series B. 343(29 Mar. 1994): 431-
434
91 Ibid. 433
92 Weissmann, C., H. Bueler, et al. (1994) op. cit. note 90: 432
93 Kingman, S. (1993) 'London meeting explores the ins and outs of prions', Science 262:180.
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strains with distinct incubation periods and pathological changes in brain. One of the
leading scientists at NPU in Edinburgh, Moira Bruce, presented her work on
transmission of BSE (Bovine Spongiform Encephalopathy), which was a newly found
scrapie-like disease in cattle also known as "mad cow disease" in Britain. Bruce was
working on BSE, which she had succeeded in transmitting into genetically
homogeneous laboratory mice.94 Seven different transmissions all showed identical
lesion profiles, suggesting that the cattle housed only a single strain of the agent.95
Moreover, cases of suspected BSE contracted from cattle had also been reported in
domestic cats and in two zoo animals, a kudu and a nyala. Bruce succeeded in
transmitting the disease from these cases into the same strain of mice. In all cases, the
lesion profile was identical to that from BSE-infected cattle, but differed significantly
from the lesion profile shown with two different strains of scrapie.
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Figure 4: Pathological change (lesion profile) in Rill mice for (a) the seven BSE
transmissions from cattle, (b) the two positive transmissions from natural sheep
scrapie, (c) the transmissions from three cats, the kudu, and the nyala and (d) the
transmissions from the experimentally BSE-infected sheep, goats and pigs.96
94 Bruce, M., A. Chree, et al. (1994) 'Transmission of bovine spongiform encephalopathy and
scrapie to mice: strain variation and the species barrier', Philosophical Transactions of the Royal
Society, London, Series B, Biological Series 343: 405-411.
95 The lesion profile was a tool to measure the quantified variation in the pathology, and was
introduced by a neuropathologist in NPU, Hugh Fraser, in the early 1960s. [Fraser, H. and A.
G. Dickinson (1968) 'The sequential development of the brain lesions of scrapie in three
strains of mice', Journal of Comparative Pathology 78: 301-311] More detailed explanation of this




Bruce took these as confirming that the cats, kudu and nyala were indeed infected
with BSE rather than scrapie or some other diseases. More importantly, she also
argued that these results, like Kimberlin's earlier study of scrapie transmission from
hamsters to mice and back, indicated that the BSE agent must possess its own
genome. If, as Prusiner and his supporters argued, prion diseases were transmitted
solely by conformational change in the host PrP protein, then a disease such as BSE
should not retain its distinctive character as it was transmitted from one species to
another. That BSE had in fact conserved its distinct character as it was transmitted
from cattle through several different species and into mice presented a serious
challenge to the conformational change theory. Such conservation, Bruce argued,
could only be explained if the infectious agent possessed its own informational
molecule that was replicated and passed on from one infection and one host species
to another.
Bruce's paper had a huge impact on many researchers. Chris Bostock, head of the
division of molecular biology of the Institute of Animal Health (LAH), told an
interviewer, "here you have PrP30 from several different species going into mice and
you get the same biological properties. I think the people who support the protein-
only hypothesis will find it difficult to explain that."97 Even Charles Weissmann
himself acknowledged, "her [Moira Bruce] results demanded a very satisfactory
explanation. A very special effort would be needed in order to integrate them into
the protein-only hypothesis."98 Nonetheless, Prusiner summed up the meeting with
an emphatic denial that scrapie and other diseases were caused by a viral agent.
According to Sharon Kingman in her report for Science, he insisted, "all the data
taken together argued persuasively that prions lack a nucleic acid".99
Nevertheless both sides proclaimed their triumph in this controversy. John
Collinge, director of the prion research unit at St. Mary's Hospital Medical School in
London and one of the foremost prion enthusiasts, argued that for many people, this
was a key turning point in the prion versus virus argument.100 On the other hand,






Moira Bruce remembers the meeting rather differently. She says, "it had dramatic
effects on people like Charles Weissmann, Stan Prusiner. They just, for some reason,
suddenly realised that this has to be explained somehow [...] In that meeting,
everybody was talking about the strains, whereas, before this, everybody was just
ignoring the whole issue [...] I brought it to the forefront, I think, as a very practical
issue, and this approach can be very useful in a practical sense. So that is accepted, in
that sense, we won! There is an acceptance that there is an informational component,
and 'what it is' is another question."101
Despite both sides claiming victory in the great battle, nobody was actually a
winner at the time. The controversy not only continued, but deepened; enmity
between the researchers become, if anything, more intense. However, the general
mood in the scientific community had been inclining gradually towards the protein-
only theory, even though every experimental result could just as easily be read in
favour of the prion-sceptics. As science writer Georgina Perry wrote in New Scientist,
"Prusiner's heresy was to challenge the received wisdom [...] now, more than a
decade later, this idea [protein-only theory] is slowly absorbed into mainstream
thinking, helping researchers to understand fatal brain diseases."102
3. Winner takes all
3.1. Attempting to demonstrate that PrP is infectious
Following the 1993 Royal Society meeting, the efforts of the prion believers
increasingly come to concentrate on attempts to demonstrate that the prion protein is
itself infectious. As discussed above, one line of prion-sceptical research during the
1980s involved demonstrating that scrapie and CJD infectivity could occur in the
absence of PrP.103 Subsequently, after 1993, the prion sceptics continue to produce
evidence suggesting that PrP might not be the infectious agent.
101 Bruce, Moira E. (1999) op. cit. note 15
i°2 Perry, G. (1994) 'Mad brains and the prion heresy', New Scientist (28 May 1994): 32
103 Manuelidis, L., T. Sklaviadis, et al. (1987) op. cit. note 51; Sklaviadis, T.K., L. Manuelidis,
E. E. Manuelidis (1989) op. cit. note 55
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In 1994, a neurologist at the Istituto Superiore di Sanita in Rome, Maurizio
Pocchiari, claimed that he found very small, virus-like particles in brain samples
from CJD patients.104 This was quite similar to results produced in the same year by
Heino Diringer at the Koch Institute at Berlin, who found similar particles in his
hamster samples.105 Furthermore, Pocchiari's team was also able to produce some
more damaging evidence against the prion hypothesis. His team treated scrapie-
infected hamsters with a drug, amphotericin B, which delays protein aggregation. He
found that this delayed the build up of protease-resistant PrP and the onset of
disease symptoms. However, it did not delay the build up of infectivity in the
infected tissues. Pocchiari's team interpreted this as suggesting that, while the
pathological form of PrP (PrP50) is necessary for the development of disease
pathology, it is not necessary for replication of the scrapie agent, i.e. this was another
piece of evidence dissociating infectivity from PrP. They argued, therefore, that the
proteinase-resistant portion of PrP50 is necessary for the development of the disease
but that it is unlikely to be essential for scrapie replication.106
Prusiner recognised that this was a problem. This was particularly so as he had
still not been able to demonstrate to his critics' satisfaction that pure PrP50 is itself
infectious. Consequently, he realised that his theory would be stabilised on much
firmer ground if he could demonstrate the transformation of PrP0 into PrP50 in vitro.
Since the late 1980s, some researchers had focused upon attempts to convert the
normal protein into an abnormal one in a cell-free system. This project had two aims.
Firstly, it provided a basis for performing further chemical tests on the protein. More
importantly, it offered a means of validating prion theory. If a brand-new PrP50
particle, created at the laboratory bench could be shown to be infectious, this would
be strong evidence that protein in the absence of nucleic acid is the real agent causing
the fatal diseases. According to Weissmartn, "the experiment of the decade in this
field will be to take biosynthetic PrP0 which you have made under conditions where
104 Ozel, M., Y.G. Xi et al. (1994) 'Small virus-like structure in brains from cases of sporadic
and familial Creutfeldt-Jakob disease', Lancet 344 (8927): 923-924
105 Ozel, M. and H. Diringer (1994) 'Small virus-like structure in fractions from scrapie
hamster brain', Lancet 343 (8902): 894-895
106 Xi, Y.G., L. Ingrosso et al. (1992) 'Amphorericin B treatment dissociates in vivo replication
of the scrapie agent from PrP accumulation', Nature 356 (6370): 598-601
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there is no possible infectious nucleic acid around. And then wave your magic wand
over the test tube, inject it, and find that it has become infectious. If that experiment
is done, I think that 99.999% of the people in the field will agree. Thafs it."107
The trick would be to take biosynthetic PrPS which is known to be
uncontaminated with nucleic acids, convert it into PrP50, then demonstrate that this
completely pure prion protein is infectious. The problem is, that this proved
impossible to achieve. While it is possible to produce biosynthetic PrPS it proved
impossible to convert it into infectious PrP^ by chemical means. Two of Prusiner's
collaborators, Fred Cohen and Glenn Telling, attempted unsuccessfully to fulfil this
aim. In an interview with Rosie Mestel in 1996, Cohen claimed that "we have
managed to create material which is rich in p-structure, and we have created material
which is protease resistant [that possesses some of the key physical and chemical
properties of PrP50]. But to date we have not created material that is infectious."108
Meanwhile, at the RML, a young biochemist, Byron Caughey, and an MIT
chemist, Peter Lansbury Jr., were trying different way to convert Prl*7 into PrP^ in
test tube.109 In 1994, at last, the collaborative team reported that they had succeeded
in converting PrP0 to PrP^ in a purified cell-free solution. They prepared artificial
PrPS radiolabeled it, and mixed it with PrP^ from infected hamsters. When they then
digested the mixture with protease-K to remove the PrPS they found that some of
the remaining PrP50 was radiolabeled, i.e. some of the PrP0 has been converted into
Prpsc.110 This was consistent with Prusiner's long-standing protein-only theory,
because the conversion in a cell-free system implied that any possible small viral
107 Mestel, Rosie (1996) op. cit. note 72: 187; Almost all the interviewees whom I interviewed
agreed with this argument. It seems to be a consensus amongst scientists that the crucial and
conclusive experiment to prove the prion theory would be in vitro conversion.
108 Mestel, Rosie (1996) op. cit. note72:188
109 This project began in the late 1980s. At that time, they attempted to construct the abnormal
form of the protein from a cloned prion gene in a cell-free system. In 1988 they obtained the
abnormal form of protein, but the newly constructed protein was not infectious at all. This led
them to conclude that infectivity and PrP were two different things. [Caughey, B., R. Race, et
al. (1988) 'In vitro expression of cloned PrP cDNA derived from scrapie-infected mouse brain:
lack of transmission of scrapie infectivity', CIBA Foundation Symposium 135:197-208.]
110 Kocisko, D.A., J.H. Come, et al. (1994) 'Cell-free formation of protease-resistant prion
protein', Nature 370: 471-474; This experimental result was reported in the New York Times
because it was assumed to be a crucial step to understanding how the normal protein was
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components could be excluded, and the conversion explained solely by pure protein
interactions. This was good news for Prusiner and bad news for the sceptics.
However, problems now arose in demonstrating that the new PrP^ is infectious. The
problem is that, in order to achieve transformation, a considerable quantity of
hamster-derived PrPSc had to be added, and the proportion of new PrP50 was tiny in
comparison. Consequently, any increase in infectivity, assuming that the new PrP50
was indeed infectious, was simply too small to measure. Here, David Bolton pointed
out why the infectivity of the conversion experiment is not measurable:
It's not that it has no infectivity, it's that you cannot measure its infectivity. Ifs a
peculiar thing about the way the experiment is done. In Byron's experiment, you radio
label some of the normal protein, so you have a relatively small amount of radio
chemically labelled normal protein. And you add to that a very large amount of the
abnormal form and you combine them in the test tube. And because the abnormal form
is not radio chemically labelled, it is transparent when you do the separation and the
autoradiography. So, if you combine them for a while and then test them for protease
resistance, you will find that over some time, the radio chemically labelled normal
protein goes from being completely protease sensitive to being some protease
resistance. The problem is, when you go for infectivity, it is like weighing a man on a
battleship. You have all the infectivity, the battleship that you have added, and now
you have added one man to it. You cannot distinguish that.111
Byron Caughey also stated "until we or someone else can measure new infectivity
the proof just isn't there."112 If the researchers had been able to do so, and if the
converted protein had been infectious, they would have had what they call "the
ultimate proof of the protein-only hypothesis".113
In other words, this attempt to prove the infectiousness of PrP^, like all other
attempts, was a failure. Meanwhile, Prusiner's team was looking for a reason why
the protease-resistant PrP that Cohen and Telling had produced might not be
infectious. Cohen suspected that, while they had managed to produce a version of
PrP with some of the properties of PrP50, they had not achieved full conversion into
PrP50. Cohen told a reporter: "our suspicion is that there is some other molecule that
transformed into the pathological form. [Blakeslee, Sandra (1994) 'New understanding of
how a protein runs amok' The New York Times (16 August 1994)]
111 Bolton, David (2000a) op. cit. note 39
112 Mestel, Rosie (1996) op. cit. note72:187
113 Rhodes, Richard (1997) op. cit. note 20: 207
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is required for the really proper folding of PrP° into a prion state." This was
consistent with the results of another series of transgenic experiments that Prusiner's
team had conducted around 1994. From early experiments done by Mike Scott,
Prusiner's team realised that wild-type mice are normally resistant to infection with
scrapie hamster-adapted scrapie agent (SHa). By contrast, if the hamster PrP gene
was transferred into transgenic mice, referred to as Tg(SHaPrP) mice, the transgenic
mice show hamster scrapie symptoms.114When an artificial host was constructed that
contained hybrid genes for both mice and hamsters PrP, referred to as a chimeric
gene, it was be susceptible to both mouse scrapie and hamster scrapie.115 However,
puzzling results occurred when Scott and another transgenic expert, Glenn Telling,
extended this experimental system to the human genome. Around 1994, they were
able to construct transgenic mice expressing human PrP0 [Tg(HuPrP)]. However,
mysteriously, the transmission of human prion disease such as CJD failed in these
transgenic mice. In contrast, in the case of transgenic mice expressing a chimeric
mouse-human PrP gene, referred to as Tg(MHu2M), which means that transgenic
mice contain a hybrid PrP gene of humans and mice, infection occurred quite
effectively in these transgenic mice.116 The researchers were left with the puzzle of
explaining why solely human transgenes cannot show the infectivity of the disease,
whereas if the transgene consisted of part-human and part-host genes, then infection
occurs. Prusiner and Cohen thought that this phenomenon might be attributed to the
involvement of unknown host encoded element - possibly an auxiliary non-PrP
molecule, provisionally designated "protein-X", which participates in the formation
of prions by interacting with newly translated PrP0 to facilitate its conversion to
prpsc 117 According to Cohen, "the right answer was that even though proteins could
114 Scott, M., D. Foster, et al. (1989) 'Transgenic mice expressing hamster prion protein
produce species-specific scrapie infectivity and amyloid plaques', Cell 59 (1 December, 1989):
847-857
115 Scott, M., D. Groth, et al. (1993) 'Propagation of prions with artificial properties in
transgenic mice expressing chimeric PrP genes', Cell 73 (4 June, 1993): 979-988
116 Telling, G. C., M. Scott, et al. (1994) 'Transmission of Creutzfeldt-Jakob disease from
humans to transgenic mice expressing chimeric human-mouse prion protein', PNAS
91 (October 1994): 9936-9940.
117 Telling, G.C., M. Scott, et al. (1995) 'Prion propagation in mice expressing human and




fold on their own, that in general they did not. In general, they used this assistant
machinery. So the concept that we put forward was that it was unlikely that this
process depended upon the prion protein alone entirely. And rather, that there were
likely to be auxiliary factors that could play a role in this that would help one over




W E3 ftSLx / \
mm a*- 9B~ EH
\ / \ /
ansa
*
/ \ / \
351- SB- SB- =»
Figure 4: The basic illustration of prion hypothesis with protein-X. The molecules of
PrPSc will combine with molecules of PrPc to form heterodimers (mixed pairs). During
the interaction, the PrPc will convert to PrPSc. The two molecules of PrPSc are then able
to separate and to go in search of further PrPc molecules. Studies using transgenic
mice suggest that another molecule, designed protein-X, may also be involved in the
conversion process.119
Cohen consequently agreed that research perspective should be shifted from the
molecular biological level to the level of protein folding mechanisms. This was quite
a significant shift as far as Prusiner's perspective is concerned. For Prusiner, it was
the first serious extension of his work from the molecular to the cellular level. Up
until that time, Prusiner himself had not been interested in process such as protein
interactions. However, when a protein-folding expert, Fred Cohen, became involved
in prion research, the whole agenda of the research had to be extended. What Cohen
and Prusiner were now interested in was the so-called protein kinetics. They
assumed that proteins would not fold by themselves, and there had to be something
else to promote protein foldings in the real cellular situation. When pathogens like
1,8 Cohen, Fred (2000) op. cit. note 88
119 Ridley, R. M. and H. F. Baker (1998) op. cit. note 71:138
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prions are injected, or invade from outside, "you have a relatively short window of
opportunity between which the agent has to establish productive infection. In the
case of prions, it has to bind the PrP3 on a cell that is capable of replicating, it has to
be internalised and start making more of it than is being degraded. If that is not
happening in a short time, then the agent is eliminated from the body and the animal
does not get sick."120 Thus, in order to understand the process of the internalisation of
exogenous malfolded prion protein and its interactionwith the normal prion protein,
it is necessary to involve various other factors at the cellular level.
However, this addition of a new layer of hypotheses in order to explain gaps in
the prion theory failed to impress sceptics such as Manuelidis and Race. Race at the
RML points out that the auxiliary factors that Prusiner now invokes are equally or
perhaps more compatible with a viral aetiology. He claims that "I don't think there
is really any good strong evidence for a 'protein-X'. Protein-X might actually be PrP.
Yes, there's something else there. It could be some viral induced component, too."121
Furthermore, Manuelidis thought that Cohen's hypotheses about helper molecules
were simply intellectual acrobatics. She claims that she was unimpressed by the
additional molecules and different classes of protease-resistant PrP molecules, some
that are infectious and others that aren't. Manuelidis' criticism was that Prusiner's
protein-X was getting into the realms of medieval thought processes. If you can't
distinguish structurally between PrP gene and helper genes, then how do you know
that they're really different?122 She even argued that the X sounds a lot like a virus.123
As can be seen, whenever the prion group produced experimental results, and
claimed that they had the momentum to prove their prion theory. Their results and
speculations, however, were always flexible enough to be interpreted differently
from the sceptical viewpoint. Nonetheless Prusiner and his prion theory (or protein
only theory) became major reference points in the field. With the outbreak of BSE
and nvCJD in the UK, his name and theory became circulated as a standard
terminology in the public domain. In 1997 the whole credit for scrapie-like disease
120 Bolton, David (2000a) op. cit. note 39
121 Race, Richard (2000) op. cit. note 19
122 Mestel, Rosie (1996) op. cit. note72:188
123 Manuelidis, Laura (2000) 'The force of prions', The Lancet 355 (10 June 2000): 2083
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research went to Prusiner. On 6 October, the Nobel committee at Karoliriska
Institute, Sweden, announced that Stanley Prusiner had won the 1997 Nobel Prize for
medicine for his work on prions.124
3.2. The triumph of the prion
Throughout all this work during the 1990s, the two camps of prion believers and
prion sceptics failed to reach agreement on the meaning of their scientific results. For
those most closely involved in work on scrapie and other supposed prion diseases,
the evidence remained insufficient to decide conclusively one way or another. In
1994, for instance, the Chancellor of the University of California at San Francisco,
Joseph Martin, who is also a neurologist, claimed that the prion hypothesis had stood
the test of every experiment that could possibly be devised.125 On the other hand, one
of the sceptics, Robert Rowher, director of the molecular neurovirology unit at the
Veterans' Affairs Medical Center in Baltimore, urged that the agent is a very hardy
and robust virus.126 Dissent still raged amongst scientists at the time.
From about that time onwards, however, influential agencies within the wider
scientific community increasingly come to side with Prusiner and his once heretical
suggestion that these diseases are caused by an infectious protein, in the absence of
any nucleic-acid-based informational molecule. This growing acceptance of the prion
hypothesis manifested itself in the form of numerous significant prizes given to
Prusiner, among them a Gairdner Foundation International Award (1993),127 the
Richard Lounsbery Medal from the National Academy of Science (NAS),128 a Charles
124 Altman, Lawrence K. (1997) 'US scientist wins Nobel Prize for controversial work', The
New York Times (7 October, 1997)
125 Kolata, Gina (1994) 'Viruses or prions: an old medical debate still rages', The New York
Times (4 October, 1994): Science Section 1
126 Ibid.
127 The Gairdner Foundation is a non-profit corporation for research into biomedicine in the
worldwide. See the Gairdner Foundation website, [www.gairdner.org]
128 Richard Lounsbery Medal is awarded for stimulating research and encouraging reciprocal
scientific exchanges between the United States and France. Prusiner was awarded this medal
for 'distinct and exciting discoveries about the pathogenesis of neurodegenerative and
malignant diseases. This award celebrates the power of modem molecular medicine in 1993'




A. Dana Award for Pioneering Achievements in Health (1992),129 and a Christopher
Columbus Quincentennial Discovery Award in Biomedical Research from the
National Institutes of Health.130 Although his work was not conclusive and still
controversial at the time, the Albert Lasker Clinical Medical Research Award
Committee, which is believed by many to be the most significant biomedical science
prize in the States,131 and is generally viewed as a "predictor" of the Nobel Prize,
announced that Stanley Prusiner was the winner of its prize in 1994. The committee
also recognised that some scientists still considered Prusiner's work to be
controversial. One of the committee members, Jordan Gutterman, professor of
clinical immunology and biological therapy at the M.D. Anderson Cancer Center in
Houston, stated that "obviously the Lasker jury did not feel that this is controversial.
Even if the final proof is debatable, some of the most outstanding minds today think
this is as solid as it can get."132
However, this winning of the Lasker award could not change the sceptics' mind.
Robert Rowher, who is one of the diehard sceptics, referred to the prion theory as the
cold fusion of infectious diseases. He also added that as such it demands scrutiny
and scepticism until it is proven.133 Indeed, even while Prusiner gained general
credibility and awards from various foundations for his transgenic work, the sceptics
continued to produce counter-experimental results against the prion theory. During
129 The Dana Foundation is a private philanthropic foundation with principle interests in
health and education. The award has been running since 1986, and is for making innovative
and pioneering achievements in health and education. Prusiner won this award for the
discovery of a new disease pathogen, both genetic and infectious in nature, called the 'prion'.
[Dana.Org (2001) 'The Dana Foundation', The Dana Foundation (www.dana.org)]
130 Spector, Barbara (1994) 'Lasker Awards cite persistence of three scientists', The Scientist 8
(17 Octorber 1994): 20
131 The Lasker foundation was established in 1942 by Albert Lasker, the late owner of the Lord
& Thomas advertising agency, and his wife Mary Lasker, who was an enthusiastic advocate
of biomedical research.
132 Kolata, Gina (1994) op. cit. note 125
133 Ibid. Gary Taubes wrote a famous prion sceptic paper in Discover (1996). This paper was so
negative towards Prusiner that the latter rarely spoke to journalists from any publication
thereafter. The main thrust of Taube's argument was that Prusiner's transgenic experiments
did not conclusively prove his claim that the infectious agents were proteins sans nucleic acid,
and that Prusiner only managed to publish his proof-of-prion paper, "After it had been
rejected by the journal Cell. Prusiner managed to find a home for it in the Proceedings of the
National Academy of Science, where it wouldn't have to be peer-reviewed." [Taubes, Gary
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the 1990s, as we have seen, each camp of scientists continued to produce many
experimental results, but in each case the evidence could be interpreted differently
by their opponents. Both sides were struggling to convince the other, but in the
context of the controversy, it was indeed hard to disprove and dismiss each others'
interpretations. Despite the interpretative flexibility of these experiments, Prusiner
and his prion alliance continued to gain credibility from the research community. As
Laura Manuelidis complained when Prusiner won the Lasker award, the viral
camp's prospects of further research funds to pursue the informational molecule
were dwindling.
Nonetheless, Prusiner continued to gain support, and in 1997 was awarded the
Nobel Prize. The Karolinska Institute announced, "Prusiner has added prions to the
list of well known infectious agents including bacteria, viruses, fungi, and parasites.
Stanley Prusiner's discovery provides important insights that may furnish the basis
of understanding the biological mechanisms underlying other types of dementia-
related illnesses - for example, Alzheimer's disease, and established a foundation for
drug development and medical treatment strategies."134 However, this
announcement faced hostile criticisms. Many researchers thought that the infectious
agent remained unknown, and there was some concern that the Nobel Assembly
might be prematurely endorsing the controversial theory. Almost all the mass media
reports stressed the controversial history of Prusiner's hypothesis, using words such
as, "once-heretical theory",135 "after years of heated debate",136 "controversial
research"137 and so forth.
Accordingly, Laura Manuelidis at the Yale Medical School criticised the decision
of the Nobel assembly, and claimed that she feared that the Nobel assembly's
endorsement of the prion theory would stifle other avenues of further inquiries.
(1997) 'Nobel Gas', Slate, Web-magazine (10 October, 1997; slate.msn.com/HeyWait/97-10-
10/HeyWait.asp)]
134 Karolinska Institutet (1997) 'The Nobel Assembly at the Karolinska Institute has today
decided to award the Nobel Prize in Physiology or medicine for 1997 to Stanley B. Prusiner',
Press Release (6 October 1997)
135 Vogel, G. (1997) 'Prusiner recognized for once-heretical prion theory', Science 278:214




Moreover, another prion sceptic, Ashley Haase, in the microbiology department at
the University of Minnesota, said that he thought that the Nobel committee should
have waited to make the award until there was proof that protein alone was capable
of causing infection.138 In spite of such strong criticisms, the Nobel committee and
other general scientists expressed different views on this issue. Ralf Pettersson, the
deputy chairman of the Nobel committee, even implied that persistent scepticism
about prion had contributed to the spread of BSE to human beings. He claimed that
the panel was not bothered by the unanswered questions. The committee was well
aware of where the field stood. The details had to be solved in the future. But no one
could object to the essential role of the prion protein.139 He added, "during the whole
of the nineteen-eighties, the prion was very controversial. Acceptance took a while.
This could have delayed moves. It was more political decision about when to take
action, and by then it was too late."140 A Nobel laureate, David Baltimore, also
supported Prusiner's winning, saying that all through the history of science there
were people who kept their own faith for many years and lived through a period of
opprobrium, and finally were discovered to be right.141 When the Nobel assembly
announced Prusiner's victory, Prusiner himself said, "concepts are vindicated by the
constant actual data and independent verification of data. No prize, not even a Nobel
Prize, can make something true that is not true."142
His triumph seemed to be decisive with the award of this Nobel Prize. However,
it was not the end. Just as the Nobel Prize winner was announced in October 1997,
another series of controversial experimental results came out. Prusiner's archrivals in
NPU, Moira Bruce and her team, published further research on BSE and new variant
CJD. Like her earlier work on BSE, this work once again raised the issue of strain
variation in prion diseases and its conservation when those diseases were
transmitted to new species - a phenomenon that, as we have seen, could not be
137 Josefson, D. (1997) 'The prion hypothesis is finally accepted by the establishment7, British
Medical Journal 315: 972
138 Altman, Lawrence K. (1997) 'US scientist wins Nobel Prize for controversial work', The
New York Times (7 October, 1997)
139 Vogel, Gretchen (1997) op. cit. notel35:214
140 Rhodes, Richard (1997) 'Pathological science', The New Yorker (1 December 1997): 54-55
141 Josefson, Deborah (1997) op. cit. note 137:972
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explained by Prusiner's prion theory, and that seemed to demand the involvement of
an informational molecule.143 On this result, some commentators claimed "whatever
the nature of the agent, our understanding of TSE biology is evidently incomplete".144
Nevertheless, the winner took all the credit for the discovery of prion disease. This
was the case even though at the time, according to Richard Rhodes, only four of the
fourteen major TSE research laboratories actually working on the infectious agent
wholeheartedly espoused prion theory, nine others considered it unlikely, and one
was undecided.145 So why in the absence of conclusive evidence did scientific
credibility swing to the prion theory? In the next chapter, we will attempt to find the
answer for this question.
142 Altman, Lawrence (1997) op. cit. note 138
143 Bruce, M. E., R.G. Will et al (1997) 'Transmissions to mice indicate that 'new variant7 CJD
is caused by the BSE agent', Nature 389 (2 October, 1997): 498-501; At the same time, the link
between BSE and nvCJD was confirmed by John Collinge's transgenic experiments. However,
this experiment also raised another question about Prusiner's protein-X. Prusiner and his
team suggested this additional concept to explain why transgenic mice possessing the human
PrP gene were not susceptible to CJD. Collinge's team showed on the contrary that his
transgenic mice with human prion gene without any additional chimeric gene did become
infected by CJD. This experimental result was contradictory to Prusiner's one. [Hill, A. F., M.
Desbruslais, et al. (1997) 'The same prion strain causes vCJD and BSE', Nature 389(6650): 448-
50]. Although Collinge is one of the prion enthusiasts in Britain, his experimental result
fuelled another controversy on protein-X.
144 Almond, Jeffrey & John Pattison (1997) 'Protein only prions?', Nature 389 (2 October 1997):
438
145 Rhodes, Richard (1997) op. cit. note 140: 55
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Chapter 9 - Molecularising prion disease
1. Introduction
As seen in the previous chapters, attempts to characterise the scrapie agent to
everyone's satisfaction have so far been inconclusive, although the weight of opinion
amongst scientists has come down on the side of Prusiner's prion theory. Many
commentators have acknowledged that no crucial experimental result has yet been
reached. When Prusiner suggested his idea in 1982, most scrapie researchers
dismissed his idea as "heretical". However, within 20 years he has gained
considerable scientific credibility from fellow scientists and the public alike.
Correspondingly, his opponents, the prion sceptics, who were once the mainstream
in this field, have been marginalised. Nevertheless, the sceptics continue to pursue
their research project to prove their own theory. For the last twenty years, the
opposing stances have not come to any point of agreement. Although each side can
point to experimental results they consider crucial, the data are flexible and open to
interpretation.
In this chapter, I am going to search for a plausible explanation of how and why
the controversy was sustained over such a prolonged period, why opinion became so
sharply polarised between prion sceptics and prion believers, and why the two sides
held so fiercely to their respective opinions. Moreover, I will then explain why the
prion advocates gained much wider credibility and support among influential
sections of the scientific community than did the prion sceptics.
Through the prion controversy, the contending factions of scientists displayed
divergent values, patterns of practice, rules of social relations, laboratory structures,
and so on. This diversity of the two groups participating in the prion controversy can
elucidate why they held so strongly to their divergent scientific beliefs about the
scrapie agent.
Consequently, in the first sections of this chapter, we will explore the divergent
styles of research programme, and the material and social circumstances that
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influenced researchers to pursue these scientific programmes. Moreover, different
patterns of persuasion will be discussed. In the later sections, we will examine why
Prusiner's group won greater credibility among fellow scientists. In particular, I will
argue that his methods and style of research owed much to the development and
proliferation of a molecular biological approach that is closely associated with new
patterns of organisational and social order in the sociological sciences. The
proliferation of this molecular biological perspective is bound up with wider social
transformation, which can be called the "molecularisation of biomedicine".1
2. Divergent styles of research programme
As seen in my earlier analysis of the closure of the Edinburgh-Compton debate in
the 1970s, the Edinburgh group gained considerable credibility from the scientific
community because, among other things, they had a broadly biological perspective
that was in keeping with the approaches favoured by the British research councils.2
The perspective of the Edinburgh group remained the predominant approach to
scrapie and related diseases in the US as in Britain during the 1980s. In this context,
however, Prusiner's early work began to diverge from other work on scrapie, in that
it abandoned the broadly biological approach for a much narrower concentration on
the biochemical aspects of the agent. Each party has since developed distinctive
intellectual and methodological frameworks in the course of the dispute. Here I
would suggest the controversy is actually sustained and promoted through the
confrontation of these two oppositely patterned styles of research programme.
1 This notion is based on various historical analyses of the impact of the molecular approaches
in twentieth-century biomedicine. Since the revelation of the structure and function of nucleic
acids and proteins in the 1950s, the spectacular success of molecular biology has had a big
impact on the whole field of biomedical science. This transformation has resulted not only
from scientific success, but also from social and political change. Historians have used the
term "molecularisation" in order to describe this radical transformation in science and
society. [Keller, Evelyn Fox (1995) Refiguring Life: metaphors of twentieth century biology (New
York: Columbia University Press); Wright, Susan (1994) Molecular Politics: developing American
and British regulatory policy for genetic engineering, 1972-1982 (Chicago: University of Chicago
Press); De Chadarevian, Soraya and Harmke Kamminga (eds) (1998) Molecularising Biology
and Medicine: new practice and alliances, 1910s-1970s (London: Harwood Academic Publisher)]
2 For more detailed analysis, see chapter 5, 'How controversy ends: disputes on the nature of
scrapie and their closure'.
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As shown in the previous chapter, the two groups of scientists produced various
experimental results, and each group believed that those results supported their own
theories of the nature of scrapie. However, the experimental evidence failed either to
decide unequivocally between the two sets of theories, or to establish common
ground on which the two groups could reach consensus. This was because the two
groups evaluated the data with reference to quite different criteria, which in turn
were embedded in two different research programmes which might be characterised
as generalist biological and specialist biochemist programme. The sceptics'
programme of scrapie research has concentrated on the issue of the complicated
phenomena of disease; in other words, the main issue was about how the disease
replicates in the host, and how the agent and the host genes interact. On the other
hand, the prion group has mainly focused on the issue of the biochemical structure of
the agent. The different primary goals and research orientations led the two groups
to construct quite distinct experimental programmes. The prion sceptics'
concentration on the nature of the disease led them to explore a variety of biological
phenomena including nature of the agent; whereas Prusiner's concentration on the
nature of the agent, led him only secondarily to ask about how it is implicated in the
phenomena of disease. The two factions thus pursued strikingly distinct ranges of
intellectual and methodological issues.
These distinct patterns of theoretical and experimental practice can best be
characterised in terms of distinct styles of research.3 Recently, there is a significant
work done by Jonathan Harwood. In his work, he addresses how differently
patterned cultures emerged and were maintained. His work embraces historicity of
styles and co-existence of different styles of thought. Unlike previous studies of style,
he stresses the importance of not reifying styles, as if they were things that possessed
the power to shape scientists' thought and action.4 Instead, we ought to see style as
3 Harwood, Jonathan (1987) 'National styles in science: genetics in Germany and the United
States between the World Wars' Isis 78: 390-414; Harwood, Jonathan (1993) Styles of Scientific
Thought (Chicago: The University of Chicago Press)
4 There are several studies of styles, which are attempts to apply the concept to various socio-
cultural phenomena. For instance, Karl Mannheim adopted the concept from art studies to
identify a variety of social groups' articulated thought (see Mannheim, Karl (1953)
'Conservative thought' Essays in Sociology and Social Psychology (London: Routledge and
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indicators that thought is patterned.5 According to Harwood, 'styles of scientific
thought exist when particular ontological and/or epistemological assumptions recur
in a variety of scientific domains and those assumptions differ from one group to
next'. He attempts to exemplify his theory by focusing on the development of
genetics in American and Germany in the early twentieth century. He analyses the
development of genetic research, and comparing it with the social, educational and
institutional background of different research community. He remarks that national
differences of scientific traditions were manifestly maintained in their practice.
Furthermore, it is demonstrated that different cognitive patterns associated with
scientists' social background can be identified within a particular national context.6
In this chapter, I extend Harwood's work on styles of thought to the domain of
scientific practice. The domain where scientific theory is constructed and every
actor7 s interests are maintained and crated is the field of practice. This kind of work
is also found in Joan Fujimura and Danny Chou's work.7 They claimed that the case
of debate on the origin of AIDS could be elucidated in terms of different patterns of
practice, in which they conceptualised styles of scientific practice. Fujimura and
Chou claimed that "style of practice are historically located and collectively
produced work processes, methods, and rules for verifying theory. [...] Style of
practice implies that practices of theory construction, adjudication, and maintenance
Kegan Paul): 74-164). Also, Ludwik Fleck drew different styles between scientific thought and
religious or metaphysical thought-collective. However, his sociological analysis is quite
idealistic: the thought collective was sometimes claimed to dictates and coerces the overall
behavioural patterns of scientific practice (Fleck, Ludwik (1979 [1935]) Genesis and
Development of a Scientific Fact (Chicago: The University of Chicago Press)). For more
general studies of styles in social studies of science, Sontag, Susan (1968) 'On style', Sontag,
Susan (ed.) Against Interpretation (London: Eyre & Spottiswoode); Bloor, David (1978)
'Polyhedra and the abominations of Leviticus', British Journal for the History of Science 11: 245-
272; Harwood, Jonathan (1986) 'Ludwik Fleck and the sociology of knowledge', Social Studies
of Science 16: 173-187; Lowy, Illana (1988) 'Ludwik Fleck's role in society: a case study using
Joseph Ben-David's paradigm for a sociology of knowledge', Social Studies of Science 18 (4):
625-651; Barnes, Barry (1994) 'Cultural change: the thought styles of Mannheim and Kuhn',
Common Knowledge 3 (2): 65-78.
5 Harwood, Jonathan (1993) op. cit. note 3:15
6 Harwood, Jonathan (1987) op. cit. note 3
7 Fujimura, Joan H. and Danny Y. Chou (1994) 'Dissent in science: styles of scientific practice
and the controversy over the cause of AIDS', Social Science and Medicine 38 (8): 1017-1036;
Fujimura, Joan H. and Danny Y. Chou (1995) 'Styles of practice in HIV/AIDS research',
Techniques and Culture 25-26:195-244
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are situated actions".8 The styles are embodied in practice, in particular, specific
scientific programme. As you will see, different styles of scientific programme in the
prion controversy pervaded their distinct ways of conducting experiments,
interpreting data, using techniques, constructing models, and organisational
structure.
2.1. Generalist biological programme of the prion sceptics
As we have seen, the prion sceptics have mainly focused on disease aetiology,
pathogenesis and agent-host interactions as well as the nature of the infectious agent.
For instance, since Dickinson's group began their research project in 1957, they have
been broadly concerned with the "nature of the disease process".9 Indeed this
biological and pathological orientation was made clear in the articles that opened the
prion controversy in 1982.10 More specifically, for Dickinson and his colleagues, the
biological diversity of the agent provided the main point of attachment for
elucidating the nature of the infectious agent. Since the 1960s, they had recognised
that there are many strains of scrapie. They also realised that this phenomenon of
strain variation posed a major challenge for the prion theory. For this reason,
Dickinson and his colleagues stressed the importance of understanding the nature of
agent variation. As Dickinson remarks in the BSE Inquiry, this distinguished his own
approach from that adopted by Prusiner:
The NPU [Neuropathogenesis Unit, Dickinson's laboratory] had distinguished itself
from most work worldwide, when most people were saying: "we want to know what
the nature of this agent is". And I, starting as a geneticist, said: "I think a more
fundamental question is: "what is the nature of agent variation?" [...] It is very
important distinction. If you think about it, there are those who claim, I think
prematurely, that they know what the nature of the agent is in chemical terms. The
outstanding question is very much: " what are strain differences?" "What is the nature
of agent variation?"11
8 Ibid., 1020-1021
9 Dickinson, Alan G. (1999b) Interview with author (Dunbar: 15 September 1999)
10 Dickinson, Alan G. (1982) 'Scrapie: strategies, stalemates, and successes', Lancet (29 May
1982): 1221-1223; Kimberlin, R. H. (1982a) 'Scrapie agent: prions or virinos?', Nature 297 (13
May, 1982): 107-108; Kimberlin, R. H. (1982b) 'Reflections on the nature of scrapie agent',
Trends in Biochemical Sciences 7: 392-394




In this respect, they developed a distinctive intellectual and experimental
programme. Interestingly, the Edinburgh researchers refer to their overall
experimental project as a "generalist project". As George Outram remarks, "scientists
themselves fall into two kinds of fundamental types generally, generalist and
specialist...our culture, I can say, is generalist. You've got a scientist who knows a lot
and is very good at some techniques and extremely complicated equipment. Then
you have generalist".12 In this statement, Outram not only identifies himself as a
generalist, but identifies a generalist orientation as fundamental to the entire research
programme that he and his Edinburgh colleagues proved. Outram explains the
whole philosophical ground of their research project. He remarks as follows:
The danger with this approach [biochemistry, immunology, virology and molecular
biology apply here] is that in order to get meaningful answers the right questions must
first be asked and, if scrapie is an unprecedented phenomenon, then the inbuilt
assumptions of any developed methodology will effectively prevent the agent from
'answering' the questions we address to it. In short, we require something more
general, i.e., less specialised, which will survey the whole phenomenon and so enable
us to identify or devise such specialised techniques as will be really appropriate.13
On philosophical grounds, the Edinburgh researchers thus concluded that before
exploring the specific characteristics of the agent, their research should aim at
providing a general understanding of the disease. Thus, "this should provide a broad
biological base against which the disease could declare itself in its own terms rather
than those imposed by some other inappropriate system."14 For the Edinburgh
researchers, strain variation was the best subject to examine, because an
understanding of strain variation would throw light on the whole biological
mechanism of the disease.
Moreover, this distinctive intellectual orientation of the sceptics was also
embodied in their research methodology. As we have seen, Dickinson and his
12 Outram, G.W. (1999) Interview with author (5th August, 1999: Edinburgh)
13 Outram, G.W. (1980) 'Mouse scrapie: black-box models and the slow encephalopathies', F.





colleagues have been to observe as many aspects of strain variation as possible,
including incubation time, lesion profiles and the affects of host genotype. For this
purpose, they needed an animal model that would make it possible both to display
the widest range of strains possible, and to standardise the biological circumstances
in which those strains were investigated. For these reasons they chose to work with
mice, spending nearly ten years breeding, selecting and inoculating a variety of in¬
bred strains that reliably and reproducibly manifested the various phenomena that
interested them.15 In this respect, it is notable that through succeeded in transmitting
scrapie into hamsters, and in demonstrating that the disease incubated more quickly
than in mice, he chose not to adopt the hamster as his preferred experimental animal.
The reason was simple: while at least twenty different strains of scrapie could be
studied in mice, only two of these could be transferred into hamsters. Thus, despite
the greater speed with which hamster experiments could be performed, they simply
did not display the range of phenomena that the Edinburgh researchers considered it
imperative to observe.16
2.2. Specialist biochemist programme of the prion group
Compared with the prion sceptics' general biological perspective, Prusiner's work
concentrated primarily on studying the agent, while aetiological and pathological
concerns were secondary. On the whole, Prusiner was interested less in how the
agent manifests itself in the form of disease, than in simply asking what the agent is,
particularly in chemical and molecular biological terms. In his early research,
Prusiner focused on revealing the biochemical structure of the agent. His priorities
were made clear when he responded to the criticisms of the prion sceptics in 1982.
Prusiner claimed:
Knowledge of the structure of the agent is mandatory before attempting to design
studies that can answer such fundamental and critical questions as: (1) how does the
15 For more detailed description and discussion of the procedure for constructing their animal
experimental model, see chapter 3, 'Genetic research into scrapie at the Moredun Institute,
Edinburgh, 1964-1979'.
16 Kimberlin, R. H., C. A. Walker (1977) 'Characteristics of a short incubation model of
scrapie in the golden hamster', Journal ofGeneral Virology 34: 295-304
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agent replicate, (2) in what cells does it replicate, and (3) how does it produce
neurological dysfunction?"17
Prusiner's view of the objective of his research was thus the precise opposite of
what Outram suggested. While Outram suggested, as we saw above, that the
primary object of research should be a general understanding of the disease, Prusiner
claimed that the priority of research should be understanding of the structure of the
agent.
Conversely, by concentrating on such a specific research aim, Prusiner and his
team were able to bring a range of specialist methods to bear on their research. As
one of Prusiner's colleagues, Mike Scott, remarks:
We're all becoming specialist in some way. I think you have to go with technology, and
the technology is molecular biology, rational drug-design, genomics, NMR, X-ray
crystallography, recombinant antibodies etc...I think anybody who doesn't embrace
the new "specialist" biotechnology is doing himself or herself a disservice.18
For Prusiner and his team, understanding the molecular structure of the agent by
using various techniques of biochemistry was the first step toward exploring the
whole biological mechanism of the disease. Since he launched his research project to
isolate the agent from the cellular components in the early 1970s, Prusiner has
consistently adopted some of the most innovative biochemical and molecular
biological techniques in a sustained assault on this single problem.
In this context, Prusiner's preferred choice of experimental animal also
distinguished him from the sceptics. As we have seen, the Edinburgh group
favoured mice because they revealed a wide range of scrapie phenomena. Prusiner,
by contrast, was initially interested in laboratory animals only as a means of
performing bioassays of the scrapie agent after exposure to various physical and
chemical treatments. For this purpose, the hamster with its shorter incubation time,
was far preferable to mice. Then, since 1989, Prusiner's team has constructed
transgenic animal models as a means of focussing yet more closely on the
17 Prusiner, Stanley B. (1982) 'Research on scrapie', Lancet (28 August 1982): 494




proteinaceous character of the scrapie agent. At each stage of his experimental
project, he has adapted animals more as a means of pursuing particular biochemical
techniques than for the biological phenomena they reveal. In this sense, Prusiner's
experimental system is more specialist-oriented than that of the Edinburgh group.19
2.3. Virino/Prion: naming as declaration of scientific programmes
As we have seen, the prion group and sceptics had quite distinctive experimental
programmes. Under those different scientific programmes, each party decided to
adopt a distinctive name for the agent. Dickinson's group called it a virino, and
Prusiner called it a prion. This can be seen in both cases as a sort of declaration that
they were doing some important and new.
When Dickinson dubbed the agent a "virino" in 1979, he intended to draw
attention to the importance of the objects they were studying - a distinctive family of
viruses with peculiar characteristics and possibly wider medical significance.20
Dickinson and his colleague, George Outram, stated that "an appropriate name for
this class of agent would be 'virinos', which (by analogy with neutrinos) are small,
immunologically neutral particles with high penetration properties but needing
special criteria to detect their presence".21 In this sense, Dickinson intended to stress
the remarkable properties of the agent - hence the reference to the neutrino, one of
the most elusive, basic, uncharged particles of matter.22
Interestingly, the term virino acquired a further layer of meaning following
Prusiner's adoption of the term "prion" in 1982. Dickinson had from the beginning
supposed that the scrapie agent must contain nucleic acids, but in 1979 this
19 It should be noted that the demarcation between generalist and specialist programmes
should not be perceived as an absolute distinction. At some level of organisation and
collaboration, any such divergence is at most a matter of degree, not one of kind. For instance,
Dickinson admitted that the Edinburgh team's progress was to an extent delayed by the lack
of biochemists, i.e. they recognise and rely on specialist skills. However, in this context, my
demarcation of generalist and specialist programmes indicates distinct tendencies of research
objectives, methodologies, and experimental systems that are best captured by the term
"style".
20 Dickinson, A. G., G.W. Outram (1979) 'The scrapie replication-site hypothesis and its
implications for pathogenesis', S. B. Prusiner & W. J. Hadlow (eds), Slow Transmissible Diseases
of the Nervous System 2:13-31 (London: Academic Press)
21 Ibid., 30
22 Cooke, Jennifer (1998) Cannibals, Cows, and the CJD Catastrophe (London: Minerva): 103
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supposition was shared by most of those working on scrapie-like diseases. The term
"virino" was therefore adopted primarily to emphasise how the scrapie agent
differed from conventional viruses. When Prusiner decleared his own willingness to
suppose that the agentmight not contain nucleic acid, however, Dickinson reasserted
the term "virino" precisely because it signified similarity to conventional viruses in
the crucial aspect of possessing a nucleic acid genome.23
From its inception, the name "prion" - to simplify a proteinaceous infectious
particle - was controversial. At this point, the naming of the agent became an
important issue in the scientific community. Some now claimed that before a clear
picture of the nature of the agent was drawn, it was premature to name the agent.24
However, Prusiner baptised the agent in his Science article. Prusiner wanted to mark
a significant break with the established biological orientation to scrapie-like diseases.
He chose the term prion to reflect this. In his article, he suggested two possible
models of prion: the first was that of a small piece of nucleic acid, which is "buried
within a tightly packed protein shell". The second model was of an infectious agent
devoid of nucleic acid.25 Prusiner himself recognised that this second hypothesis was
heretical, marking a significant break with conventional knowledge. As the editor of
Chemical and Engineering News stated in 1982, prion is a challenge to an even greater
biological wisdom. The editor claimed, "a life form that does not contain nucleic acid,
Prusiner admits, is clearly heretical. It is a central tenet of biology that nucleic acids -
DNA and RNA - are the universal bearers of the genetic code and, hence, are
necessary for life".26 Prusiner was careful at this stage not to declare a preference for
one or the other of these two hypotheses. But by deliberately emphasising the
proteinaceous character of the agent he flagged up his empiricist refusal to prejudge
23 Dickinson, Alan G. (1982) op. cit. note 4
24 According to Richard Rhodes, Gajdusek claimed in an interview to have told Prusiner that
he preferred to give disease agents a proper name only when he was sure what their
molecular structure was. Gajdusek says, "I made this point repeatedly with him [Prusiner],
explaining that it was premature to name them since, although we knew they had no nucleic
acid, we were not sure of their biochemical nature." [Rhodes, Richard (1997) Deadly Feasts:
tracking the secrets of a terrifying new plague (New York: Simon & Schuster): 161-163]
25 Prusiner, S. B. (1982) 'Novel proteinaceous infectious particles cause scrapie', Science 216
(4542): 141
26 Anonymous Editorial (1982) 'Possible new life form tinier than virus', Chemical and
Engineering News 60: 4
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the nature and constitution of the agent. Thus, Prusiner admitted that "current
knowledge does not allow exclusion of a small nucleic acid within the interior of the
particle".27 Prusiner's close collaborator, Stephen DeArmond, confirms Prusiner's
caution in this respect. He remarks, "Prusiner will not commit himself until the data
is there. And actually, in 1982, they didn't even know where the protein was formed.
It could have formed in a virus".28 Nonetheless, Prusiner's willingness even to
suggest that the scrapie agent might not contain nucleic acid was a bold more, which
his deliberate decision to privilege the proteinaceous character of the agent made
clear his commitment to biochemical methods rather than biological dogma.29
In effect, the term "prion" and "virino" thus came to stand, not just for opposing
ideas about the nature of the scrapie agent, but for two distinctive approaches to
investigating and elucidating that nature. For Prusiner, the biochemical evidence of
it, proteinaceous character was paramount. Theoretical presuppositions must be
suspended which further biochemical investigations were pursued. Dickinson, by
contrast, was concerned to take into account not just all that was known biologically
about the agent - its peculiar immunological characteristics, its pathological
behaviour - but also what was known about other viral diseases that scrapie in some
ways resembled in some ways differed from.
3. Material circumstances
In the previous section, I characterised the two factions in the prion controversy in
terms of the distinct intellectual and methodological programmes that they pursue
and styles they favour. I argued that the prion group pursued what we might call a
specialist programme, which the prion sceptics adopted what can be defined as a
generalist biological programme. I will now go on to explore some of the
circumstantial factors, which have been influential in informing and sustaining the
27 Prusiner, S. B. (1982) op. cit. note 25:141
28 DeArmond, Stephen (2000) Interview with author (18 August 2000: UCSF, San Francisco)




divergent programmes in the prion controversy. In this section, I will look at the role
of funding structure.
In the case of the prion sceptics, it is notable that they are generally working in
secure posts in long-term government-funded institutions, committed among other
things to managing and understanding disease as a broadly biological and ultimately
economic phenomenon. On the other hand, Prusiner and his colleagues are largely
dependent upon short-term grant funding, which tends to encourage the pursuit of
more narrowly defined and self-contained research projects. These differences are
clearly apparent in the different kinds of questions the two factions ask and in the
methods they use - including the very long-term genetic experiments favoured by
the prion sceptics, and Prusiner's concern to produce rapid results.
3.1. Long-term government funded research of the prion sceptics
Most prion sceptics belong to government-funded institutions such as NPU
(funded by the Biotechnology and Biological Science Research Council), IBR
(Institute for Basic Research, funded by New York State Government), and RML
(Rocky Mountain Laboratory funded by National Institutes of Health, namely, NIH).
Under this funding structure, researchers have a stabilising post in general. For
instance, at NPU (previously the Moredun-ABRO collaborative unit), most members
at the institute have a permanent post. For two decades, it scarcely ever happened
that anybody left or did other outside work; Dickinson, Fraser, Outram, Bruce, and
Kimberlin, all continued to work together until their retirement. In her interview,
Moira Bruce says, "everybody has a permanent job. There is no problem about the
short term contracts. It was stabilised funding. There was always the possibility that
the Research Council might withdraw funding, but there wasn't grant-funding
system within the BBSRC institutes at that stage. It was fairly open-ended. It was
remarkably relaxed".30
Within this funding structure, it was possible to conduct long-term experiments in
the genetics and pathology of scrapie. Indeed such experimental projects were
conditional on stable and uninterrupted funds to guarantee continuity of work. In
30 Bruce, Moira (1999) Interview with author (9 June 1999: NPU, Edinburgh)
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particular, genetic experiments into mouse scrapie took a considerable time to yield
experimental outcomes, because of the nature of the material and the need to control
a wide range of variables. As we have seen, Dickinson's group took at least ten years
to perfect their genetic experimental system. This kind of experiment would have
been nearly impossible to accomplish under a short-term grant system.
Another interesting consequence of government funding is that it has tended to
encourage the pursuit of a broad understanding of disease, including its biological
aspects. Government funding is generally informed by economic concerns. For
instance, the Moredun-ABRO research unit was set up specifically for the purpose of
solving the problems of economic loss in the agricultural industry due to epidemics
of scrapie. As seen in chapter 5, there were quite large scale scrapie epidemics in
Britain and America in the late 1950s and early 1970s, which led both governments to
launch research projects to solve this problem.31 In order to address such practical
problems, researchers sought to understand tire disease itself, not just the mystery of
the infectious agent. This explains why most sceptics have focused on the problem of
understanding the disease, not just the agent.
3.2. Short-term grant funded research of the prion group
On the other hand, in the case of Prusiner's group, we find a very different
picture from that of the NPU. Their research funds have mostly depended on short-
term grants from the NIH and private funds. This is a general tendency in the
American research system, particularly in university-based research institutes.
Moreover, the American system attaches importance primarily to the
accomplishments of individual grant holders not institutes. This individualisation is
a consequence of post-war federal support for scientific research in the States. As
SusanWright points out, during the post-war era in the 1950s and 1960s, distribution
of research money was centred on agencies such as the National Institutes of Health
(NIH).32 The empowered NIH allocated research money not to universities or
department heads, but to individual researchers, in the form of grants for specific
projects. Under this funding system, one of the most important factors for research is
31 For more detailed discussion, see chapter 5, 'how controversy ends'.
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individual outstandingness. Researchers must demonstrate the significance of their
project in the short term. Otherwise, there is no possibility of getting large amounts
of research funds. Research projects, in general, consequently, tend to be quite
narrowly defined and self-contained.
Prusiner's laboratory at UCSF is university-based. This means that he has had to
raise his own research funds from NIH and other sources. It is therefore not
surprising that he has tended to concentrate specifically on elucidating the nature of
the scrapie agent, and on developing quick and efficient methods for doing so,
including his hamster model and his incubation time bioassay method. Indeed,
Prusiner has proved himself to be highly effective not just in raising research funds,
but in managing them. His skill in the management of his laboratory is deemed to be
unique,33 including the organisation of intricate networks of collaboration, and the
planning and supervision of every stage of the resulting experiments. In this matter
ofmanagerial style, too, he differed from the prion sceptics, as we shall see.
4. Social circumstances
I will now explore how different styles of scientific programme are associated
with different forms of social relations within the two factions. The two parties
differed in terms of the patterns of interaction and collective practice in each
laboratory. Robert Kohler's work on the moral economy of laboratory culture in the
case of the Drosophila group provides a remarkably good model for investigating
such different patterns of scientific practice.34 As Kohler states, unique moral
conventions regulate access to the tools of experiments, in the sense that members
have to commit themselves to the unstated rules of the laboratory. In a similar
fashion will now explore the social and moral order that obtained in the laboratories
of the two factions in the controversy, and will show how they related both to the
32 Wright, Susan (1994) op. cit. note 1:28-29
33 Bolton, David (2000a) Interview with author (IBR, New York: 31 July, 2000)
34 Kohler, Robert E. (1994) Lords of the Fly: Drosophila genetics and the experimental life (Chicago:
University of Chicago Press).
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different research programmes explored by the two groups and to the social and
economic circumstances in which they worked.
4.1. The communitarian relation of the prion sceptics
The prion sceptics, working within long-standing research teams, tend to pursue
not just a collaborative but in effect a communal mode of research. Not only do they
pursue research programmes that bring together individuals with a variety of skills
for the purpose of illuminating the whole disease process, but they also all tend to
share in negotiating, agreeing and overseeing that research programme. For instance,
in Dickinson's group in Edinburgh, everyone in the group enjoyed free and
unhindered access to the instruments of knowledge production. For that to work, it
was necessary for all the members to have a general understanding and knowledge
of the whole experimental project. This is because genetic experiments usually need a
long-term commitment, so the process of experiments has to be rigorously
controlled. A fault occurring in the middle of the experiment could ruin at least a
year's work on the project. Therefore, all the members have to understand the
general procedure of the whole experiment.
Importantly, there is a sense that this is a shared project, and indeed that all will
succeed or fail together. This is bound up with the nature of the long-term
experiments they undertake, which involve considerable investments of time and
energy from several members of the team. For this reason, openness is a positive
virtue, which helps to avoid collective disaster. Hence, in his interview, Dickinson
insists that "people were told the day they were employed, once we'd chosen them,
'you will make mistakes, everybody makes mistakes, and what we want you to do
when you find a mistake, is come and show us. We know it will happen and we will
work it out together. You must not correct mistakes on your own.' "3S Thus, when
there is a problem in the process of experiment, the members sort it out together. For
this co-operative work, each researcher must have at least a general knowledge of the
whole procedure and basic principle of the experimental design. There is another
good example of this kind of social relations between researchers in NPU. The
35 Dickinson, Alan G. (1999b) op. cit. note 9
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building design of the NPU is open and transparent. It is deliberately designed that
way to avoid workers being isolated. In his interview, Dickinson also notes "if you
go to NPU, you will find that the lab areas, the walls are all made of glass. It is a
single unit and people can be in social contact with one another and they are doing
jobs which have been thought out from the point of view to be as efficient, as quiet,
as compatible as possible."36
That this ethos of openness and communitarian social relation is not restricted to
the NPU, but holds good throughout the whole prion-sceptic community, and even
beyond. It is seen, for instance, in the willingness of the various groups to provide
research materials including scrapie strains and mice to one another. This relates to
another element of the moral and social order, namely the distribution ownership of
knowledge. Dickinson's group needs a functionally coordinated division of labour
because of the complex nature of genetic research. Because of the cooperative nature
of the work, the ownership of the research goes to the community itself. Finding new
products such as strains of laboratory mice and the scrapie agent is not thought to be
an individual achievement. Individual ownership is discouraged in NPU. Even when
collaborating, the Edinburgh researchers dispatched their strains of the agent to other
laboratories without charge. Merz in IBR remarks that "there was sample material
that came back and forth between Edinburgh and the United States, primarily from
Edinburgh to us, because they had strains, they had type strains of the agent."37 Here
is a passage from the BSE Inquiry showing the basic attitude on sharing knowledge
products:
Dr. Bruce: We produced in-house antibodies, and in fact the first antibody that was
available was an extremely good antibody which is being used to this day.
Professor Ferguson-Smith: Where was that made?
Dr. Bruce: At NPU
Professor Ferguson-Smith: Made by you?
Dr. Bruce: By Christine Farquhar
Mr. Walker: So it is used by you, is it used by others as well? Have you supplied it to
others?
36 Ibid.
37 Merz, Patricia (2000) Interview with author (27 July 2000: IBR, New York)
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Dr. Bruce: Yes, it has been distributed very widely throughout the world.38
Even at the peak of the prion controversy in the mid-1980s, Dickinson's group
sent all the strains of the agent to other research groups in the world including their
opponents, Prusiner's group, though Prusiner did not conduct any strain work with
those resources.39 One of the prominent researchers in NPU, Hugh Fraser, claims
that "Dickinson sent Stan Prusiner all the strains of scrapie that we had, except agent
87A, because 87A was difficult to handle. In 1987,1 took them over and sent them to
different laboratories throughout all the world, and one person who received more
than anybody else was Stan Prusiner."40 In conclusion, the prion-sceptic community
shares a specific form of social relations, which I would like to call a communitarian
social order.
4.2. Contractual social order of the prion group
By contrast, Prusiner's reliance on short-term grants inclines him to pursue very
different kinds of relations with his colleagues and collaborators. The social order in
Prusiner's group inclines towards a more autocratic way of working. The laboratory
structure is based on the expertise system. Prusiner's early collaboration with the
RML is illuminating in this respect, in that he did not become absorbed into their
programme, but rather used the RML simply as a place to carry out bioassays, i.e. as
in effect a measuring instrument for the biochemical experiments he conducted in
UCSF. Short-term contract funding has also reinforced this system of short-term
collaboration, in that Prusiner not only tends to design his experiments around
clearly specified technical questions and specific technical procedures, but also tends
to bring in already-trained specialist collaborators (post-docs or established
researchers) on contractual terms to provide the skills that he lacks. In this context,
moreover, research instruments are used for highly specific purposes. Consequently,
not every member of the team is allowed open access to all of the equipment. Each
38 Fraser, Hugh, Jean Manson, et at (1999) 'Transcription of oral hearings: day 23', The BSE
Inquiry (11th June 1998: http://www.bse.org.uk/evidence/trans/transcripts.htm): 21
39 Dickinson, A. G. and G. W. Outram (1988) 'Genetics aspects of unconventional virus
infections: the basis of the virino hypothesis', Greg Bock and Joan Marsh (eds) Novel Infectious
Agents and the Central Nervous System 13 (Chichester: John Wiley & Sons): 88
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expert only deals with their own esoteric instruments, so sometimes one worker in
the group may not understand how to operate another's experimental instruments.
This fact could be useful in understanding the culture of contractual expertise that
operated in Prusiner's laboratory. While any sudden drop in the number of members
from Dickinson's NPU is rarely observed, because of the nature of the co-operative
procedure of the experimental system, in Prusiner's group there are numerous cases
of discharge from the laboratory such as Michael Bolton, Paul Bendheim, Frank
Masiarz, Karen Hsiao, MichaelMcKinley, and so on. This is because most researchers
were post-doctoral fellows on two-year contracts, so after expiry of their contract
period, researchers had to find other professional posts. However, Michael
McKinley's case gives us an interesting clue for understanding their social order; he
was a second-in-command in the lab for ten years, and co-editor of a volume about
prions with Prusiner.41 Prusiner's close collaborator, Stephen DeArmond, stated that
McKinley was loyal to Prusiner's ideas, and made an immense contribution to
development of prion theory. However, in 1991, all of sudden, McKinley dropped
out of this field. McKinley was an expert in electron microscope research. But,
around 1990, Prusiner's overall project shifted from basic biochemical research to
biotechnological projects including transgenic experiments. This being so,
McKinley's specialty suddenly became less significant, whereas the role of
newcomers such as Mike Scott and Karen Hsiao, who were specialists in advanced
biotechnology became influential. According to DeArmond:
I had long talks with Stan about that, because I didn't understand it at first. Because
McKinley was very loyal, had done a lot of things. Stan's argument about that was that
McKinley had not progressed. He was still stuck at a very basic level of doing electron
microscopy and some very basic preparations, but wasn't contributing new ideas, and
was costing us a small fortune [...] At least that is what Stan tells me.42
Another notable feature of Prusiner's style of research is the quite marked division
of labour and expertise among the collaborating scientists. The laboratory in San
40 Fraser, Hugh (1999) Interview with author (30 June 1999: NPU, Edinburgh)
41 Prusiner, S.B., M. McKinley (1987) Prions: Novel infectious pathogens causing scrapie and
Creutzfeldt-Jacob disease (New York: Academic Press)
42 DeArmond, Stephen (2000) op. cit. note 28
239
Moiecularising prion disease
Francisco consisted of several sub-groups, all highly specialised in their own subjects,
and each with their own specific ways of solving research problems, depending on
their specialties. Again, DeArmond states on this issue:
Let me tell you that the four of us are really the centre of all of the projects. Stan
[Prusiner], Fred [Cohen], Mike [Scott] and me, attend nearly all of the meetings, and I
have been with the projects the longest, and we really discuss everything that is going
on. Each one of us has our own direction that we are an expert in. It is like a soccer
team or anything, each one of us are specialised. The whole team is working together to
get goals, but each one of us approaches it in a different way, but to get the goal we
have to work together, we are always passing the ball around to each other to set up
for the goal. So, it is essentially that way, it is a true team effort.43
The highly specialised divisions in San Francisco are a prominent feature. By
contrast, which the sceptics have their own specialised subdivisions such as
pathology, electron-microscopy, virology and so forth, these divisions are still
flexible enough for members sometimes to move from one division to another.
We also need to understand how the division of labour in Prusiner's laboratory is
coordinated in order to produce coherent research. Prusiner is himself remarkably
inventive in devising experiments and exploiting new methods. And his control of
funds gives him considerable power to ensure that other scientists carry these
experiments through for him.
Social relations within Prusiner's laboratory, and between Prusiner and his
collaborators, are thus not communal or mutualistic, but rather are contractual. They
are about an exchange of money for skills, conducted between atomistic individuals
each pursuing their individual interests. This reinforces the tendency towards a
specialist division of labour. It also reinforces competitions between even
collaborators. There are several sources of evidence for the individualistic
disposition. First, while the British scientists share their basic resources with other
groups in the world, Prusiner's group regards even current collaborators as potential
competitors. This can be summed up in a word, co-opetition, that is basically a




Prusiner's collaborators in UCSF, Fred Cohen, is used in the Bay area.44 This implies
that the practitioners always keep in their mind that their collaborators can be
possible competitors in the field. Consequently, even though they have a
collaboration, they maintain a high degree of secrecy and privacy. This attitude is
observed in the case of the collaboration with Leroy Hood's group in California
Institute of Technology (Caltech). When Prusiner was collaborating with Hood's
team in Caltech for sequencing the protein chains in the early 1980s, one of his
postdoctoral researchers, Michael Bolton, wanted to move to Hood's laboratory for
the sequencing project. However, Prusiner did not want him to move, because
Prusiner thought that there could be possible competition between the Prusiner and
Hood teams in the future. Bolton says in interview:
Within Stan's laboratory, I always felt that information was shared very readily. At
least in the first few years. In the last year, I began to feel there was some secrecy
ongoing. And that is maybe one of the reasons that I left. One of the things that I was
most interested in was working on the sequencing of PrP. I went with Stan down to
Caltech to meet with Leroy Hood, to work on the collaboration. When we came back, I
said this would be a good thing for me to do, I'd like to go down there and work on
that. He was not enthusiastic about my idea, and it turned out he sent his technician,
Darlene [Groth] to do this. And that didn't please me because I felt that was something
I really wanted to work on. He said no, you shouldn't do that, Leroy Hood has a very
competitive lab or something, you wouldn't do well down there -1 don't know what it
was. But anyway, he discouraged that.45
Even within Prusiner's laboratory the flow of information was controlled by the
senior level. As mentioned before, Prusiner's team in San Francisco consisted of four
different subgroups which worked together in long-term collaboration: Prusiner's
team in the Institute for Neurodegenerative Disease (IND); DeArmond's team in the
neuropathology department; Cohen's group in the department of cellular and
molecular pharmacology; and Scott's team in the neurology department.46 Most
44 Cohen, Fred (2000) Interview with author (22 August 2000: UCSF, San Francisco)
45 Bolton, David (2000a) Interview with author (31 July 2000: IBR, New York)
46 Currently the collaboration at UCSF has been expanded, so more senior members are
involved in the whole research project. For instance, computational structural studies (Dr.
Fred E. Cohen), neuropathology (Dr. Stephen J. DeArmond), x-ray crystallography (Dr.
Robert Fletterick; Biochemistry & Biophysics Department), NMR spectroscopy (Dr. Thomas
James), cell-free synthesis (Dr. Vishwanath Lingappa; Physiology Department). [See the main
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important issues and the agenda of the project were discussed in meetings of the
senior scientists, and on some occasions, information was kept confidential.
According to Bolton, when Prusiner launched his collaborative work with Charles
Weissmann for finding the prion gene, the result of the collaboration was kept secret
for a while. Bolton states, "that collaboration started a year or so earlier when Bruno
Oesch came from Zurich to the lab [...] When they went back, and this is part of the
information that was being kept very secret, so even though this was a collaboration
betweenWeissmann's lab and Stan's lab, there were some of us in the lab that didn't
know what was going on. We sort of knew, but we weren't privy to the results."47
Moreover, the relationship of collaboration could be very fragile. Around the
early 1990s, the Prusiner-Weissmann collaborative team produced impressive results
showing that the PrP gene knockout mice do not have susceptibility to scrapie. After
that there were some uncomfortable arguments between Prusiner and Weissmann,
because Weissmann claimed the patent of the knockout mice. Here, DeArmond
describes the situation:
Charles [Weissmann] was getting over $100,000 a year to do work in collaboration.
Which was why it was such a problem when Charles Weissmann wanted to patent the
knockout mouse. That was a project that was beginning here. And Stan said he needed
to have one of his fellows have a project. So, Stan said, OK, go ahead and do it. And as
soon as he does that, he wants to patent the knockout mouse without even
acknowledging Stan, and then he started publishing papers on his own.48
The issue of patenting has become increasingly significant in science,
particularity in relation to the growth of the biotechnology industry. As Dorothy
Nelkin and Lori Andrews point out, biomedical science is the field of the "genetic
gold rush". The researchers associated with biotech companies are receiving
enormous benefits. According to Nelkin and Andrews, the Genetic Engineering News
homepage of the Institute for Neurodegenerative Disease (IND);
www.som.ucsf.edu/orus/ind]
47 Bolton, David (2000a) op. cit. note 45
48 DeArmond, Stephen (2000) op. cit. note 28. The patent of the PrP knockout mice is owned
by Charles Weissmann and his colleagues in Zurich. [US patent number: 5698763: 'Transgenic
animals lacking prion proteins', US Patent and Trademark Office Chttp://www.uspto.govVl
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now publishes a list each year of "molecular millionaires".49 The patentship is a good
indication of the degree of individual ownership. A count of the number of patents
the scrapie researchers have registered, the distinctive patterns that characterise the
prion group and the sceptics.
Table 1. Number of patents50
□ Number of Patents
As can be seen in Table 1, according to the patent database of the UK Patent
Office, Prusiner owns the highest number of patents, 135 in all, while prominent
sceptics such as Dickinson, Bruce, Kimberlin, and Carp do not hold any patents.
Furthermore, Prusiner's collaborators hold more patents (e.g. Cohen (51) and
Weissmann (45)) than do other sceptics (e.g. Manuelidis (13) and Caughey (9)). From
these records, it is evident that the prion sceptics are not productive in the
commercial sense, whereas the prion group is active in commercialising their
experimental achievements. I would suggest that the sceptics' lack of patents may
reflect their patterns of ownership more generally. As discussed above, the sceptics,
particularly those at NPU, discouraged individual ownership of the knowledge
products. This might have resulted in the lack of patents. Conversely, it is precisely
individual ownership that promotes the taking out of patents, as it apparent in
Prusiner's laboratory. The tension between Prusiner and Weissmann resulted from
this context. Of course, differences in numbers of patents might reflect different
49 Andrews, Lori, Dorothy Nelkin (2001) Body Bazaar: the market for human tissue in the
biotechnology age (New York: Crown Publishers): 46
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institutional policies (which I have not investigated), but they seem also to reflect the
informal culture of two different communities.
These examples show the underlying moral order in Prusiner's laboratory with
regard to ownership. What leads the two groups of researchers to take such different
attitudes towards the ownership of intellectual properties? On the one hand, the
Edinburgh scientists tend to have a sense of communal ownership of the products of
their experiments. On the other hand, Prusiner's group competes with other groups
of scientists, even when they are collaborators. In the wider context, such different
attitudes can be accounted for by two factors. Firstly, as mentioned briefly, the
different culture of the funding system probably led them to have different attitudes.
The American funding system encourages individual competition for research
money. Once you succeed in getting grants from NIH, then your research
achievements can be directly commercialised by patenting. By contrast, long-term
government funding of institutes tends not to encourage such individual enterprise.
Rather, funds go to the department or institute. As a result, a communal spirit is
more likely to be fostered in such institutions. This difference cannot be generalised,
but in this context, the two groups show totally different attitudes to the ownership
of their knowledge products. Secondly, as will be discussed later, the
commercialisation of biomedicine also encourages an individualistic way of research.
Leon Rosenberg, the dean of the Yale University School of Medicine, says,
"biotechnology has moved us, literally or figuratively, from the classroom to the
boardroom and from the New England Journal to Wall Street Journal."51 The
commercialisation of life sciences promotes the individual researcher as can be seen
in the case of the prion group.
The specific social relations to be found in Prusiner's laboratory thus encourage a
high degree of secrecy and privacy, the pursuit of private gain through patents, and
individual willingness to end the relationship when their partners are no longer
useful to them. What ties the whole thing together is Prusiner's central role as
dispenser of funds, employer and director of researchers. In this context, I would
50 The data are surveyed from the patent database of the UK Patent Office
[www.patent.gov.uk] and the European Patent Office [www.european-patent-office.org]
51 Andrews, Lori, Dorothy Nelkin (2001) op. cit. note 49:46
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suggest that Prusiner's laboratory can be characterised in terms of a contractural
form ofsocial relations.
The material and social relations that exist in the two laboratories are thus bound
up with the kind of knowledge or other scientific products the two groups produce.
Thus, the publicly-funded mutualist communitarian prion sceptics are interested
primarily in producing knowledge of a group of diseases of purportedly social and
economic significance. Prusiner and his collaborators on the other hand are
interested in producing not just knowledge, but also techniques and material
products that can be owned and exchanged or sold for personal gain - including
cutting-edge technical skills, but also patentable processes, mice, genes and so forth.
5. Different directions for persuasion
Since the prion controversy began around 1982, the contenders have attempted to
occupy the dominant position by persuading fellow researchers in the immediate
research community and the wider public. Both parties have developed distinctive
strategies of persuasion which, notably, are oriented in opposite directions. In the
case of the prion group, their direction of persuasion is mainly oriented towards
those outside their immediate research community - in particular, those we might
call "disciplinary neighbours".52 Sometimes this specific tendency is attributed to
personal disposition; for example, many people commented that the leader of the
group, Stan Prusiner, is very outgoing. It is not merely a matter of personality,
however. Rather it is an outcome of the strategy the group has used. On the other
hand, Dickinson and his allies tend to concentrate on persuading those inside the
scrapie research community.
This difference in persuasive orientation is closely related to the social and
economic conditions of the two groups. As we have seen, the prion sceptics are a
stable group with relatively long-term stable government funds. In this situation,
they can establish their own long-term projects, and rarely need to look outside for
support, for assistance or indeed for approval or criticism of their work. On the other
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hand, the prion group relies on short-term grants from government agencies and
private funding sources. This situation forces them to continuously take on new
people, enter into new collaborations, and endeavour to raise funds for the next
round of research. Whereas the prion sceptics are largely self-sufficient, Prusiner has
to wheel and deals make and fulfill contractual promises, self-promote and so on. In
this context, persuasion is an important part of simply keeping his research
enterprise going. Whereas the prion sceptics negotiate a common set of aims and
values among themselves, Prusiner is continuously having to convince funding
bodies to fund him and potential collaborators to join him. In this sense, Prusiner has
to sell his project, not least to other scientists.
In the following section, I will explore these distinct patterns of persuasive
practice in more detail.
5.1. Prion sceptics: orientation towards the immediate community
It is notable that most prominent prion-sceptcal scrapie researchers are quite
rigorously critical of each other. Even within particular research groups, criticisms
and struggles are common. One of the prominent scrapie researchers in the pre-prion
era, Gordon Hunter, explains why this is so:
It is partly the nature of the beast: if you set up a large experiment and then have to
wait six or eight months or even longer for disease to appear, it is not conducive to a
calm life if halfway through this period you realise on reflection that there has been a
fault in the experimental design. This is combined with the excitement generated by the
realisation that you are working right on the frontiers of knowledge in a field
important to medicine, agriculture, and basic science. You have all the ingredients for
the development of any extreme quirks of temperament.53
The leader of the NPU group, Alan Dickinson, is a typical example. According to
Hunter, Dickinson has been described as the conscience of scrapie research, and
certainly he was conscientious in his sustained criticisms of others' work.54
Sometimes his criticisms of other researchers could be particularly harsh: for
521 use this term to refer to scientists in neighbouring fields, who do not belong to the
immediate community of researchers in scrapie-like diseases.
53 Hunter, Gordon G. (1993) Scrapie and Mad Cow Disease: the smallest and most lethal living
thing (New York: Vantage Press): 108
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instance, in 1964, the meeting organisers from the Agricultural Research Service
(ARS) at Washington were astonished to witness the violent arguments between the
British scrapie workers, including dramatic walk outs and scathing criticism of each
other's work.55
Dickinson's orientation of persuasion has always been toward the insiders of the
community. Members of the group of prion sceptics rarely publish review papers on
the scrapie related diseases for the purpose of introducing the diseases to a wider
public (see Table 2). Rather, opinions are mainly exchanged within the immediate
research community. This may be an effective means of understanding the esoteric
features of the diseases, but it is not so useful for promoting their ideas to a wider
public. Dickinson notes that in the beginning, when scrapie research was just being
set up, the size of the immediate community was very small, but brought together
scientists from various backgrounds with various criteria for approaching the
disease.56 Consequently, an initial aim was to negotiate agreed methods and
standards of research. Criticism within the community should be rigorous in order to
consolidate and refine the collective research project. The intensity of this internal
debate meant they tended to neglect possibilities for persuading those outside the
community. Moreover, with their stable long-term public funds, they do not need to
look outside for support. Meanwhile, the introspective and self-referential debates
within the scrapie community resulted in the development of esoteric terminology,
which outsiders found hard to understand. Even Dickinson's loyal colleague, Moira
Bruce, acknowledges that Dickinson's terminology was a bit obscure. She says, "a lot
of people didn't understand what Dickinson was talking about."57
There is another reason why prion-sceptical scrapie researchers are oriented
towards their own immediate community. Many scrapie researchers who belong to
the sceptics' camp have grown up with the subject. Again, this reflects to social and
economic conditions: the sceptics have stable funding system, and newcomers are
54 Ibid., 98
55 The meeting was held under the heading of scrapie seminar that was sponsored by
Agricultural Research Service (ARS), US Department of Agriculture at Washington between
23rd and 30th January 1964.
56 Dickinson, A, G. (1999) op. cit. note 11: 8
57 Bruce, Moira (1999) op. cit. note 30
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recruited into long-term employment. The majority of researchers have a PhD degree
specifically on the subject of scrapie, and most are educated in the institution in
which they subsequently work. Hugh Fraser, Moira Bruce, Richard Kimberlin, and
Robert Somerville, all did PhDs on scrapie-related research at the Moredun Institute
or IRAD at Compton. This is in sharp contrast to Prusiner's group, who never had
PhD students in their institute, although their laboratory is based on the University
of California. Consequently, from the beginning of their career, the prion sceptics
have been acculturated into sharing the same standards, methods, and interests as
their immediate colleagues.
The pattern of rigorous exchange between insiders is also found in the pattern of
collaborations. One notable characteristic of the prion sceptics is that collaborations
were conducted exclusively between the immediate research groups. The leading
sceptic group at Edinburgh, NPU, had a long history of collaboration with Richard
Carp's group at the Institute of Basic Research (IBR) in New York. The IBR group has
already established and started research on scrapie in the early 1970s. One of the
researchers in IBR, Pat Merz, says, "oh, we always had good collaborations [...] Alan
[Dickinson] used to visit about once a year. Richard Kimberlin would be here about
once a year. There would be a lot of discussion about things that were going on;
helpful ways in directions, scientific directions and interpretations."58 During the
1980s, the predominant collaborative pattern was for scrapie research groups to work
with each other; collaboration with outside groups was quite a rare event. There
were collaborations between NPU and RML (Rocky Mountain Laboratory) at
Montana, IBR and the Yale group led by Laura Manuelidis during the 1980s. Those
collaborations were basically not between scrapie researchers and their disciplinary
neighbours, but between the insiders.
From those examples, we can conclude that the prion sceptics have tended to be
rigorous and exclusive when exchanging and circulating their opinions. They are
relatively detached from their disciplinary neighbours and the general public. Their
rigorous way of reviewing each other's work seemed to play a positive role in
58 Merz, Patricia (2000) op. cit. note 37
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consolidating the newly emerging research network in the early days. However, this
tendency has also resulted in isolation from the general public.
5.2. Prion group: orientation towards the disciplinary neighbours
By sharp contrast, Prusiner and his colleagues exhibit quite different patterns of
persuasion from the sceptics. Where the sceptics tend to be inward looking,
Prusiner's orientation is outward looking. A number of factors can help to explain
this. In part, it may be attributed to his failure to win acceptance from the scrapie
research group - not least because most immediate researchers in the community
thought that his new concept, prion, was premature and deviated from conventional
knowledge. As we have seen in the chapter on the prion controversy, Prusiner was
severely criticised by his immediate colleagues. Prusiner himself remarks on the
situation in the early 1980s: "[when] I introduced the term 'prion', [it] set off a
firestorm. Virologists were generally incredulous and some investigators working on
scrapie and CJD were irate."59
More importantly, his outward-looking tendency is closely bound up with the
social and economic conditions under which he tends to work. As mentioned, his
research has mainly been based on short-term grants. Consequently, he has had
constantly seek funding for new projects. This in turn has meant canvassing support
from other scientists, not least from potential collaborators whose specialist skills
might be valuable in developing further research projects. In this respect, Prusiner
has had to work hard to convince funding bodies and other researchers. In
particular, the nature of his scientific programme has forced him to look for support
from his disciplinary neighbours. He has sought to persuade not just the insiders but
also the disciplinary neighbours.
In this situation, Prusiner is quick to recognise that he needs the support of the
wider scientific community. One of the most effective ways in which he has secured
such support has been by encouraging wide usage of his term, "prion" by publishing
papers and presenting at conferences. Dining the early days of the prion controversy,
Prusiner attended many conferences to give talks about his prion hypothesis, and
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vehemently attempted to spread his idea. Some researchers found his talks to be like
near-religious experiences. Ashley Haase, a former collaborator, says, "they're a
repetition of the notion that the prion is the infectious agent. What happens to people
who have to listen to this stuff is that they come away with the impression that the
slow virus problem has been solved."60 In his publications and presentations, he
creates an "aura of inevitability" around his use of the term "prion". Although his
idea is still controversial in the scientific community, he represents it as if it is already
proved.61 In her interview, Moira Bruce summed up Prusiner's way of presenting his
case as follows:
I think they [Prusiner's group] did a lot of hard work. It was very good work. But
mostly I think it was salesmanship, he is a salesman [...] Have you seen Prusiner's
presentation? I think his talks may be quite impressive to people who know nothing
about him and his work. They are all confusing and his presentation is quite
extraordinary. He has a lot of cartoon characters on his slides. It is silly...never mind.62
This way of presenting his ideas became a major subject of criticism by the
sceptics. One of Prusiner's adversaries, Merz, says, "it is very simple, you can watch
him at a meeting, major meeting. He is an MD, PhD, and he is a neurologist. He is
very outgoing. He makes sure he meets all the editors of all the journals. He makes
sure that he is in touch with whoever is going to be there that is a top-notch person.
[...] 'oh, I've got to tell you about what I did and what I have found, what I am
doing! See how great this is!' That's basically how it happens."63
Another notable aspect of Prusiner's self-promotion among his disciplinary
neighbours is his use of public relations (PR). From the beginning Prusiner decided
that he should run his scientific programmes like a business concern. Particularly
within a short-term contractual funding environment, he realises that self-promotion
59 Prusiner, Stanley (1997) 'Stanley B. Prusiner-autobiography', Nobel e-museum (The Nobel
Foundation: http://www.nobel.se/medicineAaureates/1997/prusiner-autobio.html)
60 Taubes, Gary (1986) "The game of the name is fame. But is it science?', Discover (December
1986):46
61 Prusiner's rhetorical strategy of creating an "aura of inevitability" is discussed in Carol
Reeves' analysis. Although she focuses merely on the rhetorical feature of the prion, it gives
valuable insights. For more details, see Reeves, Carol (2002) 'An orthodox heresy: scientific
rhetoric and the science of prions', Science Communication 24 (1): 98-122
62 Bruce, Moira (1999) op. cit. note 30
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is vital. As DeArmond mentioned, "what he is a genius at, and probably even better
at, is organising. If he were in a US company, he would be the President, and he
would be making more money than anybody else. He would be Bill Gates."64 Early in
his programme, Prusiner hired a PR consultant under the name of laboratory
manager in order to help convince private foundations and the public. Although
nowadays big biotechnology companies and big laboratories routinely have public
relations consultants, at the time it was unusual. Prusiner's unprecendented
innovation provoked suspicion and criticism from many scientists. However, his
sympathisers took the view that if scrapie research costs millions of dollars to move
the project forward, this was the only practical way to raise funds. According to
Bolton, "[the claim that Prusiner hired a PR consultant] is true, but I wouldn't say
that was a bad thing. If you want to look at it that way, Stan [Prusiner] was probably
10 or 15 years ahead of his time, because I would bet a lot of big laboratories now
hire fund-raising consultants. [...] You couldn't research just by writing a NIH grant,
or asking some foundation for 50 or 100,000 dollars. So he just devoted his whole
focus to raising money."65
As well as adopting a business style of management in his scientific programme,
Prusiner also promote his ideas by using the popular mass media. For instance, in
1982, two months before his prion article was published in Science, he announced his
idea in the San Francisco Chronicle. The headline was "Tiny life form found."66
Prusiner remarked in an interview with Gary Taubes that "they put my picture and
prions in the upper left hand corner of the front page on Friday. Reagan was on the
right.. .that kind of thing did more than anything I could ever do. The prion became a
household word among biologists immediately. They didn't even have to read
Science."67
Between 1982 and 1985, his idea was reported by several newspapers from the
New York Times (7 times), and Scientific American (3 times) to the Reader's Digest
("Killer disease from the dawn of time"). While such publicity-seeking roused other
63 Merz, Patricia (2000) op. cit. note 37
64 DeArmond, Stephen (2000) op. cit. note 28
65 Bolton, David (2000a) op. cit. note 27
66 Perlman, David (1982) 'Tiny life form found', San Francisco Chronicle (19 February 1982)
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researchers' antipathy, the prion nonetheless quickly became an accepted word for
referring to the scrapie-like diseases.
Meanwhile, Prusiner has also energetically promoted his ideas within more
specifically academic media. Interestingly, Prusiner has published many more
review articles than his critics have. This strategy has done much to spread his ideas
and concepts to the disciplinary neighbours. Between 1982 and 1989, according to the
Biomed database, Prusiner published 16 review papers, whereas Kimberlin (2),
Dickinson (0), Marsh (0), Carp (2), and Gajdusek (7) published far fewer review
papers. You can see the tendency in the Table 2:
Table 2: Number of Review paper/total paper between 1982 and 198968
Furthermore, Prusiner's group displayed an extroverted tendency in their pattern
of collaboration. As have seen, the prion sceptics show an endogamous pattern of
collaboration. Their communication network is exclusively centred upon their
immediate research community. However, Prusiner's group had collaborations with
disciplinary neighbours such as biochemists (Leroy Hood), molecular biologists
(CharlesWeissmann), Molecular geneticists (George Carlson), protein chemists (Fred
Cohen), and pathologists (Stephen DeArmond). The collaborators are specialists in
subjects that have no intrinsic relationship with the scrapie-like diseases. Indeed,
before Prusiner asked them to collaborate, most of them had little or no knowledge
about the scrapie-like diseases, or at most very basic knowledge on the subject.
67 Taubes, Gary (1986) op. cit. note 60: 33
68 The survey is based on the Biomed database between 1982 and 1989.
[www.biomed.niss.ac.uk]. This specific period is selected, because all the main figures were
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Nonetheless, Prusiner manages to collaborate with those scientists successfully. One
benefit from this collaborative pattern is that Prusiner can recruit new researchers
from outside of the community. As mentioned, Prusiner's laboratory does not have
any PhD students. Instead, he tends to bring in already-trained specialist
collaborators (post-docs or established researchers) on contractual terms to provide
the skills that he lacks. All of the researchers in Prusiner's group are recruited from
different disciplines and academic background. Again, this is closely associated with
the situations in which he is located. Short-term contract funding has underlined
Prusiner's tendency to buy in specific techniques and methods on a short-term basis.
From those different directions for persuasion between the prion group and
prion sceptics, it is interesting to note that the overall map of consensus demonstrates
its different directions for persuasion. As mentioned in the previous chapter, the
prion hypothesis becomes a powerful mainstream view in the scientific community.
This was materialised when Prusiner won the Nobel Prize in 1997. Although we can
say that a great deal of the disciplinary neighbours accepted Prusiner's theory, the
core-set of TSEs researchers remained divided.69 The majority of the core-set of
research community rejected Prusiner's idea. Division of opinion within the core-set
of TSE researchers is still an issue. For instance, at a recent symposium, another
Noble laureate Kurt Wiithrich pointed out that Prusiner's key concept, infectious
prion protein is simply a build-up of garbage.70 Despite the fact that Wuthrich
contributed to the modelling of a three-dimensional structure of prion protein, he is
still critical of the prion theory, arguing that we must understand the function of the
actively involved in the controversy during this period. For instance, Dickinson retired from
the directorship of NPU in 1989.
69
The concept of core-set is first argued by Harry Collins. In his work on gravity waves, he
defines core-set as follows: firstly the core-set of scientists are those who are actively involved
in experimentation or observation. Secondly, they are making contributions to the theory of
the phenomenon or of the experiment. I think the definitions of the core-set provide a good
concept for this divisive phenomenon in the prion controversy. For more detailed, see Collins,
H.M. (1981) 'The place of the core-set in modern science: social contingency with
methodological propriety in science', History ofScience 14: 6-19
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normal prion protein before we can understand prion diseases.71 Interstingly, the
wider acceptance of the prion theory is mainly related to the disciplinary neighbours.
In contrast, the core-set is divided and majority of them rejects his theory.
6. Prusiner joins the molecular biological bandwagon
As we have seen, Prusiner lost the support of the scrapie research community in
the early stage of the prion controversy. Though besieged by sceptics, however, he
escaped the siege by collaborating with scientists outside the scrapie community.
Since then, he has tended to address himself to scientists amongst the disciplinary
neighbours as well as the members of the immediate community. He has been
remarkably successful in attracting potential collaborators who are located outside
the scrapie research community, and he has succeeded in making his work well
known and in convincing many that it is valuable. This has been invaluable in
winning him the widespread support that he and his ideas now enjoy in the scientific
community as a whole.
In remains to ask just why the disciplinary neighbours should in turn have
inclined to the prion theory? I will argue this relates closely to kinds of scientific
products that Prusiner's laboratory produces. More generally, I will suggest that
Prusiner's style of practice is in keeping with the way that many areas of biomedical
science are moving. Molecular biological approaches, in particular, are very closely
linked to commercialisation of modern biomedicine. Many of the people who pursue
this approach are becoming increasingly influential within science - not least because
they are becoming increasingly rich and increasingly closely connected to other
powerful institutions in industry and government. Prusiner has had dealings with
many of those people - hiring or collaborating with them, buying or selling scientific
71
Wiithrich won the Nobel Prize for his development of nuclear magnetic resonance
spectroscopy for determining the three-dimensional structure of biological macromolecules in
solution. Furthermore, around 1996, he applied his NMR technique to reveal the three-
dimensional structure of the prion protein. For a more detailed description of his contribution
to prion research, see Segal, Jerome and Eric Francoeur (forthcoming) 'Visualizing prions:
graphic representations and the biography of prions', Eve Seguin and Carol Reeves (eds)
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products, and so on. Indeed, his own ways of working epitomise the values of this
market-oriented new scientific culture, while his ability to claim if not to prove
fundamental breakthroughs in understanding important diseases serves to vindicate
the whole enterprise.
During the 1980s and 1990s, the so-called molecularisation of biology was
accelerated by the application of various new techniques. Joan Fujimura has
described how with the commitment of one research group after another to the
pursuit of proto-oncogenes in cancer research, molecular biological research became
a bandwagon.72 "Large numbers of people, laboratories, organisations, and resources
became committed to one approach to a problem."73 A crucial element in this
convergence of scientific interests was the availability and adoption of standardised
technologies such as NMR (Nuclear Magnetic Resonance), PCR (Polymerase Chain
Reaction), transgenic technique, and so forth. Indeed, as Steve Sturdy argues,
standardisation was a vital element in the growth of molecularisation more
generally,74 and facilitated the exchange of data, materials, and ideas within what we
might call a "molecular economy".
Prusiner hitched his own scrapie research to the molecular biological bandwagon
in the mid-1980s, when he began to look for the PrP gene. By 1989, when he began to
manufacture transgenic mice, he was a keen proponent of molecular biological
methods. DeArmond suggests that these transgenic experiments played a significant
role in winning the support of other fellow scientists. He comments that with the
transgenic model, Prusiner's group gained momentum.75 Just after reporting
Prusiner's success in transgenic experiments, the New York Times reported that the
Infectious Process, Knowledge, Discourse, and Politics of Prions (San Francisco: University
California Press)
^The molecular bandwagon is proposed with the case of cancer research by Joan Fujimura.
For more details, see Fujimura, Joan H. (1988) 'The molecular biological bandwagon in cancer
research: where social worlds meet7, Social Problems 35 (3): 361-283; Fujimura, Joan H. (1996)
Crafting Science: a sociohistory of the quest for the genetics of cancer (Cambridge, Mass: Harvard
University Press)
73 Fujimura, Joan H. (1996) op. cit. note 72:2
74 Sturdy, Steve (1998) 'Reflections: molecularisation, standardization, and the history of
science', Soraya de Chadarevian and Harmke Kamminga (edsj Molecularising Biology and




once heretical theory had now gained huge credibility within the scientific
community.76 This view is borne out by useful study how use of the term prion
proliferated in the scientific community. Carol Reeves identifies three different
groups of scientists; (1) "exposed & infected" users, who agree with Prusiner and
employ the term almost as aggressively as did Prusiner; (2) "exposed carriers", who
remain uncertain or sceptical but employ the term; (3) "exposed & uninfected" users,
who disagree with the prion idea and avoid using the term. According to Reeves'
survey, there was a gradual increase in usage of the prion terminology.77
'i r — "i rm VV n-*™
1982 1984 1986 1988 1990 1992
Table 3: Use of the term "prion" between 1982 and 1992
Note: Exposed, carriers = those who employ prion terms but are sceptical of prion
theory; exposed, uninfected = disagree with prion theory and avoid prion language;
exposed, infected = agree with prion theory an employ prion (Prusiner not author)78
However, as we can see in the Table 3, between 1990 and 1992 there was a
remarkable increase of aggressive usage of prion. Between 1990 and 1992, the
number of infected users increased remarkably. This coincides with the publication
of the results of transgenic experiments on scrapie and other prion diseases that
Prusiner and his team conducted between 1989 and 1992. In fact, before the
transgenic experiment, Prusiner's position in the scientific community was still
defensive, and many regarded his theory as heretical. By 1992, however, the whole
map of the controversy had been changed, and the general mood of the disciplinary
75 DeArmond, Stephen (2000) op. cit. note 28
76 Blakeslee, Sandra (1991) 'Heretic theory on brain diseases gains new ground', New York
Times (8 October, 1991): C12




neighbours has come down on the side of prion theory. As such the transgenic
technology played a pivotal role in persuading the disciplinary neighbours.
We can point to several reasons why Prusiner's participation in the molecular
bandwagon won him the support of his disciplinary neighbours. In the first place, his
use of transgenic mice aligned his scrapie investigations with what were widely seen
to be cutting-edge developments in other areas of biomedicine. Prusiner's adoption
of this new molecular biological technique, and its application to the elucidation of a
puzzling but important family of diseases - hitherto called the unconventional slow
viruses - helped to vindicate the investment that had been made in molecular
biology by scientists from a wide range of biomedical disciplines. Consequently,
many enthusiastic partisans of molecular biological and specially transgenic
techniques as standardised research tools in bioscience were among those who
praised Prusiner's transgenic mouse work.79
Conversely, scientists working in other fields such as Alzheimer's disease now
attempted to apply Prusiner's idea about protein folding to their own research.80 In
part, this was presumably because Prusiner's innovative use of exciting new
molecular biological techniques appeared to offer a possible way out of the
stagnating programme of research into unconventional slow viruses and other
supposedly similar neurodegenerative disorders. In part, too, the attractions of
Prusiner's transgenic method seems to have been due to the possibility that it might
open the way to a possible pharmaceutical solution for these diseases. It engaged
directly with the interests of the pharmaceutical and commercial companies.
Although supposed prion diseases are generally rare in humans, the pharmaceutical
issue became more significant when the disease in sheep was shown to transmit into
cattle in Britain. The outbreak of BSE (Bovine Spongiform Encephalopathy) alarmed
scientists. The scientific community urgently needed to produce effective means of
79 Sofroniew, M. V. and K. Staley (1991) 'Transgenic modelling of neurodegenerative events
gathers momentum', Trends in Neuroscience 14(12): 513-4; Hardy, J. (1991) 'Prion dimers: a
deadly duo?', Trends in Neuroscience 14(10): 423-4.
80 For example, there is a review paper concerning the search for a possible link between prion
and the Alzheimer's [Price, D. L., D. R. Borchelt, et al. (1993) 'Alzheimer disease and the
prion disorders amyloid beta-protein and prion protein amyloidoses', PNAS 90 (14): 6381-4];
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intervening in this epidemic. Prusiner's experimental results with transgenic mice
presaged a way to satisfy such demands by suggesting the possible development of
molecular biological techniques of diagnosis and treatment. The pharmaceutical and
biotechnology industries now came to see that their interests were involved. Since
then, researchers in the prion group have rushed to set up commercial biotechnology
companies to sell new methods of diagnosis and possible clinical solution by using
their biotechnology. For instance, at least 35 laboratories are currently searching for
commercial diagnostic and clinical possibilities in this field.81 In particular, in 1997
some of Charles Weissmann's researchers have established a biotechnological
company called "Prionics Inc." They have already commercialised two diagnostic
methods: Prionics®-Check WESTERN and Prionics®-Check LIA. 82 Moreover,
Prusiner's team attempted the first pharmacotherapeutic treatment of CJD in
humans, although it was not successful.83 The prion group's adoption standard
biotechnological methods thus met the needs and expectations of wider groups of
disciplinary neighbours, including the biotech industry. As a result, it played a role
in strengthening the prion research group.
The sceptics, on the other hand, especially the Edinburgh researchers, continued
to focus on classical genetic and pathological techniques such as measuring
incubation period and pathological change. These techniques were calculated to
engage the attention of the immediate scientific community, and played a part in
building consensus during the 1960s and 1970s. However, once the molecularisation
of biology came into play, such techniques were no longer fashionable and less likely
to be the object of attention by the disciplinary neighbours. Sometimes, the lack of a
there is also a journalistic review on the prospects of protein studies, see Taubes, Gary (1996)
'Misfolding the way to disease', Science 271 (15 March 1996): 1493-1495.
81 The official mad cow disease home page (http://www.mad-cow.org)
82 The Prionics was established by one of Charles Weissmann's researchers, Bruno Oesch, at
Zurich. For more information, see the website of Prionics Inc., http://www.prionics.ch
83 This is the famous case of Rachel Fober who was a victim of new variant CJD, and who
went to San Francisco for clinical treatment led by Prusiner and Korth. It had some success
but the victim finally died later. Dealler, Stephen (2001) 'At long last, signs of a BSE
breakthrough', Guardian (5th September 2001); Brockes, Emma (2002) 'To the last breath',
Guardian (15th January 2001); Korth, C., B.C.H. May, F.E. Cohen, S.B. Prusiner (2001)




molecular approach in the NPU was seriously considered by the members of the
institute, and some attempted to recruit new molecular biologists. Before 1986, the
NPU did not pursue any project using a biochemical and molecular biological
approach. When Prusiner and his collaborative team produced significant
experimental data on protein sequencing and found the prion gene in 1985, the NPU
still did not respond. Even when they began to recognise a need for biochemical
expertise, moreover they tended to think of it in classical genetic rather than
molecular biological terms, as a statement from one of the NPU members reveals:
Mr. Walker: [...] It may be that you can help on this question as well. If the biochemist
had been in place earlier, would additional projects have been possible? [...]
Dr. Hope: [...] Yes, certainly if we had had Nora's [Hunter who is a biochemist in
NPU] expertise at the beginning of 1985,1 think we would have been able to initiate the
genetic linkage studies earlier.84
As a matter of fact, the leaders in the institute - Dickinson, Fraser, and Kimberlin -
did not believe in the efficiency and reliability of the molecular biological approach.
Because of their experience of biophysical research conducted at Compton during the
1960s, they were inclined to think that the molecular approach was a waste of
resources.
7. Linkage of prion to social network
For twenty years, the opposed scientific programmes of the prion advocates and
prion sceptics have competed and conflicted. However, equipoise in the controversy
has gradually broken down, and the specialist programme of the prion group has
gained the upper hand. This does not mean that the Prusiner's programme has an
innate superiority. As seen, the two factions produced many valuable experimental
data, but they failed to reach an agreement. Moreover, the prion controversy cannot
be said to have reached closure. Rather, the voices of the prion sceptics, though
insistent simply attract less attention than hitherto. Consequently, there is no point in
attempting to explain this shift in opinion by pointing to some definitive piece of
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empirical research or theoretical insight that resolved all the various points of
disagreement between the two parties. Rather, we must look at the shifting networks
of interconnected scientific interests that have determined the credibility of one or
other group within the wider scientific community and beyond.
During the 1970s, the generalist biological approach was the dominant in scrapie
research. It was successful in part because the small size of the research community
enabled a handful of researchers in the early 1960s to establish a coherent agenda for
collaborative research into the diseases. Thus, the primary task at the time was
consolidation of the research network rather than expansion of the community.
Based on generally accepted genetic and pathological methodologies, the generalist
programme of Dickinson's group became a mainstream of the scrapie research
community. Meanwhile, the failure of biochemical and biophysical work on scrapie
shaped a general feeling of frustration with such approaches. As a result, in so far as
the wider scientific community took an interest in scrapie research, it tended to
regard the pathogenic studies of Edinburgh as definitive. Moreover, as we have seen,
the continuity of the Edinburgh approach was underwritten by a degree of constancy
of funding and job security that survived a series of reforms in the UK system of
government research funding in the early 1970s.85
By the mid-1980s, this kind of stable research funding, and the long-term
collaborative research programmes that it made possible, were becoming less and
less the norm, even within the British system of research council funding. At NPU,
the imposition of greater managerial controls over government scientists, and
pressure for more commercially relevant lines of research, led Dickinson to resign in
1987, over fears that the autonomy of his unit was under threat.86 Genetically
oriented research on scrapie and BSE continued under Moira Bruce and others, but it
84 Fraser, Hugh, Jean Manson, James Hope, Nora Hunter & Moira Bruce (1999)
'Transcription of oral hearings: day 23', The BSE Inquiry (11 June 1998: The BSE Inquiry): 39
85 See chapter 5, 'how controversy ends' and Wright, Susan (1994) op. cit. note 1




was increasingly integrated into a wider programme of research on animal diseases
that tended to favour biochemical and molecular biological approaches.87
Meanwhile, in the US, government science policy was changing even more
markedly in favour of the commercialisation of biomedicine. In 1980, the American
Congress passed a law that university or federal research achievements, supported
by federal funds, could be profited from personally.88 The government thus changed
their basic idea on public ownership of scientific research. After that, the
commercialisation of the life science has accelerated. Commercial molecular biology
was at the forefront of this process. The first biotechnology company, Cetus, had
been established in 1975, and as early as 1978, the Boston Globe published a headline,
"Clone business: ifs growing fast. It's growing fast."89 Interestingly, one of Prusiner's
key collaborators, Charles Weissmann, is a frontrunner in the commercialisation of
molecular biology. He was a founding member of the first biotech company in
Europe, Biogen, in the late 1970s.90 Another collaborator, Leroy Hood, also established
a biotech company, the Institute for Systems Biology, in 1999.
Prusiner's market oriented and contractual style of practice thus corresponds
closely to the kind of scientific activity favoured by policy makers and that is seen to
87 Jim Hope, who is a biochemist in NPU, became an acting director after the resignation of
Alan Dickinson and Richard Kimberlin in 1988. Despite considerable efforts to find a new
head of unit, no appointment was made. Finally, the head of the division of molecular
biology in the Institute of Animal Health (LAH), Chris Bostock, who had been increasingly
involved in developing the research strategy at the NPU, took overall charge of the unit in
1991. [Institute of Animal Health (1998) 'Research on transmissible spongiform
encephalopathies, 1986-1998: an overview7, The BSE Inquiry: statement 105 (The BSE Inquiry:
www.bse.org.uk/files/ws/sl05.pdf): 3-4]. As a matter of fact, the NPU was set up for the
purpose of unified research on the scrapie-like diseases in animals and humans. However, in
the late 1980s, there was a huge demand to set up a new research institute for molecular
biological research on the diseases, thus another unified research institute was established
including NPU. This confusion and transformation of research strategy in the unit implies
that the old autonomous non-standardised research came to an end, and the new
biotechnological package was embraced and applied.
88 The laws are the Bayh-Dole Act, and the Stevenson-Wydler Act in 1980, and the Federal
Technology Transfer Act in 1986. For more detailed explanations about the context, see
Andrews, Lori, Dorothy Nelkin (2001) op. cit. note 49: chapter 3 on the genetic gold rush.
89 Boston Globe (1978) 'Clone business: it's growing fast. It's growing fast', Boston Globe (25th
June 1978): 1
90 Weissmann established the biotech company with two businessmen, Dan Adams, and Ray
Schafer, and nine scientists including Walter Gilbert (Harvard) and Kenneth Murray
(Edinburgh). [Wright, Susan (1994) op. cit. note 1: 87]
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support some of the most commercially exciting developments in modern
biomedicine. In a context of molecularisation, which includes commercialisation and
standardisation of biomedical techniques increasingly large sections of the scientific
community tend to inhabit and favour much the same kind of socio-economic
circumstances as Prusiner inhabits - a world of short-term contracts, deals and
patents etc. Meanwhile, though the prion sceptics might be doing worthy work, they
are largely isolated from this new scientific culture. It is for this reason that their
generalist biological programme has become less convincing and less interesting
than the specialist molecular programme pursued by Prusiner. Prusiner's triumph in
the prion controversy is ultimately due not to any inherent superiority of his theories
or data, but to the peculiar scientific culture that tends to favour his entire way of
doing science over that of his opponents.
8. Conclusion
In this chapter, I have sought to answer the two major questions about the prion
controversy; how the controversy between the prion group and its sceptics was
sustained for twenty years, and why the prion group has latterly gained much wider
support from the scientific community. I have argued that the two factions of
scientists pursued quite distinct styles of research programme. The fundamental
difference between the prion group and prion sceptics derived from their divergent
research priorities and methodologies, which I have characterised in terms of a
generalist biological programme on the one hand and a specialist biochemist
programme on the other hand. The prion sceptics adopted the former style, and the
prion group adopted the latter. These divergent styles in turn embodied different
aims, methodologies and experimental systems of research.
For the purpose of elucidating why such divergent programmes have been
maintained, I have looked in particular at the material and social conditions of the
two factions of scientists. These differ quite strikingly. Differences in funding system,
especially, have played a significant role in sustaining the divergent programmes. On
the one hand, the prion sceptics are generally working in secure posts in long-term
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government-funded institutions. In these circumstances, they have been able to
conduct long-term genetics-based biological research into the scrapie-like diseases.
On the other hand, the prion group is located in a totally different situation: their
projects are largely dependant on short-term grants, which tends to encourage the
pursuit of more narrowly defined and self-contained research. This sharp difference
in material condition can elucidate why the sceptics have tended to focus on a
general understanding of the disease, whereas the prion group focuses specifically
on the structure of the agent. Under the short-term grant system, it is not possible to
launch a long-term biological project.
Furthermore, the two factions have sharp contrasts with regard to social order.
For conducting their long-term general biological experiments, the sceptics
developed what can be characterised as communitarian social relations. Their
programme requires each participant to possess a general understanding of the
whole process of their experiment, in order to conduct effective co-operative work
with colleagues. These social relations are apparent in the degree of access to
instruments of production and in the communal ownership of the products of
research. By contrast, the prion group exhibits quite different social relations. The
short-term competitive funding system leads them to maintain an individualistic and
contractual social order. In this social order, advancement is a consequence of
individual productivity. Consequently, the whole social structure of the laboratory is
based on individual expertise; not every member is allowed to access to all of the
experimental instruments, and the products of research also belong to individual
researchers. This system encourages competition between researchers, and
contractual relationship between collaborators.
Within those divergent material and social circumstances, the two factions of
researchers maintained their own research programmes during the twenty-year
controversy. Likewise, Prusiner's ultimate success in this controversy can be
elucidated in terms of wider social and economical changes in biomedicine. The
prion group conforms more closely than the prion sceptics to the way that many
areas of biomedical science are changing. In particular, modern biomedicine tends
increasingly towards commericalisation and standardisation, including individual
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competitions, short-term contracts, and the use of standardised tools for research.
This large-scale shift in biomedicine is often defined in terms of "molecularisation".
The prion group is located at the forefront of shift, whereas the sceptics are largely
isolated from it. Prusiner's programme is intimately linked into the wider social
networks that are influential in determining how scientific funds and credit are
distributed. The dominance of his prion theory is thus a consequence of the social
and cultural position he occupies, and his ability, as a scientist, to fulfil the
expectations that such a position brings with it.
264
Conclusion
Chapter 10 - Conclusion
At the start of this thesis, I set out to address two questions. Firstly, how scrapie
researchers defined and redefined the mysterious disease from the 1960s when the
first full-scale laboratory studies set up to the 1990s, when it came to be widely
regarded as the exemplar of a prion disease. Secondly, I raised the question of the
relationship between scrapie research and wider scientific and social developments.
In this chapter, I pull together various threads of the discussion from the previous
chapters.
1. How scientists defined and redefined the nature of scrapie?
This work began its analysis of early scrapie research between 1750 and 1960,
with a brief discussion of the wider socio-economic context and the emergence of
veterinary science in Britain (chapter 2). With this wider analysis as background, it
described the foundation and development of scrapie research from observations by
the gentry to the establishment of modern veterinary investigation in the twentieth
century. During the 1940s and 1950s, scrapie research was mainly conducted in the
Moredun research institute at Edinburgh. Then, in the 1950s, the ARC decided to set
up new research programmes on scrapie in Edinburgh and Compton, England. With
this institutionalisation of research on scrapie, knowledge of the disease was
transformed: from being a local matter, embodied in the crafts and practices of local
farmers and shepherds, it now came to be defined in the universalistic terms of
laboratory science.
The first large-scale programmes of research into scrapie were conducted in
Edinburgh in collaboration between the Moredun Institute and Animal Breeding
Research Organisation (ABRO), and by the scrapie research group in the Institute for
Research on Animal Diseases (IRAD) in Compton. During the 1960s, these two teams
conducted various laboratory experiments that led them to put forward opposing
speculations on the nature of the infectious agent at the end of the 1960s. These
conflicting views caused disputes in the small scrapie research community. In
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chapters 3 and 4, I described in detail the procedures of various experiments
conducted in Edinburgh and Compton. Those conducted at the Moredun-ABRO unit
were led by a geneticist, Alan Dickinson, who launched a full-scale genetic-
pathological project to clarify the mechanisms of replication and pathogenesis. Over
around 15 years, this genetic and pathological work revealed many notable
characteristics of the agent. In particular, the researchers showed specific interactions
to take place between the strain of the agent and the host genotype. They suggested
that the mechanism of infection was quite different from conventional viruses, and
argued that it should be attributed to a new type of infectious agent, a virino.
The Compton team drew a quite different picture (chapter 4). During the 1960s,
several research groups in IRAD sought to characterise the agent by using
conventional biochemical methods. However, they were not successful. In this
context, David Haig and Tikvah Alper launched a new project to estimate the
molecular size and weight of the agent using radiobiological methods. They found
not only that the agent was very small, but also that it was resistant to UV irradiation.
On the basis of these results, they speculated that the replication of the agent might
occur without involving nucleic acids, by locating the scrapie agent in a self-
replicating plasma membrane. This met with considerable criticism, because the
conclusions implied deviation from the conventional wisdom of biology, the "central
dogma". Furthermore, the conclusion of the work was also at variance with what
Dickinson's group in Edinburgh had shown, namely, strain variation of the agent.
The two ideas were the subject of controversy during the 1970s, and no consensus
was reached. The dispute between the two groups intensified, and they failed to find
a common ground from which to consider their respective findings.
The confrontation was not only centred on divergent experimental results, but
was also exacerbated by competitive relations between the two research groups.
Moreover, the highly individualised and competitive character of work at IRAD,
which encouraged the researchers to make bold claims, was at odds with the more
collaborative work at the Moredun-ABRO unit, which led the researchers to make
more cautious speculations based on a wider range of biological considerations. The
controversy ended with the dramatic intervention of the ARC, an administrative and
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funding body, which sided with the Edinburgh researchers and terminated the
scrapie programme at Compton.
In the American context, by contrast scrapie research was not major issue in
veterinary science during the 1960s, and 1970s. Although there were some research
groups interested in the disease in its own right, most interest in scrapie derived
from concern with human neurological diseases such as kuru and CJD (chapter 6).
During the 1970s, most researchers in America accepted a loosely defined concept of
scrapie as an "unconventional slow virus", as did the groups of researchers studying
kuru and CJD. This convergence enabled the different groups to forge collegial links
with other scientists and to make claims for the importance of their collective
endeavour. This convergence around the concept of unconventional slow viruses
was followed by a significant degree of methodological convergence, notably around
scrapie as a convenient laboratory model of the whole family of diseases. At the local
level, researchers came increasingly to share standardised methods of purification
and chemical treatments to isolate the putative agent of scrapie.
With this increasing standardisation, a neurologist in University of California,
San Francisco, Stanley Prusiner, set up his own research programme to purify the
agent in the early 1970s (chapter 7). During the early years, Prusiner attempted to
purify the agent by using the centrifugation method, and achieved a partially
purified form of the agent. He also developed a new faster and more economical
bioassay technique with the hamster model of scrapie. This in turn enabled him to
test the effects of a wide range of chemicals on his partially purified scrapie agent in
a very short time, and to produce a considerable amount of biochemical data. On the
basis of those experimental data Prusiner produced a high-profile publication in
Science in 1982 in which he put forward quite striking evidence for the involvement
of protein in scrapie infectivity, and an equally striking failure to find evidence of the
involvement of nucleic acids. This high profile publication also provided him with a
platform from which to suggest that scrapie represents a new category of infectious
agent for which he proposed the name "prion".
Prusiner's suggestion of the prion hypothesis caused a twenty-year controversy
in the scientific community. Many people thought that his idea of prions implied that
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they might be devoid of nucleic acids. This was clearly an unorthodox approach
because it was a violation of the biological principle that biological information must
be encoded in a nucleic acid molecule. The controversy divided the community of
scrapie research into two: the prion group and its sceptics (chapter 8). During the
1980s and 1990s, both factions of scientists produced many interesting experimental
results. However, attempts to discover the nature of the scrapie agent have been
inconclusive, although the weight of opinion amongst scientists has increasingly
come down on the side of Prusiner's prion theory..Over the past twenty years
Prusiner has gained considerable scientific credibility from fellow scientists.
Correspondingly, his opponents, the prion sceptics, who were once the mainstream
in this field, have been marginalized. Nevertheless, the sceptics continue to pursue
their research project to prove their own theory that the scrapie agent contains a
nucleic acid genome-like informational molecule.
2. How social circumstances played a role in defining the nature of
scrapie?
A laboratory is a microcosm of society. Scientific practice in a laboratory cannot
be fully accounted for without acknowledging the various social and cultural
dimensions of scientific activity. As I have shown in chapter 5, the early dispute over
the nature of the infectious agent was sustained in part by the existence of two
distinctive laboratory cultures. Each group of researchers had different goals and
traditions of research. In this context, they failed to find common ground during the
controversy. In this case, two cultural styles were in conflict, and this escalated the
intensity of the controversy between scientists. Throughout the controversy, however
Edinburgh succeeded in producing knowledge that conformed more closely to views
held elsewhere in the scientific community. Eventually, the dispute, which looked as
though it was heading for endless confrontation, was brought to an end in
Edinburgh's favour with the intervention of the ARC, an administrative body.
The case of the prion controversy also shows how different social and
cultural factors played an important role in sustaining divergent scientific
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programmes at least for twenty years (chapter 9). I have argued that the two
factions of scientists pursued quite distinct styles of research programme. The
fundamental difference between the prion group and prion sceptics derived
from their divergent research priorities and methodologies, which I have
characterised in terms of a generalist biological programme on the one hand
and a specialist biochemical/molecular biological programme on the other
hand. Also, I have looked at the material and social conditions under which the two
factions of scientists worked. Differences in funding arrangements, especially, played
a significant role in sustaining the divergent programmes. On the one hand, the
prion sceptics were generally working in secure posts in long-term government-
funded institutions. In these circumstances, they were able to conduct long-term
genetics-based biological research into the scrapie-like diseases. On the other hand,
the prion group operated under quite different circumstances; their projects were
largely dependent on short-term grants, which tend to encourage the pursuit of more
narrowly defined and self-contained research. This sharp difference in material
conditions can help to explain why the sceptics tended to focus on a general
understanding of the disease, whereas the prion group focused specifically on the
structure of the agent. Under the short-term grant system, it was not possible to
launch a long-term biological project.
Furthermore, the two factions show sharp contrasts with regard to their internal
social order. For conducting their long-term general biological experiments, the
sceptics developed what can be characterised as communitarian social relations.
Their programme required each participant to possess a general understanding of
the overall process of their experiments, in order to conduct effective co-operative
work with colleagues. These social relations are apparent in the degree of shared
access to the instruments of production and in the communal ownership of the
products of research. By contrast, the prion group exhibited quite different social
relations. The short-term competitive funding system led them to maintain an
individualistic and contractual social order. In this social order, advancement is a
consequence of individual productivity. Consequently, the whole social structure of
the laboratory is based on individual expertise; not all members are allowed to access
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to all of the experimental instruments, and the products of research also belong to
individual researchers. This system encourages competition between researchers,
and contractual relationship between collaborators.
A few words must be said about why the prion theory has lately come to be
favoured by fellow scientists and public (chapter 9). Prusiner's ultimate success in
this controversy can be elucidated in terms of wider social and economic changes in
biomedicine. The organisation and practice of the prion group conforms more closely
than the prion sceptics to the way that many areas of biomedical science are
changing. In particular, modern biomedicine tends increasingly towards
commericalisation and standardisation, including individual competitions, short-
term contracts, and the use of standardised tools for research. This large-scale shift in
biomedicine is often defined in terms of "molecularisation". The prion group is
located at the forefront of this shift, whereas the sceptics are largely isolated from it.
Prusiner's programme is closely linked into the wider social networks that are
influential in determining how scientific funds and credit are distributed. Therefore,
the dominance of his prion theory can be said to be a consequence of the social and
cultural position he occupies, and his ability, as a scientist, to fulfil the expectations
that such a position brings with it. While Prusiner himself declares of the whole
controversy that "the saga of prions truly represents the triumph of scientific
investigation over prejudice",11 would like to rephrase this to suggest that "the saga
of prions truly represents the triumph of a specialist biochemical/molecular
biological programme over a general biological programme".
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